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This investigation sought to establish new and adaptable methods for incorporating an 
enantiomeric component into NHC ligands and to develop novel precatalyst prototypes 
capable of asymmetric induction for use in transition metal mediated catalysis. This 
thesis details the fulfilment of these objectives through the design, synthesis and 
characterisation of forty‐eight previously unreported compounds including twenty‐six 
new NHC proligands and fourteen NHC complexes.  
 
NHC derivatives of the chiral mono‐terpene camphor are explored in Chapter 2, 
primarily through the synthesis of a series of bornyl‐acetamide linked NHC proligands, 
demonstrating expedient incorporation of an enantiomeric moiety by acetamide 
linkage. Bornyl‐acetamide NHC complexes of Ag(I), Pd(II), Pt(II) and Ru(II) are studied 
and structural elucidation supported by comparison with the Pd(II) and Pt(II) complexes 
of an achiral cyclohexyl‐acetamide analogue (Chapter 3). Chapter 4 introduces metallo‐
NHC proligands derived from imidazo[4,5‐f][1,10]phenanthroline, capable of backbone 
coordination of a ruthenium‐polypyridine component. Alternatively, use of an 
acetamide‐tether provides metallo‐NHC proligands of 5‐acetamido‐1,10‐
phenanthroline and 4‐acetamido,2,2’‐bipyridine (Chapter 5). Also outlined is the 
synthesis of several remarkable hetero‐dinuclear NHC complexes in addition to the 
effective enantiomeric resolution of a metallo‐NHC proligand. 
 
The performance of selected systems in an asymmetric Suzuki coupling is examined in 
Chapter 6. Several of the organic‐NHC ligands elicit comparable activity to reported 
systems, however, product formation is not observed when using an acetamide‐linked 
metallo‐NHC ligand. This is most likely related to amide‐group coordination which 
occurs readily for the metallo‐NHC ligands compared with the bornyl and cyclohexyl 
analogues. Such conclusions are supported by the comprehensive structural elucidation 
of all NHC complexes prepared in this thesis, providing evidence for the behaviour of 
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1.1. Stereochemistry and Chirality 
 
Isomers are compounds that have the same atomic composition, that is, the same 
molecular formula, but a different molecular arrangement.1  Constitutional isomers 
differ in the connectivity of molecular components. For example, a compound with the 










Isomers that have the same connectivity but a different spatial arrangement are 
referred to as stereoisomers and are classified as either diastereomers or enantiomers. 
Diastereomers of a compound have distinct chemical energies, usually related to a 
difference in the distance between structural components. They are therefore 
distinguishable spectroscopically and can be chemically separable. Diastereomers 























Figure 1.1: Constitutional isomers with the molecular formula C6H7N. 
Figure 1.2: Examples of E/Z- and cis/trans-, and conformational diastereoisomers. 





Enantiomers are compounds that are non‐superimposable mirror images of one 
another. As such, the internuclear distance between any two atoms in one enantiomer 
is identical for the equivalent pair of atoms in the other enantiomer (Figure 1.3). As a 
result, they have the same chemical energy and are spectroscopically indistinguishable 
(with the exception of polarimetry). The two enantiomers of a compound will rotate the 
plane of monochromatic‐linearly polarised light in opposite directions and hence are 
often referred to as optical isomers and given the descriptor + or – depending on 
whether the light is rotated clockwise, (+), or counterclockwise, (–). The designations D 
















Molecules that exist as pairs of enantiomers are chiral compounds. Chiral, from the 
Greek “cheiro” meaning “hand,”2 is in reference to our left and right hands which, like 
enantiomers, are non‐superimposable mirror images. Enantiomers can arise due to the 
presence of a stereogenic centre; a tetrahedral node, commonly carbon, bearing four 
different substituents as represented in Figure 1.3. Molecules with more than one 
stereocentre can give rise to enantiomers and diastereomers (Figure 1.4).  It is important 
to emphasise here that it is possible for any molecule with more than one enantiomeric 
Figure 1.3: Enantiomers shown as their non-superimposable mirror images. 
mirror plane 




component it to exist as diastereomers. This is also true for chiral molecules engaged in 
non‐bonding interactions. Therefore, when a pair of chemically indistinguishable 
enantiomers associate with another singularly enantiomeric species, a pair of 
diastereomeric adducts is generated. Because diastereomers are chemically distinct, 
this provides a mechanism by which to differentiate between the original enantiomers. 
Every stereochemical application relies on this concept in some way and it is central to 













The absolute configuration of the stereocentre can be assigned on the basis of its three‐
dimensional structure using the Cahn‐Ingold‐Prelog (CIP) rules which provide an R or S 
designation.3 Other three‐dimensional configurations can give rise to enantiomers even 
in the absence of an asymmetric centre; examples of this are shown in Figure 1.5. A 
molecule such as 1,1’‐binaphthalene‐2,2’‐diol (BINOL) contains a chiral axis due to the 
mutually axial orientation of its aromatic rings.4 Stereoisomers of this type are known as 
atropisomers. Planar chirality, such as that exhibited by mono substituted ferrocenes, is 
another source of enantiomerism.5 Molecules including helicene provide an example of 
a helically chiral structure which is analogous to a left or right handed screw‐thread.6 
This concept is also relevant to macro‐molecular helices like DNA and the tertiary 
structure of many proteins. Again, these enantiomers are designated in accordance with 
the CIP rules using M (minus) or P (plus) descriptors, although, R/S can also be used for 
cases of axial and planar chirality.  
R,S S,R S,S R,R 
enantiomers enantiomers 
diastereoisomers 









Another manifestation of helical chirality is the Δ/Λ stereochemistry of octahedral metal 
complexes bearing two or more chelating ligands. Tris‐bidentate octahedral complexes 
such as [Ru(phen)3]2+ exist as one of two enantiomers that are determined by the helical 
sense of the coordination sphere generated by the ligands. Figure 1.6 shows how the Λ‐
enantiomer has a sense of anti‐clockwise rotation, resembling a left handed screw when 























1.1.1. Chirality in biochemical systems 
 
 
Chirality is ubiquitous in nature with many of the biomolecules essential to the 
processes of life occurring as only one enantiomer. L‐amino acids and D‐carbohydrates 
predominate in natural systems as do stereochemical preferences for the helical 
arrangement of polymers, including DNA and proteins. Because natural systems are 
stereochemically enriched, it follows that the different enantiomers of chiral bioactive 
molecules including pharmaceuticals can elicit different biochemical responses. Despite 
the two enantiomers of a compound being chemically indistinct, their association with 
the inherently chiral receptor of, for example, an enzyme, results in diastereomeric 
transient states that are energetically differentiable. Hence organisms can recognise and 
respond differently to the two enantiomers of a chiral compound.  
 
Often, only one enantiomer of a pharmacologically active chiral compound (called the 
eutomer) has the desired therapeutic effect while the other enantiomer (the distomer) 
has no impact or, at worst, an adverse effect.7 For example, the R-enantiomer of the 
notorious class‐A drug methamphetamine is actually a decongestant. It is the S‐
enantiomer that makes methamphetamine highly addictive and affords it its stimulant 


















identical physical and 
chemical properties 
different pharmacology 




By convention the ratio of enantiomers in a sample of chiral compounds is expressed as 
the enantiomeric excess (ee). This is calculated as the percentage excess of the major 





 × 100 
 
A sample with an equal ratio of the two enantiomers has an ee of 0% and is known as a 
racemic mixture or a racemate. 
   
Chiral compounds are the active component in over 50% of today’s pharmaceuticals, 
and drug regulation agencies increasingly favour single enantiomer therapeutics above 
racemates.9 This is a justified measure against potential side effects caused by the 
distomer.  
 
1.1.2. Enantiomeric enrichment of compounds by resolution 
 
In the realm of drug design and isolation there is demand for pharmaceutical 
preparations to deliver enantiomeric and diastereomeric purity of products.10 In some 
convenient cases the starting material is derived from a naturally occurring chiral 
compound (such as enzymatically expressed amino‐acids), however, more often than 
not, chirality is introduced during synthesis from achiral starting materials. Synthesis of 
enantiomers in this way, without any external stereochemical influence, will always 
result in a racemic mixture because each enantiomer forms via degenerate transition‐
states and are themselves, chemically identical.  
 
Separation of enantiomers can be achieved in the presence of some other 
enantiomerically enriched chiral component. This relies on the two enantiomers of a 
racemate interacting differently with an external chiral species through the formation 
of intermediary diastereomers. These, by virtue of their different chemical properties, 




and is applied in a number of ways. Enantiomers can be synthetically converted into 
diastereomeric pairs and separated by traditional means such as crystallisation of 
diastereomeric salts often referred to as “classical resolution”. The popular anti‐
inflammatory drug S‐(+)‐ibupropen is isolated in this way by crystallisation with (S)‐







Another approach is kinetic resolution which relies on one enantiomer being consumed 
faster than the other in a reaction.  For example, the hydrolytic kinetic resolution of 














(S)‐ibuprofen + (S)‐Lysine 
 
(R)‐ibuprofen + (S)‐Lysine 
 
crystallisation 













Chiral chromatography can also be performed to resolve the enantiomeric components 
of a racemic mixture.14 Non‐bonding interactions between the enantiomeric species and 
a chiral stationary phase result in transient diastereomers, one of which is more stable 
than the other. The more stable transient species has a stronger association to the 
column hence is retained longer, providing the basis for separation. 
 
Several techniques are used to evaluate the enantiomeric composition of a material. 
Foremost is optical rotation spectroscopy which provides the angle of optical rotation 
(α).15 Polarimetry measures α for a specific wavelength, conventionally the D‐line 
emission of a sodium vapour lamp at 589 nm (αD) whereas optical rotatory dispersion 
(ORD) provides a spectrum of α over a range of wavelengths. The absolute optical 
rotation [α] is the angle of rotation for a given concentration and is always quoted with 
the temperature and wavelength at which it was recorded, for example [α] 
  . 
Racemates have zero optical rotation (α = 0o). To calculate the ratio of enantiomers in a 
sample, [α] must be known for one of the enantiomers thus limiting this technique to 
known resolved compounds. X‐ray crystallography has become an invaluable tool for 
characterising the absolute configuration of a crystallised enantiomer,16, 17 but it is not 
suited to the screening of enantiomeric mixtures. Other techniques that are better 
suited to this include chiral HPLC11, 18 and chiral shift reagents for NMR detection.19‐21 
Reacting the analyte with a chiral auxiliary to produce diastereomeric products for 
analysis is another approach.21 
 
Even in light of the above resolution methods, separating the enantiomeric constituents 
of a racemic mixture is often difficult and expensive. Furthermore, the undesired 
enantiomer is inevitably wasted unless it can be easily racemised and subjected to 
sequential separations. It is therefore preferable when the yield of the target 







1.1.3. Asymmetric Synthesis 
 
Asymmetric synthesis refers generally to a synthesis in which enantiomers or 
diastereomers are generated under some form of stereochemical control. This is 
achieved by introducing a substrate or catalyst with a predefined chirality into the 
reaction.  
 
A substrate controlled asymmetric synthesis employs an enantiomerically pure auxiliary 
species which is incorporated into the starting material to provide a chiral precursor. 
The reaction to form a new enantiomer now proceeds diastereoselectively because of 
the influence of the chiral fragment. The auxiliary species can be cleaved at the 
conclusion of the reaction to provide the enantiomerically enriched product.22 
Numerous auxiliaries have been applied to asymmetric synthesis and are often derived 
from compounds that occur naturally as a single enantiomer. These are broadly classed 
as “chiral pool” molecules and include amino‐acids, carbohydrates and various 
terpenes.23 Scheme 1.3 illustrates a diastereoselective aldol condensation performed 





















A more convenient way of achieving stereochemical control is through chiral induction 
by an enantiomerically pure catalyst. Efficient asymmetric catalysis is a powerful method 
by which a single enantiomer can be generated from achiral synthons as dictated by a 





A catalyst is an additive that acts to accelerate a chemical process without being 
consumed itself. Catalysis is a kinetic effect in which the catalyst brings together and 
mediates the combination of substrates, thereby decreasing in the activation barrier of 
a reaction and speeding up the process (Figure 1.8). However, it is a falsehood to assume 
that all catalysts simply lower the transition state energy of the un‐catalysed pathway.  
In many cases a catalyst can facilitate the formation of an entirely different product than 
what would be formed in its absence. In fact, many reactions do not proceed un‐
catalysed. As will be addressed, coupling reactions such as the Suzuki coupling of aryl‐
halides and aryl‐boronic acids relies on catalysis as these substrates will not react 
independently. 
 
When the catalyst is in a different phase to the reactant media it is termed 
heterogeneous catalysis. Palladium on activated charcoal is an example of a 
heterogeneous catalyst used to facilitate hydrogenation reactions. Homogeneous 
catalysts function in the same phase as the reacting species and are typically dissolved 
in solution with the substrates. The following discussion and examples will focus on 




























1.2.1. Transition metal mediated synthesis 
 
Transition metals have been used to catalyse numerous chemical transformations with 
myriad substrates.26 Their catalytic activity is reliant on the coordination and 
dissociation of ligands from the electropositive metal centre which is notionally 
equivalent to substrate binding and release. Ligand exchange is a fundamental aspect of 
transition metal chemistry that is enabled by the ability of an individual centre to 
Figure 1.8: A representative catalyst cycle and reaction coordinate diagram showing 




undergo changes in its valence electron count. This can be rationalised in the context of 
the 18‐electron rule which dictates that the most stable ligand field is one in which the 
transition metal centre has a valence configuration of 18 electrons. Although, stable 
transition metals complexes with 12 – 22 valence electrons are known, it is generally 
true that low oxidation state organometallic complexes tend to obey the 18‐electron 
rule.27 However, the catalytic capability of a transition metal centre is often dependent 
on its ability to support an active 16‐electron configuration. This is the basis of catalysis 
by “platinum group” metals, a historical term that encompasses platinum, palladium, 
iridium, rhodium, ruthenium and osmium. These are prone to forming coordinatively 
unsaturated 16‐electron complexes in addition to more “traditional” coordinatively 
saturated 18‐electron species. It is the 16‐electron species that is responsible for 
catalytic induction and may be introduced as a stable, pre‐formed complex or generated 
in situ (see section 1.2.2.1).28   
 
Being coordinatively unsaturated and capable of supporting a valence electron count 
below 18‐electrons enables these centres to engage in oxidative addition, the crucial 
first step in most catalytic pathways. Reductive elimination is the reverse process by 
which the product is released and the active species regenerated. These concepts will 
be elaborated in the context of palladium catalysed coupling reactions in the following 
section. 
 
1.2.2. Palladium catalysed coupling reactions 
 
Palladium catalysed coupling reactions have become a foundational method in modern 
organic synthesis due to their widespread applicability and appreciable substrate 
tolerance. Palladium facilitates bond formation between coupling partners as per a 
generally accepted cyclic mechanism, an example of which is provided for the Suzuki 
coupling in Scheme 1.5. In principle, the pathway is similar for most palladium mediated 
couplings. All reactions of this type begin with oxidative addition of an aryl halide (or 
pseudo‐halide such as OTf or OAc) to the active LnPd(0) species.29 Besides this initiation 




In Mizoroki‐Heck type reactions, oxidative addition is followed by coordination of a 
terminal alkene which is coupled with the initial substrate to give a disubstituted alkene 
product.30 Alternatively, the second coupling partner can be introduced by 
transmetalation of an organometallic species to generate a 16‐electron Pd(II) 
intermediate bearing two organic coupling partner fragments. Reductive elimination 
releases the coupled product and regenerates the active LnPd(0) species. Main group 
metals are commonly used in the organometallic coupling partner and are associated 
with named reactions, these include tin (Stille), zinc (Negishi), boron (Suzuki) and for 
alkynes, copper (Sonogoshira). Lithium, magnesium, aluminium, zirconium and silicon 
(Hiyama) have also been used.28 This methodology can also be applied to formation of 
carbon to heteroatom bonds, notably carbon‐nitrogen bond formation by the 
Buchwald‐Hartwig amination reaction.31  
 
This thesis is concerned with the synthesis and structural elucidation of novel palladium 
complexes with an eye towards applying them in catalysis. The abundance of systems 
and coupling partners with which palladium functions provides ample opportunity to 
find an operational system. Limited time and resources meant that only the catalytic 
performance of these new complexes in an asymmetric Suzuki coupling was assessed as 
part of this work. Suzuki couplings are explored further in the following section, 
although, the principles apply generally to all palladium catalysed cross‐couplings with 
organometallic partners.  
 
1.2.2.1. Aryl-Aryl Suzuki couplings 
 
The palladium (and nickel) catalysed cross‐coupling reactions of organoboron 
compounds is referred to as a Suzuki‐Miyaura coupling, or simply Suzuki coupling. It is 
named for the pioneering work of Norio Miyaura and Akira Suzuki and is one of the 
foremost methods for coupling aryl fragments.32 Suzuki couplings are often favoured 
over the tin and zinc based Stille and Negishi couplings because the organoboron 
reagents are comparatively stable, non‐toxic and synthetically accessible.33 Arylboronic 
acids are the most widely applicable organoboron reagent to aryl‐aryl coupling, 




acids are readily synthesised by lithiation of the corresponding aryl‐bromide, followed 
by reaction with a boric ester such as trimethyl borate. The resulting boronic ester is 
hydrolysed under acidic conditions to provide the desired boronic acid (Scheme 1.4). 
Numerous other syntheses of boronic acids and related organoboron substrates are 









Scheme 1.5 depicts the generalised catalytic cycle of a Suzuki coupling. As has been 
established, initiation occurs with oxidative addition of a LnPd(0) adduct (I) into the Ar1–
X bond to produce the 16‐electron intermediate LnXPd(II)–Ar1 (II). Typically, the most 
reactive Ar1–X substrates are diazonium salts (X = N2+) followed by halides (I < Br < Cl) 
which are by far the most common substrates. Sulfonates are the least reactive 
substrates (OTf < OTs < OMs), however, the generalised reactivity series presented here, 
diazonium salts < halides < sulfonates, is dependent on the catalyst and the reaction 
conditions.35  
 
The subsequent transmetalation step is preceeded by conversion of the borane, boronic 
acid or boronic ester precursor into an anionic boronate species. This requires attack by 
a hard anion such as hydroxide, alkoxide, carbonate, fluoride or phosphate (Y), one of 
which is introduced at the outset of the reaction. Transmetalation of the boronate to 
generate L2Pd(II)–Ar1Ar2 (III) proceeds slowly and is the rate limiting step. Reductive 
elimination provides the coupled product Ar1 – Ar2 and the active species L2Pd(0). 
 
The final elimination step relies on the organic fragments Ar1 and Ar2 being mutually cis 
to one another, however, bulky aryl‐groups favour a trans‐configuration. Judicious 
arylboronic acid 




choice of the auxiliary ligand L can hugely influence the geometric preference of L2Pd(II)–

















The catalyst is often introduced to the reaction in its active form. Stable, zero‐valent 
palladium complexes such as tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) or 
tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) can be used for this purpose. It is 
also possible to generate the active species in situ from a palladium(II) precatalyst. A 
study by Moreno‐Mañas and coworkers revealed that reduction of Pd(II) to Pd(0) can 
occur via homocoupling of aryl boronic acids.36 Other researchers suggest that reductive 
elimination of an ancillary ligand adduct is responsible in specific cases.37, 38 Regardless 
of the precise pathway, the literature abounds with examples of palladium(II) 
precatalyst complexes that have been successfully applied to Suzuki coupling 
reactions.29, 39 Precatalyst based systems are often preferred for asymmetric synthesis 
as they can be prepared with well‐defined stereochemical attributes.   
 














1.2.3. Asymmetric catalysis and the “privileged ligands” 
 
The objective of asymmetric catalysis is to generate large quantities of optically active 
material using a tiny amount of enantiomeric promotor. Excellent enantiomeric 
excesses of over 98% have been realised for an array of asymmetric reactions.22 
However, these are often specific to individual syntheses and hence researchers are 
perpetually required to develop new catalysts to expand the scope of asymmetric 
systems.40 
 
Ancillary ligands play a nuanced role in homogeneous asymmetric catalysis. As in all 
metal mediated catalysis, the active centre behaves as a templating agent, bringing the 
reacting substrates together. Ancilliary ligands are required to stabilise the various 
catalytic intermediates and prevent deactivation through, for example, aggregation, 
whilst maintaining sufficient reactivity. In homogeneous catalysis the ligand is essential 
to maintaining solubility in the chosen media. Additionally, asymmetric catalysts require 
ligands that possess an enantiomeric functionality or are arranged in a stereochemical 
architecture that exerts steric influence over the active centre (see section 1.2.3.1). To 
render efficient stereoselectivity at the active site, the directing ligand must remain 
bound throughout repeated catalyst cycles, often to a metal that is alternating between 
different oxidation states.  
 
Certain ligand types have excelled at fulfilling all of the above obligations to provide 
outstanding selectivity in multiple types of reactions. These are known as the privileged 
ligands (Figure 1.9)41 and include the C2 symmetric ligands BINAP (related to BINOL, 
Figure 1.5), the metallocene forming Brintzinger’s ligand, bis‐oxazolines and salen 
complexes of the type used in used in the kinetic resolution of epoxides (Scheme 1.2). 
Several specialist chiral phosphines also qualify (Scheme 1.7).22 Note that these are all 
bidentate ligands, which is often advantageous because it enforces cis relationship 















BINAP, for example, derives its chirality from an atropisomeric 2,2‐binaphthalene 
fragment. Having this chiral axis dictates the relative orientation of phenyl‐rings around 
the active centre, thus imposing stereochemical requirements on the coordinating 
substrates. Quadrant diagrams are useful for illustrating how the phenyl rings of the 












Shaded quadrants indicate a forward phenyl ring is obstructing this region whereas the 
unshaded quadrants are relatively unoccupied. Scheme 1.6 shows how (M)‐BINAP 
generates an environment that is selective for one enantiomeric product of a palladium 
catalysed asymmetric allylation reaction. The major product forms with its main 
substituents in the unoccupied quadrants such that steric clashes with the phenyl rings 
are minimised. 
 






















A well‐known example of an industrialised asymmetric synthesis is that of the precursor 
to (L)‐DOPA, a commercially available drug used in the treatment of Parkinson’s disease. 
Chemical manufacturing giant Monsanto successfully employs an asymmetric 
hydrogenation reaction42, 43 using a rhenium catalyst with the chiral phosphine ligand 
(R,R)‐DIPAMP to obtain the precursor in a 90% yield at 95% ee in quantities of one ton 









Despite a handful of celebrated cases such as the one above, asymmetric catalysis 






















90%, 95% ee  
Scheme 1.7: Synthesis of the precursor to L-DOPA using an asymmetric hydrogenation
catalyst with the enantiomeric phosphine ligand (R,R)-DIPAMP. 
major S-enantiomer minor R-enantiomer 
Scheme 1.6: (M)-BINAP driven selectivity of an asymmetric allylation reaction illustrated 




classical resolution of racemic mixtures or enzymatic resolution is still preferred. There 
is therefore ample incentive to further the field of asymmetric catalysis for wholescale 
application.  
 
1.2.3.1. Metal-centred chirality in asymmetric catalysis 
 
It is important to draw attention here to a niche class of asymmetric catalyst which 
contain metal‐centred chirality as it is immediately relevant to this work. Broadly 
speaking, catalyst systems that utilise metal centred chirality can be divided into two 
categories; those in which the chiral centre is also the active centre, and those in which 
the chiral centre is distinct from the active centre. Numerous examples also exist where 
centrochiral metal complexes are used as auxiliaries44, 45 however, these will not be 
discussed here. 
 
Figure 1.11 provides two examples of catalysts in which the metal centre is bifunctional. 
This includes an example of the C2 symmetric Brintzinger system introduced previously. 
Here the achiral ligand is locked into a conformation with planar chirality by the 
coordinating titanium centre. Complexes such as ansa‐bis(tetrahydroindenyl)titanium 
dichloride (Figure 1.11a) are useful polymerisation and lewis acid catalysts.46  Also 
shown is an octahedral iridium catalyst with Δ/Λ‐stereochemistry (Figure 1.11b) used 











Figure 1.11: Examples of bifunctional asymmetric catalysts in which the active metal 




More relevant to this work are catalysts where the enantiomeric metal centre comprises 
part of a stereodirecting ligand as in Figure 1.12. For example, the rhodium 
hydrogenation catalyst in Figure 1.12a is coordinated by bridging phosphine donors to a 
pseudo‐tetrahedral rhenium piano‐stool complex providing a formal stereocentre.47 The 
diastereomeric phosphine ligand in Figure 1.12b contains both an organic stereocentre 
and a ferrocenyl moiety with planar chirality.48 This has been employed in asymmetric 
cross‐couplings. Figure 1.12c presents an interesting system containing an octahedral 
tris‐bidentate iridium complex with resolved Δ or Λ stereochemistry appended to a 
hydrogen bonding organocatalyst. The enantiomeric iridium moiety has shown excellent 
proficiency for stereodirecting transfer hydrogenation, producing enantiomeric 










Despite the above examples, there has only been stuttered development in this arena 
of asymmetric catalysis.50 Curiously, enantiomerically resolved tris‐bidentate octahedral 
complexes have not been derivatised as stereodirecting ligands for a separate active 
metal centre.51 This would be conceptually similar to the system in Figure 1.12c, but for 
metal driven catalysis rather than organocatalysis. It is surprising given that 
enantiomeric resolution of complexes such as [Ru(phen)3]2+ and related precursors is 



















Figure 1.12: Examples of asymmetric catalysts with metal centred chirality separate 




they are resistant to racemisation which is cited as a major drawback of utilising metal 
centred chirality in asymmetric syntheses.40, 50, 52 Part of this research project therefore 
endeavoured to establish a synthetic protocol towards plausible ligands bearing 
enantiomerically resolved Δ‐[Ru(phen)3]2+ or Λ‐[Ru(phen)3]2+ components for use in 
metal‐mediated catalysis. This is discussed further in section 1.1.1. 
 
1.3. N-heterocyclic carbenes 
 
A carbene is defined as a compound with a neutral divalent carbon centre that has six 
electrons. Carbenes have long been employed as highly reactive intermediates in 
organic synthesis,53 however, their status as transient species was revised in 1991 when 
Arduengo and co‐workers isolated and crystallised the first free carbene, the N‐










This ground‐breaking demonstration of NHC stability heralded an explosion of interest 
and in the intervening years NHCs have become ubiquitous in the literature, particularly 
as ligands for transition‐metals.  
 




The term N‐heterocyclic carbene refers to a broad class cyclic carbene with a nitrogen 
atom adjacent to the carbene centre. There are a number of possible NHC core motifs 
derived from different N‐heterocycles, some of these are shown in Figure 1.14. 
Imidazole based imidazolin‐2‐ylidene NHCs are the most frequently reported class of 
NHC ligand. As they are also the focus of this thesis, the following introduction will 
centre on NHCs of this type. Nonetheless, modulation of the NHC core provides a 
valuable means of diversifying a system’s functionality. For example, saturated 
imidazolidin‐2‐ylidenes have different σ‐basicity and π‐acceptor ability when compared 
with imidazolin‐2‐ylidenes due to the lack of conjugation. This can appreciably change 
the reactivity of both the free carbene and its complexes.55, 56  Different core structures  
are exploited for tailored applications as is the case for thiazole and triazole derived 
NHCs which have excelled as organocatalysts in umpolung reactions such as the benzoin 
condensation.57 As the 6‐membered hexahydropyrimidin‐2‐ylidene shows, NHCs are not 
restricted to 5‐membered heterocycles. Carbenes of 3, 4 and 7‐membered N-













NHC ligands have been utilised for a variety of applications including supramolecular 
frameworks,59, 60 luminescent probes61‐63 and in medicinal compounds.64 Their most 
widespread application, however, continues to be as ligands in metal‐mediated catalysis 















exploited with tremendous success.65 Introduction of new structural features to NHCs 
sees their catalytic uses continue to expand. 
 
1.3.1. Organometallic N-heterocyclic carbene compounds 
 
NHCs have been shown to form stable complexes with all of the transition metals as well 
as many lanthanides and main‐group elements.58 Stabilisation of carbenes by metal 
coordination has long been utilised in organometallic synthesis. The first ligated carbene 
was isolated as a tungsten carbonyl carbene complex; (CO)5WC(OMe)Me by Fischer in 
1964.66 Heteroatom substituted singlet‐carbene ligands, including NHCs, are known as 
“Fischer carbenes” in homage to this pioneering work. Prior to this, Wanzlick had begun 
investigating the chemistry of NHCs,67 however, it was not until 1968 that he and 








Carbenes have either a triplet or singlet electronic state depending on how the two non‐
bonding electrons are distributed within a σ‐molecular orbital and p‐atomic orbital 
(referred to as pπ) (Figure 1.15a). A singlet ground‐state occurs when both electrons 
occupy the σ orbital with an anti‐parallel spin orientation giving rise to an sp2-hybridised 
carbon centre. Alternatively, in a triplet ground‐state, the carbon centre is sp‐hybridised 
and the two non‐bonding electrons separately occupy the σ and pπ orbitals with parallel 




spins.58 Steric and electronic effects of the substituents at the carbene centre control 
the multiplicity of the ground state which, in turn, affects its reactivity.  
 
 
(a)                                                                              (b) 










Singlet carbenes are significantly stabilised by π donation into the empty pπ orbital, and 
by σ‐withdrawing substituents adjacent to the carbene centre. In NHCs, heteroatom 
stabilisation is provided by at least one nitrogen atom neighbouring the carbene centre 
(Figure 1.15b). Consequently, Fischer type carbenes, including NHCs, invariably have a 
singlet configuration to ensure a vacant pπ orbital. Stabilisation in this way offsets the 
pairing energy required to overcome electron‐electron repulsion in a singlet spin‐state. 
Because NHCs possess a filled σ‐orbital and empty pπ orbital they are proficient σ‐donors 
with the capacity to accept electron density and, as such, are ambiphilic in nature.58 
Organometallic bonding of NHCs is characterised by strong σ‐donation coupled with the 













Figure 1.15 (a): Orbital occupations of triplet and singlet carbenes and, (b) electronic 




















Alkylidene or Schrock carbene complexes have no heteroatoms adjacent to the carbenic 
carbon and hence are devoid of heteroatom stabilisation. These favour a triplet‐
configuration to minimise inter‐electron repulsion and are considered to be a diradical. 
The metal‐alkylidene bond is covalent in nature resulting from the coupling of two triplet 
















Figure 1.16: Showing the organometallic bonding of NHC (Fischer type) complexes and 









R = C or H 
 
Figure 1.17: Showing the organometallic bonding of alkylidene (Schrock type) complexes 




These species are nucleophilic and much less stable than their Fischer carbene 
counterparts. 
 
1.3.2. Structure and properties of NHC complexes 
 
Early investigations of the use of NHC ligands treated them as simple tertiary phosphine 
mimics due to their comparable σ‐donating ability. However, although  NHCs and 
phosphines have similar electronic properties, NHCs are more tolerant to manipulation 
of substituents and are therefore more tuneable.69 Figure 1.18 indicates the sites for 
modification of an imidazolin‐2‐ylidene complex. Changing N-atom substituents R1 and 
R3, referred to here as pendant groups, allows for manipulation of the kinetic stability 
of the free carbene as well as the stability of the NHC‐metal complex through steric 
effects. Bulky N‐bound substituents provide crucial kinetic stabilisation to free NHCs by 
sterically shielding the carbene centre. It is no coincidence that the first isolable NHC 















Conversely, increased steric crowding reduces NHC – metal bond stability by enforcing 
a longer metal to ligand bond.70 Pendant groups can be modified with coordinating 
pendant groups 
‐ Influence ligand sphere of metal 
‐ Control NHC‐metal bond stability eg.  
   Steric repulsion, chelation 
 
carbene centre 
‐ strong σ‐bonding 
‐ partial π bonding; electron transfer 
 
peripheral groups 
‐ tune electronic properties 
‐ influence pendant conformation 
‐ general functionalisation 
 




substituents to produce stabilising multi‐dentate ligands with both traditional or NHC 
donors.58 Regarding catalysis, pendant groups are used to tune the steric environment 
at the active metal centre and modulate precatalyst stability through, for example, 
chelation.71 Appropriate choice of peripheral R4 and R5 substituents can be used to 
manipulate the solubility of catalysts in different media,70 or for fixation of catalytically 
active NHCs onto a solid support.71 Bulky backbone substituents can also influence the 
conformation of the pendant groups whereby geometric information is transferred from 
the NHC backbone to the active site of catalysis via the pendant groups (see Scheme 
1.10 for an example).  
 
NHC ligands with moderately bulky pendant groups can elicit a similar steric influence 
to the bulkiest of tertiary phosphine ligands. This is because NHC pendant groups are 
directed into the coordination sphere of the metal whereas phosphine substituents 














A study by Nolan and co‐workers experimentally quantified this assertion by comparing 
crystal structures of a series of nickel‐carbonyl complexes of the type Ni(NHC)(CO)n and 
Ni(PR3)(CO)3.72 In an extreme case,  the steric bulk of NHCs with pendant adamantyl or 
tertiary‐butyl groups disallowed coordination of a third CO ligand resulting in trigonal 
planar Ni(NHC)(CO)2 complexes. Nolan and Cavallo have also developed a model to 
 
 




quantify NHC steric bulk as “percent buried volume” (%Vbur).73 This is defined as the total 
volume of the metal coordination sphere occupied by the ligand and is calculated using 
crystallographic data. 
 
As well as structural advantages, analysing the bond dissociation energies (BDEs) of 
metal to ligand bonds in a series of NHC complexes revealed them to be more stable 
than their phosphine analogues.70, 72, 74 In addition to NHC to metal σ‐donation, NHC to 
metal π‐donation and metal to NHC‐π* back‐donation also contribute to bond stability. 
The excellent electron donating ability of NHCs coupled with their steric tunability has 
seen them replace tertiary phosphines in many catalytic systems.65 
 
1.3.3. N-heterocyclic carbene complexes in catalysis. 
 
NHC ligands enjoy widespread application in metal mediated homogeneous catalysis for 
the reasons stated above.39, 65, 75 Ruthenium‐mediated alkene cross‐metathesis catalysts 
are perhaps the most celebrated systems employing NHC ligands. The 
commercialisation of Grubb’s catalysts (Figure 1.20)76 has made alkene metathesis 


















Recognising the significance of this, the 2005 Nobel Prize in chemistry was jointly 
awarded to Robert Grubbs, Yves Chauvin and Richard Schrock “for the development of 
the metathesis method in organic synthesis."76‐79 
 
Development of Grubb’s second generation catalyst provides an interesting case study 
exemplifying some of the merits of NHC ligands in catalysis. Scheme 1.9 depicts a 
generalised mechanism for ruthenium‐mediated alkene metathesis.80 The catalyst is 
introduced as a 16‐electron ruthenium complex and initiation relies on dissociation of 
L2 to produce the active 14‐electron species. A low ratio of L2 re‐association is required 
for high activity. Replacing the phosphine ligand in the L1 position (first generation) with 
a bulky NHC ligand (second generation) promotes dissociation of L2 and inhibits re‐
association through steric destabilisation. Furthermore, the stronger σ‐donor ability of 
the NHC promotes ligand exchange through the kinetic trans effect and ensures a strong 








This NHC‐metal bond stability is central to the effectiveness of NHC ligands in catalysis 
as it ensures long‐lived active species with preservation of the active site environment 
for product consistency. This is particularly important for achieving high enantiomeric 
excess in stereoselective reactions. Because structural alteration of the NHC core can be 
performed without greatly weakening its organometallic bonding, existing catalyst 








































workers successfully developed a catalyst suited to asymmetric ring closing metathesis 
by replacing the achiral NHC ligand of their second generation catalyst with an 








Here the NHC ligand dictates the stereochemical configuration of the metathesis 
product. Interestingly, this also demonstrates how chiral information from the 
peripheral substituents can be communicated to the active site via the pendant groups. 
Related systems have also been deployed in the stereoselective synthesis of some 
pharmaceutically relevant compounds such as (+)‐erogorgiaene, an inhibitor of 
mycobacterium tuberculosis.82 
 
More relevant to this current investigation is the application of NHC ligands for 
palladium mediated coupling reactions such as the Suzuki‐Miyaura coupling. Again, 
NHCs are well suited to substitute phosphines in this role as they coordinate strongly to 
both Pd(II) and neutral Pd(0). As in the metathesis example above, the NHC renders 
electronic and kinetic stabilisation to the active Pd(0), in fact, NHC complexes of zero‐
valent Pd(0)83 and Ni(0)84 have been isolated and characterised. Strong bonding is 
maintained throughout the cycle of Pd(II) intermediates, preserving the active site 
environment. Several simple NHC ligated palladium complex motifs have proven to be 
effective systems for Suzuki cross coupling reactions and other palladium couplings. 
These include Pd(NHC)(allyl)Cl,85 Pd(NHC)(acac)Cl,38 Pd(NHC)(Me)Br86 and PEPPSI 
systems87 (Figure 1.21). 
82% conversion, 
90% ee (S) 
(R,R)‐ catalyst 










The PEPPSI (Pyridine‐Enhanced Precatalyst Preparation Stabilization and Initiation) 
class in particular has emerged as a highly efficient, stable precatalyst for palladium 
mediated couplings and can be purchased commercially on a multi‐kilogram scale. 
PEPPSI catalysts employ a 3‐chloro‐pyridine “throw‐away” ligand which serves to 
stabilise the precatalyst whilst facilitating rapid activation by dissociating readily.88 The 
NHC ligand binds the metal tightly throughout the cycle and its steric bulk improves 
reductive elimination of the substrate which in turn increases the turnover number 
(TON).89 Unlike traditional palladium phosphine catalysts, PEPPSI is robust and can be 
stored indefinitely outside an inert atmosphere. During reactions it is resistant to 
decomposition at elevated temperatures and in aqueous conditions. The active NHC‐
Pd(0) is generated in situ through reduction of the Pd(II) precatalyst. As such, it is 


















Pd(NHC)(allyl)Cl Pd(NHC)(acac)Cl Pd(NHC)(Me)Br 
Pd(NHC)(3‐Cl‐Py)Cl2 
(PEPPSI system) 




Implementation of enantiomeric NHCs for asymmetric palladium couplings has been 
less successful than for metathesis or ruthenium, rhodium and iridium catalysed 
hydrogenation and transfer hydrogenation.75, 90 Nonetheless, interest in this burgeoning 
field continues to simmer and many attempts have been made to exploit the power of 
palladium NHC complexes for asymmetric synthesis. One of the more successful 
examples, shown in Scheme 1.11, is a chiral adaptation of the PEPPSI system.91 This has 
been applied to the synthesis of axially chiral biaryl compounds, although, only modest 









Employing a well‐defined NHC‐Pd(II) precatalyst affords control over the structure of the 
active entity, however, it is not necessary to use a preformed species. Often an NHC 
proligand is introduced to the reacting system as an imidazolium salt along with a Pd(II) 
source.39 This is commonplace in Suzuki couplings which proceed under basic conditions 
enabling precatalyst formation in situ. It is routinely observed that withholding the NHC 
proligand prevents any catalysis, confirming that the NHC is essential to maintaining the 









This research endeavour sought to develop novel, enantiomeric NHC ligands and 
incorporate them into existing catalyst systems such as those shown in Figure 1.21. The 
aim of doing so being to diversify NHC ligand sets and access new systems to improve 
enantioselectivity. This is necessary because moderate asymmetric induction and 
system dependence continue to hamper to the wholescale application of NHCs in 
synthetically relevant asymmetric palladium couplings.92  
    
1.3.4. Synthesis of NHC precursors 
 
NHCs can be generated from a variety of precursors, the syntheses of which have been 
detailed in an excellent review by César et al.93 For imidazolin‐2‐ylidene NHCs, the most 
universally applicable precursors are imidazolium salts. All NHCs prepared in this study 
are derived from imidazolium salts which serves to illustrate how one approach can be 
manipulated to produce a myriad of different NHCs. 
 
Methods for preparing imidazolium salts are varied and typically chosen depending on 
the chemistry of the appended functional groups. Scheme 1.12 summarises several 
common routes to imidazolium salt NHC precursors. Highly substituted symmetrical 
imidazolium salts are often prepared by annulation of substituted diazdienes using a C1 
electrophile as in route A. The electrophile is typically formaldehyde, chloromethylethyl‐
ether or trimethyl‐orthoformate.94 A related one‐pot synthesis using a 1,2‐diketone with 
a primary amine and formaldehyde has been demonstrated for less hindered 
precursors.95 Alternatively, pendant groups can be appended stepwise as shown in 
route B. This involves the nucleophilic substitution of a halogenated electrophile by a 
preformed N‐substituted imidazole and is well suited to the preparation of 
unsymmetrical NHC precursors.96 A less used but still efficient methodology employs the 
reaction of a formamidine (either symmetrical or unsymmetrical) with an α‐
bromoketone as in route C.97 Oxazolines are also useful intermediates although they are 





















1.3.5. Synthesis of NHC complexes 
 
NHC complexes can be prepared by numerous methods using various imidazolyl‐
adducts.58 Imidazolium salt precursors are converted to NHCs by removal of the NCHN 
proton under basic conditions. Generally, for the synthesis of NHC complexes this is 
conducted in one of 3 ways; substitution of a labile ligand by a free NHC, in situ 
generation of the free NHC from an imidazolium salt in the presence of a metal source 
or, transmetalation from an NHC‐silver complex.39 The choice of approach is ultimately 



































Stable NHC ligands can be prepared under anhydrous conditions by reaction with a 
strong base such as t‐BuOK or NaH and isolated to be combined with a metallic fragment 
in a separate step.38 It is, however, much more common to generate the NHC complex 
in situ by deprotonating the imidazolium salt in the presence of the metal source. NHCs 
generated in this way are rapidly sequestered by the metal, thus driving equilibrium 
towards NHC formation (Scheme 1.14).99 This enables the use of much weaker bases 
including K2CO3, sodium acetate, or pyridine and can be applied to more functionally 
diverse imidazolium salts. Primary generation of a free NHC typically provides better 
stoichiometric control than in situ NHC‐complex formation. 
 
 
Substitution by free NHC 
in situ generation of free NHC 
LB – basic ligand eg. OAc 
transmetalation from silver complex 











Concomitant NHC formation and coordination can also be achieved using basic metal‐
ion sources. These can be mildly basic salts such as metal‐oxides,100‐102 hydrides103 or 
acetates,71 or complexes with basic organic ligands including alkyls104 and acetyl‐
acetonate (acac).105 Synthesis by this method is again driven by the strong metallic 
bonding of NHCs.  
 
Useful late transition metal NHC complexes are regularly prepared via transmetalation 
of an NHC‐silver complex. This has emerged as the foremost method of NHC complex 
preparation due to the robust and adaptable synthesis of silver‐NHC complexes by 
reaction of an imidazolium salt with Ag2O. It occurs in a variety of solvents at room 
temperature, although, elevated temperatures can be employed if necessary.106  Silver‐
NHCs are often sufficiently stable to be isolated, although, are more commonly reacted 
onwards by in situ treatment with a transition metal precursor. The lability of the NHC 
– Ag(I) bond ensures efficient transmetalation that is often driven by precipitation of an 
insoluble silver halide.   
 
Precursors other than imidazolium salts have also been applied to NHC generation. One 
example is by thermal decomposition of imidazole adducts substituted in the C2 
position; these are considered “protected carbenes.” A representative example shown 
in Scheme 1.15 employs a pentafluorophenyl‐NHC adduct.107 This approach has also 













1.4. Novel system design and development 
 
Despite a handful of notable exceptions, the application of enantioselective synthesis in 
industry remains in its infancy. This is due to the lack of efficient and generally applicable 
methodologies and, for this reason, researchers remain in pursuit of novel asymmetric 
catalysts. Continual development of functional enantioelective syntheses is crucial to 
accessing new chiral compounds of social importance such as pharmaceuticals. 
Improved asymmetric synthesis will also serve to streamline existing commercial 
preparations which rely on the expensive and wasteful resolution of racemates. This 
would provide an essential cost saving measure to improve consumer access to life‐
saving therapeutics. 
 
NHC ligands have been used expansively in transition metal catalysis with notable 
examples including Grubbs metathesis catalysts and PEPPSI coupling catalysts. However, 
enantiomeric NHC ligands are yet to be applied widely to asymmetric palladium 
couplings. As such, the power of NHC ligands in palladium‐mediated asymmetric 











This being the case, this research undertook to expand the library of enantiomeric NHC 
ligands, introducing several novel contributions with an eye to their use in asymmetric 
palladium couplings. The broad intention of this research was to: 
 
1) Develop new methods for incorporating “traditional” enantiomeric functionality into 
active systems. 
2) Introduce metal‐centred helical chirality of tris‐bidentate octahedral complexes as a 
novel stereodirecting unit for metal mediated asymmetric catalysis. 
 
Systems have been established which fulfil this overall vision. Four of the NHC complexes 
targeted during this research are shown in Figure 1.22. These are broadly classed as 












chiral organic NHC ligand  achiral organic NHC ligand  
chiral metallo-NHC ligand (peripheral) chiral metallo-NHC ligand (pendant) 




In three of these targets the NHC is tethered to the defining unit by an acetamide 
linkage. Acetamide linked NHCs are discussed in the next section. Also introduced here 
is the novel application of a ruthenium tris‐bidentate moiety to impart stereochemical 
control over a catalytically active centre. Otherwise, further explanation of these 
targets, and others, and the reasons for their selection is provided in their respective 
chapters. A brief survey of their catalytic function in an asymmetric Suzuki coupling is 
presented in Chapter 6. 
 
1.4.1. System functionalisation; acetamide-linked NHC derivatives 
 
Acetamide linking units have emerged as an expedient method of NHC functionalisation 
but remain largely unexplored in the context of asymmetric catalysis. The acetamide‐
linked class of NHC derivatives encompasses many NHC proligands, NHCs and NHC 
complexes with at least one N-substitution of the azole core occurring to the C‐terminus 
of an acetamide moiety (Figure 1.23). This discussion will be restricted to monoamido‐
functionalised NHC derivatives of imidazole (Figure 1.23a).  
 
 












Ligands of this type are one of the most synthetically accessible and easily modulated 
sources of NHC derivatives with potentially anionic functionality.110 Incorporation of an 
azolium core  
acetamide linking unit  
Figure 1.23 (a): Monoamido-functionalised and, (b) diamido-functionalised NHC 




anionic component into an NHC ligand system may be desired for several reasons 
including to; improve complex stability,111 reduce overall complex charge and to act as 
a hemilabile, potentially basic group, in bifunctional catalysis.112, 113  
 
Complexation of monoamido‐functionalised NHCs results in one of three coordination 
motifs; chelate, pendant or bridging (Figure 1.24). This variability is a consequence of 
the flexible linking unit between the NHC and a secondary amide donor that can be 
selectively coordinated depending on the synthetic conditions. The result is a dual 







The most commonly reported coordination mode is N‐amidate/NHC chelation between 
the deprotonated amide nitrogen and the NHC. Chelation between the neutral amide 
oxygen and the NHC is also possible, however, O‐amido/NHC type binding has been 
reported exclusively for complexes with Ru(II).114, 115 When acting as a monodentate 
ligand, coordination only occurs via the NHC resulting in a pendant type complex. These 
form preferentially with metals that favour a linear geometry such as Ag(I) and Au(I)116, 
117 or when reaction conditions are insufficiently basic to allow deprotonation of the 
amide.105, 118 It has been shown in this study that pendant type complexes are also 
favoured by ligands with bulky N‐amido substituents due to steric destabilisation of the 
corresponding chelated form. The bridging of two metal centres by amido‐
functionalised NHC ligands is uncommon, demonstrated once by Ghosh et al. through 






















N-amidate/NHC chelate O-amido/NHC chelate pendant bridging-a idate/NHC chelate O-amido/NHC chelate t i g 




The potential of these ligands as supramolecular synthons does not appear to have been 
explored further.  
 
N‐amido/NHCs have been successfully deployed as ligands in several palladium‐
mediated couplings.119 In this context the presences of an amide chelating arm has 
several advantages. In addition to the robust NHC donor, the anionic acetamide 
chelation can impart a high electron density on the palladium centre thus improving 
oxidative addition and enabling the use of less reactive substrates such as aryl‐
chlorides.120 Chelation also contributes to catalyst stability and facilitates the reductive 
elimination of products.118  
 
These principles were applied by Lee et al. to a highly efficient NHC‐Pd catalyst for Heck 
cross‐couplings using an ionic liquid solvent tetra‐n‐butylammonium bromide (TBAB) at 


















cat. A, 54% yield, 94% trans 
cat. B, 60% yield, 94% trans 
catalyst A catalyst B 
Scheme 1.16: Heck coupling N-amidate/NHC palladium catalyst and a non-activated 




The cis‐NHC complex (catalyst A) was found to perform adequately using aryl‐chloride 
substrates, however, initiation times were slow due to having two tightly bound NHCs 
obstructing the active site. Efficiency was slightly improved by substituting one N‐
amido/NHC ligand for a similarly anionic but weaker binding 2‐(trifluoromethyl)‐5‐(2‐
pyridyl)‐pyrazolate (fppz) ligand (catalyst B). This system (and others) demonstrate the 
efficacy of using N‐amido/NHC ligands for coupling with less reactive chloride 
substrates. Furthermore, it highlights the benefits of employing mono‐N‐amido/NHC 
precatalysts, a notion that was carried into this work. 
 
It has also been shown that the N‐amido/imidazolium salt can be introduced to the 
reaction mixture with a palladium source for the effective mediation of Suzuki 
couplings.122 A range of variably functionalised N‐amido/imidazolium salts were applied 




















A, 45% yield 
B, 89% yield 
C, 97% yield 
D, 99% yield 
E, 22% yield 
NHC.HBr 
A B C D E 
Scheme 1.17: N‐amido substituent effect of the yield of a Suzuki cross coupling using an 





While these ligands displayed an excellent tolerance to a range of aryl bromides and 
heteroaryl bromides, they were found to be sensitive to the choice of boronic acid.  
Moderate efficiency was demonstrated using aryl chlorides. Most important of all, this 
study demonstrated that the nature of the N-amido functionality influences product 
turnover. 
 
N‐amide/NHC ligands were deemed a suitable target system based upon their ease of 
functionalisation and demonstrable catalytic performance. Furthermore, they remain a 
relatively unstudied class of NHC ligand, particularly in the context of asymmetric 
catalysis, with few examples of enantiomeric N‐amide/NHC ligands known.113, 115 
 
The synthesis and chemistry of acetamide‐linked NHC proligands and N‐amidate/NHC 
type complexes is addressed further in Chapter 1. 
 
1.1.1. Harnessing supramolecular chirality 
 
In section 1.2.3.1 the concept of chiral induction using metal templated enantiomers 
was introduced. It was noted that Δ/Λ helical chirality of tris‐bidentate octahedral metal 
complexes has been used in organocatalytic asymmetric induction but have yet to be 
employed as stereodirecting groups to a separate, catalytically active metal centre.51 
One objective of this project was to develop a system that incorporates an 
enantiomerically resolved ruthenium‐polypyridine ([Ru(ppy)3]2+) component into an 
NHC ligand which could coordinate to a catalytically active metal centre. This constitutes 
a novel source of chirality which, as yet, has not been applied to metal mediated 
asymmetric catalysis. 
 
Octahedral ruthenium complexes with bidentate polypyridine (ppy) ligands of the type 
[Ru(ppy)3]2+ are well known as being thermally stable. Enantiomers of these are resistant 
to racemisation, although, this process can be induced photochemically.123 Protocols for 
the resolution of racemic Δ/Λ‐[Ru(ppy)3]2+ (and precursor complexes) into their 




Because both enantiomers of a [Ru(ppy)3]2+ stereodirecting group can be obtained 
expediently, a functioning system could easily be prepared in both its Δ‐[Ru(ppy)3]2+ and 
Λ‐[Ru(ppy)3]2+ forms. Catalysts for both enantiomeric products of an asymmetric 
synthesis are therefore equally accessible (Scheme 1.18). This is a tremendous 
advantage over many “chiral pool” derived systems which may only be readily obtained 
as one of their enantiomers hence are only useful for the preparation of one 









Besides their stereochemical attributes, the metallo‐NHC ligands designed and 




enantiomer A enantiomer B 
asymmetric synthesis 
Scheme 1.18: Illustrating how straightforward resolution of a racemic [Ru(ppy)3]2+
precursor provides both the Λ and Δ forms of a catalyst to selectively provide the two 




hydrophilic moiety such as [Ru(ppy)3]2+ makes these complexes suited to catalysis in 
aqueous media pending selection of an appropriate counteranion such as chloride.124 
Catalysts with stereodirecting groups derived from organic fragments are less tenable 
to aqueous synthesis.125 The remarkable photochemistry of [Ru(ppy)3]2+ provides 
another avenue of investigation as does potential electronic communication between 
metal centres in these hetero‐dinuclear complexes.126 Being bridging ligands also makes 
them potential supramolecular synthons. Many of these applications are beyond the 
scope of this thesis but serve to demonstrate the broad applicability of these systems 
for the benefit of future investigators.  
 
1.1.2. Application in stereoselective synthesis. 
 
It is hypothesised that the chiral [Ru(ppy)3]2+ architectures are suited to imparting 
stereocontrol over aromatic substrates. This is due to the, planar, aromatic surfaces of 
the polypyridine ancillary ligands. These systems were therefore trialled in the synthesis 
of axially chiral biaryl compounds by palladium catalysed asymmetric Suzuki cross‐
coupling. As such, the performance of several [Ru(ppy)3]2+ acetamide‐linked NHC ligands 
were surveyed in this synthesis as were their organic chiral and achiral counterparts 
(Figure 1.22). It was hoped that the large structural differences between the N‐amido 
functionality in this NHC ligand series could provide clearer insight into the effect of N‐
amido substituents on catalysis, particularly because chiral induction by these systems 
will be enhanced by re‐association of the N-amidate during the catalytic cycle. It is 
proposed that the slow transmetalation step affords an opportunity for the catalytic 
intermediates to reconfigure (Figure 1.25). 
 
Disassociation and re‐association of the amidate group is expected to be heavily 
influenced by the steric bulk of the N‐amido substituents as well as by resonance 
stabilisation of the amidate anion. Therefore, this series provides an opportunity to 


































Figure 1.25: Suzuki coupling mechanism highlighting how coordination of the amidate 
could occur following oxidative addition, bringing the palladium coordination sphere into 




































Terpenes are an extensive structurally diverse class of organic compounds produced by 
a variety of plants, particularly conifers, and some insects.127 They are typically fragrant 
and perform a variety of biological functions from deterring herbivores to attracting 
pollinating insects.128 Biosynthesis of terpenes proceeds by the assembly of isoprene 
units with the molecular formula C5H8. Monoterpenes consist of two isoprene units and 
hence have a ten carbon molecular core. Examples of monoterpenes include 
limonene which is present in citrus fruits, myrcene in hops, linalool which is responsible 



















Most terpenes are chiral and occur naturally in a single enantiomeric form as the result 
of their stereospecific biosynthesis and therefore inhabit natures famed “chiral pool.” 








Figure 2.1: Some examples of monoterpenes all of which are biosynthetically derived 




excellent candidates for derivatisation. Camphor is one such chiral monoterpene and is 
readily available in both of its enantiomeric forms, although it occurs naturally as (R)‐
(+)‐camphor (Figure 2.1). Methods for the functionalisation of camphor are well 
established making it a particularly versatile chiral synthon.129 For this reason, camphor 
derivatives have been incorporated into numerous systems, including as a chiral 
auxiliary,23, 130 ligands in asymmetric catalysis,131‐135 organocatalysts,136‐138 as NMR shift 
reagents20, 21 and as precursors in natural product synthesis.129, 139   
 
Several works have been published in which NHC ligands bearing bornane functionality 
have been deployed as ligands for stereoselective catalysis.113, 140‐142 Grubb’s and co‐
workers demonstrated that the steric attributes of a pendant bornane group could 
impart excellent selectivity for terminal alkene formation over self‐metathesis products 
in an ethenolysis reaction (Scheme 2.1).142 This represents a valuable method to convert 








A nickel complex with bornyl derivatised NHC ligands reported by Ghosh et al. was used 
as a bifunctional catalyst in an asymmetric base‐free Michael addiction (Scheme 2.2).113 
This system with its amido‐chelating unit is closely related to the acetamide‐linked NHCs 
developed in this study. The authors propose that the amidate dissociates to 
deprotonate the substrate and form the reactive enolate, essentially participating as a 
catalyst 46% yield, 
95% selectivity 
Scheme 2.1: Ethenolysis of methyl oleate using a bornane functionalised NHC catalyst 




hemi‐labile group. Although an effective catalyst, it provides no stereoselectivity. This is 
attributed to the cis‐relationship of the NHC ligands causing the chiral bornane 








The above example demonstrates that a coordinated amidate can be an active 
participant in catalysis. This poses the question of whether introducing a chiral 
component at the amide terminus could benefit asymmetric induction. Part of this 
research investigation therefore sought to develop a series of NHC‐acetamide ligands 
with bornyl‐amide functionality. 
 
In all of the aforementioned applications, the rigid bicyclic bornane scaffold facilitates 
stereocontrol and selectivity by way of its steric bulk. This study aimed to exploit this 
feature to influence the metal environment in NHC complexes and elucidate new, 
structurally unique compounds. Platinum‐group metals were targeted for NHC‐complex 
synthesis due to their known catalytic activity. The novel complexes presented in the 
following work represent a new class of catalyst with potential stereodirecting 
capabilities. It is important to reiterate that all bornane compounds discussed in this 
section were derived directly from natural (R)‐(+)‐camphor. The chirality in this system 
therefore originates from a naturally occurring enantiomerically pure precursor. 
 
94% yield, 
0% ee catalyst 





2.2. Synthesis of bornyl-NHC proligands 
2.2.1. Acetamide-linked bornyl-imidazolium salts 
 
Following a known procedure,135  natural (R)‐(+)‐camphor was condensed with 
hydroxylamine in EtOH/water giving (R)‐camphor oxime (78% yield) which was 
subsequently converted into exo‐(‐)‐isobornylamine (25% yield) by reduction with 










Selectivity for the exo‐bornylamine over the endo‐bornylamine is achieved under kinetic 
control by slow, portion‐wise addition of sodium borhydride and low reaction 
temperatures (‐60 oC followed by 4 hours at ‐30 oC). Despite performing this reaction 
twice with careful regulation of the reaction conditions, only low yields of ≤ 25% were 
attained. Both times, chromatographic isolation of the product (silica, 5% MeOH/DCM) 
returned a considerable portion of unreacted camphor oxime. The reaction may 
therefore need more time to go to completion or a larger excess of sodium 
borohydride/NiCl2, although, it is difficult to assess how this would affect 
stereoselectivity. Other researchers using the same method have reported yields of 
50%135 and 33%113  suggesting that some variation is to be expected. 
Reaction of the amine with chloro‐acetylchloride provided 2‐chloro‐N‐exo‐
bornylacetamide (2.1) (Scheme 2.4).  
 
78% 25% 


















Despite being a useful bornane‐linked electrophile, the synthesis of 2.1 has only been 
attempted once in the literature using a Ritter reaction on (‐)‐borneol.143  This produces 
racemic (±)‐2‐chloro‐N‐exo‐bornylacetamide, racemising via an alleged hydride 
migration in the carbocation intermediate. The approach described herein using exo‐
bornylamine is the first synthesis of 2.1 in which the stereochemical configuration of the 
(R)‐(+)‐camphor starting material is retained. This has been confirmed by measurement 
of the optical rotation and designation of its absolute structure by X‐ray crystallography. 
 
A standard procedure for the chloro‐acetylation of an amine performed in DCM with 
triethylamine as base provided 2.1 in an 81% yield after purification by flash 
chromatography (silica, 3:2 Et2O/pet‐ether). Optimal yields were achieved with dry DCM 
and freshly distilled trimethylamine. Crude 2.1 could also be purified by recrystallisation 
from hot MeOH/water, however, an oily brown residue occasionally deposited with the 
colourless needles of 2.1.  
 
Compound 2.1 is obtained as a single enantiomer with an absolute optical rotation [α]D 
(MeOH, 20 oC) of ‐ 32.68 o. Furthermore, X‐ray crystallography confirms that 2.1 retains 
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Scheme 2.4: Synthesis and subsequent substitution of 2.1 to give 1-[2-(exo-




Figure 2.2: Asymmetric unit of compound 2.1 with relevant atoms labelled and amide 
hydrogen bonding contacts shown. Only hydrogen atoms involved in these interactions 
have been included. Thermal ellipsoids are drawn at a 50% probability level. 
centrosymmetric, orthorhombic space group P212121 with two molecules of 2.1 in the 
asymmetric unit (Figure 2.2). The low Flack (x) and Hooft (y) values (0.007(2) and 
0.030(2), respectively) confirm assignment of the correct absolute structure. The 
chlorine atom present in 2.1 is deemed sufficiently heavy to provide the anomalous 
differences required for accurate calculation of these parameters from data collected 





















In the structure of 2.1 the secondary amide group is seen to adopt a Z-configuration 
which, as is generally the case,145 has an obvious steric advantage over the E‐amide. The 
dihedral angle between the N11 – H and C2 – H bonds of 131.7(2)o and 150.0(2)o (A and 
B) are lower than the 158 –  180o anti‐orientation often preferred by NH – CHα 
containing Z‐amides.146 This may be a consequence of the borane’s steric bulk. The Z‐




O1B = 3.086(2) Å, N11B ··· O1A = 2.901(2) Å) reinforced by a non‐conventional CH ··· O 
interaction with the methylene group (C13A ··· O1B = 3.215(2) Å, C13B ··· O1A = 3.360(2) 
Å). The resultant Z‐amide hydrogen bonded chain is reminiscent of that reported for the 
racemate (±)‐2.1.143 
 
The reaction of 2.1 with two equivalents of the N‐substituted imidazoles in hot solvent 
afforded the 1‐[2‐(exo-bornylamine)‐2‐oxoethyl]‐1H‐imidazolium salts 2.2.HCl – 2.5.HCl 
(Scheme 2.4). These reactions were monitored by TLC and it was observed that the rate 
reflected the steric bulk of the imidazole‐nucleophile. In refluxing MeCN, substitution by 
1‐(2,6‐diisopropyl)phenyl‐imidazole took 96 hours compared with 62 hours for the 1-(2‐
pyridyl)‐imidazole and 24 hours for the 1‐alkyl‐imidazoles. If desired, the reaction could 
be accelerated by employing DMF as the solvent and reacting at 100 oC for 20 hours. 
This generated compounds 2.4.HCl and 2.5.HCl in yields of 70% and 86% respectively. 
The salts can be precipitated from the condensed reaction‐liquor in a pure form by 
addition of Et2O.  
 
The synthesis and purification of all compounds from exo‐(‐)‐bornylamine to 
imidazolium salts 2.2.HCl – 2.5.HCl involved TLC evaluation. Visualisation of the TLC 
plates was achieved using a permanganate stain prepared by a reported method.147 This 
was necessary as few of the bornane‐derivatives are UV‐active and all respond poorly 
to iodine vapour. 
 
The presence of an imidazolium moiety in compounds 2.2.HCl – 2.5.HCl is highlighted in 
their 1H‐NMR spectra by a downfield singlet at ~ 9.58 ppm due to the NCHN proton. The 
position of signals for NH and CH2 hydrogen atoms of the acetamide linkage are 
conserved for salts 2.2.HCl – 2.5.HCl (~ 8.25 ppm and ~ 5.12 ppm respectively) but 
shifted significantly downfield when compared to the precursor 2.1 (7.50 ppm and 4.04 
























This is because, unlike the chlorine in compound 2.1, the electron‐deficient imidazolium 
ring of compounds 2.2.HCl – 2.5.HCl invokes both inductive and anisotropic deshielding 
of the adjacent methylene CH2 proton. As the amide is more distant from the 
imidazolium ring it is reasoned that other interactions, such as hydrogen bonding, 
contribute to its large shift of Δδ ≥ 0.69 ppm. This can occur between the NH and 
chloride anion116 and/or through intramolecular association of the amide carbonyl and 
the electron deficient NCHN proton. Interestingly, the methylene CH2 protons are non‐
equivalent in the spectrum of 2.1, producing doublets at 4.07 ppm and 4.01 ppm with a 
geminal coupling of 12.5 Hz. Divergence of these diastereotopic proton environments 
has been shown to be solvent dependent (compare the 1H‐NMR spectra of 2.2 in DMSO‐
d6 [Figure 2.3] and 2.3 in MeCN [Figure 2.17]). They are often affected by 
conformational restriction of the methylene group as is observed for many of the 
complexes discussed in section 2.3. For 2.1, such restrictions may occur as a result of 
intermolecular interactions such as hydrogen‐bonding or hydrophobic association of the 
bornane‐groups. A propensity for intermolecular association is alluded to by the mass‐













Figure 2.3: Collated 1H-NMR spectra of 2.1 (black) and 2.2.HCl (red) in DMSO-d6. Note 




registers at equal intensity to the expected monomolecular species  ([2.1 + H]+ = 
230.1263). 
 
The application of imidazolium salts 2.2.HCl – 2.5.HCl as NHC proligands in the synthesis 
of organometallic compounds is explored in section 2.3. 
 
2.2.2. Imidazolium salts derived from 3-amino-borneol 
 
Certain NHC ligands derived from 3‐aminoborneol are capable of tridentate 
coordination (Figure 2.4a). With regard to catalysis, this binding mode is expected to 
improve precatalyst stability and facilitate enantiomeric induction by maintaining the 
chiral sphere of the bornane‐frame in a position proximal to the active site. It is 
anticipated that the bornane‐group will crowd the catalytic site to a greater extent with 
exo‐derivatives of 3‐amino‐borneol than for those of the corresponding endo‐isomer 











Both isomers of 3‐amino‐borneol can be prepared selectively, however, endo‐3‐
aminoborneol is reportedly difficult to isolate without further modification.148 
Therefore, exo‐3‐aminoborneol was used initially with the intention to exploring endo‐
exo-complex endo-complex 
Figure 2.4 (a): Possible tridentate coordination motif for NHC complexes based upon 3-
amino-borneol and, (b) rendered again to highlight the stereochemical differences 




3‐aminoborneol derivatives in future. However, following difficulties in the synthesis of 
compounds from exo‐3‐aminoborneol, this idea was abandoned. 
 
Exo‐3‐aminoborneol was prepared by a published methodology beginning with natural 
(R)‐(+)‐camphor (Scheme 2.5).149 This was converted into camphorquinone‐3‐oxime via 
the camphor‐enolate which reacts with iso‐amylnitrite to give a mixture of the syn- and 
anti-isomers of the oxime after acidification. A reduction of the oxime using LiAlH4 at 0 
oC provides 3‐aminoborneol and, although the exo‐isomer is favoured, the endo‐product 







The purification of this material is non‐trivial; it does not recrystallize or sublime well 
and adheres tightly to any chromatographic media. The only reported purification 
method is to react the crude material with triphosgene and purify the resultant 
oxazolidone by chromatography then recrystallisation (Scheme 2.5).150, 151  This can then 
be hydrolysed to regenerate pure exo‐3‐aminoborneol quantitatively. Other researchers 
Scheme 2.5: Synthesis of 3-amino-borneol and a possible purification route via 




have demonstrated however, that proceeding with the material as is and purifying 
following subsequent synthetic steps can be a more agreeable approach.24, 149   
 
Two strategies for appending an imidazolium moiety to 3‐aminoborneol were explored 
(Scheme 2.6). In route A, chloro‐acetylchloride is used as the coupling agent in a way 
that is analogous to the synthesis of the bornyl‐acetamide derivatives discussed in 
section 2.2.1. Alternatively, route B involves reacting exo-3‐aminoborneol directly with 






Using a reactive coupling agent such as chloro‐acetylchloride was considered less 
compatible with this system due to regioselectivity issues arising from having both an 
amino‐ and a hydroxyl‐ nucleophile present. However, the synthesis of compound 2.7 
by Periasamy et al. suggests that the chloro‐acetamide 2.8 is formed prior to cyclisation 
which is promoted by treatment with NaOH (Scheme 2.7).152 It was hoped that 
conditions existed under which 2.8 could be isolated and several of the condition sets 
trialled are discussed.  
 
All attempts required a stoichiometric equivalent of chloro‐acetylchloride and to reduce 
the impact of acidic‐impurities the chloro‐acetylchloride was purified before use by 



















route A route B
 




acteylchloride (DCM, triethylamine, 0oC or MeCN, NaHCO3, 0oC) a brown tacky residue 
was recovered and confirmed by 1H‐NMR as being a complex mixture. The mass‐
spectrum suggested that the desired product 2.7 had formed along with the cyclised 
product 2.6 and numerous others. TLC indicated that, like 3‐aminoborneol, its 

















Chloroacetamide formation using glacial acetic acid as solvent is another common 
approach153 that was attempted in the hope that the acidic conditions would disfavour 
side reactions via substitution of the chloride (including cyclisation). This again 
generated an unresolvable mixture. Unwilling to invest further time in the synthesis of 
an acetamide‐linked species, focus shifted towards the preparation of compounds via 
route B which was showing early promise. It is probable however, that persistent 
experimentation could produce 2.7, perhaps by using chloro‐acetic anhydride as a 
milder coupling agent. Forming then reacting 2.7 in situ to give the desired acetamide‐









Instead, the ethyl‐linked compound 2.9.HBr was targeted by implementing route B by 
the method depicted in Scheme 2.8. This novel approach in which the imidazolium‐
tethered electrophile 2.8.HBr is reacted with exo-3‐aminoborneol was devised on the 
basis that the amine could be selectively alkylated using reported conditions.149  
Furthermore, having pre‐formed the imidazolium salt minimised the probability of 
cyclisation or oligomerisation reactions occurring. The bromo‐ethyl imidazolium salt 
2.8.HBr has previously been utilised as a precursor to non‐symmetrical bis‐imidazolium 
salts154 but has never been explored as a means of tethering an imidazolium moiety to 







Compound 2.8.HBr is prepared by stirring 1‐methylimidazole in a twenty‐fold excess of 
dibromoethane at 70 oC. Surprisingly, despite this excess, the formation of the bis‐
imidazolium salt 2.11.2HBr was sometimes produced (see Scheme 2.9), on one occasion 
in a 1:1 mixture with 2.8.HBr. Removing the 2.11.2HBr contaminant from 2.8.HBr was 
difficult due to their similar solubility properties and it was typically easier to repeat the 
synthesis. Because compound 2.8.HBr is insoluble in dibromoethane, it begins to 
separate as a viscous oil after an hour of heating the reaction. The starting material 1‐
methylimidazole may become concentrated in this ionic liquid phase thus promoting the 
formation of 2.11.2HBr. Minimising this effect through vigorous stirring and uniform 
heating of the reaction vessel resulted in purer 2.8.HBr. 
 




















The conditions used to generate 2.9.HBr are analogous to those reported for the 
synthesis of exo-3‐(morpholino)isoborneol by N-alkylation of exo-3‐aminoborneol.149 
Here, 2.8.HBr and triethylamine were stirred with a slight excess of crude exo‐3‐
aminoborneol in DMSO at room temperature for 48 hours (Scheme 2.9). This produced 
a mixture of the desired product 2.9.HBr, its protonated salt 2.9.2HBr, and, surprisingly 
the bis‐imidazolium salt 2.11.2HBr. Other compounds derived from impurities in the 
crude starting material were also identified including the endo‐isomer 2.10.2HBr, and 




















































Compound 2.9.HBr was isolated as the protonated adduct 2.9.2HBr, the protonation 
state of which was revealed by X‐ray diffraction analysis (Figure 2.5). The crystal 
structure also helped confirm the presence of the minor endo‐isomer 2.10.2HBr which 
co‐crystallised with 2.9.2HBr. Although slightly convoluted, the best purification 
strategy was to add the DMSO reaction solution dropwise into stirring EtOAc and collect 
the resultant white solid by filtration. This material was a mixture of 2.9.2HBr and 
2.11.2HBr (usually ~ 3:2, 2.9.2HBr / 2.11.2HBr) from which the 2.9.2HBr was isolated by 
recrystallisation from MeCN. The EtOAc filtrate contained a mixture of compounds 
Scheme 2.9: Synthesis of 2.9.HBr and other identified compounds. 
2.8.HBr 
2.9.HBr 2.9.2HBr 





including starting material and 2.9.HBr. This was condensed by rotary‐evaporation and 
the resultant oil dissolved in THF. Acidification by dropwise addition of a 0.5 M solution 
of HBr in THF allowed 2.9.2HBr to be obtained as a precipitate which was collected and 
washed with THF. This was contaminated with compound 2.12.2HBr which was washed 
from the product with DCM and obtained from the filtrate in a pure form. Compound 
2.12.2HBr comprised ~ 0.5% of the mass expected for quantitative conversion of the 
limiting reagent 2.8.HBr. The structural resolution of 2.12.2HBr and its chemical origin 
will be discussed shortly. A poor overall yield of 16% 2.9.2HBr was recovered by this 
method.  
 
Several attempts were made to improve this yield but to no avail. Solvent variations 
were limited by the poor solubility of the precursor salt 2.8.HBr, however, MeCN and 
butanol were trialled as substitutes. In both cases formation of product was observed 
by 1H‐NMR but the isolated yield was negligible and, as before, 2.11.2HBr was also 
produced. Substituting triethylamine with ammonium carbonate as base met with a 
similar outcome as did a base free set of conditions with heating (DMSO, 100 oC, 72 
hours).  
 
In using this approach, a dilemma arises from the fact that the starting material 2.8.HBr 
is sensitive to deprotonation of the imidazolium moiety whereas the other starting 
material, exo-3‐aminoborneol, is moderately basic. Exo-3‐aminoborneol is a β‐hydroxy 
amine for which the dihedral interfunctional angle is ~ 0o due to the rigid bicyclic 
skeleton. These are known to be significantly more basic than flexible β‐hydroxy amines 
because the protonated state is stabilised by intramolecular hydrogen‐bonding between 
the ammonium salt and the hydroxyl‐oxygen at minimal entropic cost.155 This 
stabilisation is expected to increase upon substitution of the amine. Unfortunately, 
there is no experimental data for exo-3‐aminoborneol and its derivatives, however, the 
repeated isolation of 2.9.2HBr directly from the reaction shown in Scheme 2.9 implies 
that 2.9.HBr is of a comparable basicity to triethylamine. If exo-3‐aminoborneol is also 
competitively basic then it may become protonated during the reaction, diminishing its 
reactivity. This however, was not acknowledged as an issue in synthesis of  exo-3‐




cannot be substituted as a stronger base would deprotonate the imidazolium salt of 
2.8.HBr or of any 2.9.HBr formed. On the other hand, the formation of the bis‐
imidazolium salt 2.11.2HBr points towards some unpredicted, adverse reactivity of the 
bromine‐tethered imidazolium salt 2.8.HBr. As yet, the mechanism of formation of 
compound 2.11.2HBr is not understood.  
 
As mentioned above, the identity of the protonated adduct 2.9.2HBr was verified by X‐
ray diffraction analysis using crystals grown by slow vapour diffusion of Et2O into a 
MeOH solution of the compound. The data was solved in the non‐centrosymmetric, 
monoclinic space group P21 with an asymmetric unit containing one molecule of 
2.9.2HBr with full occupancy and another positionally disordered site containing 73% 
2.9.2HBr and 27% 2.10.2HBr (Figure 2.5). The presence of two bromide anions per 
imidazolium compound confirms that the amine is protonated. The disordered bornane‐
cluster was effectively modelled as two parts by refining the free variables of each part 
to an overall site occupancy factor of one. For the exo‐isomer, the distance O20 – N11 
(A / B) is 2.672(6) Å / 2.678(6) Å, which is slightly longer than in the endo‐isomer 
(2.577(14) Å). Likewise, the dihedral angle O20‐C2‐C3‐N11 (A / B) is larger for the exo‐
isomer (11.8(6)o / 11.8(8)o) than the endo (1.2(2)o). These values corroborate the 
previously made assessment that the hydroxyl and amino groups are spatially adjacent 
with low interfunctional angles. This arrangement is expected to support intramolecular 
hydrogen bonding, however, the anticipated N11H ··· O20 interaction was not detected 
with the hydrogen atom donor in its calculated position. No attempt to manipulate the 































The structure of 2.12.2HBr was initially deduced using NMR and mass‐spectroscopy and 
verified by X‐ray crystallography. The mass‐spectrum of the then unknown compound 
2.12.2HBr displays a dominant signal at 262.2281, equivalent to the mass of [2.9.H]+ 
minus an oxygen atom (calculated m/z, [2.9.H – O]+ = 262.2278). An 1H‐NMR analysis 
revealed that the signals pertaining to the imidazolium moiety and ethyl linker are 
conserved when compared to the spectrum of 2.9.2HBr, however, the “bornane” region 
of the spectrum was altered. Figure 2.6 shows this region of the compounds HMBC plot 
with the 1H‐NMR and 13C‐NMR spectra comprising the horizontal and vertical axis, 
respectively.  
Figure 2.5: Asymmetric unit of compound 2.9.2HBr with relevant atoms labelled and 
some hydrogen bonding contacts shown. The outlined site is occupied by molecules of 
2.9.2HBr and 2.10.2HBr in a 73 : 27 ratio. These have been rendered separately. All non-
bonding hydrogen atoms have been omitted for clarity. Thermal ellipsoids are drawn at 
a 50% probability level. 








A two proton multiplet at 3.43 ppm and a pair of doublets at 3.26 ppm and 3.16 ppm 
corresponding to one proton each are evidence of two “new” methylene environments. 
Three tell‐tale methyl signals at 1.15 ppm, 1.00 ppm and 0.96 ppm allude to the 
retention of some bornane‐character and HMBC analysis confirms that these are 
associated with the same structural unit as the “new” methylene protons through 
several two and three bond correlations to the same carbon signals.  The remaining 
signals between 2.20 – 1.80 ppm are similarly correlated and are attributed to five 
proton bonded to C4, C5 and C6. In bornyl‐derivatives, chemically unique exo- and endo‐
proton environments are observed due to the rigidity of the [2.2.1]‐bicycle. The 
chemical shift difference between exo- and endo-proton is typically over 0.5 ppm for the 
C5 and C6 methylenes. Interestingly, for compound 2.12.2HBr there is little distinction 







H2 H3 H4, H5, H6 
H8 H9 H10 
MeOH 
H3a → C5 
H2a → C6 
H2a → C1 
H2a → C7 





between the exo and endo environments, probably due to the increased flexibility of the 
camphidine‐like [3.2.1]‐bicycle.  
 
X‐Ray crystallography helped verify the structural assignments made using NMR and 
mass‐spectrometry. Diffraction data was collected using crystals grown by slow vapour 
diffusion of Et2O into a MeOH/MeCN solution of 2.12.2HBr which crystallised in the non‐
centrosymmetric orthorhombic space group P21212. Two molecules of the compound 
are present in the asymmetric unit along with four bromine counter anions and a water 





The structure clearly shows the unmistakeable seven‐membered azepane ring of a 
camphidine‐moiety. The oxygen of the water molecule occupies a site on the two‐fold 
Figure 2.7: Asymmetric unit of 2.12.2HBr with some hydrogen-bonding interactions 
highlighted. All non-bonding hydrogen atoms have been omitted for clarity. Thermal 




axis and hydrogen atom positions could not be calculated effectively. There was 
insufficient residual density in the difference map to assign these hydrogen atoms 
manually. Regardless, it is inferred that this water molecule participates in the hydrogen 
bonding network that pervades the packed structure. It acts as a hydrogen bond 
acceptor in a CH ··· O interaction with the imidazolium NCHN hydrogen (C15B ··· O1 = 
3.029(11) Å) and donor in an OH ··· Br interaction (O1 ··· Br3 = 2.966(8) Å). A weaker NH 
··· Br interaction is observed between the protonated amine and bromine (N11A ··· Br1 
= 3.185(6) Å and N11B ··· Br2 = 3.318(8) Å). 
 
Compound 2.12.2HBr probably originated with a camphidine impurity (2.13, Scheme 
2.10) that reacted with 2.8.HBr. A cation of mass 154.1595, equivalent to that of 
protonated 2.13 (calculated m/z, [2.13 + H]+ = 154.1590) is observed in the mass‐
spectrum of the crude exo-3‐aminoborneol. Camphorquinone‐3‐oxime can undergo a 
Beckmann rearrangement in acidic conditions to give camphorimide156 which in turn, 















Under the reducing conditions used (see Scheme 2.5), it may be that acidic impurities 
facilitate the Beckmann rearrangement. Camphidine is therefore a plausible side 













Scheme 2.10: Possible route for the formation of camphidine 2.13 via an acid assisted 




camphorquinone‐3‐oxime. Unfortunately, there was insufficient sample to analyse the 
optical rotation of 2.12.2HBr 
 
Compound 2.12.HBr or another camphidine‐tethered NHC proligand would be an 
interesting target compound for a future researcher. Chloro‐acetylation of camphidine 
is achievable and would provide interesting acetamide‐linked NHC ligands with the 
chiral, tertiary amide providing a novel hemilabile group. 
 
2.3. Synthesis of bornyl-NHC complexes 
 
This section will explore the synthesis of bornyl‐acetamide NHC complexes from 
proligands 2.2.HCl – 2.5.HCl. In the ensuing discussion these will be generally referred 
to as BA ligands or BA‐N when adopting NHC‐amidate coordination.  
 
Acetamide‐linked NHC ligands have been used in mono‐NHC complexes but are more 
frequently reported in square planar, ML2 type systems with the d8 metals nickel, 
palladium and platinum. Achieving the desired NHC‐amidate chelation requires a 
moderately strong base, typically K2CO3, and heat input, however, resonance stabilised 
amidates can form and coordinate spontaneously at room temperature.114, 158 For 
square planar ML2 type complexes, the two NHC ligands will coordinate in either cis or 
trans geometries. Additional variants may arise depending on whether the ligand 
coordinates in a monodentate or bidentate fashion. Figure 2.8 depicts the three pairs of 
diastereomers that are anticipated when monodentate and bidentate coordination 








For unhindered NHC‐acetamide ligands the synthesis of complexes with a bis‐bidentate 
motif is conveniently achieved using an excess of ligand, K2CO3 and heat with 
straightforward separation of cis and trans isomers by crystallisation or 
chromatography.112, 113, 118 For BA‐N complexes however, the amidate‐metal bond is 
destabilised both kinetically and thermodynamically by the steric bulk of the bornane‐
group. This statement is supported by several examples in the following text (sections 
2.3.1). One consequence of this phenomenon is that when desired, coordination via the 
amide‐nitrogen is easily avoided using mild conditions thus affording a degree of 
control. Unfortunately, it has proven extremely difficult to reliably prepare BA‐N type 
complexes and complicated product mixtures are routinely observed. This otherwise 
simple approach of preparing bis‐bidentate ML2 complexes now becomes difficult 
because, despite the NHC coordinating, the amide may or may not associate. The 







Figure 2.8: Possible [ML2] complexes using mono-acetamide linked NHC ligands, cis 












Proligand 2.2.HCl was heated with PdCl2 in MeCN until a homogeneous solution was 
obtained then K2CO3 was added. Over 15 hours the suspension faded in colour from a 
deep ochre to faint yellow/grey. The mixture was cooled and filtered through celite and 
the contents of the filtrate analysed by 1H‐NMR after removal of the solvent. This 
alluded to an irresolvable cocktail of products but remarkably, the low resolution mass‐
spectrum was dominated by a signal at 328.62 which is similar in mass to the species 
[Pd(2.2)2]2+ (calculated m/z, [Pd(2.2)2]2+ = 328.15). 
 
To avoid the convolution arising from the synthesis of ML2 type complexes, only mono‐
NHC complexes were explored in depth using proligands 2.2.HCl – 2.5.HCl. The 
remaining discussion will centre on the synthesis of these complexes, specifically those 
depicted in Figure 2.9. Unfortunately, this prevents any direct comparison between 












































Many of the synthesised bornyl‐acetamide NHC complexes possess interesting 
structural features and some curious conformational isomerism. Therefore, in addition 
to being catalytically useful compounds, considerable structural analysis was performed 
and some preliminary insight into their dynamic behaviour has been provided. Beyond 
the context of catalysis, the results presented in the following sections augment the 
present understanding of organometallic NHC compounds in the wider field. 
 
2.3.1. M(NHC)(acac) type complexes 
 
An O,O’‐chelated acetylacetonate (acac) ancillary ligand employed with a chelated BA‐
N NHC could provide neutral complexes of the type Pd(BA-N)(O,O’‐acac) and Pt(BA-
N)(O,O’‐acac) (Figure 2.9). Acac was chosen for its fairly predictable coordination 
properties, forming stable O‐bound six‐membered chelates. The rationale behind using 
an oxygen donor ligand was to minimise congestion around the metal centre, improving 
the likelihood of amidate‐coordination. Examples of M(NHC)(acac) type complexes with 
M(BA-N)(O,O’‐ac ) Pd(2.5)Cl2
Pd(BA)(a lyl)Cl [R ( )(p‐cymene)Cl]+




Pd(II)38, 159‐162 and Ni(II)84 were first isolated some time ago but recently, the class has 
expanded to include an array of metal centres including Co(III),163 Ir(II),164 and Os(II)165. 
These have mostly been employed in catalysis, although, a Pt(II) example has been 
investigated for its photoluminescence.61 Here is discussed the successful inclusion of 
ligand 2.4 into some highly relevant and interesting Pd(NHC)(acac) and Pt(NHC)(acac) 
systems. 
 
2.3.1.1. Synthesis of Pd(2.4 - H)(O,O’-acac) complexes 
 
There are several plausible approaches by which to prepare Pd(BA-N)(O,O’‐acac) type 
complexes, however, a one‐pot, three component synthesis was deemed the most 
appropriate. This is because chelation by the sterically hindered amidate is promoted by 
the use of excess base and elevated temperatures. As discussed in the opening to this 
section, reaction conditions employing MeCN as solvent with K2CO3 are complementary 
to preparing similar organometallic chelates. Under these same conditions in situ NHC 
generation can coincide with the generation of anionic ancillary ligands by 
deprotonation of a precursor. Kantchev and Ying outlined this methodology in their one‐
pot, multi‐component synthesis of Pd(NHC)(dmba)Cl complexes in which both the NHC 
and ancillary ligand were formed by in situ deprotonation.166 Because these conditions 
support both formation of the desired NHC‐amidate chelate and coordination of acac, 












This was attempted for the synthesis of Pd(2.4 - H)(O,O’‐acac) and although the complex 
was prepared and characterised, the yields were routinely low (≤ 14%). Various aspects 
of the procedure were tweaked in an effort to improve this but with little success. 
Typically the reaction was performed as follows; the precursor salt 2.4.HCl and an 
equivalent of PdCl2 were heated at 80 oC in MeCN under an inert atmosphere until all 
the PdCl2 was dissolved. Finely divided K2CO3 (7.5 equivalents) was then added and 
heating continued. The duration of this step was varied between 10 and 90 minutes, 
however, the effect on yield was difficult to evaluate. After 60 minutes neither the 
imidazolium NCHN or amide NH proton signals are observed in the 1H‐NMR spectrum of 
the reaction mixture suggesting that this is sufficient time to form an intermediary 
Pd(2.4 - H)(X)n complex. A bleaching of the dark ochre colour of the Pd(MeCN)Cl2 
solution during this period also supports NHC coordination. An equivalent of 
acetylacetone or sodium acetylacetonate (Na(acac)) was then added and heating 
continued, usually for around four hours. The reaction with a representative set of 
conditions is shown in Scheme 2.13. 
Pd(NHC)(dmba)Cl 
(81 – 96%) 
M(BA-N)(O,O’‐acac) 
Scheme 2.12: Previously reported Pd(NHC)(dmba)Cl type complexes as plausible 










The cooled reaction mixture was filtered through celite then condensed by rotary 
evaporation. The residue could then be taken up in Et2O and again filtered through celite 
to remove any ionic impurities including starting material, although, there was rarely 
any present at this stage. After removal of the solvent the material was triturated in 
pentane for several hours which provided acceptably pure Pd(2.4 - H)(O,O’‐acac) as an 
off white solid. Slow evaporation of the pentane filtrate occasionally yielded an 
additional crystalline deposit of product. In its crystalline form, Pd(2.4 - H)(O,O’‐acac) 
could be washed with cold Et2O and MeCN to give very pure material. Unfortunately, 
these reactions proved to be extremely temperamental. Often no Pd(2.4 - H)(O,O’‐acac)  
formation was observed when replicating a condition set which had produced it in a 
previous instance. Another complex was invariably isolated as the major product of this 
reaction (yield ≤ 30%), the identity of which was not immediately obvious. After a 
rigorous NMR analysis and comparison with the platinum complex of 2.4 (see section 
2.3.1.2), it was determined to be Pd(2.4)(O,O’‐acac)(γC‐acac). The structural elucidation 









of compounds Pd(2.4 - H)(O,O’‐acac) and Pd(2.4)(O,O’‐acac)(γC‐acac) will be discussed 
in section 2.3.1.4. The reaction progress could be monitored by 1H‐NMR spectroscopy 
through which the presence of Pd(2.4 - H)(O,O’‐acac) and Pd(2.4)(O,O’‐acac)(γC‐acac) 
were clearly indicated by signals in the region between 4 ppm and 7 ppm. Signals due to 
several other minor products were also observed and may be attributed to ML2 type 
complexes. Such species were identified by low‐resolution mass spectroscopy owing to 
spectral signals at 1047.57 and 474.26 corresponding to a calculated m/z of 
[Pd(2.4)2(O,O’‐acac)]+ = 1047.57 and [Pd(2.4)2]2+ = 474.26. Surprisingly, Pd(O,O’‐acac)2 
was also detected in a small amount despite only using one equivalent of acetylacetone.  
 
As will be discussed, Pd(O,O’‐acac)2 is implicated in the formation of complex 
Pd(2.4)(O,O’‐acac)(γC‐acac). The presence of Pd(O,O’‐acac)2  and its derivatives strongly 
insinuate that under the conditions described above, ligand exchange is occuring. 
Various aspects of the procedure were tweaked in an effort to manipulate these system 
dynamics and these are discussed in section 2.3.1.5. In this section, the condition sets 
that were trialled for the reaction shown in Scheme 2.16 are summarised in Table 2.1. 
 
2.3.1.2. Synthesis of Pt(2.4 - H)(O,O’-acac) complexes 
 
The complex Pt(2.4 - H)(O,O’‐acac) was prepared as a structural analogue to Pd(2.4 - 
H)(O,O’‐acac). This was synthesised under the conditions displayed in Scheme 2.14. 
DMSO was used as the solvent to accommodate the slightly higher reaction temperature 
(110 oC) deemed necessary to promote ligation at the more kinetically inert Pt(II) centre. 
Work‐up of the reaction required dissolution of the reaction mixture in DCM followed 
by filtration to remove any inorganic matter including K2CO3 before washing with water 
and brine to remove the DMSO. The organic phase was dried over MgSO4 and the 
solvent removed to provide a crude mixture of Pt(2.4 - H)(O,O’‐acac), Pt(2.4)(O,O’‐










The chelated complex Pt(2.4 - H)(O,O’‐acac) was collected as an off‐white solid after 
trituration in pentane and, as with its palladium analogue, crystals of Pt(2.4 - H)(O,O’‐
acac) formed upon slow evaporation of the pentane filtrate which could be collected 
and washed with Et2O and MeCN. The combined crops of Pt(2.4 - H)(O,O’‐acac) equated 
to an overall yield of 22%. The remaining material was adequately pure Pt(2.4)(O,O’‐
acac)(γC‐acac)  which was obtained in a 59% yield due to a slight excess of Na(acac) being 
used. This was purified for analysis by dissolving in MeCN and extracting into pentane. 
Rotary‐evaporation of the pentane extract provided pure Pt(2.4)(O,O’‐acac)(γC‐acac) as 
a white solid.  
 
The reaction proceeds slightly better with Pt(II), producing Pt(2.4 - H)(O,O’‐acac) in a 
22% yield compared with a best yield of 14% for Pd(2.4 - H)(O,O’‐acac). This may be 
because complexes of Pt(II) are more kinetically inert when compared with Pd(II).27 
Additionally, the NHC – Pt(II) bond is stronger than the NHC – Pd(II) bond. The softer 




Pt(II) centre accommodates greater σ‐orbital overlap with the carbene ligand as well as 
contributing more electron‐density to π* back‐donation.55, 167 The enhanced interaction 
of carbon‐donors with Pt(II) proved important to the structural determination of 
complex Pt(2.4)(O,O’‐acac)(γC‐acac) by enabling the C‐bound acac ligand to remain 
associated for detection of the complete complex by mass‐spectrometry (see section 
2.3.1.4). As the NHC – Pt(II) complex is more thermodynamically stable and kinetically 
inert than the NHC – Pd(II) congener, issues associated with ligand exchange are 
reduced. It is also surmised that using a larger metal centre such as Pt(II) decreases the 
kinetic barrier to coordination of the hindered amidate. That is, having a less congested 
coordination sphere than the isostructural Pd(II) complex should facilitate coordination 
of the bornyl‐amidate moiety. However, because this reaction was only performed once 
it is difficult to assess the true extent to which chelated complex formation improves 
with the employment of Pt(II). As addressed in section 2.3.1.5, it is equally likely that the 
elevated temperature of the reaction promotes formation of the desired product. In the 
cyclohexyl‐acetamide series there is no significant difference in the yields recorded for 
Pd(CyA‐N)(O,O’‐acac) (46%) and Pt(CyA‐N)(O,O’‐acac) (47%) however, as noted in 
section 3.3.1, the less cumbersome cyclohexyl‐group could make these ligands less 
discerning between Pt(II) and Pd(II). 
 
2.3.1.3. Characterisation of Pd(2.4 - H)(O,O’-acac) and Pt(2.4 - H)(O,O’-acac) 
 
The complexes Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) were fully characterised 
using NMR spectroscopy, mass spectrometry, IR spectroscopy and X‐ray crystallography. 
In the mass‐spectrum, these complexes are detected as an [MH]+ cation which produce 
a signal at 626.2592 for the Pd(II) complex and at 715.3175 for the Pt(II) complex 
(calculated m/z, [Pd(2.4 - H)(O,O’‐acac) + H]+ = 626.2574, [Pt(2.4 - H)(O,O’‐acac) + H]+ =  
715.3184). Definitive structural insight was provided by X‐ray crystallography which 
compliments the NMR and IR spectra. This discussion will begin by addressing the crystal 
structures of Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac). 
 
Crystals of Pd(2.4 - H)(O,O’‐acac) suitable for single crystal diffraction analysis were 




the monoclinic space group P21 with two molecules of Pd(2.4 - H)(O,O’‐acac) in the 









Having an enantiopure bornane component renders the structure non‐centrosymmetric 
with Flack(x) and Hooft(y) parameters of ‐0.001(8) and ‐0.0059(6) respectively. These 
verify that the correct stereochemical solution was obtained. The ligand 2.4 - H is 
coordinated in a bidentate fashion, chelating between the carbenic carbon C15 and 
deprotonated amide nitrogen N11. That the N11 is coordinated as an amidate is implicit 
in the neutrality of the complex and the relatively trigonal planar configuration of bonds 
around the amidate nitrogen N11 as defined by their tetrahedron volumes of 0.090 Å3 
(A) and 0.316 Å3 (B). 
Figure 2.10: Contents of the asymmetric unit of Pd(2.4 - H)(O,O’-acac) with relevant 
atoms labelled. Hydrogen atoms have been omitted for clarity. Thermal ellipsoids are 





Relevant amide bond lengths in Pd(2.4 - H)(O,O’‐acac) (A / B) are C12 – O1 = 1.236(7) Å 
/ 1.242 Å  and N11 – C12 = 1.321(6) Å / 1.333 (7) Å which fall within the range of values 
reported for similar NHC‐amidate chelated complexes and are unchanged from the 
bond‐lengths found in a neutral, uncoordinated amide.118, 120, 168 The resultant 6‐
membered chelate ring is seen to adopt a shallow boat configuration with the apical 
methylene carbon C13 projected away from plane defined by the square‐planar Pd(II) 
centre as defined by θCH2 (see later). In order to reduce steric interactions with the acac 
ligand, the bornane and diisopropyl‐phenyl groups occupy the other side of this 
hypothetical plane thus inducing the observed puckering of the 6‐membered chelate.  
 
This divergence from planarity gives rise to atropisomerism, with the bonds Pd1 – C15 
and Pd1 – N11 each representing a chiral axis. The enantiomeric designation for each 
axis depends on which side of the bisecting molecular plane the major substituents 
reside. Because of the conserved chirality of the bornane moiety these two 
conformations are diastereomeric and for this reason, molecules A and B of the 
asymmetric unit are diastereomers (Figure 2.11). In the diastereomer of Pd(2.4 - 
H)(O,O’‐acac) labelled “A”, the bond Pd1 – C15 is a helically chiral P-axis and Pd1 – C15 
is an M‐axis. Both axes convert to their opposite enantiomer when the chelate ring 
conformation is flipped to produce diastereomer “B”. The extent to which this chelate 
ring distorts away from a planar geometry is quantifiable by the torsion angles along the 
chiral axis, C15‐Pd1‐N14‐C12 and N11‐Pd1‐C15‐N14. For diastereomers A / B these are 
52.1(6)o / 63.6(5)o and 32.0(4)o / 35.8(4)o respectively. Despite the difference in these 
torsions, the relative position of the methylene group remains fairly conserved. This can 
be represented by the angle between the line intersecting Pd1 and C13 and the plane 
defined by N11, C15 and Pd1, referred to as θCH2. For Pd(2.4 - H)(O,O’‐acac), θCH2 (A / B) 
is 28.4(2)o / 30.7(2)o. These values are consistent with those observed for Pt(2.4 - 











Bonding to the Pd(II) centre is characterised by the following bond lengths Pd1 – C15 = 
1.949(5) Å / 1.945(6) Å, Pd1 – N11 = 2.030(4) Å  / 2.046(4) Å, Pd1 – O2 = 2.015(3) Å / 
2.011(3) Å and Pd1 – O3 = 2.056(4) Å / 2.058(4) Å. Strong bonding by the NHC to Pd(II) 
is implied by the comparatively contracted Pd1 – C15 bond length. A relatively elongated 
Pd1 – O3 bond is evidence of the renowned trans‐influence of NHC ligands in their 
capacity as strong σ‐donors.167 The angles between these bonds are C15 – Pd1 – N11 = 
87.6(2)o / 86.1(2)o, C15 – Pd1 – O2 = 89.7(2)o / 92.5(2)o, N11 – Pd1 – O3 = 89.7(2)o / 
92.5(2)o, O2 – Pd1 – O3 = 90.6(2)o / 91.3(2)o.  This bonding information highlights the 
moderate variation between the two diastereomers of Pd(2.4 - H)(O,O’‐acac) (A and B) 
in the solid state. Visual inspection indicates that these isomers differ significantly in the 
relative orientations of the bornane moiety. This difference is best expressed by the 
torsion angle C13‐N11‐C2‐C3 which is 43.2(8)o for A and 172.0(5)o for B.  The geometry 
of the amidate nitrogen N11 is also affected with N11 being trigonal planar in A with a 
tetrahedron volume of 0.090 Å3 but slightly pyramidal in B with a larger tetrahedron 
volume of 0.316 Å3 as noted previously.  
 
The sterically congested nature of Pd(2.4 - H)(O,O’‐acac) is exemplified by several short, 
intramolecular non‐bonding contacts between the bornane frame and other parts of the 
complex at a distance greater than three bonds away (Figure 2.11). Diastereomer B 
Figure 2.11: The contents of the asymmetric unit arranged as to better illustrate the 
diastereoisomerism of the two conformations A and B. Also shown are several non-




contains the shortest such non‐bonding inter‐nuclear distances between C10B ··· O1B at 
2.884(8) Å and C3B ··· O3B at 2.839(7) Å. The closest interactions greater than three 
bonds apart in diastereomer A occur between C8A ··· O1A at 3.031(7) Å and C3A ··· O1A 
at 3.049(7) Å. It is tentatively inferred from this that, on a steric basis, diastereomer B is 
the less stable of the pair. This may help explain why diastereomer B also has more 
extreme torsions across the metal‐ligand bonds (torsion angles C15‐Pd1‐N14‐C12 and 
N11‐Pd1‐C15‐N14, see above) and a non‐trigonal planar amidate nitrogen. However, the 
crystallisation of both diastereomers in the asymmetric unit implies that crystal packing 
effects override any steric preferences. Interchange between these two diastereomeric 
conformations is observed by NMR as will be discussed. There are no stabilising 
intermolecular interactions of note.  
 
A crystal structure of Pt(2.4 - H)(O,O’‐acac) was obtained using a crystal grown by slow 
vapour diffusion of pentane into a toluene solution of the compound. This crystallised 
in the non‐centrosymmetric monoclinic space group P21 with two molecules of Pt(2.4 - 
H)(O,O’‐acac) in the asymmetric unit (Figure 2.12).  The complex Pt(2.4 - H)(O,O’‐acac) 
is an isostructural, crystallographic isomorph of its Pd(II) congener and has Flack(x) and 
Hooft(y) parameters of ‐0.011(3) and 0.006(2) respectively. Two A‐level alerts occur in 
the checkcif report due to two large residual density peaks of 9.040 eÅ‐3 and 3.920 eÅ‐3, 
each of which is adjacent to one of the Pt(II) centres (within ~ 0.90 Å). Inspection of the 
reciprocal lattice hinted at the presence of a very minor twin component, however, 
refinement of the solution with resolved twin lattices did not reduce the peak intensity. 
Strong absorption by the heavy platinum atoms may give rise to the observed residual 
density. Absorptions were corrected using the SCALE3 ABSPACK multi‐scan method in 
CrysAlisPro, however, more rigorous absorption corrections may be necessary. 
Alternatively, due to the intense scattering of platinum, a minor degree of disorder may 
result in Q‐peaks being observed for partially occupied Pt atom sites and not for the 
lighter atoms. Regardless, these unassigned density peaks do not prevent this model of 










Although it is anticipated that the larger Pt(II) centre can better accommodate chelation 
of the bornyl‐amidate, no major indication of this is observed in the solid state. The M – 
Ccarbene bond length Pt1 – C15 of 1.931(5) Å / 1.937(5) Å is notably shorter than Pd1 – 
C15 (1.949(5) Å / 1.945(6) Å) owing to the stronger Pt – NHC interaction identified in 
section 2.3.1.2. Otherwise, bonding and torsional measurements related to the 
coordination conformation of ligand 2.4 - H are comparable with the Pd(II) analogue. 
Data related to bonding at the Pt(II) centre is summarised in table 3.1, section 3.3.1.3. A 
complete structural analysis comparing data for the M(2.4 - H)(O,O’‐acac) and M(3.3 - 
H)(O,O’‐acac) complexes is also undertaken in that section. There are no mentionable 
features of Pt(2.4 - H)(O,O’‐acac) that have not been addressed regarding Pd(2.4 - 
H)(O,O’‐acac). 
 
Figure 2.12: Contents of the asymmetric unit of Pt(2.4 - H)(O,O’-acac) with relevant 
atoms labelled. Hydrogen atoms have been omitted for clarity. Thermal ellipsoids are 





NMR and IR spectroscopy support the structures elucidated by X‐ray crystallography. 
The presence of bornane and diisopropyl‐phenyl substituents in the complexes was 
readily confirmed by the 1H‐NMR and 13C‐NMR spectra. That the complex bore a 
coordinated NHC moiety was evidenced in each 1H‐NMR spectrum (Figure 2.13) by the 
conspicuous absence of a downfield singlet due to the NCHN proton (H15) of the 
imidazolium proligand. A signal due to the carbenic carbon (C15) is found in the 13C‐NMR 
spectrum of Pd(2.4 - H)(O,O’‐acac) at 153.55 ppm. This is consistent with a reported 
Pd(II) bonded carbene resonance when trans to O‐bound acac.38 The equivalent signal 
in the 13C‐NMR spectrum of the Pt(II) congener resonates at a lower frequency of 139.25 
ppm due to the greater electronic shielding of the carbon nucleus afforded by the more 
π‐donating, electron rich Pt(II) centre. This effect is noted to a lesser extent for the 
carbonyl carbon signals due to the acac ligand which are detected in the spectra of 
Pd(2.4 - H)(O,O’‐acac) at 185.98 ppm and 184.44 ppm and slightly upfield at 183.56 ppm 
and 182.64 ppm for Pt(2.4 - H)(O,O’‐acac). The chemical shift of the amidate carbonyl 
carbon is 170.29 ppm and 171.56 ppm for each complex.   
 
Signals attributed to the O‐bound acac ligand are found in the 1H‐NMR spectrum of the 
Pd(II) complex at 5.05 ppm ((CH3CO)2CH, H33), 1.89 ppm (CH3, H31) and 0.98 ppm (CH3, 
H35) and for the Pt(II) complex at 5.13 ppm ((CH3CO)2CH, H33), 1.77 ppm (CH3, H31) and 
0.93 ppm (CH3, H35). In both spectra it was noted that one of the H35 methyl‐proton 
resonances was unusually low field given that, in CDCl3 the methyl proton of O‐bond 
acac ligands typically resonate between 1.1 – 2.0 ppm with Pd(II)38, 169 and between 1.8 
– 2.1 with Pt(II).170, 171 This shift to below 1.0 ppm is most likely due to anisotropic 
shielding of the methyl group that is directed towards the face of the diisopropyl‐phenyl 
ring.  Evaluation of the crystal structures shows this to be a reasonable assessment. In 
the 13C‐NMR spectrum of both complexes the (CH3CO)2CH carbon (C33) is found at ~ 
100.0 ppm and the two methyl carbons at ~ 26.5 ppm and ~ 25.2 ppm. The proton of 
the imidazole‐2‐ylidene ring adjacent to the aryl ring (H17) is also anisotropically 
shielded. Its signal arises in the spectrum of both complexes at ~ 6.7 ppm which is ~ 1.1 































An amide NH proton is also missing from the 1H‐NMR spectrum. Although this implies 
that amidate chelation has occurred, this signal can be broadened out by other effects 
and hence its absence is not definitive evidence of deprotonation. In this case however, 
the presence of a deprotonated amide moiety was verified by IR spectroscopy. In a 
coordinated amidate, the amide anion is stabilised by association with the metal and 
conjugation of the negative charge onto the oxygen atom. This increases its iminol 















H33 H18 H17 
Figure 2.13 (a): The 1H-NMR spectrum of complex Pd(2.4 - H)(O,O’-acac) and, (b)




spectrum as a lowering of its vibrational stretching frequency. In the IR‐spectrum of the 
precursor salt 2.4.HCl the amide carbonyl stretch occurs at 1687 cm‐1. In the complexes 
Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) the vibrational energy of the NHC‐ligand 
based carbonyl stretch is reduced to 1575 cm‐1 and 1574 cm‐1 as expected. The carbonyl 
stretch associated with the O‐bound acac ligand in each respective complex are 1515 
cm‐1 and 1521 cm‐1, closely mirroring the carbonyl stretching frequency recorded for 
Pd(O,O’‐acac)2  at 1516 cm‐1. In this way, concomitant IR‐spectroscopy was used to 
confirm that the bulk material contained a coordinated amidate moiety.  
 
In addition to structural assignments, the 1H‐NMR and 13C‐NMR spectrum of complexes 
Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) aptly communicate how the 2.4 - H 
ligand is sterically restricted yet still conformationally fluxional. The non‐equivalence of 
proton and carbon environments due to the diisopropyl‐phenyl moiety and the 
emergence of diastereotopic methylene proton signals (H13) belies some degree of 
conformational restraint. However, the severe broadening of all signals associated with 
the bornane frame and methylene linker is indicative of slow molecular motion relative 
to the NMR timescale. This conformational dynamism will be explored through 
comparison of these spectral features with those of the complexes Pd(3.3 - H)(O,O’‐
acac) and Pt(3.3 - H)(O,O’‐acac) in section 3.3.1.3. Signal sharpening occurs at elevated 
temperatures due to acceleration of this motion, for an example of this see Figure 2.15 
in section 2.3.1.4. 
 
2.3.1.4. Characterisation of Pd(2.4)(O,O’-acac)(γC-acac) and Pt(2.4)(O,O’-
acac)(γC-acac) 
 
Of the complexes Pd(2.4)(O,O’‐acac)(γC‐acac) and Pt(2.4)(O,O’‐acac)(γC‐acac), the 
former was isolated some time before the latter and its identity was not immediately 
obvious. Despite exhaustive efforts, diffraction quality crystals were unable to be 
obtained for either complex. The difficulty in characterising Pd(2.4)(O,O’‐acac)(γC‐acac) 
arose from the fact that its mass‐spectrum was identical to that of Pd(2.4 - H)(O,O’‐acac) 
displaying a lone signal at 626.2570 (m/z, [Pd(2.4 - H)(O,O’‐acac) + H]+ = 626.2574). On 




compounds in a 70 : 30 ratio in CD3CN, neither of which were the chelated complex 
Pd(2.4 - H)(O,O’‐acac). These compounds were clearly closely related and could not be 
separated by chromatography. Synthesis of the Pt(II) version enabled identification of 
the true complex mass by mass spectrometry. For Pt(2.4)(O,O’‐acac)(γC‐acac) a single 
cation of mass 815.3714 is observed which corresponds to a calculated m/z, 
[Pt(2.4)(O,O’‐acac)(γC‐acac) + H]+ = 815.3711. In this way it was determined that these 
species contain one 2.4 ligand and two acac ligands, one of which is weakly bound given 
that it dissociates in the mass‐spectrum of Pd(2.4)(O,O’‐acac)(γC‐acac). A thorough NMR 
and IR analysis subsequently confirmed the structural identity of these compounds to 
be of the type shown in Figure 2.14. The two species observed in the NMR spectra were 
found to be amide rotamers hence are distinguished as having either Z or E‐amide 
geometries. 
 
For the NMR characterisation of Pd(2.4)(O,O’‐acac)(γC‐acac) and Pt(2.4)(O,O’‐acac)(γC‐
acac) it was beneficial to use spectra collected on a 600 MHz spectrometer to maximise 
signal resolution. With the exception of a couple of signals, the 1H‐NMR and 13C‐NMR 
spectra of Pd(2.4)(O,O’‐acac)(γC‐acac) and Pt(2.4)(O,O’‐acac)(γC‐acac) compare closely, 
hence, for convenience, the following analysis will focus on the spectra of the Pd(II) 
complex. Upfield regions of the 1H‐NMR and 13C‐NMR spectra of Pd(2.4)(O,O’‐acac)(γC‐
acac) are shown in Figure 2.14. At a glance, the alkyl regions of these spectra are too 
congested to be informative to this discussion and hence have been omitted. It is 
important to note that all alkyl environments are accounted for and have been assigned 
through careful interpretation with the aid of HSQC, HMBC, COSY and 2D‐NOESY 
experiments. 
 
It is deduced from these that the BA – NHC ligand adopts a monodentate “pendant” 
motif. This is clear from the presence of an amide hydrogen signal (H11) and the 
distinctive, geminally coupled doublets of the methylene hydrogen environments (H13). 
These are observed at 5.43 ppm and 4.75 ppm for the major isomer and at 5.19 ppm 
and 4.98 ppm for the minor with the 2JH‐H coupling constant of both being 16 Hz. This 
characteristic AB splitting pattern is routinely used to identify coordination of 





























It is further inferred from these spectra that there is one O‐bound and one C‐bound acac 
ligand in the complex. The O‐bound acac ligand contributes carbonyl‐carbon resonances 
at 188.64 ppm and 187.63 ppm (C27/C28) and the pseudo‐aromatic carbon resonance 
(C27) at 100.38 ppm with its bonded hydrogen (H27) detected at 5.32 ppm in the proton 
spectrum. More importantly, we find conclusive evidence that a σ‐bonded acac ligand 
occupies the remaining coordination site. The chemical shift of these proton and carbon 













Figure 2.14: Upfield regions of the 1H-NMR and 13C-NMR spectra of Pd(2.4)(O,O’-
acac)(γC-acac) in CD3CN. Selected signals are labelled with the suffix Z or E denoting the 














spectrum is particularly informative with the carbonyl‐carbon of γC‐acac generating the 
highest frequency signals between 207.80 ppm – 206.94 ppm (C31/C33). The metal‐
bonded carbon centre is seen to resonate at a lower frequency when compared with 
the O‐bound acac due to greater nuclear shielding as a result of its sp3 character. Signals 
for both isomers due to this environment are found at 48.68 ppm (C32‐Z) and 48.31 ppm 
(C32‐E) and the associated proton resonances are 3.40 ppm (H32‐Z) and 3.32 ppm (H32‐
E). HMBC analysis shows that the γCH signal is correlated to the carbonyl‐carbon 
resonances as expected. Further correlations enabled the two methyl environments to 
be assigned. In both Pd(2.4)(O,O’‐acac)(γC‐acac) and Pt(2.4)(O,O’‐acac)(γC‐acac), the 1H‐
NMR and 13C‐NMR chemical shifts agree with reported values for C‐bound acac.38, 169‐173  
 
IR‐spectroscopy complemented this structural assignment through identification of 
several characteristic carbonyl stretching frequencies. Both Pd(2.4)(O,O’‐acac)(γC‐acac) 
and Pt(2.4)(O,O’‐acac)(γC‐acac) produced comparable IR spectra with three strong 
signals at 1672 cm‐1, 1578 cm‐1 and 1515 cm‐1 for the former and at 1674 cm‐1, 1575 cm‐
1 and 1520 cm‐1 for the latter. The observed signal at ~ 1670 cm‐1 falls neatly within the 
range for a typical amide carbonyl stretching frequency (1640 cm‐1 – 1690 cm‐1) and 
resembles the related stretch at 1687 cm‐1 observed in the spectrum of the proligand 
2.4.HCl. This strongly suggests that the amido‐functionality is not involved in 
coordination. Stretching of the O‐bound acac carbonyl produces the signals at ~ 1520 
cm‐1, mirroring the equivalent signal observed in the spectrum of Pd(2.4 - H)(O,O’‐acac), 
Pt(2.4 - H)(O,O’‐acac) and Pd(acac)2 (see section 2.3.1.3). The intermediary stretch is 
most likely due to the C‐bound acac. Several much weaker signals are interspersed 
amongst these carbonyl stretching frequencies and may be attributed to amide N – H 
bending, aromatic C – C stretching or to the carbonyl stretches of the minor isomer. 
 
Confident of the structure assigned to Pd(2.4)(O,O’‐acac)(γC‐acac) and Pt(2.4)(O,O’‐
acac)(γC‐acac), attention turned to identifying the perceived mode of isomerism 
apparent in NMR spectra of these compounds. An equilibrium relationship between the 
two observed isomers of Pd(2.4)(O,O’‐acac)(γC‐acac) and Pt(2.4)(O,O’‐acac)(γC‐acac) 
was anticipated on the basis that they are inseparable and consistently recovered in an 




substituent could similarly affect these complexes as it does for the chelate complexes 
Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) (section 2.3.1.3). The molecule contains 
a number of rotatable bonds which could plausibly be restricted by steric interactions 
to give the two distinct species observed by 1H‐NMR (as in Pd(2.4)(allyl)Cl, section 
2.3.3.2), however, the evidence at hand suggests amide rotamers are a probable cause 
(Scheme 2.15). The occurrence of Z and E-amide geometries is a well understood 
phenomenon arising from the significant π‐bond character of the resonance stabilised 




















An initial indication that such isomerism is taking place in complexes Pd(2.4)(O,O’‐
acac)(γC‐acac) and Pt(2.4)(O,O’‐acac)(γC‐acac) is the position of the proton and carbon 
NMR resonances for the N – CHα environment. It is well established that secondary N‐











(ϕ = 0o, φ = 180o) 
Z-syn  
(ϕ = 0o, φ = 0o) 
E-anti  
(ϕ = 180o, φ =180o) 
E-syn  
(ϕ = 180o, φ =0o) 
 
 





CH proton (Scheme 2.15). When in the Z‐anti configuration, the amide carbonyl bond 
anisotropy has a large deshielding influence on Hα whilst shielding Cα.174 This effect was 
observed in the spectra of both complexes for which the equivalent bond is labelled N11 
– C2 (see Figure 2.14). For (Z / E)‐Pd(2.4)(O,O’‐acac)(γC‐acac), H2 resonates at 3.95 ppm 
/ 3.84 ppm and C2 at 58.41 ppm / 58.81 ppm, and for (Z / E)‐Pt(2.4)(O,O’‐acac)(γC‐acac) 
at 3.97 ppm / 3.86 ppm and 58.37 ppm / 58.66 ppm. None of the precursor acetamide 
compounds 2.1 and 2.2 – 2.5.HCl exhibit observable isomerism, nor for that matter, do 
any reported NHC‐acetimide derivatives.  Moreover, it is surprising that a distinction 
between E / Z geometries in the ligand 2.4 should arise following an increase in the bulk 
of the imidazole terminus which, on steric grounds, should overwhelmingly favour the 
Z-amide geometry.  
 
Variable temperature 1H‐NMR experiments were used to confirm that the isomers were 
dynamically interconverting, rotationally related species. Coalescence of signals is 
expected at elevated temperatures due to accelerated rotation relative to the timescale 
of the NMR. The analysis was performed using DMSO as the solvent and heating at 10 – 
15 oC increments between from 25 oC to 130 oC (Figure 2.15a). CD3CN was the preferred 
solvent for these experiments as it produces 1H‐NMR spectra with clear resolution of 
isomeric signals (Figure 2.14). Unfortunately, only minor spectral changes occurred at 
temperatures approaching its boiling point of 82 oC necessitating the use of DMSO‐d6 
to access higher temperatures. 
 
Resonances were observed to have fully coalesced by 110 oC. As expected, proton 
resonances adjacent to the amide bond are most affected. The amide NH proton (H11) 
and CHα (H2) coalesce neatly to a single peak. Signals due the methylene proton (C13) 
likewise merge but are not seen at temperatures above 100 oC. Measuring the spectrum 
again at 25 oC after cooling from 130 oC showed that the original isomeric ratio was 














































130 oC →25 oC, DMSO 
Pd(2.4 - H)(O,O’‐acac) 
25 oC, DMSO 
Figure 2.15 (a): Series highlighting the changes in the 1H-NMR spectrum of Pd(2.4)(O,O’-
acac)(γC-acac) as a function of temperature in DMSO‐d6 and, (b) its spectrum recorded 
at 25 oC after heating to 130 oC in comparison with the 1H-NMR spectrum of Pd(2.4 -
H)(O,O’-acac).  The formation of the chelated species upon heating of Pd(2.4)(O,O’-
acac)(γC-acac) accounts for the emergence of signals denoted by *. These signals persist 







No attempt was made to quantify the rotational free energy barrier ΔG‡ using the 
coalescence temperature method.175, 176 This is complicated by the asymmetry of the 
compound and conversion to Pd(2.4 - H)(O,O’‐acac) at higher temperature. Observing 
the reversible coalescence of proton resonances related to the amide moiety is 
adequate confirmation of interconverting amide rotamers.  
 
Curiously, irreversible formation of the chelated amidate complex Pd(2.4 - H)(O,O’‐acac) 
emerged as a competing side‐process, onset of which occurred at 70 oC.  Diagnostic 
signals due to this species are denoted by an asterisk in Figure 2.15a and it is shown to 
persist in solution upon cooling through comparison with the room temperature 
spectrum of Pd(2.4 - H)(O,O’‐acac) in DMSO‐d6 (Figure 2.15b).  Sharp signals due to 
Pd(2.4 - H)(O,O’‐acac) are observed at elevated temperature due to acceleration of the 
ring flipping action identified in section 2.3.1.3 and its very formation provides some 
mechanistic insight as elaborated in section 2.3.1.5.  
 
The effect of solvent polarity on the rotamer equilibrium was studied in an effort to 
determine why the E‐amide configuration of ligand 2.4 becomes so prevalent when 
incorporated in this complex. As mentioned previously, coordination of the NHC 
represents a large increase in steric bulk which should favour the Z‐amide. However, 
while steric interactions are usually the main driving force, electrostatic and entropic 
factors can be influential.145, 146, 174, 177, 178 The relative Z / E populations were determined 
by integration of selected proton signals in the 1H‐NMR spectra of Pd(2.4)(O,O’‐acac)(γC‐
acac) in several different solvents. An E‐amide population of ~ 30% is observed in 
benzene‐d6, CD3CN and CD3OD but drops slightly to 24 % in chloroform. Signals are too 
poorly separated in the spectrum recorded using DMSO‐d6 to determine a ratio and the 
compound is insoluble in D2O. It is difficult to draw a definitive conclusion based on 
these findings, but regardless of this, a room temperature E‐amide population of ~ 30% 
is large for a secondary amide. It is suspected that the E-amide geometry is stabilised by 
non‐polar interactions between the bornane group and the hydrophobic pockets 
formed between the isopropyl substituents on 2.4 and methyl groups of the acac 




amide configuration compared with the Z-amide is shown in Figure 2.16 for both 
Pd(2.4)(O,O’‐acac)(γC‐acac) and a tailor‐made literature compound.178  
 
 
















In the conformation shown, the carbonyl group can also participate in hydrophilic 
interactions with keto‐groups of the γC‐acac ligand and the amide moiety can be co‐
planar to the pseudo‐aromatic O,O’‐acac ligand. These complementary intramolecular 
hydrophilic and hydrophobic interactions may explain why the Z / E ratio exhibits only 
minor solvent dependence. If the driving interaction is predominantly non‐polar a polar‐
protic solvent such as MeOH would be expected to promote association of the 
hydrophobic surfaces increasing the E‐amide population compared to say, benzene. This 
is demonstrated by the example in Figure 2.16b for which the E‐amide configuration 
minimises the hydrophobic surface area and exposes hydrophilic contacts. This leads to 
an E‐amide population of 24% in D2O and only 6% in CDCl3.178 Because intramolecular 
bornane 
Z – Pd(2.4)(O,O’‐acac)(γC‐acac) E – Pd(2.4)(O,O’‐acac)(γC‐acac) 
Z / E 
 
 70 / 30, MeOD  
Z / E 
 
 76 / 24, D2O  
Z – amide E – amide 
Figure 2.16 (a): E / Z – amide configurations of Pd(2.4)(O,O’-acac)(γC-acac) and, (b) a 




contacts such as these reduce the amount of solvent accessible surface area, 
desolvation upon conversion to the E‐amide configuration provides an entropic 
motive.177 Furthermore, this accounts for why the imidazolium salt proligands 2.2.HCl – 
2.5.HCl are not observed as amide rotamers; an E‐amide configuration would bring the 
highly hydrophobic bornane proximal to the hydrophilic imidazolium salt moiety. The Z‐
amide configuration therefore minimises both steric strain and electrostatic repulsion 
in 2.2.HCl – 2.5.HCl. Conversion into a neutral, coordinated NHC reverses the 
electrostatic relationship between imidazolyl moiety and the bornane unit. The E‐
configuration which was destabilising to the precursor becomes energetically available 
in the complex. This has interesting implications for the role for these compounds in 
asymmetric catalysis. Interaction with the stereodirecting bornane unit via chelation by 
the amide requires it to be in the Z‐geometry however, “non‐chelated” electrostatic 
association improves with an E‐geometry. 
 
Such behaviour has been documented in a number of organic compounds and, most 
notably, in relation to the study of protein dynamics.179 Furthermore, 
hydrophobic/hydrophilic interactions have been exploited to tune Z / E-amide equilibria 
in order to understand and control receptor binding of amide‐containing compounds for 
enzyme regulation and inhibition.179‐181  
 
2.3.1.5. Discussion of reaction conditions and possible improvements 
 
Although complex Pd(2.4)(O,O’‐acac)(γC‐acac) proved to be interesting in its own right, 
the chelated complex Pd(2.4 - H)(O,O’‐acac) was the desired target and considerable 
effort was invested in its synthesis. The condition sets that were trialled for its 














Condition sets 1, 2, 4 and 5 were the most successful albeit still low yielding. These used 
K2CO3 as base and are similar in that the reaction was heated for 4 hours after the 
addition of acetylacetone. Condition set 7 which used DMSO at an extreme temperature 
of 110 oC yielded no product, however, it was likely reacted for too long (15 hours) 
leading to degradation of the product and reactants. The formation of Pd(2.4)(O,O’‐
acac)(γC‐acac) as the major product was suspected to occur via reaction of the NHC 
ligand with Pd(O,O’‐acac)2. 
 
To support this hypothesis, complex Pd(2.4)(O,O’‐acac)(γC‐acac) was prepared in a 59% 
yield by a targeted synthesis using sodium acetylacetonate as base (Scheme 2.17). This 
2.4.HX 
















1 Cl MeCN PdCl2 K2CO3 80 0 4 ~ 10%
2 Cl MeCN PdCl2 K2CO3 80 10 4 12%
3 Cl MeCN PdCl2 K2CO3 80 90 1 trace
4 Cl MeCN PdCl2 K2CO3 reflux 45 4 14%
5 PF6 MeCN Pd(OAc)2 K2CO3 reflux 90 4 ~ 10%
6 Cl MeCN PdCl2 NEt3 80 10 4 0
7 Cl DMSO Pd(PhCN)2Cl2 K2CO3 110 60 15 0
 (i)
Scheme 2.16: In situ synthesis of Pd(2.4 - H)(O,O’-acac) from 2.4.HX via one or more  
uncharacterised Pd(NHC) intermediates. The conditions trialled for (i) and (ii) are 




presumably produces the compound by reorganisation of one O‐bound acac ligands of 
Pd(O,O’‐acac)2 to accommodate coordination of the NHC in a manner that has been 
previously acknowledged.38 Furthermore, this supports the notion that Pd(2.4)(O,O’‐
acac)(γC‐acac) forms because Pd(O,O’‐acac)2 is a thermodynamically and kinetically 
favoured product that forms rapidly under the conditions before coordination by the 








































It is likely that even when not using Na(acac) as base, as per the conditions in Table 2.1, 
Pd(O,O’‐acac)2 forms readily. This is despite efforts to pre‐form the NHC – Pd bond, as 
in step (i), Scheme 2.16. Formation of Pd(2.4)2 type species, which were detected by 
mass spectrometry, may be driven by the formation of Pd(O,O’‐acac)2 after the initial 
addition of acetylacetone. Because of the extremely hindered nature of 2.4, the Pd(2.4)2 
complexes are likely prone to ligand dissociation, availing 2.4 to react with Pd(O,O’‐
acac)2. 
 
Interestingly, attempts made at the synthesis of Pd(2.2)(O,O’‐acac) derivatives using 
proligand 2.2.HCl and condition set 4, Table 2.1 and also with Na(acac) as base (as in 





Scheme 2.17: Targeted synthesis of Pd(2.4)(O,O’-acac)(γC-acac) and the probable 




resolution mass spectra bore a single major signal at ~ 330.13 which is attributable to 
[Pd(2.2)2]2+ species (calculated m/z, [Pd(2.2)2]2+ = 328.15). Formation of Pd(2.2)2 
explains the complexity of the 1H‐NMR spectrum of the product mixtures as addressed 
in section 2.3. The propensity for ligand 2.2 to favour Pd(NHC)2 type complexes is 
explored further in section 2.3.3.1 in relation to the Pd(2.2)(allyl)Cl complex (see Scheme 
2.21). 
 
It is likely that the bulky diisopropyl‐phenyl group of 2.4 is crucial to disfavouring 
Pd(NHC)2 coordination, enabling the isolation of mono‐NHC complexes Pd(2.4 - H)(O,O’‐
acac) and Pd(2.4)(O,O’‐acac)(γC‐acac). Mono‐NHC complexes could not be isolated using 
ligand 2.2 highlighting the subtleties of synthesising mono‐NHC complexes by this 
method. This is why acetamide‐linked NHC ligands are typically used to prepare 
M(NHC)2 type complexes or for coordinating an NHC to a stable complex with the 
desired ancillary ligand pre‐coordinated.120 The latter approach was taken with the 
directed synthesis of Pd(2.4)(O,O’‐acac)(γC‐acac) from Pd(O,O’‐acac)2 (Scheme 2.17). 
Variable temperature NMR analysis of Pd(2.4)(O,O’‐acac)(γC‐acac) showed the 
formation of Pd(2.4 - H)(O,O’‐acac) at temperatures above 70 oC (Figure 2.15). 
Therefore, synthesising Pd(2.4)(O,O’‐acac)(γC‐acac) and then converting it to the 
chelated form through careful heating is a rational approach. Unfortunately, there was 
insufficient time to attempt this. 
 
2.3.2. Ag(NHC) intermediary complexes 
 
The complexes discussed in sections 2.3.3, 2.3.4 and 2.3.5 are all prepared via 
transmetalation of the NHC ligand from an Ag(I) centre, as are many of the complexes 
prepared in Chapters 3 and 5. This approach is ubiquitous in the field of NHC‐complex 
synthesis, however, because the NHC‐Ag(I) complexes are often treated as intermediary 
species, they are rarely isolated or characterised. However, to provide an appreciation 
of their reactivity and spectral properties, two complexes Ag(2.2)Cl and Ag(2.3)Cl, were 
isolated for analysis. This helped to improve later evaluation of reaction progress and 




this study, the 1H‐NMR spectra of most other NHC‐Ag(I) intermediates were recorded 
and found to be comparable with the characterised species.  
 
It is worth noting here that because of the geometric ambivalence of Ag(I) complexes it 
is difficult to predict the structure of the NHC‐Ag(I) species, particularly in the presence 
of the potentially coordinating amide wing. Selecting the appropriate counter‐anion of 
the imidazolium salt proligand affords some degree of control. Halides typically favour 
neutral, mono‐NHC complexes of the type Ag(NHC)X, although, numerous halo‐bridged 
and ion‐pair complexes have been reported.100 Non‐coordinating anions such as PF6 
generally form cationic, bis‐NHC complexes ([Ag(NHC)2][PF6]). This is best illustrated by 














The choice of anion is governed by the solubility of the proligand salt (imidazolium 
halides are typically less organic soluble), solubility of the NHC‐Ag(I) intermediate and 
the nature of the target NHC‐M complex. Regardless of the anion, organic solubility was 
rarely an issue for these bornyl‐acetamide compounds because of the bornane 



























Scheme 2.18: Coordination behaviour of NHC-Ag complexes with coordinating (Br) and 




complexes in Chapter 5. However, it was found that using an imidazolium PF6 precursor 
increased the likelihood of forming undesired bis‐ligated M(NHC)2 complexes due to the 
Ag(NHC)2 intermediate (see section 5.3.2.1). Using the chloride salts, as obtained from 
the proligand synthesis, was therefore preferred. However, without detailed structural 
characterisation such as an X‐ray crystal structure it is difficult to assign the true nature 
of NHC‐Ag(I) complexes prepared from an imidazolium chloride salt.  For the sake of this 
discussion, NHC‐Ag(I) complexes are assumed to adopt a linear at metal geometry with 
a monodentate BA‐NHC ligand represented here as Ag(BA)Cl.100 This assumption has no 
major experimental basis, it is purely for convenience. 
 
2.3.2.1. Synthesis and Characterisation of Ag(2.2)Cl and Ag(2.3)Cl 
 
Complex Ag(2.2)Cl and Ag(2.3)Cl were prepared by stirring the corresponding 
imidazolium chloride proligand in DCM with half a molar equivalent of Ag2O. Like most 
Ag(I) complexes, these are light sensitive so reactions are performed in darkness. 
Reaction progress is seen in the gradual disappearance of the grey Ag2O into a colourless 
solution or turbid, white suspension. Reaction time appeared to be dependent on the 
bulk of the pendant group with synthesis of Ag(2.4)Cl taking over 20 hours. For the 
smaller alkyl‐appended species Ag(2.2)Cl and Ag(2.3)Cl, reactions were complete after 
7 hours and 14 hours, respectively. Complex Ag(2.2)Cl was isolated after filtering 
through celite and removing the solvent carefully by rotary‐evaporation, avoiding 
heating and overexposure to light. This provided pure compound as a fluffy white solid 
in 86% yield. This batch was partitioned and used in separate synthesis of Pd(2.2)(allyl)Cl 
(section 2.3.3.1) and [Ru(2.2)(p‐cymene)Cl][Cl] (section 2.3.5.1). The solid sample was 
air and moisture stable over a one‐week period, however, in solution grey material, 
probably metallic silver or silver oxide, deposited within two days. Attempts to grow 
crystals likewise resulted in deposition of a grey powder and this was true for all organic 
NHC‐Ag(I) complexes in this study. Ag(2.3)Cl was similarly isolated but only a portion 
was taken from the reaction mixture for analysis so yields could not be calculated. The 





Being the simplest NHC complexes prepared in this work, their NMR spectra are suited 
to comparison with those of the proligands to clearly highlight the changes undergone 



















Here the loss of the NCHN (H15) proton signal at 9.28 ppm is conspicuous as is the 
upfield shift of the amide NH (H11) from 8.39 ppm in 2.3.HCl to 6.83 ppm in Ag(2.3)Cl 
(Δδ = 1.56 ppm). The strongly coupled methylene proton environments (H13) converge 
slightly and shift modestly upfield (Δδ ~ 0.30 ppm). Interestingly, H11 is shifted to a 
greater extent than H13 despite being more remote to the site of modification. This 
supports the assertion made in section 2.2.1 that the amide group of imidazolium salt 
proligands is involved in hydrogen bonding, either between the amide carbonyl and H15 
or H11 and the chloride anion (or both). Deprotonation and NHC coordination prevent 
these interactions, returning the H11 signal to an upfield position (as in 2.1). 
Furthermore, the most affected bornane environment is the methyl H8 which juts over 


















Figure 2.17: Collated 1H-NMR spectra of Ag(2.3)Cl (red) and 2.3.HCl (black) in CD3CN with 




inductive deshielding considering that H2, which is adjacent to the NH, remains 
unchanged. Irrespective of their origin, it is plain to see the formation of a carbenic 
species based on these changes. 
 
Each NHC‐Ag(I) species was identified by low resolution mass‐spectroscopy as a minor 
signal due to the [Ag(NHC)2]+ cation at 657.30 for [Ag(2.2)2]+ and at 715.37 for [Ag(2.3)2]+ 
(product of deuterium exchange with NMR solvent) for which the calculated m/z are 
[Ag(2.2)2]+ = 657.30 and [Ag(2.3)2]+ (‐2H, +2D) = 715.37. Much larger signals due to the 
corresponding imidazolium salts ([2.2.H]+ or [2.3.H]+) were evident in each spectra. This 
alludes to the acknowledged weakness of the NHC – Ag(I) bond so necessary for 
transmetalation. Despite NHC – Ag(I) compounds being potentially useful in a variety of 
applications,64 in this study they were employed solely as intermediates. 
 
2.3.3. Pd(NHC)(allyl)Cl type complexes 
 
LnPd(η3‐allyl) complexes represent a class of organo‐palladium compounds containing a 
π‐bonded, formally anionic allyl(η3) ligand. An allyl ligand can be variably substituted 
however, the following synthesis and discussion is concerned solely with the simplest 
allyl C3H5. The canonical forms of the free ligand are reflected in the organometallic 
bonding of the coordinated species (Figure 2.18). When π‐bonded it is considered a 
bidentate ligand. A fluxional relationship between π and σ coordination modes of allylic 
ligands is often observed, the nature of which depends on the metal centre, other 
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The selection of an allyl ancillary ligand was decided based upon their synthetic 
practicality and air and moisture stability. Several Pd(NHC)(allyl)Cl type complexes have 
been applied as catalysts in Suzuki‐Miyaura and Buchwald‐Hartwig cross‐coupling 
reactions,37, 184 the telomerisation of amines185 and in the α‐arylation of ketones.85 In all 
cases the authors have noted their efficient pre‐catalyst activation.   
 
Reported Pd(NHC)(allyl)Cl complexes are synthesised by reacting the dimeric complex 
[Pd(allyl)Cl]2 with an NHC source; either the free NHC ligand or an NHC‐Ag(I) complex. 
The latter transmetalation route was employed, in this study, for the synthesis of 
Pd(BA)(allyl)Cl complexes with ligands 2.2 and 2.4. This approach is generalised in 










The precursor [Pd(allyl)Cl]2 was conveniently prepared by oxidative addition of Pd(0) 
into the allyl‐Cl bond of allylchloride following the method of Nolan et al.37 PdCl2 is 
stirred with excess allylchloride and KCl in degassed, distilled water under an inert 
atmosphere at room temperature. After 20 hours the faint yellow suspension is 
extracted with chloroform which is dried over MgSO4 and the solvent removed providing 
[Pd(allyl)Cl]2 as a fine yellow powder. This approach relies on the in situ reduction of 
Pd(II) to Pd(0). Optimal yields of over 90% are achieved by the careful exclusion of 
oxygen and using freshly distilled allylchloride. 
 
The following sections explore the synthesis and study of Pd(BA)(allyl)Cl complexes 
prepared from [Pd(allyl)Cl]2 in accordance with Scheme 2.19.  
Pd(NHC)(allyl)Cl 
[Pd(allyl)Cl]2, 91% 
Scheme 2.19: Conditions for the synthesis of [Pd(allyl)Cl]2 and its reaction to form an 





2.3.3.1. Synthesis of Pd(2.2)(allyl)Cl and Pd(2.4)(allyl)Cl  
 
Compounds Pd(2.2)(allyl)Cl and Pd(2.4)(allyl)Cl were prepared by carbene transfer from 
their respective NHC‐Ag(I) complexes. Complex Pd(2.2)(allyl)Cl was prepared from 
isolated Ag(2.2)Cl however, as mentioned in section 2.3.2, it is not always necessary to 
isolate the NHC‐Ag(I) intermediate. For Pd(2.4)(allyl)Cl, the Ag(I) precursor was 
prepared, and reacted onwards in situ. Aside from this exception the two approaches 
were identical as shown in Scheme 2.20, the quoted yields were calculated from the 
imidazolium salt. The lower yield for Pd(2.2)(allyl)Cl is due to product lost during 








The reaction was performed in darkness and under an inert atmosphere by adding a 
DCM solution of [Pd(allyl)Cl]2 to a stirred DCM solution of the NHC‐Ag(I) species.  In each 
case the solution immediately becomes white and cloudy from precipitation of AgCl. 
After 20 hours transmetalation is complete and products are obtained following the 
removal of AgCl by filtration of the reaction mixture through celite and evaporation of 
the solvent. This provided Pd(2.4)(allyl)Cl in pure form as a fluffy, faint yellow solid. Like 
Pd(2.4)(O,O’‐acac)(γC‐acac) and Pt(2.4)(O,O’‐acac)(γC‐acac), this complex of ligand 2.4 
was observed to exist as a mixture of two isomers, contributing to the complexity of its 
NMR spectra (see section 2.3.3.2).  
 
R = Me,  Pd(2.2)(allyl)Cl, 62% 
R = AriPr, Pd(2.4)(allyl)Cl, 82% 





Purification of methyl‐appended version, Pd(2.2)(allyl)Cl was impeded by its apparent 
instability and only a crude yield could be determined. Its 1H‐NMR spectrum in 
chloroform contained numerous broad peaks, although, the ligand 2.2 was clearly 
present. After several hours the sample had begun to blacken, presumably depositing 
Pd(0). In DMSO‐d6, the sample darkened rapidly and two distinct species were observed 
by 1H‐NMR. Pd(2.2)(allyl)Cl is assumed to exhibit isomerism also however, in addition to 
this, its mass‐spectrum indicated the presence of two distinct species. The larger signal 
at 422.1421 corresponds to the desired product with the chloride ligand missing while 
the smaller signal at 697.3433 is assigned to the cationic complex [Pd(2.2)2(allyl)]+ (m/z, 
[Pd(2.2)(allyl)]+ = 422.1424, [Pd(2.2)2(allyl)]+ =  697.3421). It is possible to extract the 
cationic impurity into an aqueous phase by washing an Et2O solution with water or 
directly rinsing the solid with water. Addition of KPF6 solution results in precipitation of 
a white solid which has a messy 1H‐NMR spectrum, albeit clearly indicating the presence 
of 2.2. Its mass‐spectrum is clean, showing the same two signals for Pd(2.2)(allyl)Cl and  
[Pd(2.2)2(allyl)]+, however, the latter signal is now much larger. Analysis of the “purified” 
Pd(2.2)(allyl)Cl shows it to be unchanged. Evidently, ligand 2.2 is moderately labile and 
an equilibrium exists between Pd(2.2)(allyl)Cl and [Pd(2.2)2(allyl)]+ which may be 
exacerbated by nucleophilic solvents (Scheme 2.21). This no doubt contributes to its 
observed degradation in solution and for this reason complex Pd(2.2)(allyl)Cl was not 




























Transmetalation of carbene ligands between Pd(II)‐centres is uncommon but has been 
explored in a comprehensive study by Canovese et al.186  They demonstrated the 
exchange of NHC ligands bearing thio‐ether or pyridyl groups constituting hemi‐labile 
chelating arms (Scheme 2.22). An associative mechanism of exchange was postulated 
and suggested to occur via a dimeric intermediate which is reliant on having arm‐groups 
capable of bridging interactions.  Only NHC ligands with a methyl substituent underwent 
ligand interchange. The steric bulk of mesityl‐ or diisopropyl‐phenyl‐ substituted NHC 
ligands shielded the Pd(II) centre, preventing associative exchange. There are obvious 




2  Pd(2.2)(allyl)Cl 
4  [Pd(2.2)2(allyl)]Cl 
[Pd(allyl)Cl]2 
Scheme 2.21: Possible equilibrium explaining the persistent occurrence of 
[Pd(2.2)2(allyl)]+. 
25% 25% 50% 
Scheme 2.22: Pd(II) to Pd(II) transmetalation of NHC ligands with hemi-labile 




2.3.3.2. Characterisation of Pd(2.4)(allyl)Cl 
 
Complex Pd(2.4)(allyl)Cl is sufficiently stable to be isolated in a pure form and 
demonstrably catalyses the synthesis of hindered biaryls by Suzuki‐Miyaura coupling 
(Chapter 6).  Employment of well‐defined precatalysts is desired to better predict the 
structure of the active species making Pd(2.4)(allyl)Cl particularly interesting. Full 
structural assignment was achieved using NMR, IR and mass‐spectroscopy. Suitable 
crystals for X‐ray diffraction could not be obtained although the analogous cyclohexyl‐
derivative Pd(3.3)(allyl)Cl was studied by crystallography (section 3.3.2.2). 
 
The complex Pd(2.4)(allyl)Cl produced a solitary signal in its mass‐spectrum at 568.2533, 
attributable to the species [M – Cl]+ (calculated m/z, [Pd(2.4)(allyl)]+ = 568.2519). NMR 
analysis in solvents including CDCl3, CD3CN and benzene‐d6 show Pd(2.4)(allyl)Cl to exist 
as two interconverting diastereomers, however, only a single species is apparent in the 
spectrum recorded using DMSO‐d6 alluding to some curious solvent dependent 
behaviour (Figure 2.19). For the previously discussed complexes Pd(2.4)(O,O’‐acac)(γC‐
acac) and Pt(2.4)(O,O’‐acac)(γC‐acac), the occurrence of isomers was attributed to Z/E-
amide geometries of ligand 2.4 (2.3.1.4). In Pd(2.4)(allyl)Cl the well‐studied 
conformational dynamism of the allyl ligand introduces further modes of isomerism. As 
will become apparent, it is difficult to assign the exact nature of allyl‐isomerism without 
a lengthy spectroscopic analysis187‐190 hence only preliminary insight is provided herein. 
For convenience, the structural assignment of Pd(2.4)(allyl)Cl will be discussed in 
relation to the NMR spectra in DMSO‐d6 before evaluating the compound’s dynamic 
behaviour. 
 
The 1H‐NMR and 13C‐NMR spectra of Pd(2.4)(allyl)Cl in DMSO‐d6 clearly present a single 
species (Figure 2.19a). Ligation by 2.4 is readily confirmed by the presence of signals 
pertaining to the bornane group in the alkyl‐region of each spectrum along with 
aromatic signals assignable to the diisopropyl‐phenyl and imidazolyl moieties. 
Methylene proton environments (H13) are diastereotopic, presenting as two doublets 
at 5.16 ppm and ~ 4.97 ppm (overlapping with H26) with a large germinal coupling of 




and the emergence of a downfield 13C resonance at 182.22 ppm corresponding to the 
carbene environment (C15). 
 








    
 














This assignment was confirmed on the basis of HMBC correlations between this signal 
and the H13, H17, H18 and H27 proton environments. The signal due to the amide NH 
environment (H11) is concealed under the multiplet at 7.60 ppm – 7.38 ppm but is 
identifiable by integration over this range and further confirmed to be at around 7.48 




































Figure 2.19 (a): The 1H-NMR spectrum of Pd(2.4)(allyl)Cl in DMSO-d6 and, (b) in CD3CN. 
Selected signals labelled and, where relevant, major and minor isomers denoted by the 




at 167.09 ppm and 56.77 ppm, respectively. The relative peak position of the amide NH 
environment typically varies with solvent hence is observed as a broad singlet or doublet 
in spectra using CDCl3, CD3CN and benzene‐d6. This alludes to “pendant” coordination 
as verified by IR spectroscopy in which the observed carbonyl‐stretching frequency of 
1672 cm‐1 is comparable to the proligand 2.4.HCl (ν (C=O) = 1687 cm‐1).  
 
Proton environments of the allyl auxiliary are observed as a multiplet at ~ 4.95 ppm 
(H26) and two doublets at 3.81 ppm (syn‐H27) and 2.76 ppm (anti‐H27). Syn and anti‐
environments relative to the central hydrogen (H26) are distinguished by their coupling 
constants which fall within the range expected for vicinal coupling of the type 3Jcis/rans 
(syn‐H27, 3Jcis = 7.4 Hz and anti‐H27, 3Jtrans = 13.3 Hz).191, 192 Carbon signals for the allyl 
ligand are found at 144.79 ppm (C26), 71.22 ppm (C27) and 49.22 ppm (C25). The 
position of C27 being trans to the NHC is reflected in the upfield location of its signal 
relative to that of C25.193 Interestingly, the syn/anti‐CH2 allyl resonances correlate to 
C27 and not C25 in the HSCQ‐map. The C25 environment is only assignable by three‐
bond correlation in the HMBC spectrum (Figure 2.20) suggesting that the syn/anti‐H25 




















H2 → C2 





Figure 2.20: HSQC (left) and HMBC (right) spectra of Pd(2.4)(allyl)Cl in DMSO-d6. 
Highlighted correlations show the detection of C25 through a 3-bond correlation with 




They are however, visible in the other solvents used (see Figure 2.19b for CD3CN).  
 
It is tempting to attribute the Z/E-amide geometric isomerism proposed for 
Pd(2.4)(O,O’‐acac)(γC‐acac) and Pt(2.4)(O,O’‐acac)(γC‐acac) to the isomerism of 
Pd(2.4)(allyl)Cl. NMR evidence suggests, however, that allyl fluxionality is the sole 
contributor. This evidence includes; (a) a near 1:1 isomeric ratio, (b) minor chemical shift 
differences between the two isomers which are only observed for environments 
associated with the coordinated groups, not the bornyl group and (c) a single species 
observed by NMR in DMSO‐d6. These points will be addressed systematically. 
 
Without a strong driving force, such as well‐defined intramolecular hydrogen‐bonding,  
a near 1:1 Z/E ratio for a secondary acetamide derivative is unheard of.145, 177 In the 1H‐
NMR spectrum of  Pd(2.4)(allyl)Cl using CDCl3, CD3CN and benzene‐d6, respective minor 
isomer populations of 41%, 47% and 43% are observed. In the Pd(2.4)(O,O’‐acac)(γC‐
acac) complex, it is postulated that electrostatic interactions provide the impetus to 
overcome the steric strain present in the E-amide geometric diastereomer. It is difficult 
to envisage the compact Pd(allyl)Cl environment supporting the same interactions, 
especially not to a greater degree. 
 
Inspecting the 1H‐NMR spectrum of Pd(2.4)(allyl)Cl in CD3CN (Figure 2.19b) we find five 
non‐isomeric allyl‐proton environments corresponding to syn/anti‐H25, H26 and 
syn/anti‐H27 (syn/anti‐H25 was not observed in DMSO‐d6). These signals differentiate 
the two species along with those of the amide NH environment (H11), methylene CH2 
(H13) and the methine environments of the diisopropyl‐phenyl group (H23). This holds 
true for the spectra in CDCl3 and benzene‐d6. Notably, the N – CHα (H2) environment is 
the same for both isomers (~ 3.89 ppm overlapped with anti‐H27 signal) when Z/E‐
amide isomers have very different N – CHα environments (Section 2.3.1.4). Raising the 
temperature at which the spectra were recorded resulted in reversible coalescence of 
signals at 55 oC. This variable temperature NMR analysis was performed using CD3CN as 





















The low coalescence temperature compared with the 110 oC required for Pd(2.4)(O,O’‐
acac)(γC‐acac) in DMSO‐d6 implies a much lower energy barrier to free rotation. The 
amide NH and methylene environments coalesce cleanly, however, the methine proton 
signals appear to dissipate. Interestingly, signals due to the allyl‐CH2 environments 
pseudo‐trans to the carbene (syn/anti‐H27) become strong and well resolved at 
elevated temperature whereas the pseudo‐cis allyl‐CH2 (syn/anti‐H25) merge with the 
baseline. Scheme 2.23 shows how allyl group pseudo‐rotation, referred to here as syn-
anti interchange, produces chemically distinct forms of Pd(2.4)(allyl)Cl.  
 
A diastereomer of isomer 2 can also be produced from isomer 1 by rotation around the 
Pd – NHC bond (not shown). This may also be a relevant mode of interchange, although, 
would not be expected to exhibit such dramatic solvent dependence. In the structure 
depicted, it is clear how accelerating syn-anti interchange could cause the abutting 
methine and cis-allyl proton environments (H23 and syn/anti‐H25) to become 
convoluted while the pseudo‐trans allyl‐CH2 proton environments (syn/anti‐H27) 







Figure 2.21: Series showing a portion of the 1H-NMR spectra of Pd(2.4)(allyl)Cl as a 
function of temperature in CD3CN. Top spectrum in DMSO-d6 at 25 oC highlighting its 














The dynamic nature of Pd(allyl) complexes is an ongoing subject of investigation 
however, it is generally accepted that an η3 – η1 – η3 (alternatively π – σ – π) 
interconversion is responsible for much of their fluxional behaviour.188, 189, 193 This 
mechanism can be applied to allyl syn-anti interchange by reorientation of the σ‐bonded 











This behaviour is known to be highly solvent dependent and is accelerated by lewis‐
acidic solvents, particularly DMSO.183, 191 This almost certainly accounts for the 
seemingly anomalous 1H‐NMR spectrum recorded in DMSO‐d6, which at 25 oC shares 
isomer 1 isomer 2 
syn-anti 
interchange 
η3 (π) η1 (σ) η3 (π) 
Scheme 2.23: Depicting isomeric forms of Pd(2.4)(allyl)Cl generated by syn-anti 
interchange of the allyl auxiliary. 
Scheme 2.24: Mechanism of syn‐anti interchange. The highlighted ligand (L*) may be an 
additive or nucleophilic solvent molecule. It is not required for interchange occur but can 




similar features with one recorded in CD3CN at elevated temperature (Figure 2.21). 
These features include suppression of the methine and cis-allyl proton environments 
(syn/anti‐H25) which is an understandable consequence of accelerated syn-anti 
interchange.  
 
Often, conformational changes in an allyl auxiliary are analysed through the chemical 
shift differences between diagnostic proton environments on a “reporter ligand” also 
bound to Pd(II).187, 190, 194 In this sense, observance of syn-anti interchange through 
differences in the ligand 2.4 of Pd(2.4)(allyl)Cl is reasonable. Of course, further solution 
studies are necessary to unequivocally prove this hypothesis, although, based on the 
evidence, it appears much more likely than E/Z‐amide isomerisation or some other 
conformational change. Through‐space NMR correlation experiments such as NOESY 
spectra could be used to assign each isomer (i.e. isomer 1 and 2 Scheme 2.23) and the 
precise mode of isomerisation.195 It may however, be more informative to synthesise an 
analogue of the compound with a substituted allyl‐auxiliary such as 2‐methylallyl to 
emphasise isomeric differences.  This remains an interesting challenge for future 
researchers. 
 
2.3.4. Pd(NHC)Cl2 type complexes 
 
Chelation as a bidentate NHC‐amidate ligand such as is observed for the M(2.4 - H)(O,O’‐
acac) complexes (section 2.3.1) is difficult to achieve due to the steric bulk of the 
bornane‐group. On the other hand, monodentate coordination by the NHC is very 
accessible. However, this “pendant” motif is susceptible to isomeric ambiguities making 
them less well defined pre‐catalysts than their chelated counterparts. Furthermore they 
are potentially less stable as observed for Pd(2.2)(allyl)Cl (section 2.3.3.1). Bulky 
pendant substituents such as diisopropyl‐phenyl (ligand 2.4) generally improve complex 
stability and catalytic activity.65 However, to reduce conformational strain, they 
promote pendant like coordination by forcing the NHC into an orthogonal orientation to 





A ligand such as 2.5 (Scheme 2.25) provides a partial remedy to these problems by 
having a coordinating pendant group in addition to the acetamide moiety. In this case, 
chelation by the pyridyl substituent stabilises the complex whilst bringing the imidazolyl 
ring coplanar with the coordination plane.  Preventing rotation around the NHC – M 
bond also reduces the conformations available to the bornyl‐acetamide wing‐group 
hence it is anticipated to have more predictable structural attributes. Formation of the 
NHC – pyridyl chelate would hopefully also have a pre‐organising effect, poising the 
amide‐nitrogen to coordinate in a tridentate 5,6‐chelate arrangement.  
 
2.3.4.1. Synthesis and Characterisation of Pd(2.5)Cl2 
 
The pro‐ligand 2.5.HCl was prepared in order to investigate these possibilities and 
applied to the synthesis of Pd(2.5)Cl2 via the NHC‐Ag transmetalation method (see 
section 2.3.2). No attempt was made to characterise the Ag(2.5) intermediate.  The 
reaction was performed by stirring the proligand 2.5.HCl and Ag2O in DCM in the 
absence of light for 12 hours followed by the addition of Pd(PhCN)2Cl2 as a DCM solution. 
Immediate precipitation of white AgCl indicated successful transmetalation.  After 12 
hours the reaction mixture was filtered through celite yielding a faint orange/brown 











It was noted following the compounds initial synthesis that its solubility in various 
solvents decreased with subsequent purification steps. For example, despite being 
Pd(2.5)Cl2 75% 




isolated from a DCM solution, it could not be dissolved again in DCM. After several 
recrystallisation attempts is was only sparingly soluble in warm MeCN or MeNO2 and 
insoluble in acetone. A crystal structure of Pd(2.5)Cl2 (discussed shortly) was obtained 
using crystals grown by slow evaporation of a MeCN/toluene solution of the compound. 
Analysis of these same crystals by NMR in DMSO‐d6 revealed that the observed species 
was unchanged from that initially isolated. Ultimately, purification by bulk crystallisation 
of the crude product material by slow evaporation of its MeCN/toluene solution was 
effective. The resulting white microcrystalline solid was washed with acetone and dried 
in vacuo to give pure Pd(2.5)Cl2 in a 75% yield. 
 
Mass‐spectrometry revealed a myriad of signals due to cations with a mass within the 
range of m/z  ~ 440 to ~ 570 and was difficult to assign definitively. A moderately intense 
signal at 443.1050 could be attributed to the tridentate chelated species (calculated 
m/z, [Pd(2.5 - H)]+ = 443.1063) but the majority of more intense signals appeared to be 
variously ligated cations of the type [Pd(2.5)(L)n]+ and [Pd(2.5)(L)Cl]+, where L is MeOH 
(sample solvent) or water and their deprotonated adducts along with many unassigned 
signals. Samples prepared from the NMR sample solution contained a major signal at 
563.1346 due to a DMSO‐d6 ligated species (calculated m/z, [Pd(2.5)(DMSO‐d6)Cl]+ = 
563.1346). This is not present when the solution is prepared from straight MeOH. 
Fragmentation to this degree is not observed for any of the other NHC – Pd(II) complexes 
prepared during this work and suggests that substitution of the chloride ligands can 
occur readily, a feature especially highlighted by the species [Pd(2.5)(DMSO‐d6)Cl]+. This 
behaviour is likely to be a consequence of the trans‐influence of the NHC ligand that has 
been highlighted in previous discussions. In all previous complexes, the trans‐position is 
occupied by a bidentate ligand, negating any kinetic trans‐effect on ligand exchange. 
Similar behaviour due to this is observed in the mass‐spectrum of [Ru(phen)2(Pd{5.10 - 
H}Cl)][PF6]2 (see section 5.3.2). Despite the mass‐spectral evidence, there is no definitive 
sign of ligand exchange species by NMR. 
 
X‐Ray analysis of the crystals obtained as described above was performed using 
synchrotron radiation of frequency 0.71073 nm (Mo/Kα) due to the small size of the 




in the non‐centrosymmetric orthorhombic space‐group P212121 with two molecules of 






Flack (x) and Hooft (y) parameters of 0.007(6) and 0.004(7) respectively verify that the 
structure is a resolved chiral species. The Pd(II) centre is bound within the anticipated 5‐
membered NHC – Py chelate with two chloride ligands completing the neutral complex.  
A contracted chelate angle C15 – Pd1 – N24 (A / B) of 79.9(2)o / 79.8(2)o causes a 
distorted square‐planar geometry. The remaining bond angles around the Pd(II) centre 
are (A / B); C15 – Pd1 – Cl1 = 95.9(2)o / 96.2(2)o, N24 – Pd1 – Cl2 = 93.5(2)o /  93.4 (2)o 
and Cl1 – Pd1 – Cl2 = 90.6(1)o / 90.5(1)o. Metal to ligand bond lengths are as follows (A 
/ B); Pd1 – C15 = 1.972(6) Å / 1.972(6) Å, Pd1 – N24 = 2.052(5) Å / 2.028(5) Å, Pd1 – Cl1 
= 2.285(2) Å / 2.292(2) Å and Pd1 – Cl2 = 2.360(2) Å / 2.362(2) Å. Elongation of the Pd1 
Figure 2.22: Contents of the asymmetric unit of Pd(2.5)Cl2. All non-bonding hydrogen 





– Cl2 bond occurs in response to the trans‐influence of the NHC ligand. Pd – Ccarbene and 
Pd – Npyridyl bond lengths are in agreement with related complexes reported in the 
literature.86, 196, 197   
 
The methylene linkage is oriented such that the CH2 – Camide bond is perpendicular to 
the mean‐plane of the complex as expressed by the torsion angle C15‐N14‐C13‐C12 (A 
/ B) of 87.8(6)o / 81.2(6)o. The bornane moiety is rotated to bring the CHα (C2) into an 
anti‐configuration relative to the amide NH. Complexes assemble such that the planar 
organometallic components are stacked with bridging occurring via Z-amide supported 
NH ··· O hydrogen bonds (N11A ··· O1B = 2.821(7) Å, N11B ··· O1A = 2.901(2) Å) (Figure 
2.22). A stacked packing motif has been noted for related Pd(NHC – Py) complexes as 
being driven by π – π interactions.86, 197 Here, formation of a hydrogen‐bonded array 
necessitates staggering of the planar groups causing weak n – π interactions between 
the chloride ligands and the aromatic pyridyl (Py) or imidazolyl (Im) rings to 
predominate. These have Cl to centroid distances of; Cl1A ··· PyB = 3.514(3) Å, Cl1B ··· 
PyA = 3.455(3) Å, Cl2A ··· ImB = 3.498(3) Å and Cl2B ··· ImA = 3.486(3) Å. Weak, non‐
conventional hydrogen bonds of the type CH ··· Cl occurs between the chloride ligand 
(Cl2) trans to the carbene and the imidazolyl‐moiety of the adjacent complex (Figure 








NMR analysis of the same batch of crystalline material used to obtain the crystal 
structure of Pd(2.5)Cl2 showed it to be unchanged from the compound initially isolated. 
The spectra were collected on the sample in DMSO‐d6 as it is only sparingly soluble in 
the other common deuterated solvents.  No isomerism was seen to occur, although, a 
trace of impurity persisted, seen only in the 1H‐NMR spectrum. Impurity signals are 
particularly visible in the region below ~ 0.75 ppm which are probably related to 
bornane methyl groups. This may be due to the species [Pd(2.5)(DMSO‐d6)Cl]+ observed 
by mass‐spectroscopy but unfortunately, this could not be corroborated by 13C‐NMR. 
The 1H‐NMR and 13C‐NMR spectra are shown in Figure 2.24 with some key signals noted.  
 
These spectra have no major features that have not been addressed in the previous 
discussions of Pd(2.4)(O,O’‐acac), Pd(2.4)(O,O’‐acac)(γC‐acac) and Pd(2.4)(allyl)Cl other 
than environments related to the pyridyl‐group. Conversion of the imidazolium salt 
2.5.HCl into Pd(2.5)Cl2 coincides with a moderate downfield shift of the α‐positioned 
pyrdidine proton (H23) from 8.65 ppm to 9.21 ppm (Δδ = + 0.56 ppm). A minor 
coordination induced shift of + 0.19 ppm is observed for H21 and changes in H20 and 
H22 are negligible. Here, NHC – Py chelation augments the downfield shift of the H23 




resonance by forcing it into the deshielding environment of the nearby chloride ligand. 
























Resonances due to the methylene‐proton (H13) appear similarly affected, although, to 
a lesser extent. Here the distinctive H13 doublets occur at 5.68 ppm and 5.30 ppm, 
slightly further downfield than in any of the previously discussed complexes for which 
the largest equivalent resonance occurs at, or below 5.30 ppm in DMSO‐d6. Differences 
also arise in the relative positions of the imidazolyl‐proton environments H17 and H18. 
For complexes of 2.4 these occur between 7.25 ppm – 7.75 ppm with anisotropic 































group, shifting its resonance upfield relative to H18. In Pd(2.5)Cl2, the pyridyl and 
imidazolyl‐rings are coplanar and the resultant anisotropic deshielding of H17 accounts 
for its chemical shift of 8.37 ppm, downfield of H18 at 7.54 ppm.  
 
In the 13C‐NMR spectrum the carbenic carbon signal (C15) is found at 153.85 ppm, 
having a near identical chemical environment to that of Pd(2.4)(O,O’‐acac) (153.55 
ppm).  In both complexes the NHC participates in bidentate coordination with a nitrogen 
donor. However, carbenic resonances are typically difficult to predict on such a basis. 
 
In most cases the pyridyl‐group is expected to be the more labile than the NHC,198 this 
is indeed crucial for catalysis.  Interestingly however, a study by Willans et al. reported 
curious NHC ligand exchange phenomena in their 4‐methyl‐pyridyl substituted NHC‐
Py(Me) complex shown in Scheme 2.26.197 Although the target [Pd(NHC‐Py(Me))2Br]Br 
species was observed by NMR, only the neutral species Pd(NHC‐Py)Br2 was crystallised 
(crystallisation conditions not specified). Furthermore, the 4‐methoxy‐pyridyl analogue 
only produced the mono‐NHC species when reacted with 0.5 equivalents of Pd(OAc)2. 
Only pyridyl‐groups with mildly electron donating substituents behaved in this manner 














This emphasises that such systems do not necessarily behave predictably. Facile 
substitution of the halides trans to the NHC by MeCN to give cationic complexes of the 
type [Pd(NHC)(MeCN)X]+ have also been noted in related complexes.197, 199 Such 
behaviour may account for the shifting solubility of Pd(2.5)Cl2 and in light of the above 
discussion, it is not surprising that the neutral complex can be recovered by 
crystallisation. These complications can be mitigated by using a chelating auxiliary such 
as an allyl ligand.195 Complexes of 2.5 with an allyl or acac coligand ligand are interesting 
synthetic targets with probable catalytic applicability.  
 
2.3.5. Ru(NHC)(arene)Cl type complexes 
 
To demonstrate the compatibility of these ligands with alternative systems the 
ruthenium‐arene complex [Ru(2.2)(p‐cymene)Cl][Cl] was prepared. Ru(II) is a known 
centre for catalysis and its octahedral geometry provides an alternative architectural 
scaffold to the square planar Pd(II) and Pt(II) complexes discussed previously.  NHC 
ligands have been employed in a variety of Ru(II) precatalysts,65, 200, 201 most notably for 
use in alkene metathesis.80 In particular, precatalysts with an Ru(NHC)(arene) motif have 
been shown to catalyse numerous processes including hydrogenation and transfer 
hydrogenation,69 cyclopropanation,202 alkyne dimerization203 and furan synthesis.204  
 
Two reports have shown the coordination of acetamide‐linked NHC ligands to an 
Ru(arene) unit by facile transfer from the NHC – Ag(I) intermediate. In both cases the 
bidentate NHC‐amidate chelate could be produced either by the spontaneous loss of 
HCl114 or following treatment of cationic carbonyl‐bound species with KOH.115 These 
complexes possess a stereogenic centre derived from the pseudo‐tetrahedral geometry 
of the Ru(II)50 and Sakaguchi and co‐workers demonstrated that using one enantiomer 
of a chirally‐functionalised NHC‐acetamide ligand produces two diastereomers in an 87 
: 13 molar ratio.115 In the case shown, conversion to the amidate‐bound chelate was 
found to proceed for one diastereomer only generating diastereomerically pure product 







This is because amidate‐chelation brings the stereochemical‐component of the ligand 
closer to the chiral coordination sphere of the Ru(II). This observed diastereoselectivity 
therefore provides a rudimentary assessment the stereodirecting components influence 
over the metal‐centre as in a catalysis scenario. A similar diastereoselective synthesis of 
an Ru(NHC)(arene) complex has been reported by Gade et al. using a chiral NHC – 
oxazoline ligand.205 
 
2.3.5.1. Synthesis and Characterisation of [Ru(2.2)(p-cymene)Cl][X] 
 
It was anticipated that utilising a bornyl‐acetamide NHC ligand would elicit similar 



































two diastereomers (S,S and S,R) 
87 : 23 
 
one diastereomer 
Scheme 2.27: Sakaguchi’s diastereoselective synthesis of Ru(NHC)(arene) complexes 
using a chirally functionalised NHC-acetamide ligand. No comment on the SS or SR




however, only the synthesis of [Ru(2.2)(p‐cymene)Cl][Cl] was successful. The failure to 
synthesise Ru(2.4)(p‐cymene)Cl is attributed to hindrance by the diisopropyl‐phenyl 
group of 2.4 and will not be discussed further.  
 
Complex [Ru(2.2)(p‐cymene)Cl][Cl] was prepared by transmetalation from the isolated 
complex Ag(2.2)Cl (see section 2.3.2) by the previously addressed method (Scheme 
2.28). The precursor [Ru(p‐cymene)Cl2]2 was synthesised in accordance with a literature 
procedure and obtained as an orange, microcrystalline solid in a yield of 79%.206 After 
removal of the precipitated AgCl by filtration, rotary evaporation of the DCM reaction 











This could be purified by flash column chromatography (silica, 5% MeOH/DCM) but 
more expediently so by precipitation as its PF6 salt from an aqueous solution. The 
following discussion will focus on this species [Ru(2.2)(p‐cymene)Cl][PF6], which has 
been characterised spectroscopically and by X‐ray analysis.  
 
Complex [Ru(2.2)(p‐cymene)Cl]+ generates a mass‐spectrum with a lone signal at 
546.1817 corresponding to the expected cation (calculated m/z, [Ru(2.2)(p‐cymene)Cl]+ 
= 546.1820). As anticipated, two diastereomers were observed by NMR, however, their 
occurrence in a 1:1 ratio implies that the ligand does not impart any appreciable 
selectivity. No attempt to separate these was made. A crystal structure of [Ru(2.2)(p‐
[Ru(2.2)(p‐cymene)Cl]Cl, 89% 
Ag(2.2)Cl 





cymene)Cl][PF6] was obtained with both diastereomers in the asymmetric unit. This will 
be explored foremost to aid the explanation of their NMR spectra.  
 
Crystallisation of [Ru(2.2)(p‐cymene)Cl][PF6] was achieved by slow evaporation of a 
CHCl3 solution of the compound. It resides in the triclinic space‐group P1 with four 
molecules [Ru(2.2)(p‐cymene)Cl]+, four PF6 anions and eight molecules of CHCl3 that 
could be modelled in the asymmetric unit (Figure 2.25). The enantiopure bornane 
component renders the structure a pure enantiomorph with Flack (x) and Hooft (y) 
parameters of ‐0.03(1) and ‐0.025(4) respectively. Ligand 1.2 is clearly coordinated via 
the amide‐carbonyl oxygen in addition to the NHC and, overall, complex [Ru(2.2)(p‐
cymene)Cl]+ is arranged in the classical three‐legged piano stool geometry around the 






For the sake of this discussion, the R / S notation used to define the Ru(II) stereogenic 
centre is extended to distinguish the two diastereomers (the R‐diastereomer and the S‐
Figure 2.25: Asymmetric unit of [Ru(2.2)(p-cymene)Cl][PF6], hydrogen atoms and 





diastereomer). As there are two of each diastereomer in the asymmetric unit, these will 
be defined as R‐A, R‐B, S‐A and S‐B (Figure 2.26). Bonding to the Ru(II) is characterised 
by the following bond lengths Ru1 – C15, Ru1 – O1, Ru1 – Cl1 and Ru1 – centroid and 
angles C15 – Ru1 – O1, C15 – Ru1 – Cl1, O1 – Ru1 – Cl1 which are summarised in Table 
2.2 along with bond lengths O1 – C12 and N11 – C12 of the amide (centroid is p‐cymene 
centroid, angles related to this are not discussed). Evaluating the key bonding 
information reveals few differences between the two diastereomers. The Ru1 – C15 
bond length is shorter for occupant R – (B) by ~ 0.027 Å but there is no obvious reason 
for this anomaly. The only notable difference between diastereomers is observed for 
the bonds Ru1 – O1 and O1 – C12 which are slightly elongated in the S diastereomer by 
~ 0.021 Å. This may be in response to the closer proximity of the bornane‐methyl groups 
to the p‐cymene ligand in this isomer. Distances for Ru1 – C15, Ru1 – Cl1 and Ru1 – Cent 
and associated bond angles are in agreement with reported values for piano‐stool Ru – 






Figure 2.26: Two diastereomers of [Ru(2.2)(p-cymene)][PF6] with label suffix R or S
denoting the stereochemical configuration of the pseudo-tetrahedral ruthenium centre. 




Weak hydrogen‐bonding interactions are prevalent within the asymmetric unit with 
each PF6 anion accepting hydrogen‐bond donation from the amido‐NH and supported 
by a non‐conventional interaction with the adjacent methylene‐CH2 (N11 ··· F = 3.04(2) 
Å, 3.03(2) Å, 3.03(2) Å and 3.04(2) Å and C13 ··· F = 3.25(2) Å, 3.23(2) Å, 3.30(2) Å and 
3.31(2) Å).  Interactions of the type Cl3CH ··· Cl occur between each ligated chloride and 
a chloroform solvate molecule (Cl3C ··· Cl1 = 3.33(2) Å, 3.33(2) Å, 3.150(3) Å and 3.186(3) 
Å). There are no perceptible interactions between molecules of [Ru(2.2)(p‐cymene)Cl]+.  
 
Table 2.2: Summary of relevant X-ray crystallographic measurements for the four 
molecules of [Ru(2.2)(p-cymene)]+ occupying the asymmetric unit. Diastereomers are 
denoted R and S.  
 
In the 1H‐NMR spectrum of [Ru(2.2)(p‐cymene)Cl][PF6], the most discernible difference 
between the two diastereomers is the position of resonances due to the C10 methyl‐
group. It can be envisaged, based upon the solid state structure, that in the S-
diastereomer, the C10 methyl‐group abuts the p‐cymene ligand more so than in the R‐
diastereomer hence is subject to greater anisotropic deshielding in the former. 
IR‐spectroscopy corroborates that the amide‐group is involved in chelation with the 
carbonyl stretching frequency of 1614 cm‐1 decreased from that of the proligand 2.2.HCl 
R - (A) R - (B) S - (A) S - (B)
Ru1 ‐ C15 2.044(9) 2.019(2) 2.045(2) 2.050(9)
Ru1 ‐ O1 2.126(7) 2.120(7) 2.143(7) 2.144(7)
Ru1 ‐ Cl1 2.409(2) 2.410(2) 2.412(2) 2.410(2)
Ru1 ‐ Cent 1.691(4) 1.698(4) 1.701(4) 1.703(4)
O1 ‐ C12 1.240(2) 1.236(2) 1.256(2) 1.261(2)
N11 ‐ C12 1.316(2) 1.321(2) 1.328(2) 1.324(2)
C15‐Ru‐O1 83.5(3) 82.9(4) 82.6(3) 82.7(3)
C15‐Ru‐Cl1 87.3(3) 87.2(3) 88.1(3) 88.0(3)



























































(1659 cm‐1). This coordination shift has been noted previously for a closely related 
complex (carbonyl stretch, 1619 cm‐1)115 and has been addressed in the discussion of 
the amidate‐chelated complexes Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) (see 
section 2.3.1.3). The possibility of amidate coordination in solution is negated by 
identification of the amide NH proton environment (H11) by 1H‐NMR spectroscopy. The 
1H‐NMR and 13C‐NMR spectra of [Ru(2.2)(p‐cymene)Cl][PF6] in CDCl3 are shown in Figure 
2.27.  
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Figure 2.27: The 1H-NMR and 13C-NMR spectra of Ru(2.2)(p-cymene)Cl2 in CDCl3 with 





All signals due to ligand 2.2 and p‐cymene are accounted for. Two diastereomers are 
discernible and the R‐ or S‐ configurations could be definitively distinguished for the 
bornane methyl environment H10 and p‐cymene environments H21 and H22. As noted 
in the discussion of the crystal structure, the closer proximity of the C10 methyl 
environment to the field of the arene ligand in the S‐diastereomer is expected to 
increase its proton resonances. The downfield position of H10s (0.98 ppm) relative to 
H10R (0.74 ppm) is the realisation of this effect. On the other hand, carbon resonances 
due to the equivalent nuclei of each diastereomer are very similar; for example, C10s 
and C10R are 11.46 ppm and 11.40 ppm respectively. It is therefore difficult to employ 
through‐bond correlations to H10, such as in the HMBC spectrum, to further assign 
signals to each diastereomer. Through‐space correlation spectra such as NOESY could 
be used to scrupulously characterise the R and S-diastereomers although this was not 
performed here due to time constraints. 
 
The anticipated diastereotopic methylene‐CH2 environments (H13) arise at 5.12 ppm 
and 4.60 ppm (2JH‐H = 16.0 Hz). In previous examples, the chemical‐shift of these signals 
has elucidated differences between conformational‐isomers, however, in the case of 
these diastereomers the differences are minor. Both have identical H13 environments 
and similar C13 resonances (C13(R or S) = 51.73 ppm and 51.64 ppm). The carbenic carbon 
(C15) resonates at 175.24 ppm / 175.00 ppm which is comparable to resonances 
reported for related NHC – Ru(II) complexes.158, 205, 208 Coordination of the carbonyl‐
group to Ru(II) produces a C12 resonance of 170.00 ppm / 169.92 ppm, not unlike those 
observed for Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) in CDCl3 (170.29 ppm and 
171.56 ppm). 
 
It is surprising that ligand 2.2 affords no stereochemical control over complexation 
whereas the much less bulky literature example does. It is possible that in the reported 
case (Scheme 2.27), intermediary association of the hemi‐labile hydroxyl moiety guides 
selectivity by orienting the chiral group during complex formation. It was hoped that 
conversion of the O‐chelated complex [Ru(2.2)(p‐cymene)Cl][Cl] into the neutral 
amidate‐chelated congener Ru(2.2 - H)(p‐cymene)Cl would exhibit some diastereomeric 




KOH(aq) to a stirred, aqueous solution of the salt at room temperature (Scheme 2.29). 
Unfortunately, the starting material was retained and heating of the solution resulted in 












This is perhaps unsurprising given the steric barrier to coordination of the bornyl‐
amidate which has been addressed previously in section 2.3.1. It has been established 
that the application of heat is necessary to achieve this; hence, in the case of Ru(2.2 - 
H)(p‐cymene)Cl, it may be possible using a different base and/or solvent. However, 
having already achieved the aim of incorporating ligand 2.2 into an alternative, 
potentially catalytically active system, this was not pursued. 
  
2.4. Summarising remarks 
 
A series of novel acetamide‐linked imidazolium salts derived from exo‐(‐)‐
isobornylamine have been prepared as precursors to the chiral NHC ligands 2.2 – 2.5. 
Investigation of an alternative system based on exo‐3‐aminoborneol was also 
undertaken, however, this was hampered by issues during synthesis and difficulty of 
product isolation. Regardless, a precursor to the very unique, potentially tridentate NHC 
ligand 2.9 was successfully isolated and characterised. 
[Ru(2.2)(p-cymene)Cl]Cl 
Ru(2.2 - H)(p-cymene)Cl 
not formed 






Bornyl‐acetamide NHC proligands were applied to the synthesis of several NHC 
complexes with Ag(I), Pd(II), Pt(II) and Ru(II). Complex motifs were selected for their 
potential catalytic activity, particularly in the case of the Pd(II) systems, and to benefit 
structural elucidation. 
 
Complexes based upon the M(NHC)(O,O’‐acac) motif provided neutral mono‐NHC 
species with coordination of the deprotonated amide. The diisopropyl‐phenyl NHC 
ligand 2.4 could be used to generate the desired N‐amidate/NHC chelated species 
Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) albeit in low yield. These will be 
discussed further in Chapter 3. The pendant species Pd(2.4)(O,O’‐acac)(γC‐acac) and 
Pt(2.4)(O,O’‐acac)(γC‐acac) formed competitively and were also isolated and 
characterised. The latter, non‐chelated complexes where found to exist as two 
interconverting species attributed to E/Z‐amide geometric diastereomers. This was 
verified by detailed NMR analysis including variable temperature NMR and is extremely 
interesting given the relatively high proportion (~ 30%) of the sterically disfavoured E‐
amide geometry.  
 
The silver transmetalation route to NHC complexes was successfully employed for the 
synthesis of Pd(2.4)(allyl)Cl, Pd(2.5)Cl2 and Ru(2.2)(p‐cymene)Cl. Properties of NHC‐Ag(I) 
intermediates Ag(2.2)Cl and Ag(2.3)Cl were explored despite these intermediates not 
typically being isolated. In complexes Pd(2.4)(allyl)Cl and Pd(2.5)Cl2, the amide group is 
uncoordinated whereas in [Ru(2.2)(p‐cymene)Cl][PF6] it coordinates via the amide‐
carbonyl oxygen. Pd(2.4)(allyl)Cl exhibits fluxional diastereoisomerism attributable to 
syn-anti interchange of the allyl ancillary ligand. Remarkably, 1H‐NMR spectra of 
Pd(2.4)(allyl)Cl performed in DMSO‐d6 are missing some allyl‐environments due to 
solvent‐assisted acceleration of this interconversion. Unlike other “pendant” complexes 
in this study, the pyridyl appended NHC complex Pd(2.5)Cl2 did not exhibit any form of 
diastereoisomerism. As such, the formation of a pyridyl/NHC chelate had the desired 
pre‐organising effect on the ligand conformation however, possible ligand exchange in 
Pd(2.5)Cl2 is a source of potential ambiguity. Two diastereomers of Ru(2.2)(p‐cymene)Cl 




an additional enantiomeric centre at the Ru(II) resulting from its pseudo‐tetrahedral 
piano‐stool geometry. Observance of a 1:1 ratio indicates that the bornane moiety 
imparts no stereochemical control over the geometry of the piano‐stool in [Ru(2.2)(p‐
cymene)Cl][PF6]. This implies that N‐amidate/NHC chelation is required to bring the 
chiral bornane unit sufficiently close to the active metal centre to provide asymmetric 
induction in a catalytic scenario. 
 
2.5. Scope and future work 
 
Besides their potential catalytic applications, the NHC complexes prepared in this study 
offer considerable insight into the organometallic chemistry of acetamide‐linked NHC 
compounds.  
 
It has been demonstrated that the synthesis of imidazolium salts from 2‐chloro‐N‐exo‐
bornylacetamide (2.1) is tenable to expedient modulation of the pendant group leading 
to a range of NHC precursors including those synthesised [2.2.H]+ – [2.5.H]+. Likewise, 
this study shows that these ligands are compatible with a variety of complex system and, 
as such, this class of NHC ligand is readily diversifiable and could be applied to generate 
numerous novel chiral complexes. 
 
Of the complexes synthesised, Pd(2.4 - H)(O,O’‐acac) and Pd(2.4)(O,O’‐acac)(γC‐acac) 
are particularly interesting candidates for further investigation given the demonstrated 
catalytic ability of the related complex Pd(3.3 - H)(O,O’‐acac) (see Chapter 6). 
Furthermore, NMR spectra of Pd(2.4)(O,O’‐acac)(γC‐acac) collected in DMSO‐d6 reveal 
that elevated temperatures can cause the irreversible conversion to the chelated form 
Pd(2.4 - H)(O,O’‐acac). It would be beneficial to study this conversion as a means 
towards preparing Pd(2.4 - H)(O,O’‐acac) in useable isolated yields or for in situ 
generation.  
 
Both Pd(2.4)(O,O’‐acac)(γC‐acac) and Pd(2.4)(allyl)Cl exhibit fluxional stereoisomerism 




example, a detailed NMR analysis of Pd(2.4)(O,O’‐acac)(γC‐acac) including NOESY or 
ROESY NMR would better elucidate the relationship between its E/Z‐amide conformers 
and the types of interaction that are driving this phenomenon. The synthesis of related 
Pd(BA)(O,O’‐acac)(γC‐acac) systems would also be informative, as would be the 
successful crystallisation of Pd(2.4)(O,O’‐acac)(γC‐acac) or its adducts for X‐ray analysis. 
 
This work has established that the steric bulk of the bornane group impedes formation 
of the N‐amidate/NHC chelate which may be important for asymmetric induction during 
catalysis. This being the case, a slightly less hindered, more flexible chiral terpene such 
as menthol may provide a more suitable scaffold. Synthesis of (+ or ‐)‐menthylamine 
could be performed as reported135 and used analogously to exo‐(‐)‐isobornylamine in 
Scheme 2.4 to provide acetamide‐linked imidazolium salts for the synthesis of NHC 














Scheme 2.30: General scheme showing the synthesis of an M(NHC)(O’O-acac) type 

































































Several of the complexes bearing bornyl‐acetamide NHC ligands displayed interesting 
structural features arising from the steric bulk and inflexibility of the bornane‐skeleton 
(Chapter 2). An achiral system was targeted to evaluate how these features might 
translate to catalytic ability. Replacing the chiral bornyl‐actamide NHC ligand with an 
achiral cyclohexyl‐acetamide was considered a comparable reference point for some of 
the NHC complexes. As a cyclic alkane, the cyclohexyl‐group is chemically related to 
bornane and hence tenable to the same synthesis. Furthermore, its reduced steric bulk 
and rigidity was sought to improve the potential for chelation of the amidate, thus 
avoiding some of the synthetic handicaps encountered with the bornyl‐acetamide 
derivatives. More importantly, these ligands provided an achiral control against which 
to reference any enantiomeric‐excesses generated during catalysis involving their chiral‐
counterparts. 
 
3.2. Synthesis of cyclohexyl-NHC proligands 
3.2.1. Acetamide-linked cyclohexyl-imidazolium salts 
 
Cyclohexyl‐acetamide imidazolium salt proligands 3.2 – 3.4 were prepared in an 
identical manner to the bornyl‐acetamide imidazolium salt proligands 2.2 – 2.5 (Scheme 
3.1). Chloroacetylation of cyclohexylamine provided 2‐chloro‐N‐cyclohexylacetamide 
(3.1) by the same method used for 2.1. An old batch of cyclohexylamine was used 
because impurities did not badly affect the synthesis and the product was easily isolated. 
For this reason, no particular care was taken to employ anhydrous conditions as in the 
synthesis of 2.1. After 14 hours the reaction mixture was taken up in ethyl‐acetate and 
washed with water followed by brine. The organic phase was dried over MgSO4 and 
filtered through a silica‐plug before removal of the solvent. Recrystallisation of the light 
brown residue from hot Et2O provided large white crystals of 3.1 in an overall yield of 
70%. Compound 3.1 has been prepared previously by a variety of methods and the 


















i) DCM, Et3N, 
  0 oC
ii) RT, 14 hr
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As with the bornyl‐acetamide proligands, heating the chloroacetamide with the 
corresponding mono‐substituted imidazole provided the desired imidazolium salt 
(Scheme 3.1). Salts of the methyl derivative 3.2.HCl, 3.2.HBF4 and 3.2.HPF6 have been 
reported previously in a patent on ionic liquids,210 however, access could not be gained 
via the Chinese outlet through which it was published. Here, the compound was isolated 
as the PF6 salt due to the unmanageably sticky constitution of the chloride. Some 
material was lost during these manipulations causing its comparatively low yield of 48%. 
Salt 3.2.HPF6 has a melting point of 64 oC and based on this, it is unsurprising that salts 
of [3.2.H]+ have been explored in the context of ionic liquids.  
 
Compounds 3.2.HCl and 3.3.HCl are new and all three have been fully characterised. 
Their spectroscopic features are largely unremarkable. In the 1H‐NMR spectrum, signals 
due to the cyclohexyl group are well resolved into axial and equatorial proton 
environments suggesting, as expected, that the amide‐group favours an equatorial 
position.211 The methylene proton environments of the acetamide linker resonate as a 
singlet at ~ 5 ppm. This is in contrast with the bornyl analogues for which these 
environments are often observed as two doublets. Because the cyclohexyl group is 
3.1, 70% 3.2, 48% (PF6) 
3.3, 70%  
3.4, 67%  
Scheme 3.1: Synthesis and subsequent substitution of 3.1 to give 1-[2-(cylclohexyl)-2-




achiral these environments are enantiotopic as opposed to diastereotopic as in the case 
of chiral bornane. 
 
3.3. Synthesis of cyclohexyl-NHC complexes 
 
Complexes of the cyclohexyl‐acetamide NHC ligands were prepared as structurally 
related, achiral analogues of the bornyl‐acetamide NHC complexes. Ideally all complex 
syntheses discussed in Chapter 2 would be repeated for ligands 3.2 – 3.4 but in the 
interest of time, the most informative and catalytically relevant systems were targeted. 
Therefore, the following discussion focusses on the complexes Pd(3.3 - H)(O,O’‐acac), 























3.3.1. M(NHC)(acac) type complexes 
3.3.1.1. Synthesis of M(3.3 - H)(O,O’-acac)   
 
Complexes Pd(3.3 - H)(O,O’‐acac) and Pt(3.3 - H)(O,O’‐acac) were prepared in a similar 
fashion to their bornane‐counterparts, however, the reactions proceeded much more 
favourably providing each product in yields of 46% and 47%, respectively (Scheme 3.2). 
M(3.3 - H)(O,O’‐acac) Pd(3.3)(allyl)Cl




This is compared with the ~ 14% and 22% yields recorded for Pd(2.4 - H)(O,O’‐acac) and 




















The Pd(II) complex Pd(3.3 - H)(O,O’‐acac) was isolated after filtration of the cooled 
reaction mixture and removal of the solvent by triturating the off white residue in 
pentane. Filtering the material, air drying then rinsing with water and quickly with MeCN 
provided pure product. Isolation of the Pt(II) congener was achieved by uptake of the 
reaction mixture into a DCM phase and washing with water and brine to remove the 
DMSO. After drying over MgSO4, filtering, and removing the solvent, the off white 
residue was rinsed with cold MeCN to give a faint yellow product. An 1H‐NMR analysis 
of the MeCN rinse revealed that it contains a mixture of products including the desired 
complex. It is predicted based on this that an improved purification could recover the 
product in yields upwards of 60%. None of the pendant side product M(3.3)(O,O’‐
Pd(3.3 - H)( O,O’‐acac), 46% 
Pt(3.3 - H)( O,O’‐acac), 47% 
M(3.3)(O,O’‐acac)(γC‐acac)  
 




acac)(γC‐acac) was observed which is unsurprising given that one equivalent of 
acetylacetone was used. Observing at least 50% conversion to M(3.3)(O,O’‐acac) leaves 
residual acac to form a maximum of 25% M(3.3)(O,O’‐acac)(γC‐acac). No effort was 
made to synthesise or isolate M(3.3)(O,O’‐acac)(γC‐acac). 
 
3.3.1.2. Characterisation of Pd(3.3 - H)(O,O’-acac) and Pt(3.4 - H)(O,O’-acac) 
 
Complexes Pd(3.3 - H)(O,O’‐acac) and Pt(3.3 - H)(O,O’‐acac) were characterised by NMR, 
mass‐spectrometry and IR analysis. Crystal structures of both compounds were also 
obtained. Features of the 1H‐NMR spectrum of Pd(3.3 - H)(O,O’‐acac) are discussed in 
section 3.3.1.3 through comparison with Pd(2.4 - H)(O,O’‐acac). Resonances in the 13C‐
NMR pertaining to the O,O’‐acac ligand, imidazolyl‐moiety and acetamide‐linkage are as 
expected, having been addressed in the previous discussion of the related bornyl‐
acetamide complexes in section 2.3.1. Interestingly however, the carbenic carbon 
resonance of Pd(3.3 - H)(O,O’‐acac), found at 145.31 ppm, is upfield of its bornyl 
counterpart at 153.55 ppm. On the other hand, the equivalent resonances for Pt(3.3 - 
H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) are similar (138.80 ppm and 139.25 ppm, 
respectively). It is unclear why this difference in the carbene resonance is so significant 
for the Pd(II) complexes. Again, IR was used to support assignment of the N‐
amidate/NHC chelated species through observance of the anticipated coordination 
induced reduction in the amide carbonyl stretching frequency. This is found at 1575 cm‐
1 for Pd(3.3 - H)(O,O’‐acac) and 1524 cm‐1 for Pt(3.3 - H)(O,O’‐acac), down from 1672 cm‐
1 in the precursor imidazolium salt 3.3.HCl. 
 
Crystals of Pd(3.3 - H)(O,O’‐acac) suitable for single crystal diffraction analysis were 
grown by slow evaporation of an Et2O solution of the compound. This crystallised in the 
monoclinic space group P21/c with one molecule of the neutral complex Pd(3.3 - 
H)(O,O’‐acac) in the asymmetric unit (Figure 3.2). The structure reveals that ligand 3.3 - 
H is coordinated as a 6‐membered chelate that adopts a puckered ring conformation 





















As before, the extent to which the chelate ring is distorted from the idealised mean‐
plane of the square‐planar Pd(II) centre is represented by the torsion angles C11‐Pd1‐
N7‐C8 and N7‐Pd1‐C11‐N10 which are 47.1(2)o and 35.4(2)o, respectively. As discussed 
in section 2.3, internal chiral axes arise from this fixed solid‐state conformation along 
the C11 – Pd1 and N7 – Pd1 bonds of Pd(3.3 - H)(O,O’‐acac). However, because the 
molecule contains no permanent stereo‐centres, the two conformations are 
enantiomeric and both enantiomers are present in the unit cell. This point will be 
expanded in the discussion of the 1H‐NMR spectra of these compounds in section 
3.3.1.3. The relative position of the methylene group described by the angle θCH2 is 
60.91(8)o for Pd(3.3 - H)(O,O’‐acac). The cyclohexyl substituent is found in a well‐defined 
chair conformation with the amido‐functionality in the equatorial position as expected. 
Bond lengths pertaining to the Pd(II) centre are as follows; Pd1 – C11 = 1.956(2) Å, Pd1 
– N7 = 2.032(2) Å, Pd1 – O2 = 2.013(2) Å and Pd1 – O3 = 2.044(2) Å. The angles between 
these bonds are C11 – Pd1 – N7 = 87.10(9)o, C11 – Pd1 – O2 = 90.84(9)o, N7 – Pd1 – O3 
Figure 3.2: Asymmetric unit of complex Pd(3.3 - H)(O,O’-acac). Hydrogen atoms have 




= 90.42(8)o and O2 – Pd1 – O3 = 91.61(7)o. The observed disparity in bond lengths has 
been highlighted in previous discussions and is consistent with the strong bonding and 
large trans‐influence of the NHC ligand. The bite‐angle of 3.3 - H (C11 – Pd1 – N7) is ~ 
4.5o smaller than that of the O,O’‐acac despite both forming 6‐membered chelates. It is 
deemed that contraction of the C11 – Pd1 – N7 bond angle coincides with the puckering 
of the chelate ring. This occurs in order for the compound to crystallise with the 
minimum internal steric interactions. The cyclohexyl ring does not engage in close 
contacts with other atoms of the complex at a distance greater than three bonds apart. 
This is unlike its bornyl counterpart which contained related contacts as short as 
2.839(7) Å. The shortest such contact in Pd(3.3 - H)(O,O’‐acac) is 3.166(3) Å for C6 ··· O3 
suggesting that there is less steric strain associated with the cyclohexyl ring.  
 
The Pt(II) complex Pt(3.3 - H)(O,O’‐acac) was also successfully crystallised by slow 
evaporation of an Et2O solution of the compound. As with Pd(3.3 - H)(O,O’‐acac), this 
crystallised in the monoclinic space group P21/c with one molecule of the neutral 




Figure 3.3: Asymmetric unit of complex Pt(3.3 – H)(O,O’-acac). Hydrogen atoms have 




Complexes Pd(3.3 - H)(O,O’‐acac) and Pt(3.3 - H)(O,O’‐acac) are crystallographically 
isostructural, sharing many similar bond lengths and angles. The chelate ring is distorted 
to the same extent with the torsion angles C11‐Pd1‐N7‐C8 and N7‐Pd1‐C11‐N10 of 
46.1(3)o and 35.4(3)o respectively, closely matching those of the Pd(II) complex. So too 
does the angle θCH2 which is 61.0(1)o. Bond lengths and angles pertaining to the Pd(II) 
centre are as follows; Pt1 – C11 = 1.944(3) Å, Pt1 – N7 = 2.023(3) Å, Pt1 – O2 = 2.012(2) 
Å and Pt1 – O3 = 2.046(2) Å, C11 – Pt1 – N7 = 87.7(2)o, C11 – Pt1 – O2 = 91.0(2)o, N7 – 
Pt1 – O3 = 89.7(1)o and O2 – Pt1 – O3 = 91.65(9)o. There are no features that have not 
been noted in the discussion of Pd(3.3 - H)(O,O’‐acac) above. Many of the 
crystallographic measurements discussed here are summarised in Table 3.1 in the 
following section. 
 
Complex Pd(3.3 - H)(O,O’‐acac) was shown to perform acceptably as a precatalyst for 
the synthesis of hindered biaryls by Suzuki coupling (Chapter 6). The structural 
characterisation discussed above, and in the next section, therefore fosters an 
understanding of the active species. Because there was an insufficient amount of the 
bornyl species Pd(2.4 - H)(O,O’‐acac) remaining to perform a full catalysis study, the 
applicability of Pd(3.3 - H)(O,O’‐acac) becomes important by analogy. It provides further 
incentive for a researcher interested in improving the synthesis of Pd(2.4 - H)(O,O’‐acac) 
and studying its catalysis. 
 
3.3.1.3. A comparative analysis of M(2.4 - H)(O,O’-acac) and M(3.3 -H)(O,O’-
acac)  
 
That the bornane appendage of the M(2.4 - H)(O,O’‐acac) complexes elicits greater steric 
congestion of the metal‐centre is clearly communicated by comparison with the less 
encumbered cyclohexyl analogues. As has been noted prior, the cyclohexyl‐acetamide 
NHC complexes Pd(3.3 - H)(O,O’‐acac) and Pt(3.3 - H)(O,O’‐acac) are produced in yields  
~ 25% larger than the best yields obtained for the bornyl‐acetamide NHC complexes 
Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) under similar conditions. These larger 
yields reflect the ready chelation of the cyclohexyl‐amide nitrogen compared with the 




greater degree of conformational strain exists within the complexes M(2.4 - H)(O,O’‐
acac) when compared with M(3.4 - H)(O,O’‐acac). This is manifested as a reduction in 
close contacts between the cyclohexyl moiety and the remainder of the complex when 
compared with the bornane complex. Scrutiny of the X‐ray crystal structures provided 
several geometric measurements relevant to the conformation of the NHC‐amidate 
ligand (Table 3.1). Typically, the values obtained for the cyclohexyl‐amidate complexes 
are equal to one of, or fall within the range of values obtained for the two diastereomers 
of each bornyl‐amidate complex. Some subtle differences are observed for the bond 
length M – O3 and the torsion angle Nam‐M‐Ccarb‐N(CH2). The M – O3 bond length is 
longer for the bornyl complexes by ≤ 0.01 Å. This may be due to the bulky bornane 
substituent pushing away the adjacent part of the acac ligand resulting in elongation of 
the nearby M – O bond.  
 
The torsion angle Nam‐M‐Ccarb‐N(CH2) represents the twist of the imidazolyl moiety 
relative to the metal‐centred coordination plane. This torsion is greater for the bornyl 
complexes by upwards of 10o and may be due to twisting of the ligand to accommodate 
the bulkier substituent. It is in this torsion that the greatest variation between the two 
crystallised diastereomers of M(2.4 - H)(O,O’‐acac) is observed (A ~ 52o and B ~ 64o). It 
is touched on in section 2.3.1.3 that, of the two diastereomers, the structure of 
diastereomer B harbours more destabilising internal steric clashes. Diastereomer B, 
presumptively the most encumbered of the two, also has the larger Nam‐M‐Ccarb‐N(CH2) 
torsion angle. It therefore, may be true that the reduced torsion of ~ 47o observed in 
the M(3.3 - H)(O,O’‐acac) complexes reflects their less congested nature. It was thought 
that contortion of the ligand might be quantifiable by the angle θCH2, however, this was 






































































































































Table 3.1: Summary of relevant X-ray crystallographic measurements for M(2.4 -
H)(O,O’-acac) and M(3.3 - H)(O,O’-acac) complexes based on labelling in Figure 3.4. 





The X‐ray crystal structures of these complexes shows that, in the solid state, the six‐
membered chelate ring adopts a puckered conformation with the methylene group 
directed away from the plane defined by the square planar metal centre. In solution 
however, the N‐amidate/NHC chelated ligand is conformationally mobile with the major 
substituents moving in tandem by “flipping” of the chelate ring as illustrated in Figure 
3.5 and Figure 3.6. NMR spectroscopy supports this assessment and, furthermore, 
implies that transitional energy barrier (ΔETS) between the two extreme conformations 
is higher for the bornyl‐appended complexes than their cyclohexyl‐appended 
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Figure 3.5: A region of the 1H-NMR spectrum highlighting the limited conformational 




This implication is made on the basis that, in the 1H‐NMR spectra of complexes Pd(2.4 - 
H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac) at 25 oC, signals pertaining to the acetamide‐
linker and bornane moiety are observed as broad, featureless mounds. Each of the two 
diastereotopic methylene hydrogen atoms contribute a separate signal due to 
occupying chemically distinct positions. The same is true for many of the hydrogen and 
carbon atom environments of the diisopropyl‐phenyl group. Many that are equivalent 
in the spectra of the complexes Pd(3.3 - H)(O,O’‐acac) and Pt(3.3 - H)(O,O’‐acac) are non‐
equivalent in the spectra of Pd(2.4 - H)(O,O’‐acac) and Pt(2.4 - H)(O,O’‐acac). These 
contrasting features are highlighted in the portion of 1H‐NMR spectrum shown in Figure 
3.5 for complex Pd(2.4 - H)(O,O’‐acac) and in Figure 3.6 for its cyclohexyl analogue Pd(3.3 
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Figure 3.6: A region of the 1H-NMR spectrum highlighting the conformational fluxionality 




For M(2.4 - H)(O,O’‐acac) complexes, the broad, non‐equivalent methylene hydrogen 
atom environments and those of, for example H21a and H21b, strongly suggests that 
the molecule spends most of its time in the puckered ring arrangement revealed by X‐
ray crystallography. However, the molecule is still observed to be conformationally 
mobile, albiet slowly on the NMR timescale as evidenced by the broadening of noted 
signals. The fact that the two extreme conformation states shown in Figure 3.5 are 
diastereomeric and hence not degenerate is expected to contribute to the convolution 
of their NMR spectra. Conversely, the cyclohexyl appended complexes Pd(3.3 - H)(O,O’‐
acac) and Pt(3.3 - H)(O,O’‐acac) interconvert rapidly between conformation states 
causing the enantiotopic methylene hydrogen atoms to generate a singlet proton signal 
in the 1H‐NMR spectrum (Figure 3.6). Also, the environment of the diisopropyl‐phenyl 
H15 resonates as one doublet and signals related to the cyclohexyl moiety are slightly 
better defined. It is gleaned from these observations that the bornyl‐amidate complexes 
harbour greater internal congestion which hinders their conformational mobility when 


















Figure 3.7: Representative energy profile for conversion between the two extreme 












M(2.4 - H)(O,O’‐acac) 
 





One interesting similarity between the two spectra is the relatively upfield resonance of 
the imidazolyl‐proton adjacent to the diisopropyl‐phenyl group (H17/H11 ~ 6.77 ppm). 
This is attributed to anisotropic shielding by the aromatic ring which is roughly 
perpendicular to the imidazolyl ring in solution. This analysis clearly establishes that the 
bornyl‐substituent crowds the metal centre to a greater extent than the cylohexyl‐
group. In light of their intended application in catalysis, this will hypothetically enhance 
the stereodirecting capabilities of the bornane group. 
 
3.3.2. Pd(NHC)(allyl)Cl type complexes 
 
With regard to application in palladium mediated synthesis, the Pd(NHC)(allyl) family of 
complexes represent a well‐heeled class of precatalyst with predictable catalytic 
performance. Synthesis of Pd(2.4)(allyl)Cl in section 2.3.3 demonstrated selectivity for 
an unchelated “pendant” motif. It was necessary to determine if this was true also for 
the cyclohexyl‐species which, in light of the above discussion, is shown to be much more 
receptive to amidate‐chelation. It was also important to have a related non‐chelated 
species for comparison with Pd(3.3 - H)(O,O’‐acac) which represents the class of organic, 
amidate‐chelated precatalysts. This would help assess the role of amidate‐chelation in 
active species formation and product conversion.  
 
Successful synthesis of the pendant complex Pd(3.3)(allyl)Cl provided the desired 
“intermediate chelator,” something that can chelate under the conditions of a Suzuki 
coupling, but is selectively isolated in an unchelated form. It finalises the series with the 
pre‐chelated species Pd(3.3 - H)(O,O’‐acac) and one in which chelation is sterically 
disfavoured, Pd(2.4)(allyl)Cl. 
 
3.3.2.1. Synthesis of Pd(3.3)(allyl)Cl 
 
Complex Pd(3.3)(allyl)Cl was prepared in an identical manner to Pd(2.4)(allyl)Cl via the 
silver transmetalation method and isolated in a yield of 78% (Scheme 3.3). The reaction 




to the NHC – Ag(I) was indicated by 1H‐NMR prior to addition of [Pd(allyl)Cl]2 as a DCM 










The completed reaction was filtered through a celite pad and the solvent removed in 
vacuo to provide a fluffy white mass of pure Pd(3.3)(allyl)Cl. Being slightly less organic 
soluble than the bornyl congener meant it could be purified further by rinsing with pet‐
ether to provide very pure material for analysis. 
 
3.3.2.2. Characterisation of Pd(3.3)(allyl)Cl 
 
 
Full characterisation of Pd(3.3)(allyl)Cl was successfully performed and NMR analysis 
revealed the same curious isomerism exhibited by Pd(2.4)(allyl)Cl which is attributable 
to allyl‐auxiliary dynamics. Further evidence allying allyl group fluxionality with the 
observed solution‐state isomerism was provided by a crystal structure of Pd(3.3)(allyl)Cl.  
 
Crystals of Pd(3.3)(allyl)Cl were obtained by slow evaporation of a concentrated Et2O 
solution of the compound. This crystallised in the monoclinic spacegroup P21/c with one 
molecule of Pd(3.3)(allyl)Cl in the asymmetric unit (Figure 3.8). Ligand 3.3 is seen to 
coordinate in a monodentate fashion via the NHC with a chloride and the bidentate allyl 
auxiliary completing the distorted square planar geometry of Pd(II). The acetamide‐NHC 
ligand is oriented perpendicularly such that the inter‐planar angle between the 
coordination plane of Pd(II) and that of the imidazolyl moiety is 102.3(2)o. This limits 
Pd(3.3)(allyl)Cl, 78% 




contact between the diisopropyl‐phenyl substituent and the remainder of the ligand 
field. Likewise, the acetamide arm and diisopropyl‐phenyl substituent are both rotated 
to be orthogonal to imidazolyl moiety generating an C9‐N8‐C7‐C6 torsion of 91.3(4)o and 






Coordination to Pd(II) is quantified by the following bond lengths; Pd1 – C9 = 2.047(3) Å, 
Pd1 – C19 = 2.095(5) Å, Pd1 – C21 = 2.169(4) Å and Pd1 – Cl1 = 2.3643(9) Å, and angles; 
C9 – Pd1 – C19 = 100.7(2)o, C19 – Pd1 – C21 = 68.8(2)o, C21 – Pd1 – Cl1 = 99.2(2)o and 
C9 – Pd1 – Cl1 = 91.2(2)o. Palladium to carbon separations for the allyl carbons are 
differentiated due to the trans influence of the NHC ligand causing the pseudo‐trans 
bond Pd1 – C21 to be elongated compared to Pd1 – C19. A crystallographic study 
performed by Vicui and co‐workers on eight simple Pd(NHC)(allyl)Cl complexes reported 
measurement ranges for related Pd – Ligand bonds.212 These are; Pd – Ccarbene = 2.028(4) 
Å – 2.062(2) Å, Pd – Callyl(cis) = 2.098(6) Å – 2.160(10) Å, Pd – Callyl(trans) = 2.167(3) Å – 
2.236(4) Å and Pd – Cl = 2.358(9) Å – 2.419(8) Å.  Bond lengths vary considerably 
depending on the nature of the NHC wing groups however, the Pd – Ccarbene and Pd – Cl 
Figure 3.8: Contents of the asymmetric unit of Pd(3.3)(allyl)Cl. Hydrogen atoms have 




bond lengths recorded for Pd(3.3)(allyl)Cl fall neatly within the reported ranges. Pd – C 
distances for the allyl ligand, however, are at the low end or outside in the case of Pd1 
– C19 and compare more closely with a reported Pd(NHC)(allyl)Br complex.193 Bond 
angles are comparable to those reported in the above sources, importantly these 
corroborate the narrow angle between terminal carbons of the allyl ligand (C19 – Pd1 – 
C21). The acetamide pendant adopts a Z‐amide configuration allowing it to participate 
in bridging hydrogen bonds of the type NH ··· O (N5 ··· O1 = 2.878(4) Å, N5 – H ··· O1 = 
155.7(2)o) (Figure 3.9). The resultant linearly polymeric packing motif was also seen in 
the structure of the “pendant” complex Pd(2.5)Cl2. The aromatic diisopropyl‐phenyl 
rings appear to stack, however, the offset is too large to constitute a genuine π ··· π 
interaction (centroid to centroid = 4.537(4) Å, plane to plane shift = 2.505(8) Å, plane to 









The allyl ligand itself exhibits positional disorder of the central carbon C20 which arises 
due to the syn-anti interchange mechanism discussed previously. It is found that the C20 
sites are occupied in a 70 : 30 ratio. As has been noted, fixing the position of the allyl 
group and rotating the Pd – NHC bond produces a different diastereomer to the one 
observed. Inspection of the crystal structure suggests that this rotation is unrestricted 
and could occur more rapidly than syn-anti interchange making it unlikely to contribute 
to the isomerism witnessed on the NMR timescale. The two diastereomers shown in 
Scheme 3.4 are implicated in the observance of two species by NMR. A previous study 




















These conformations of the allyl ligand were witnessed as separate species by NMR in 
solvents other than DMSO‐d6. As in the case of the related bornyl‐acetamide species, 
their dynamic behaviour was probed through variable temperature NMR. First however, 
syn-anti 
interchange 






Scheme 3.4: The diastereomeric products of syn‐anti interchange by the allyl-auxiliary 
as observed crystallographically in the form of positional disorder. A different 





it is convenient to address the general characterisation of Pd(3.3)(allyl)Cl in relation to 
the more simplistic DMSO‐d6 NMR spectra before discussing the compounds dynamics.   
 
The mass‐spectrum of complex Pd(3.3)(allyl)Cl identifies a single species of mass 
514.2055 corresponding to the [M – Cl]+ cation (calculated m/z, [Pd(3.3)(allyl)]+ = 
514.2050). Features of the 1H‐NMR and 13C‐NMR spectra of Pd(3.3)(allyl)Cl in DMSO‐d6 
(Figure 3.10) mirror those of the bornyl‐acetamide analogue Pd(2.4)(allyl)Cl. Resonances 
due to the allyl‐ligand are found at ~ 4.97 ppm (H20, overlapped with H7), 3.79 ppm 












































Figure 3.10: The 1H-NMR and 13C-NMR spectra of Pd(3.3)(allyl)Cl in DMSO-d6 with 




Note again that the allyl‐proton environments pseudo‐cis to the NHC (H25) are absent 
in the 1H‐NMR spectrum due to rapid allyl syn-anti interchange induced by the DMSO‐
d6 solvent. Broadening of the spatially adjacent diisopropyl‐phenyl methine proton 
signals (H23) is a further consequence of this. All allyl environments are accounted for 
in the 13C‐NMR spectrum at 114.75 ppm (C20), 71.01 (C21) and 49.30 (C19). Ligand 3.3 
is readily identifiable by its carbenic carbon signal at 182.15 (C9) and an amide carbonyl 
resonance at 166.20 (C6). Proton resonances due to 3.3 are as expected with the 
exception of the amide NH environment H5 which resonates at 8.03 ppm, moderately 
downfield of the equivalent signal in the bornyl‐acetamide analogue (~ 7.48 ppm). This 
is probably occurring because the cyclohexyl‐appended amide NH is more exposed to 
hydrogen bond donation to the solvent than the comparatively shielded bornyl‐
appended amide. A similar relationship is seen in CD3CN although to a lesser extent. 
 
Isomerism in the 1H‐NMR spectrum of Pd(3.3)(allyl)Cl in CD3CN is barely detectible 
compared with Pd(2.4)(allyl)Cl and is only significantly indicated by two singlets for the 
methylene proton environment (H6) at 5.06 ppm and 5.03 ppm and possible splitting of 
the H20 environment, although, this is obscured by the H6 signal. Signals due to the 
diisopropyl‐phenyl environments H15 (~ 7.31 ppm) and H18 (~ 1.26 ppm and 1.05 ppm) 
are observed as multiplets that converge to doublets at higher temperature. Here, all 
allyl proton environments are observed including H19 which is pseudo‐cis to the NHC 
and undetected in DMSO‐d6.  Allyl resonances in CD3CN are 5.05 ppm (H20, overlapped 
with H7), 3.91 ppm (syn‐H21), 3.18 (syn‐H19), 2.88 ppm (anti‐H21, overlapped with 
H17), 1.86 ppm (anti‐H19). Two distinct methine H17 environments are also observed 
at 2.84 ppm (overlapped with anti‐H21) and at 2.59 ppm. Observing separate 
diisopropyl‐phenyl methine environments implies that rotation around the Pd – NHC 
bond is not occurring as rapidly on the NMR timescale as might be expected. 
Interestingly, in CD3CN, the imidazolyl proton environments H11 and H12 at 7.38 ppm 
and 7.23 ppm couple to one another at a frequency of 1.96 Hz with a slight roof effect. 
Such coupling was not witnessed elsewhere in this study (or in the wider literature) and 
it is unknown why it arises for this complex. Because it is retained at high temperatures, 





A variable temperature 1H‐NMR experiment in CD3CN was performed to demonstrate 
the convergence and elimination of signals resulting in a spectrum resembling that in 
DMSO‐d6 (Figure 3.11). The findings here fortify the assertion that syn-anti interchange 


















Convergence to a spectrum resembling that in DMSO‐d6 is observed at 65 oC. At this 
temperature, the methylene signals (H7) have merged into a neat singlet. Also both syn 
and anti H19 ally environments dissipate into the baseline as do the diisopropyl‐phenyl 
methine H17 environments. That both methine signals disappear implies that rotation 
around the Pd – NHC bond also accelerates which is unsurprising. These observations 
are shared with the variable temperature analysis of Pd(2.4)(allyl)Cl and the conclusion 
drawn therein apply here. 
 
Complex Pd(3.3)(allyl)Cl fulfilled its role as a structural reference for Pd(2.4)(allyl)Cl. 
Much less distinct isomerism due to syn-anti interchange is noted for Pd(3.3)(allyl)Cl, 
compared with the bornyl‐acetamide species. This is important because it indicates that 
syn-H19 





Figure 3.11: Series showing a portion of the 1H-NMR spectra of Pd(3.3)(allyl)Cl as a 
function of temperature in CD3CN. Top spectrum in DMSO-d6 at 25 oC highlighting its 




the structure of the amide N‐group influences the immediate ligand sphere of the Pd(II) 
centre. This is despite it being relatively remote to the Pd(II) in the non‐chelated pendant 
arrangement. Greater differentiation in the electronic environments of the allyl ligand 
and NHC – acetamide ligand is observed for Pd(2.4)(allyl)Cl because the bulkier, more 
hydrophobic bornane group elicits greater conformation organisation of the overall 
complex. This restricts key proton environments on ligand 2.4 to report on changes in 
the allyl ligand (and visa versa). Ligand 3.3 can only achieve this to a limited extent.  
 
3.4. Summarising remarks 
 
Complexes Pd(3.3 - H)(O,O’‐acac), Pt(3.3 - H)(O,O’‐acac) and Pd(3.3)(allyl)Cl fulfilled 
their desired function as structural analogues to related complexes in the bornyl‐
acetamide series. More efficient N‐amidate/NHC chelation by the less hindered 
cyclohexyl‐amidate allowed Pd(3.3 - H)(O,O’‐acac) and Pt(3.3 - H)(O,O’‐acac) to be 
obtained in respective yields of 46% and 47%, by un‐optimised purification methods. 
Comparison of X‐ray crystal structures of Pd(3.3 - H)(O,O’‐acac) and the bornane 
appended Pd(2.4 - H)(O,O’‐acac) revealed how significantly the bornane unit crowds the 
metal centre in the N‐amidate/NHC chelate form. These steric influences were also 
identifiable by 1H‐NMR contributing to signal broadening in the spectrum of Pd(2.4 - 
H)(O,O’‐acac) as a result of slow conformational exchange relative to the NMR 
timescale.   
 
Isolation and subsequent characterisation of Pd(3.3)(allyl)Cl bolstered the 
understanding of this compound class, particularly regarding the syn-anti interchange 
mechanism. This was aided greatly by an X‐ray crystal structure of Pd(3.3)(allyl)Cl in 







3.5. Scope and future work 
 
Cyclohexyl‐acetamide NHC proligands have been shown to be applicable to similar 
synthesis as those used in the bornyl‐acetamide NHC series. It is therefore possible to 
make additional achiral analogues such as the pyridyl/NHC chelated complex Pd(3.4)Cl2 
or an Ru(NHC)(arene) derivative such as [Ru(3.2)(p‐cymene)Cl][PF6]. These would be 
interesting as the cyclohexyl‐amide chelates more readily than the bornyl‐amide and 
hence could provide access to related structures but with an anionic‐chelate. It would 
also be interesting to target the synthesis of Pd(3.3)(O,O’‐acac)(γC‐acac) for comparison 
with Pd(2.4)(O,O’‐acac)(γC‐acac) to improve understanding of it curious isomerism. As 
was true for Pd(3.3)(allyl)Cl, it may be possible to obtain a crystal structure of 
Pd(3.3)(O,O’‐acac)(γC‐acac) where it was not possible with Pd(2.4)(O,O’‐acac)(γC‐acac). 
 
The availability of cyclohexylamine and relative ease of subsequent synthesis makes this 
a particularly cheap and accessible NHC ligand system. Furthermore, it is likely that the 
synthesis of Pd(3.3 - H)(O,O’‐acac) could be developed into a simple, high yielding 












































NHCs derived from 1H-imidazo[4,5‐f][1,10]phenanthroline 4.1 (Scheme 4.1) are a class 
of aromatic, heterodentate ligands capable of linearly bridging two metal centres (Figure 
4.1). The imidazo[4,5‐f][1,10]phenanthroline core of these compounds will here‐in be 
referred to as IP. Several recent studies have reported the incorporation of IP‐NHCs into 
heteronuclear complexes for applications including; carbon monoxide detection,213, 214 
solar driven hydrogen evolution,215 in addition to the study of their photophysical 
properties.216 Their synthetic utility is based on the selective conversion of the 
imidazolium component into an NHC ligand. This facilitates the stepwise assembly of 
dinuclear complexes by enabling the bidentate phenanthroline to be coordinated first, 


















This approach could likewise be applied to the preparation of a ruthenium(II) polypyridyl 
complex fused to an NHC ligand for metal mediated catalysis (Figure 4.2). This assembly 
was considered an interesting target for evaluating the electronic influence of the bound 
ruthenium(II) complex on catalysis more so than its stereochemical influence. It was 
expected (and has since been established)216 that the bridging IP ligand would facilitate 
electronic communication between the two nuclei. However, the relative orientation, 
and large distance between the catalytic centre and enantiomeric component was 
deemed too large to enable any form of stereocontrol. Unfortunately, the investigation 
t roline-i idaz li  salt phenanthroline-NHC 
Figure 4.1: The stepwise assembly dinuclear complexes with imidazo[4,5-




of these systems was hampered by synthetic difficulties and ultimately energy was 
diverted towards systems more amenable to use in enantioselective synthesis. 
Regardless, several interesting new IP based ligands were developed along with 
complexes of the type [Ru(bipy)2(IP)]n+. Furthermore, UV‐visible and fluorometric 
analysis on these compounds revealed some curious photophysical properties in several 
derivatives. Despite recent advances in the literature their application in homogeneous 








4.2. Synthesis of 1,10-phenanthroline annelated NHC precursors 
4.2.1. General route to 1,10-phenanthroline annelated imidazolium 
salts 
 
Synthesis of several IP imidazolium salts was attempted by stepwise N‐substitution of 
1H-imidazo[4,5‐f][1,10]phenanthroline (4.1) (Scheme 4.1). This approach was appealing 
because the parent imidazole 4.1 is easily prepared from 1,10‐phenanthroline in a two‐
step process beginning with conversion to 1,10‐phenanthro‐5,6‐dione.217 Annulation 
 
Figure 4.2: General structure of 1,10-phenanthroline-annelated (IP) NHC complexes with 




with ammonium‐acetate and formalin in acetic acid gives 4.1 in an overall 82% yield 








Another possible route by the cyclisation of a substituted diimine (Route A, Scheme 1.12, 
Chapter 1), was also trialled but found to be infeasible. This was because no 1,10‐
phenanthroline‐5,6‐diimines could be prepared from 1,10‐phenanthroline‐5,6‐dione 
with either aniline or less hindered alkyl‐amines. Several imine‐condensation protocols 
were followed including using TiCl4 as a strong Lewis acid, but none provided any 
evidence of product formation. 
 
4.2.2. N-substituted imidazo[4,5-f][1,10]phenanthrolines 
 
Three mono‐substituted IP derivatives, shown in Figure 4.3 were prepared from 4.1 
(Step 3, Scheme 4.1). The mono‐benzylated 1‐benzyl‐imidazo[4,5‐
f][1,10]phenanthroline 4.2 was prepared under dry conditions by the reaction of the 
parent imidazole with benzylbromide in DMF at 100 oC using K2CO3 as base. Under these 
conditions the product 4.2 could react with another equivalent of benzylbromide 
resulting in di‐substituted salts. Loss of product this way may account for the moderate 
yield of 47%, however, due to the availability of the starting material little effort was 
made to improve this. The mono‐arylated derivatives 1‐phenyl‐imidazo[4,5‐
f][1,10]phenanthroline (4.3) and 1‐(2‐pyridyl)‐imidazo[4,5‐f][1,10]phenanthroline (4.4) 
were prepared by a pseudo‐Ullmann coupling using Cu(OAc)2 as the source of Cu 
4.1, 82% 
 




catalyst. Initially the synthesis of 4.3 was attempted following a literature procedure for 
arylation of various azoles.219 The reaction was carried out under conditions similar to 
those used for 4.2 but with iodobenzene and 1.0 mol% Cu(OAc)2. After 24 hours only a 
trace amount of product was observed so the reaction was repeated using a 5 mol 
excess of iodobenzene and a larger catalyst loading of 10 mol% Cu(OAc)2. This provided 
a product yield of 22% after an aqueous work up and continued modification of the 
procedure achieved an optimal yield of 60%. It was found that refluxing the reaction 
mixture for one hour before addition of the Cu(OAc)2 catalyst improved the yield greatly, 










The same methodology was applied to the synthesis of 4.4 which was obtained in a 45% 
yield using 2‐bromopyridine as the aryl‐halide. A more direct synthesis has since been 
published in which several 1‐aryl‐imidazo[4,5‐f][1,10]phenanthroline compounds are 
prepared from 1,10‐phenanthro‐5,6‐dione by an in situ annulation reaction with an aryl‐
amine, ammonium‐acetate and formalin.220 This produces 4.3 in a 79% yield. No 
synthesis of 4.4 has been reported and given the poor nucleophillicity of 2‐ and 4‐
aminopyridines preparation by the above mentioned approach would be unsuitable. 
The aromatic regions of the 1H‐NMR spectra of 4.2, 4.3 and 4.4 in CDCl3 are shown in 
Figure 4.4.  
 
4.2, 47% 4.3, 60% 4.4, 45% 
Figure 4.3: Mono-substituted imidazo[4,5-f][1,10]phenanthroline derivatives 4.2, 4.3, 
















The chemical shift of signals due to proton environments on the IP core are relatively 
conserved with the exception of H4 and H6. In the 1H‐NMR spectrum of 4.2 the H4 
doublet occurs at 8.23 ppm but is shifted upfield in the spectra of 4.3 and 4.4 to 7.72 
ppm and 7.93 ppm, respectively. This is most likely the result of anisotropic shielding of 
the H4 proton by the aryl pendant substituent which will occur if H4 is projected toward 
the face of the phenyl or pyridyl side‐group. The aryl‐substituents must therefore be 
rotated out of the molecular plane. The position of the singlet H6 proton signal is similar 
in the spectra of 4.2 and 4.3 (8.05 ppm and 8.06 ppm respectively) but is shifted 
downfield in the spectrum of 4.4 to 8.23 ppm. This is a consequence of electron 
withdrawal by the π‐deficient pyridine substituent and may also explain the higher 














Figure 4.4 (a-c): Aromatic region of 1H-NMR (CDCl3) spectra of 4.2, 4.3 and 4.4, (d)




4.2.3. 1,10-phenanthroline annelated imidazolium salts 
 
Conversion of these N‐substituted IP derivatives into imidazolium salts (Step 3, Scheme 
4.1) was attempted with varying degrees of success. Synthesis of 1,3‐benzyl‐1H‐
imidazolium[4,5f][1,10]phenanthroline bromide (4.5.HBr) was achieved by refluxing 4.2 
in chloroform with excess benzylbromide for two days (Scheme 4.2). The resultant 
precipitate was collected by filtration and washed with additional chloroform to give the 
pure product in 62% yield. NMR and mass‐spectrometry for 4.5.HBr matched data which 
was reported after our synthesis.215 This compound appeared to be unstable under 
aqueous conditions, isomerising to give other N‐benzylated salts [4.6]+ and [4.7]+, or 





4.3 4.5.HBr, 62% 
4.6.PF6 4.7.PF6 
Scheme 4.2: Synthesis of 4.5.HBr and conversion to phenanthrolin-(N-benzyl)-ium salts 




This was noted when, in an attempt to improve its organic solubility, [4.5.H]+ was 
precipitated as its PF6 salt by addition of KPF6 to an aqueous solution of 4.5.HBr at room 
temperature. The product obtained was bright yellow (instead of the faint orange of 
4.5.HBr) and its 1H‐NMR spectrum showed a mixture of several products. The mass‐
spectrum still showed a major signal which matched [4.5.H]+ but also a signal due to 4.2. 
Using flash column chromatography on alumina with 9:1 DCM/MeOH, 4.2 was 
separated from the two phenanthrolin‐(N‐benzyl)‐ium salts 4.6.PF6 and 4.7.PF6, which 
eluted as a single bright yellow band and were obtained as a mixture. No 4.5.HPF6 could 
be eluted from the column. 
Crystals of 4.6.PF6 suitable for single‐crystal X‐ray diffraction were grown by slow 
vapour‐diffusion of diethyl‐ether into a DCM solution of the mixture. Compound 4.6.PF6 
crystallised in the monoclinic space group P21/c, with one molecule of [4.6]+ and a PF6 










This structure unambiguously shows benzyl substitution at the N11 position instead of 
at the desired N7 position and the presence of a PF6 counter‐ion provides further 
Figure 4.5: Asymmetric unit of 4.6.PF6. Hydrogen atoms have been omitted for clarity. 









Figure 4.6 (a): Aromatic region of 1H-NMR (DMSO-d6) spectra of 4.6.PF6 and, (b) of the 
mixed material with signals due to 4.7.PF6 highlighted. 
evidence of salt formation. The nitrogen atoms N5 and N11 that are each bonded to a 
methylene carbon remain conjugated as indicated by their trigonal planar geometry and 
the internal angles around the N5 and N11 centres which sum to 360.0(4)o and 359.8(4)o, 
respectively. A layered packing arrangement arises from the surficial alignment of the 
planar IP cores. Each layer has a front‐to‐front interface where the benzyl‐groups face 
towards the opposing surface and a back‐to‐back interface where they face away. At the 
front‐to‐front interface, edge‐to‐face π – π interactions occur between the N5 and N11 
benzyl groups (C to centroid distance = 3.538(6) Å and 3.742(6) Å) and N1 pyridyl ring 
and N11 benzyl group (C to centroid distances = 3.720(6) Å) of opposite molecules. A 
slipped face‐to‐face interaction between the imidazole and N11 pyridyl ring (centroid to 
centroid distances 3.569(3) Å) occurs at the back‐to‐back interface. Each PF6 anion is 
involved in a number of short CH ··· F contacts with five molecules of [4.6]+ (C ··· F = 
3.198(6) Å to 3.600(6) Å) and is participating in weak hydrogen bonding with H6 (C ··· F 
= 3.206(5), C – H ··· F angle = 160.0(4)o). 
These same crystals were used in NMR and mass‐spec analysis allowing 4.6.PF6 to be 
fully characterised. Although isomer 4.7.PF6 was unable to be isolated the remaining, 
unassigned signals in the 1H‐NMR spectrum of the mixture could be attributed to the 
proposed structure (Figure 4.6).  
 










The isomerisation and decomposition reactions undergone by [4.5.H]+ are 
understandable considering the well‐known lability of benzyl substituents especially 
when appended to a quaternary azole nitrogen.221 Although this conversion was not 
explored in depth the evident instability of [4.5.H]+ suggested that benzyl pendant 
groups are unsuitable for NHC precursors in this system. This assessment is explored 
further in section 4.4.2. 
Phenyl‐appended imidazolium salts based on 4.3 were identified as useful NHC 
precursors because the phenyl pendant offers greater steric shielding of the carbene 
centre when compared with benzyl and n‐alkyl groups. The synthesis of several such 
derivatives including a 1‐Phenyl‐3‐butyl‐1H‐imidazolium[4,5f][1,10]phenanthroline salt 
[4.8.H]+ and 1‐Phenyl‐3‐methyl‐1H‐imidazolium[4,5f][1,10]phenanthroline salt [4.9.H]+ 
and a symmetrical 1,3‐bis‐phenyl‐1H‐imidazolium[4,5f][1,10] phenanthroline salt  





























The synthesis of 4.8.HI was attempted based on a procedure for appending an n‐butyl 
group to form a similar compound.213 Surprisingly, using these conditions with 4.3 and 
excess 1‐iodobutane, only the phenanthrolin‐(N‐butyl)‐ium iodide salts 4.11.I and 4.12.I 
were formed (Scheme 4.3). The 1H‐NMR spectrum of the product mixture showed that 
these were present in a 2.2:1 ratio of 4.11.I: 4.12.I. Some starting material was retained 
but none of the desired 4.8.HI was detected. Gradient flash chromatography on alumina 
with 2% ‐ 5% MeOH/DCM provided a sufficient amount of pure 4.11.I and 4.12.I for 
characterisation, however, poor chromatographic resolution meant the majority 



























Both products gave identical mass‐spectra as expected but could be clearly 
distinguished by 1H‐NMR spectroscopy (Figure 4.8). In each case all signals due to 
protons bonded to the core IP unit were shifted downfield relative to those of the 











starting material 4.3. However, protons bonded to the N‐substituted pyridine ring were 
shifted to the greatest extent (Δδ > 0.7 ppm) with the most affected signals being those 
of the proton environments adjacent to the newly quaternised nitrogen centre. For 
4.11.I this signal (H10) arrived at 10.33 ppm, shifted from 9.19 ppm in 4.3 (Δδ = 1.14 














The structure of 4.11.I was verified by single‐crystal X‐ray analysis for which suitable 
crystals were grown by slow evaporation chloroform solution spiked with toluene. 
Compound 4.11.I crystallised in the triclinic space group P1 , with two molecules of 
[4.11]+ (A and B) and two iodine anions present in the asymmetric unit (Figure 4.9). 
Molecules A and B are differentiated by their butyl chain conformations as well as 
numerous other bond lengths and angles. The lengths of bonds to the quaternary 
nitrogen are N11 – C10 (A / B) = 1.351(4) Å / 1.349(4) Å and N11 – C17 (A/B) = 1.389(3) 
Å / 1.393(3) Å. These are elongated when compared with the same bond lengths in 
unsubstituted 1H-imidazo[4,5‐f][1,10]phenanthroline (1.326(3) Å and 1.355(3) Å)222 due 
to a reduction in π‐bonding character as a result of the nitrogen cation. The observed 
warping of the polyaromatic IP core is represented by several moderate torsion angles 
including (A / B) C18‐N5‐C14‐C13 = 25.3(4)o / 20.4(3)o, N5‐C14‐C13‐C4 = 8.6(4)o / 11.5(4)o 
and N1‐C12‐C17‐N11 = 14.5(3)o / 14.8(3)o. This is evidence of the steric strain imposed 
by the N‐substituents, however, the differences in the torsion angles across the same 





























Close, face‐to‐face π – π stacking occurs between the central benzenoid rings of each IP 
unit (centroid‐to‐centroid distance [shift] = 3.5073(15) Å [0.572(4) Å / 0.400(4) Å]). The 
peripheral rings are also in close contact but with a larger offset (centroid to centroid 
distance [shift] = 3.510(2) Å [1.409(4) Å / 0.980(4) Å], 3.821(2) Å [1.511(4) Å / 1.196(5) 
Å] and 3.601(2) Å [1.336(5) Å / 1.323(4) Å]). Various π – π, CH ··· π and CH ··· I interactions 
Figure 4.9: Asymmetric unit of 4.11.I. Hydrogen atoms have been omitted for clarity. 





are observed in the packed structure. Hydrogen bonding between N7 and H8 is also 
observed (C8 ··· N5 = 3.367(4) Å, C8 – H8 ··· N5 angle = 171.6(2)o). The electron deficiency 
of C8 due to mesomeric electron withdrawal onto the pyridinium nitrogen renders it a 
feasible hydrogen bond donor.223  
 
Despite the clear regioselectivity issues associated with these molecules, success could 
be had with a slightly more potent electrophile. This was demonstrated by substituting 
1‐iodobutane with iodomethane to produce 4.9.HI in a 32% yield under analogous 








A crude material which was precipitated from the reaction mixture by addition of Et2O, 














with warm DCM removed 4.13.I into a bright yellow filtrate leaving pure 4.9.HI as an off 
white solid. When the reaction was performed in refluxing DCM no imidazolium salt was 
formed and the only material isolated, other than starting material, was 4.13.I although, 
a trace amount of 4.14.I was detected by NMR. 
 
Again NMR was indispensable in distinguishing which regiosomers had formed. As well 
as the emergence of a signal due to methyl‐protons, compound 4.9.HI could be readily 
identified by the downfield singlet that is characteristic of the imidazolium NCHN proton 
(H6). This was found at 10.15 ppm (Figure 4.10a). Likewise, 4.13.I produced an 1H‐NMR 
spectrum with the anticipated large downfield shift of protons in the vicinity of the 
formal positive charge. The most downfield signal, at 10.38 ppm, belonged to the proton 
adjacent to the methylated nitrogen (H10) as expected (Figure 4.10b). 
 
 











Remarkably, neither synthesis produced more than a trace amount of the third possible 
regioisomer 4.14.I. Of the two phenanthrolinium salts the one formed by substitution 
at the phenanthroline nitrogen nearest the substituted nitrogen of the imidazole (N1) is 
less favoured in both examples (4.12.I and 4.14.I). Neither position offers any obvious 
advantages for electronic stabilisation of the pyridinium‐cation hence the selectivity 
may have a steric basis. The x‐ray crystal structure of 4.11.I shows a pronounced warping 
of the IP body structure to accommodate substitution of the phenanthroline nitrogen 
Figure 4.10 (a): Aromatic region of 1H-NMR spectra of 4.9.HI in CD3CN and, (b) of 4.13.I




(Figure 4.9). It is probable that substitution at the phenanthroline nitrogen furthest from 
the phenyl ring as in 4.11.I and 4.13.I invokes a less strained distortion than when it 
occurs at the nearest site as in 4.12.I and 4.14.I. 
 
Of the three target phenyl‐appended imidazolium salts, [4.10.H]+ is expected to be the 
most stable and, the much bulkier phenyl group should favour substitution at the 
imidazole nitrogen, surmounting the regioselectivity issues discussed previously. 
Typically, bis‐aryl imidazolium salts such as [4.10.H]+ are formed through an annulation 
reaction between an aryl‐diimine and a C1‐electrophile but, as mentioned previously, 
this approach is not applicable to this system. Therefore, the preparation of [4.10.H]+ 
from 4.3 requires N‐aryl quarternisation of the imidazole nitrogen. This can be 
performed using a very electron deficient aryl‐halide such as 2,4‐
dinitrochlorobenzene,224 or some pyridyl‐halides,101 but for a poor aryl electrophile such 
as benzene an extremely effective leaving group is necessary. The hypervalent‐iodine 
compound diphenyliodonium triflate, in which iodobenzene acts as the leaving group, 
has been demonstrated as a useful reagent for forming phenyl‐substituted imidazolium 
salts assisted by a Cu(II) catalyst.225 Such a procedure was adapted for the synthesis of 
4.10.HOTf (Scheme 4.5), however, despite observing the consumption of 



























Although this is a synthetically interesting approach, fine tuning was clearly needed and 
given the various difficulties already encountered with this system it was not pursued 
further. A more robust strategy for N‐aryl quarternisation which emerged after this 
attempt employs coupling using arylboronic acids to prepare imidazolium salts.226 
 
The synthesis of imidazolium salts using 4.4 will be discussed in section 4.4.2. 
 
4.3. Photophysical properties of substituted IP derivatives 
 
Interestingly, substitution of the phenanthroline nitrogen to form the phenanthrolinium 
salts 4.6.PF6, 4.7.PF6, 4.11.I, 4.12.I and 4.13.I induced a colour change from the very 
faint yellow/off‐white of the mono‐substituted precursors 4.2 and 4.3, to a vivid yellow. 
The imidazolium salts 4.5.HBr and 4.9.HI on the other hand were a faint yellow/brown. 
To better understand and quantify this observation an analysis of the absorption and 
emission properties of these compounds was undertaken. The key spectral features are 
summarised in Table 4.1. 
 
 
a Recorded in MeCN, all others recorded in DCM. 
 
Table 4.1: Summary of the absorption and emission maxima of IP derivatives. 
emission emission
λmax (nm) ε (Lmol
‐1cm‐1) λmax (nm) λmax (nm) ε (Lmol
‐1cm‐1) λmax (nm)
4.2
252, 283       





















282, 337       
354
15838, 679   
368 
388 4.13.HI





























































































































Figure 4.11 (a): UV-visible spectra and, (b) UV-visible with overlaid photoluminescence 
spectra of 4.2, 4.3, and 4.4 in DCM at room temperature, concentration ~ 10-5 molL-1. 
The UV‐visible absorption spectra of the three mono‐substituted derivatives (Figure 
4.11a) display similar absorption maxima at ~ 384 nm and ~ 255 nm, however, 
compound 4.4 produced a significantly broadened curve. Having an N‐appended aryl 
substituent (4.3 and 4.4) caused no appreciable increase in molar absorptivity when 
compared with the benzyl‐appended 4.2. This suggests that neither aryl π‐system is 
significantly conjugated with the IP core, further evidence that the two ring systems are 
anti‐planar in solution.  The aryl substituents do, however, increase absorption below ~ 
250 nm. All spectra exhibit weak absorption features at ~ 338 nm and ~ 354 nm which 
contribute to their faint yellow colouration. Evidently the electronic structure of the 


















Excitation at ~ 284 nm results in emission at λmax = 388 nm for all three derivatives 
(Figure 4.11b). Compounds 4.3 and 4.4 produce fairly sharp emission curves with 4.3 
displaying an emerging fine structure. The spectrum of 4.2 however, is distinguishable 
by a shoulder of emissive intensity around ~ 490 nm. This may be because the flexible 
benzyl group of 4.2 enables more vibrational relaxation pathways than the 























































































Figure 4.12 (a): UV-visible spectra and, (b) UV-visible with overlaid photoluminescence 
spectra of 4.11.I, 4.12.I, and 4.13.I in DCM at room temperature, concentration ~ 10-5 
molL-1. 
 
The UV‐visible absorption spectra of the three phenanthrolinium salts derived from 4.3 
is shown in Figure 4.12a. These all feature similar intense absorption in the ultraviolet 
region with λmax ~ 235 nm and ~ 255 nm. The lowest energy π – π* transition which 
occurs at 283 nm in 4.3 is slightly red‐shifted to ~ 300 nm in 4.11.I, 4.12.I and 4.13.I. This 
is consistent with a lowering of the LUMO energy due to the electron acceptor ability of 
the pyridinium cation. Furthermore, torsional distortion, such as that observed in the 
XRD structure of 4.11.I, may contribute to HOMO destabilisation by reducing the π‐
orbital overlap.6 Compound 4.11.I absorbs at twice the intensity of 4.12.I and 4.13.I, the 
reason for this is not yet understood.  
 
 














The emission spectra, more‐so than the absorption spectra, highlights the subtle 
electronic differences between the N1 and N11 substituted salts. The N1 salt 4.12.I 
emits at a slightly lower energy (λmax = 499 nm, 20000 cm‐1) than the N11 salts 4.11.I and 
4.13.I which have near identical emission curves (λmax = 482 nm, 20700 cm‐1). 
Substitution of the phenanthroline nitrogen induces a large bathochromic shift of 









The bright yellow colour of these phenanthrolinium salts is due to a moderately intense 
absorption around ~ 390 nm which is not present in the neutral precursor. This may be 
attributed to intramolecular charge transfer (ICT) between the substituted imidazole 
nitrogen donor and the quarternary nitrogen acceptor or a π(N‐Ph) – π*(pyridinium) 
transition. This is analogous behaviour to other systems in which pyridinium rings have 
been incorporated for their π‐electron acceptor ability most notably in the hemicyanine 
stilbazolium salt family.227‐231 Ionic ICT based organic dyes are of interest for their 
potential non‐linear optical (NLO) properties which have been applied in optoelectronic 
and photonic devices.227 Unfortunately, however, the ICT absorption band of 
compounds 4.11.I, 4.12.I and 4.13.I are weak (εmax ~ 1000 – 2000 Lmol‐1cm‐1) when 
compared with literature pyridinium based dyes (typically, εmax > 20000 Lmol‐1cm‐1).227, 
228 One possible reason for this low molar‐absorptivity is illustrated by a comparison of 
the ICT excited states of compound 4.13.I and the stilbazolium salt trans‐4'‐
(dimethylamino)‐N‐methyl‐4‐stilbazolium hexfluorophosphate ([DAST][PF6]) (Figure 
4.13).227, 229 Neither excited state is aromatic, however, aromaticity is lost in four rings 
of 4.13.I instead of just two in [DAST]+.  Furthermore, steric strain in the excited state of 








λmax = 389 nm (2954 Lmol‐1cm‐1) 
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λmax = 470 nm (42800 Lmol‐1cm‐1)  
Figure 4.13: Probable ICT excited state resonance forms of a 1-phenyl-imidazo[4,5-
























The π – π* ICT excitation depicted in Figure 4.13 invokes a large charge displacement 
hence these molecules are inevitably highly polarizable and probably exhibit 
solvatochromism.228  Their application as solvatochromic agents has yet to be studied.   
 
The imidazolium salt 4.9.HI is insoluble in DCM and had to be studied as a MeCN solution 
meaning its absorption and emission spectra are not amenable to direct comparison 
with the previously discussed compounds. Regardless, the UV‐visible spectrum did show 
this unsymmetrical imidazolium salt only absorbs significantly in the far ultra‐violet (λ < 
330 nm) in contrast to the phenanthrolinium salts.  
 
4.4. Synthesis of [Ru(2,2'-bipyridine)2(IP)]n+-type complexes  
4.4.1. Complexes with N-substituted imidazo[4,5-
f][1,10]phenanthroline ligands 
 
Complexes [Ru(bipy)2(4.2 – 4.4)][PF6]2 were prepared by reacting the corresponding N‐
substituted IP ligand with Ru(bipy)2Cl2 in a microwave reactor using ethylene‐glycol as 
the solvent (Scheme 4.6). The reactions typically required 5 – 10 minutes of microwave 
irradiation before all ligand and Ru(bipy)2Cl2 were consumed as indicated by TLC (silica, 





4.2  ‐ 4.4 








After cooling, the reaction mixture was poured onto water and the aqueous solution 
filtered through celite. Although all products were ultimately isolated as PF6 salts, TLC 
analysis of the reaction mixture of [Ru(bipy)2(4.2)]+2 indicated that a minor by‐product 
was present. This is potentially [Ru(bipy)2(4.1)]+2, formed by loss of the benzyl 
substituent. Therefore, the aqueous solution was first loaded onto a column of sephadex 
– C25 ion‐exchange resin which was eluted with 0.00 – 0.20 M NaCl solution. This 
rigorous purification was later found to be unnecessary as each product could be 
adequately purified simply by precipitating it as a PF6 salt then washing the collected 
solid with water. Recrystallisation from a hot MeOH/water mixture could also be 
performed if desired. 
 
Crystals of [Ru(bipy)2(4.2)][PF6]2 suitable for single‐crystal X‐ray analysis were grown by 
slow vapour‐diffusion of iPr2O into an MeOH solution of the compound. Complex 
[Ru(bipy)2(4.2)][PF6]2 crystallised in the monoclinic space group P21/c with one molecule 
of [Ru(bipy)2(4.2)]2+ and two PF6 anions present in the asymmetric unit (Figure 4.14). A 
region occupied by disordered solvent was also present. This was adequately modelled 
as containing one iPr2O and four MeOH molecules, all of which displayed partial 
occupancy. Hydrogen atoms bonded to MeOH molecules could not be satisfactorily 
modelled and all attempts to calculate their positions resulted in poor refinement. The 
structure of [Ru(bipy)2(4.2)]2+ shows an octahedral ruthenium centre with  the expected 
propeller arrangement of polypyridyl ligands. The bite angles for the three ligands, N1 – 
Ru – N11, N1A' – Ru – N1A'' and N1B' – Ru – N1B'' are 79.46(8)o, 78.99(8)o and 78.92(9)o 
respectively and Ru – N bond lengths fall within a narrow range between 2.060(2) Å for 
Ru – N1B' and 2.065(2) Å for Ru – N1. The C6 – N7 bond (1.309(4) Å) is shorter than the 
C6 – N5 bond (1.354(4) Å) due to its greater double‐bond character as expected for a 
mono‐substituted imidazole. The benzyl ring projects away from the mean plane of the 










An X‐ray structure of [Ru(bipy)2(4.3)][PF6]2 was obtained using crystals grown by slow 
vapour‐diffusion of Et2O into a MeCN solution of the complex. This crystallised in the 
triclinic space group P1  with one molecule of [Ru(bipy)2(4.3)]2+ and two PF6 anions in the 
asymmetric unit (Figure 4.15) along with three molecules of MeCN and one of Et2O. The 
bite angles for the three ligands around the octahedral ruthenium centre N1 – Ru – N11, 
N1A' – Ru – N1A'' and N1B' – Ru – N1B'' are 79.35(6)o, 78.78(8)o and 78.72(7)o 
respectively and Ru – N bond lengths fall within a narrow range between 2.057(2) Å for 
Ru – N1 and 2.068(2) Å for Ru – N11. The phenyl ring is rotated out of the plane of the 
IP core by 58.42(9)o. As with [Ru(bipy)2(4.2)]2+, bond length asymmetry also exists 
between C6 – N7 (1.309(3) Å) and C6 – N5 (1.373(3) Å) due to the greater double‐bond 
character of C6 – N7. 
Figure 4.14: Asymmetric unit of [Ru(bipy)2(4.2)][PF6]2. Hydrogen atoms, PF6 anions and 











The compact nature of ligand 4.3 allows [Ru(bipy)2(4.3)]2+ cations to adopt a closely 
packed configuration in which several intermolecular π – π contacts are observed. Each 
of the two molecules in the unit‐cell arrange such the IP cores are parallel with N7 of the 
imidazole adjacent to the plane of the N11 pyridine subunit (N7‐to‐centroid distance = 
3.534(2) Å). Also observed is an edge‐to‐face interaction between the C6 – N7 edge of 
the imidazole and the N1A' pyridine subunit (N7‐to‐centroid distance = 3.377(2) Å). This 
is unlike [Ru(bipy)2(4.2)]2+ in which tight packing of the cations is obstructed by the 
benzyl arm. 
 
Crystals of [Ru(bipy)24.4][PF6]2 were unable to be grown despite numerous attempts. 
 
Figure 4.15: Asymmetric unit of [Ru(bipy)2(4.3)][PF6]2. Hydrogen atoms, PF6 anions and 









The two possible routes for preparing ruthenium coordinated imidazolium salts based 
on IP ligands are defined by whether imidazolium salt formation occurs “pre‐
complexation” or “post‐complexation” (Scheme 4.7). Both routes were explored in the 







Successful application of the pre‐complexation route hinges on the stability of the 
imidazolium salt and judicious choice of reaction conditions. This pathway was first 
attempted for the synthesis of [Ru(bipy)2(4.5.H)]3+. Having recognised that 
isomerisation of [4.5.H]+ can occur in aqueous media (see section 4.2.3) it was hoped 
that “protecting” the phenanthroline nitrogen by coordination to ruthenium might 
negate this issue. Synthesis of [Ru(bipy)2(4.5.H)]3+ was attempted using a microwave 
pre-complexation post-complexation 
Scheme 4.7: Retrosynthetic “pre-complexation” and “post-complexation” routes to 




reactor (350 W) (Scheme 4.8, route A) with the same conditions as those used for the 
synthesis of [Ru(bipy)2(4.2 – 4.4)]2+. Complex formation and the consumption of 
Ru(bipy)2Cl2 was monitored by TLC (silica, 4:1:1 DMF/water/1 M NH4Cl), consumption of 
4.5.HBr was also monitored by TLC (alumina, 1:4 MeOH/DCM). After three 2 minute 
bursts of microwave radiation 4.5.HBr could no longer be observed by TLC, however, a 
spot due to Ru(bipy)2Cl2 persisted and a bright orange product spot had emerged. This 
product was obtained as a PF6 salt after successful isolation by sephadex – C25 ion‐










































Scheme 4.8: Attempted synthesis of [Ru(bipy)2(4.5.H)]3+ (route A) and successful 




Subsequent NMR and mass‐spectrometric analysis on the bright orange material 
revealed this to be [Ru(bipy)2(4.2)][PF6]2 (acquired in a 53.7% yield) instead of the 
desired complex [Ru(bipy)2(4.5.H)][PF6]3. Other diffuse yellow bands collected from the 
column were shown by mass‐spectrometry to contain [Ru(bipy)2(4.2)]2+ and other 
unidentified species of various mass. As with during the purification of ligand 4.5.HBr, 
the lability of the benzyl pendant proved to be a tremendous liability. Milder reaction 
conditions such as refluxing in an EtOH/water mixture, were not considered because it 
was anticipated that the prolonged reaction time and aqueous solvent would lead to 
decomposition of the [4.5.H]+ ligand. It therefore came as a surprise when work 
published by Peuntinger et al. demonstrated the reaction of 4.5.HBr with Ru(tbbpy)2Cl2 
to form [Ru(tbbpy)2(4.5.H)][PF6]3 in a 65% yield under harsh microwave conditions in a 
EtOH/water solution (Scheme 4.8, route B).215  
 
Decomposition of [4.5.H]+ in route A was probably facilitated by excessive heating 
(ethylene‐glycol boils at 197 oC). As route B shows, [4.5.H]+ is compatible with polar‐
protic solvents including water, just not to extreme temperatures. This partially 
contradicts the observation that [4.5.H]+ isomerises in the presence of water at room 
temperature, however, this finding may have been misleading. Other factors, such as a 
solubility driven equilibrium shift caused by association of the PF6 anion may have been 
more influential than the solvent itself. The synthesis of [Ru(bipy)2(4.5.H)][PF6]3 was not 
revisited using milder conditions because success was being had with the more durable 
ligand [4.9.H]+. This was successfully reacted with Ru(bipy)2Cl2 to give the complex 
[Ru(bipy)2(4.9.H)]3+ under conditions analogous to those reported for the synthesis of 
[Ru(tbbpy)2(4.5.H)]3+, however, heating was performed on a hot‐plate rather than in a 
microwave (Scheme 4.9). The product was isolated as a PF6 salt after flash 
chromatography (silica, 9:1.5:1 MeCN/water/saturated KNO3(aq)) giving 










The characterisation of [Ru(bipy)2(4.9.H)][PF6]3 was aided by X‐ray diffraction analysis 
which was performed on a crystal grown by slow‐vapour diffusion of Et2O into a MeCN 
solution of the complex. Complex [Ru(bipy)2(4.9.H)][PF6]3 crystallised in the monoclinic 
space group P21/c with one molecule of [Ru(bipy)2(4.9.H)]3+ in the asymmetric unit 
(Figure 4.16). One of the three PF6 anions present resides on a special position and there 
is one solvate molecule of MeCN. The bite angles for the three ligands around the 
octahedral ruthenium centre N1 – Ru – N11, N1A' – Ru – N1A'' and N1B' – Ru – N1B'' are 
79.14(7)o, 78.38(8)o and 78.80(8)o respectively and Ru – N bond lengths fall within a 
range between 2.047(2) Å for Ru – N11 and 2.066(2) Å for Ru – NA'. The average of the 
Ru – N(IP) bond lengths (Ru – N1 and Ru – N11) in this structure is 2.054(2) Å which is 
slightly shorter than those in the complexes with mono‐substituted IP ligands 
[Ru(bipy)24.2]2+ (2.064(2) Å) and [Ru(bipy)24.3]2+ (2.063(2) Å). This observation is in 
alignment with the average Ru – N(IP) bond lengths reported for similar compounds.215, 
232 Also unlike [Ru(bipy)2(4.2)]2+ and [Ru(bipy)2(4.3)]2+ this structure exhibits symmetric 
bond lengths between C6 – N5 and C6 – N7 (1.329(3) Å and 1.322(3) Å respectively) as 
expected for an imidazolium salt. In the packed structure, H6 of the electron deficient 
C6 carbon participates in hydrogen bonding with the fluorine of one PF6 anion (C ··· F = 

























In addition to [Ru(bipy)2(4.9.H)][PF6]3, a ruthenium bound imidazolium salt based on the 
2‐pyridyl substituted IP ligand 4.4 was sought as a proligand for chelation stabilised NHC 
complexes. In light of the difficulties associated with regioisomer formation discussed in 
section 4.2.3, the post‐complexation route holds obvious advantages. Coordination to 
ruthenium renders the nitrogen of the phenanthroline terminus unable to compete with 
the imidazole nitrogen as the reactive nucleophile. This is particularly pertinent to the 
synthesis of imidazolium salts from 4.4 which can be substituted at the pyridyl nitrogen 
in addition to the three nitrogen of the IP core. Applying this logic, methylation of 
complex [Ru(bipy)2(4.4)]+2 to give [Ru(bipy)2(4.15.H)]+3 was attempted using ten‐fold 
excess of iodomethane in DMF at 100 oC (Scheme 4.10). These conditions were based 
on those reported for the synthesis of a similar compound.216 The low boiling point of 
iodomethane (42 oC), necessitated the use of a sealed tube to prevent its loss while 
reacting at 100 oC. This meant that the reaction was unable to be monitored by TLC 
without returning to room‐temperature and as a result when the reaction was stopped 
Figure 4.16: Asymmetric unit of [Ru(bipy)2(4.9.H)][PF6]3. Hydrogen atoms, PF6 anions 
and solvent molecules have been omitted for clarity. Thermal ellipsoids have been drawn 




after 48 hours it was found that only a small amount of product had formed. Rather than 
resuming the reaction the complex was isolated for analysis using flash chromatography 
(silica, 9:1.5:1 MeCN/water/saturated KNO3(aq)) and obtained by precipitation as a PF6 
salt. Complex [Ru(bipy)2(4.15.H)][PF6]3 was obtained in a 21% yield and 69% of the 







Comparison of the 1H‐NMR spectrum of the starting material Ru(bipy)2(4.4)][PF6]2 with 
that of the product revealed the hallmark downfield shift of the imidazolyl proton signal 
(H6) associated with imidazolium salt formation (Figure 4.17). This singlet moved from 
8.59 ppm to 9.51 ppm in the product spectrum confirming that methylation had 
occurred to produce the desired imidazolium salt [Ru(bipy)2(4.15.H)]+3, rather than the 

















Figure 4.17 (a): Aromatic region of 1H-NMR spectra of [Ru(bipy)2(4.4)][PF6]2 in CD3CN 
and, (b) that of  [Ru(bipy)2(4.15.H)][PF6]3. 
 












With regards to the low yield there are several possible explanations. The kinetic 
handicap of electronic repulsion between the doubly‐cationic nucleophile and the 
electrophile could be sufficient to slow the reaction in which case a longer reaction time 
would be required.  The reaction may also be in an equilibrium which favours the 
starting material.  Alternatively, the iodomethane may simply have been lost to the 
system, either being consumed through side reactions with the DMF solvent and its 
degradation products or by escaping through the seal. Some of these issues could be 
circumvented by using a less volatile methylating agent such as dimethyl‐sulfate which 
would allow elevated temperatures to be used without requiring a sealed tube. 
However, as an adequate quantity of analytically pure [Ru(bipy)2(4.15.H)][PF6]3 had 
already been obtained this synthesis was not amended in practice.  
 
4.5. Photophysical properties of [Ru(2,2'-bipyridine)2(IP)]n+ type 
complexes 
 
The photophysical properties of ruthenium‐polypyridine type complexes remain a 
subject of interest despite having been studied intensively for decades.124, 126, 233, 234 Of 
these complexes, the [Ru(bipy)3]2+‐type motif is the most commonly encountered. These 




transfer state (MLCT) which is generated by photoexcitation of one electron from a 
metal‐centred t2g orbital to a ligand‐centred π* orbital. As such, the absorption 
wavelength associated with the MLCT is an indicator of the HOMO‐LUMO energy gap in 
these complexes.233 The resulting excited state is long lived (~ 600 ns) and can be 
described as having a ruthenium(III) centre with one bipy ligand that has undergone a 
single electron reduction.235  
 
The optical properties of a handful of [Ru(bipy)2(IP)]2+‐type complexes have also been 
investigated and applied in various roles. Complexes of the type shown in Figure 4.18a 
have been employed as pH‐dependent luminescence probes236 and as photoactive DNA 
binding agents.237‐239 Moreover, work by Park et al. has demonstrated that the 
ruthenium bound IP‐imidazolium salt shown in Figure 4.18b can act as both the 








The new [Ru(bipy)2(IP)]2+ derivatives prepared during this research project were studied 
by UV‐visible and fluorescence spectroscopy to assess their viability as photochemical 
agents for applications such as those discussed above. Data for these complexes is 
























Figure 4.19 (a): UV-visible spectra and, (b) UV-visible (visible region) with overlaid 
photoluminescence spectra of [Ru(bipy)2(4.2 – 4.4)][PF6]2 in MeCN at room temperature, 

































































































Table 4.2: Summary of the absorption and emission maxima of complexes 




a data for [Ru(bipy)3][Cl]2 in water240 
 
 
The three complexes with N‐substituted IP ligands, [Ru(bipy)2(4.2 – 4.4)][PF6]2 produce 
UV‐visible spectra that differ only in their molar absorptivity (Figure 4.19a). The UV‐
region is dominated by ligand‐centred (LC) transitions at ~ 254 nm and ~ 284 nm with 
the characteristic visible MLCT absorption occurring at ~ 454 nm with a shoulder at ~ 
425 nm. The emission spectra of the three complexes are identical with λmax ~ 600 nm 
(Figure 4.19b). These spectral features are analogous to those reported for [Ru(bipy)3]+2 
(Table 4.2).  
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Figure 4.20 (a): UV-visible (visible region) with overlaid photoluminescence spectra of 
[Ru(bipy)2(4.9.H)][PF6]3 and [Ru(bipy)2(4.15.H)][PF6]3 with [Ru(bipy)2(4.3)][PF6]3 and 
[Ru(bipy)2(4.4)][PF6]3 for comparison. Recorded in MeCN at room temperature, 
concentration ~ 10-6 molL-1. 
The visible region of the UV‐visible absorption spectrum of the complexes 
[Ru(bipy)2(4.9.H)][PF6]3 and [Ru(bipy)2(4.15.H)][PF6]3 are shown in Figure 4.20. Not 
shown, are absorption maxima at ~ 245 nm and ~ 285 nm that are similar to those 
observed in the spectra of [Ru(bipy)2(4.2 – 4.4)][PF6]2 and [Ru(bipy)3]+2, an additional 
absorption at ~ 275 nm can therefore be attributed to an IP‐imidazolium ligand centred 
π – π* transition. A broad absorption band in the visible region (360 nm – 530 nm with 
λmax ~ 437 nm) is ascribed to multiple overlapping MLCT transitions. In particular, 
excitation from the ruthenium‐centre onto the imidazolium salt ligand would explain 
the shoulder of intensity occurring in both spectra at ~ 469 nm. Less energy is required 
to promote an electron onto the cationic entity due to the reduction in the energy of 
the LUMO that is elicited by imidazolium salt formation. This assessment is supported 
by the emission spectra of [Ru(bipy)2(4.9.H)][PF6]3 and [Ru(bipy)2(4.15.H)][PF6]3 shown 
in Figure 4.20. Here the maximum emission value for both spectra (λmax ~ 632 nm, 15800 
cm‐1) undergoes a bathochromic shift of ~ 844 cm‐1 from the emission maxima observed 
for complexes [Ru(bipy)2(4.2 – 4.4)][PF6]2. This correlates to a lowering in energy of the 





















































The electronic absorption and photoluminescence properties of the new complexes 
discussed above are in agreement with the properties of conventional [Ru(bipy)3]2+ type 
complexes and may therefore be amenable to many of the same applications.  
 
4.6. Summarising remarks 
 
The investigation of NHC precursors with an imidazo[4,5‐f][1,10]phenanthroline core 
and backbone ruthenium‐polypyridine functionality was undertaken. Two new metallo‐
NHC proligands, [Ru(bipy)2(4.9.H)][PF6]3 and [Ru(bipy)2(4.10.H)][PF6]3 were identified. 
 
N-Quaternisation of N‐substituted imidazo[4,5‐f][1,10]phenanthroline derivatives to 
give imidazolium salts encountered regioselectivity issues associated with N‐
substitution of the phenanthroline nitrogen instead of the imidazole. Several of the 
resulting phenanthrolinium salts, 4.11.I, 4.12.I and 4.13.I, were able to be characterised. 
A post‐complexation approach was investigated whereby the imidazolium salt is 
prepared after coordination of the phenanthroline to ruthenium leading to effective 
protection of the phenanthroline nitrogen. This was successfully employed for the 
synthesis of [Ru(bipy)2(4.10.H)][PF6]3 although, a low yield of 21% was obtained. 
 
The photochemical properties of ruthenium‐polypyridine complexes with imidazo[4,5‐
f][1,10]phenanthroline derived ligands have been studied in the literature for use in 
various applications. New complexes of the type [Ru(bipy)(IP)]n+ prepared in this work 
were studied by UV‐visible and fluorescence spectroscopy and found to conform to 
established norms. Uncoordinated imidazo[4,5‐f][1,10]phenanthroline derivatives have 
been less studied in this context prompting their photochemistry to be examined also. 
Of particular interest are the unusual phenanthrolinum salts which were revealed by 
UV/vis to possess a moderately intense absorption around ~ 390 nm that is not present 
in the neutral precursor 4.3. This is attributed to intramolecular charge transfer (ICT) 
which gives rise to the yellow colouration of these compounds. ICT capable salts such as 




coefficient of the phenanthrolinium salts is much weaker than those of reported ICT 
salts such as [DAST]+. 
 
4.7. Scope and future work 
 
This section introduced two new unsymmetrical metallo‐NHC proligands 
[Ru(bipy)2(4.9.H)][PF6]3 and [Ru(bipy)2(4.15.H)][PF6]3 which are of particular interest 
both as NHC proligands213‐215 and potential photocatalysts.232 Although related NHC‐
complexes have been prepared, their application as ligands in metal‐mediated couplings 
have not been explored. These could be easily introduced into the protocol developed 
in Chapter 6 to study their behaviour in Suzuki couplings but could not be conducted 
here due to time limitations. Synthesis of a PEPPSI palladium precatalyst using an 
[Ru(bipy)2(IP)]2+ type NHC ligand could also be an achievable and interesting endeavour. 
This would provide a known system with which to study the effect of the coordinated 
ruthenium on the activity of the palladium centre. 
 
It has been noted previously that IP derived systems are interesting for their 
optoelectronic properties. The identification, characterisation and photophysical 
analysis of the phenanthrolinium salts 4.6.PF6, 4.7.PF6, 4.11.I, 4.12.I and 4.13.I 
represents a previously unexplored aspect of IP chemistry. Their bright yellow 
colouration, quantified by a moderately intense absorption around ~ 390 nm in the 
UV/vis spectrum, is attributed to an ICT event. It would be worthwhile to investigate the 




































The previous chapter introduced a 1,10‐phenanthroline fused NHC system in which the 
ruthenium‐polypyridine moiety occupies a peripheral site relative to the NHC centre. It 
was proposed that increasing the steric interplay of the enantiomeric Ru(II) moiety and 
NHC node would improve the stereodirecting capabilities of such metallo‐NHC ligands. 
Affixing the NHC moiety closer to the phenanthroline coordination site is one way of 
achieving this objective. Otherwise, an acetamide tether could be utilised similarly to 
the bornyl‐acetamide NHC complexes in Chapter 1, to exploit N‐amidate/NHC chelation 
as a means of interacting the chiral and catalytic environments.  Derivatives of 3‐
imidazole‐1,10‐phenanthroline were targeted as representatives of the “appended” 
sub‐class with acetamide‐linked 1,10‐phenanthroline derivatives forming the basis of 
the “tethered” category (Figure 5.1). In this chapter, the shorthand expressions 3‐IMP 














The development and application of some general and specific protocols for the 
enantiomeric resolution of metallo‐NHC proligands is also detailed in this section. It is 
generally accepted that resolution of the Δ/Λ‐enantiomers of octahedral ruthenium 
complexes are more efficient for those with 1,10‐phenanthroline ancillary ligands 
appended metallo-NHC complex tethered metallo-NHC complex 























compared with 2,2’‐bipyridine ligands. This prompted 2,2‐bipyridine, which is more 
affordable, to be exchanged with 1,10‐phenanthroline for the synthesis of “tethered‐
imidazolium” compounds. Effectively the precursor Ru(bipy)2Cl2 was substituted with 
Ru(phen)2Cl2 in later syntheses. 
 
5.2. Synthesis of metallo-NHC proligands 
5.2.1. Appended 1,10-phenanthroline NHC precursors and their 
ruthenium-polypyridine complexes 
 
Previous researchers have demonstrated that imidazolyl‐appended polypyridine 
compounds can be obtained by substitution of a halo‐polypyridine precursor. In the 
context of NHC ligands, this has been demonstrated by Liu and co‐workers who 
prepared 2,9‐diimidazolium‐1,10‐phenanthroline salts by substitution of 2,9‐diiodo‐
1,10‐phenanthroline, either by quaternising an imidazole‐phenanthroline intermediate 
(route A, Scheme 5.1) or by direct reaction with an N‐substituted imidazole (route B, 
Scheme 5.1).101 Similarly, 3,8‐diimidazol‐1,10‐phenanthroline has been prepared as a 













Route A Route B 
R = benzyl or allyl 
alkyl groups only 
R = mesityl 
bulky R‐groups 
Scheme 5.1: Synthetic routes to 2,9-diimidazolium-1,10-phenanthroline successfully 




The 2,9‐diiodo‐1,10‐phenanthroline mentioned above is prepared by a non‐trivial multi‐
step synthesis. A more direct approach was sought for this study, ideally using mono‐
imidazolyl‐1,10‐phenanthroline derivatives to avoid an unnecessarily complicated 
system. A mono‐halogenated polypyridine precursor was therefore required, however, 
preparations of halogenated 1,10‐phenanthrolines and 2,2’‐bipyridines are typically low 
yielding and produce poly‐halogenated products.242 A suitable starting point was found 
in 3‐bromo‐1,10‐phenanthroline which could reportedly be obtained in a 33% yield from 
1,10‐phenanthroline along with 3,8‐dibromo‐1,10‐phenanthroline (17% yield).243 The 
reaction was performed by heating 1,10‐phenanthroline mono‐hydrochloride in 
nitrobenzene at 140 oC for 3 hours following the dropwise addition of bromine to the 
heated solution. Purification by careful chromatography provided both 3‐bromo‐1,10‐













The route taken by Lui et al. which enabled access to bulky aryl pendant imidazolium 
salts (route B, Scheme 5.1) was not viable. This is because halides in the 3‐position of 
1,0‐phenanthroline are less reactive to nucleophilic substitution than those in the 2 and 
4‐positions and using bromine in place of iodine further reduces this reactivity.244 
Synthesis via the imidazole was the only option, however, this meant the system would 









5.2.1.1. Imidazolium salts derived from 3-imidazo-1,10-phenanthroline 
 
The 3‐bromo‐1,10‐phenanthroline was reacted under conditions outlined for the 
synthesis of 3,8‐diimidazol‐1,10‐phenanthroline241 to provide 3‐imidazol‐1,10‐
phenanthroline (5.1), which has not been reported (Scheme 5.3). This required heating 
the 3‐bromo‐1,10‐phenanthroline in an imidazole melt at 180 oC with K2CO3 and 2.5 
mol% anhydrous CuSO4 under an inert atmosphere. The product was isolated 
analogously to 3,8‐diimidazol‐1,10‐phenanthroline by stirring the reaction mixture in 
water and extracting into chloroform. This procedure was greatly hampered by 
formation of a green emulsion making the organic extracts difficult to recover. 
Regardless, pure 5.1 was obtained from the dried extracts in a 55% yield. Difficulties 
with the extraction may have been avoided by employing an aqueous ammonium 












Quaternisation of the base imidazole 5.1 by reaction with excess iodomethane in 
refluxing DCM provided the methyl imidazolium salt 3‐(1‐methylimidazolium)‐1,10‐
phenanthroline iodide (5.2.HI) (Scheme 5.3). Refluxing was performed for 24 hours, with 
the highly volatile iodomethane being topped up after 14 hours. Crude 5.2.HI 
precipitates during the reaction and can be collected by filtration and washed with DCM 
and Et2O providing material suitable for synthesis. If desired, further purification is 
achieved by dissolving this in water and precipitating as a PF6 salt, providing 5.2.HPF6 in 





















5.1, 55% 5.2.HPF6, 35% 




annelated imidazoles discussed in Chapter 4, substitution of the phenanthroline 
nitrogen to form phenanthrolinum salts instead of the desired imidazolium salt may 
occur competitively. In the case of 5.2.HI, the dark yellow complexion of the initial 
reaction mixture and DCM washes may indicate the presence of such impurities which 
have been proven to be highly coloured (see section 4.3).  
 
This procedure could be optimised by using a sealed tube reaction to minimise the loss 
of the iodomethane and access higher temperatures. However, there is a risk of 
displacing the imidazolyl moiety at elevated temperatures as noted in the following 
section. To avoid formation of phenanthrolinium salt biproducts a post‐complexation 
quartenisation pathway could be adopted as demonstrated for the synthesis of 
[Ru(bipy)2(4.9.H)][PF6]3 from [Ru(bipy)2(4.4)][PF6]2 (section 4.4.2). Here, the imidazole 
precursor 5.1 would be coordinated to Ru(II) and the resulting complex 
[Ru(bipy)2(5.1)][PF6]2 reacted onward to form the imidazolium salt. Using a more 
reactive alkylating agent such as benzylbromide could also be advantageous. These 
advancements were not attempted due to time limitations.  
 
Both 5.2.HPF6 and its precursor 5.1 were characterised spectroscopically and an X‐ray 
structure of 5.2.HPF6 was obtained. The 1H‐NMR and 13C‐NMR spectra of both are as 
expected (1H‐NMR spectrum of 5.2.HPF6, Figure 5.3a). As is commonplace, a downfield 
shift is noted for the imidazolyl NCHN proton (H16) upon formation of the imidazolium 
salt, going from 8.06 ppm in 5.1 (CDCl3) to 9.07 ppm in 5.2.HPF6 (CD3CN). A new signal 
attributed the methyl group arises in the 1H‐NMR and 13C‐NMR spectra of 5.2.HPF6 at 
4.04 ppm and 36.51 ppm, respectively. 
 
Crystals of 5.2.HPF6 suitable for single crystal diffraction analysis were grown by slow 
vapour diffusion of THF into a MeCN solution of the compound. This crystallised in the 
monoclinic space group P21/c with one molecule of [5.2.H]+ and one PF6 counter‐anion 
in the asymmetric unit (Figure 5.2). A shorter bond length between the imidazolyl‐
nitrogen and phenanthroline N15 – C3 of 1.425(3) Å compared with the methyl group 
bond N17 – C20 of 1.464(2)o is observed due to conjugation between the aromatic rings. 




Figure 5.2 (a): Asymmetric unit of 5.2.HPF6 and, (b) Complementary CH ··· N hydrogen 
bonding between molecules of [5.2.H]+. Hydrogen atoms not involved in H-bonding have 
been omitted for clarity. Thermal ellipsoids are drawn at a 50% probability level. 
31.4(2)o. This twist enables intermolecular hydrogen bonding between the imidazolium 
proton on C19 and the phenanthroline nitrogen atoms of neighbouring molecules (C19 
··· N1 = 3.519(2) Å and C19 ··· N10 = 3.246(2) Å). These occur in a reciprocal manner 
forming a weakly H‐bonded dimer. Additionally, phenanthroline units are stacked such 
that face‐to‐face π – π interactions are observed between the central benzenoid ring 
and N10 rings generating a centroid‐to‐centroid distance of 3.567(1) Å shifted by 
1.069(3) Å / 1.141(3) Å.  
 














Ligand 5.2.HPF6 was carried forward into synthesis of [Ru(bipy)2(5.2.H)][PF6]3. The 
methodology described above allows for salts of 5.1 to be prepared with other alkyl 
pendant groups, however, this was not deemed necessary. 
 
5.2.1.2. Synthesis of [Ru(2,2’-bipyridine)2(5.2.H)][PF6]3 
 
Target complex [Ru(bipy)2(5.2.H)][PF6]3 was successfully prepared by the reaction of 
5.2.HPF6 with Ru(bipy)2Cl2 in ethylene‐glycol using a microwave reactor and monitoring 




combined in ethylene‐glycol and the mixture heated by microwave irradiation (450 W) 
in 2 minute bursts, requiring a total of 6 minutes to dissolve the Ru(bipy)2Cl2 and react 
all material.  Two products were isolated following ion‐exchange chromatography with 
gradient elution (sephadex – C25, 0 to 0.20 M NaCl) and found to be the desired product 
[Ru(bipy)2(5.2.H)][PF6]3 (28% yield) and the ethylene‐glycol adduct [Ru(bipy)2(5.3)][PF6]2 























Formation of [Ru(bipy)2(5.3)]2+ undoubtedly occurs by substitution of the imidazolium 
moiety by an ethylene‐glycol solvent molecule under the highly energetic reaction 
conditions. Modifying the approach so that the reaction mixture was pre‐heated to 






















[Ru(bipy)2(5.2.H)][PF6]3         [Ru(bipy)2(5.3)][PF6]2 
 
MW irradiation, 6 minutes                  28%                                                40% 
Ru(bipy)2Cl2 pre‐dissolved 
MW irradiation, 2 minutes                                                              89%                                          not isolated 





provided [Ru(bipy)2(5.2.H)][PF6]3 in an 89% yield. In this instance the product was 
isolated as its PF6 salt following the reaction and purified by washing with water and 
methanol.  
 
Given the formation of [Ru(bipy)2(5.3)]2+, the synthesis of [Ru(bipy)2(5.2.H)]3+ may have 
suited milder conditions such as the refluxing EtOH/water method used for the synthesis 
of [Ru(bipy)2(4.9.H)]3+ (section 4.4.2) and the acetamide tethered complexes discussed 
shortly. However, sufficient product was obtained by truncating the reaction time so 
this was not attempted. 
 
The complex [Ru(bipy)2(5.2.H)][PF6]3 and the solvolysis product [Ru(bipy)2(5.3)][PF6]2 
were both fully characterised and their structures unambiguously confirmed by X‐ray 
crystallography. Four cations attributable to the complex [Ru(bipy)2(5.2.H)][PF6]3 were 
identified by mass spectrometry with the two most intense signals at 225.0476 and 
410.0532 belonging to [Ru(bipy)2(5.2.H)]3+ and [[Ru(bipy)2(5.2.H)][PF6]]2+ (calculated 
m/z, [Ru(bipy)2(5.2.H)]3+ = 225.0517 and [Ru(bipy)2(5.2.H)][PF6]2+ = 410.0599). 
Interestingly, a less intense signal due to the free NHC species [Ru(bipy)2(5.2)]2+ was 
found at 337.0682 (calculated m/z, [Ru(bipy)2(5.2)]2+ = 337.0739). A minor signal due to 
[[Ru(bipy)2(5.2.H)][PF6]2] + was also observed.  
 
Comparison of the 1H‐NMR spectrum of [Ru(bipy)2(5.2.H)][PF6]3 and the free ligand 
5.2.HPF6 revealed several notable coordination induced shifts (Figure 5.3). As is typical 
of Ru(II) polypyridine complexes, proton environments adjacent to the pyridyl nitrogen 
shift significantly upfield upon coordination as a result of anisotropic shielding by 
adjacent rings of pyridyl ligands. For 5.2.HPF6, the H2 and H9 resonances shifted from 
9.32 ppm and 9.21 ppm to 8.22 ppm and ~ 8.13 ppm in [Ru(bipy)2(5.2.H)][PF6]3 (Δδ = ‐
1.10 ppm and ~ ‐1.08 ppm, respectively). Interestingly, proton environments on the 
imidazolium moiety also shifted upfield, albeit to a lesser extent. Signals for H16, H18 
and H19 shifted from 9.07 ppm, 7.67 ppm and 7.96 ppm to 8.77 ppm, 7.58 ppm and 7.71 
ppm upon coordination (Δδ = ‐0.30 ppm and ‐0.09 ppm and ‐0.25 ppm, respectively). 
The methyl environment undergoes a small upfield shift of ‐0.09 ppm. Again, anisotropic 






















which are directed towards the face of the geometrically cis‐pyridyl ring of a 2,2‐
bipyridine ligand, unlike H18 and H20. This is obvious from the crystal structure (Figure 
5.4). Environments H4, H5, H6 and H7 which are further afield from the ligand sphere of 
the complex exhibit downfield shifts of 0.17 ppm, 0.31 ppm, 0.21 ppm and 0.20 ppm as 
a consequence of electron density withdrawal onto Ru(II).  
 
 
   (a)                                                                      (b) 
 
 














The 1H‐NMR and 13C‐NMR spectra of [Ru(bipy)2(5.3)][PF6]2 was also fully assigned and 
the ethylene‐glycol appendage confirmed by two ethylene proton multiplets at 4.22 
ppm and 3.84 ppm and a singlet due to the hydroxyl proton at 3.00 ppm as well as 
ethylene carbon signals at 72.09 ppm and 60.83 ppm. 
 
X‐ray diffraction analysis was performed on [Ru(bipy)2(5.2.H)][PF6]3 using crystals grown 
by slow vapour diffusion of benzene into a MeCN solution of the compound. This 
crystallised in the monoclinic space group P21/c with one molecule of [Ru(bipy)2(5.2.H)]+ 




Figure 5.3 (a): Aromatic region of the 1H-NMR spectra of 5.2.HPF6 and, (b)




and three PF6 anions in the asymmetric unit (Figure 5.4). The octahedral ruthenium 
centre supports the expected propeller arrangement of bidentate ligands. The bite 
angles for the three ligands, N1 – Ru – N10, N1A' – Ru – N1A'' and N1B' – Ru – N1B'' are 
79.95(9)o, 78.58(9)o and 79.02(9)o, respectively and Ru – N bond lengths fall within a 
narrow range between 2.055(2) Å for Ru – N1B'' and 2.072(2) Å for Ru – N1B'. A twist of 
the imidazolyl‐ring out of the phenanthroline plane by 35.8(3)o is similar in magnitude 
to that observed in the crystal structure of the free ligand, 5.2.HPF6.  Bond lengths 
related to the imidazole including N15 – C3 = 1.433(3) Å and N17 – C20 = 1.468(3) Å are 



















Packing of the extended structure is characterised by numerous short CH ··· F contacts 
involving electron poor carbon environments such as C19 ··· F = 3.163(4) Å, C16 ··· F = 
3.397(4) Å and C6A' ··· F = 3.220(3) Å. A largely offset but still face‐to‐face π – π 
Figure 5.4: Asymmetric unit of [Ru(bipy)2(5.2.H)][PF6]3. Hydrogen atoms and PF6 anions 




interaction is seen between phenanthroline components of neighbouring [5.2.H]+ 
ligands with corresponding benzenoid rings and N1‐pyridyl rings at a centroid‐to‐
centroid distance of 3.650(2) Å and plane‐to‐centroid shift of 1.515(4) Å / 1.454(4) Å. 
The shortest carbon‐to‐plane distances are C4 ··· plane = 3.344(3) Å and C5 ··· plane = 
3.335(3) Å.  
 
The crystal structure of [Ru(bipy)2(5.3)][PF6]2 was obtained using crystals grown by slow 
vapour diffusion of benzene into a MeCN solution of the compound. This crystallised in 
the triclinic spacegroup P1  with one molecule of [Ru(bipy)2(5.3)]2+, two PF6 anions and 
one benzene solvate molecule in the asymmetric unit (Figure 5.5). This clearly shows an 




















The octahedral coordination geometry of the Ru(II) is characterised by the bond angles 
N1 – Ru – N10, N1A' – Ru – N1A'' and N1B' – Ru – N1B'' are 80.2(2)o, 78.6(2)o and 78.7(2)o, 
Figure 5.5: Asymmetric unit of [Ru(bipy)2(5.3)][PF6]2. Hydrogen atoms, PF6 anions and 
the benzene solvate molecule have been omitted for clarity. Thermal ellipsoids have been 




respectively. Ru – N bond lengths fall within the range of 2.047(3) Å for Ru – N1B'' and 
2.076(3) Å for Ru – N10. Oxygens of the ethylene‐glycol group are gauche to one another 
as expressed by the O15‐C16‐C17‐O18 torsion angle of 61.9(4)o. As with 
[Ru(bipy)2(5.2.H)][PF6]3 there are numerous hydrogen bonding contacts with PF6 
flourine acceptors most notably; O18 ··· F = 2.987(6) Å, C7 ··· F = 3.317(5) Å and C6A' ··· 
F = 3.322(4) Å. Likewise, adjacent phenanthroline units of the 5.3 ligand stack such that 
the benzenoid rings are overlapped, having a centroid‐to‐centroid distance of 3.684(3) 
Å at an offset of 1.493(6) Å and centroid‐to‐plane distance of 3.368(4) Å. The N1A' 
pyridyl rings of adjacent 2,2’‐bipyridine ligands also associate in a face‐to‐face manner 
with a centroid‐to‐centroid distance of 3.805(3) Å at an offset of 1.735(6) Å and centroid‐
to‐plane distance of 3.387(4) Å. 
 
This pathway was eventually disfavoured in place of the acetamide derivatives which 
are ripe for variation of the opposing pendant group and are much easier to synthesise. 
Furthermore, the acetamide methodology is more adaptable to other systems for 
comparison such as the bornyl and cyclohexyl systems (Chapter 1 and Chapter 2).  
 
5.2.2. Acetamide tethered 1,10-phenanthroline NHC precursors and 
their ruthenium-polypyridine complexes 
 
It has been shown in previous chapters that the use of an acetamide linking unit lends 
itself to exploration of tethered NHC compounds because it is highly adaptable and 
tolerant to variation of the imidazolyl moiety. As with the bornyl‐acetamide and 
cyclohexyl‐acetamide derivatives, this approach hinges on the synthesis of a 
chloroacetamide electrophile from an amine of the core compound, in this case 1,10‐
phenanthroline. By far the most well documented and synthetically accessible amine for 
this is 5‐amino‐1,10‐phenanthroline however, preparations for 2‐amino‐1,10‐
phenanthroline245 and 4‐amino‐1,10‐phenanthroline246 can be found along with 4,7‐
diamino‐1,10‐phenanthroline247 and 5,6‐diamino‐1,10‐phenanthroline.248 These offer 





Following reported procedures, 1,10‐phenanthroline was nitrated to give 5‐nitro‐1,10‐
phenanthroline249, 250 (90% yield) which was subsequently reduced using hydrazine 
hydrate and 10% Pd/C to provide 5‐amino‐phenanthroline251 in an 81% yield. 
Chloroacetylation of 5‐amino‐1,10‐phenanthroline to give 2‐chloro‐N‐1,10‐
phenanthrolin‐5‐yl‐acetamide 5.4 has been reported, however, the preparations 
followed were found to require some modifications. For one synthesis of 5.4, 5‐amino‐
1,10‐phenanthroline was reacted with chloroacetyl‐chloride in MeCN using NaHCO3 as 
the base.251 Supposedly 5.4 could be collected by filtration at the conclusion of the 
reaction, however, the solid material was found to be a mixture of 5.4 and its protonated 
adduct along with inorganic contaminants including unreacted NaHCO3. After rinsing the 
solid with water, additional product was isolated by basifying the filtrate and collecting 
the precipitated product which provided crude 5.4 in an overall yield of 70%. A more 
succinct approach was found in which a suspension of 5‐amino‐1,10‐phenanthroline and 
triethylamine in THF was cooled to 0 oC and treated with chloroacetyl‐chloride under 
anhydrous and oxygen free conditions (Scheme 5.5).252 After an hour the beige material 












Again, it was found that addition of 10% NaOH to the filtrate provided an additional crop 
of product, giving 5.4 in an overall yield of 86%. This source suggested that the 
compound is air sensitive, although, the nature of this sensitivity was not elaborated. It 
was noted, however, that when using the earlier preparation method, different 
coloured samples of 5.4 were isolated ranging from light orange to dark brown and 
5.4, 86% 





sometimes pink. Sample isolated after avoiding exposure to air remained a beige 
powder as described. 
 
5.2.2.1. Acetamide tethered 1,10-phananthroline imidazolium salts 
 
Acetamide tethered 1,10‐phenanthroline imidazolium salts were prepared from the 
chloroacetamide 5.4 by reaction with several N‐substituted imidazoles. This is in analogy 
to the synthesis of bornyl‐acetamide and cyclohexyl‐acetamide imidazolium salts 
described previously. The salts 5.5.HX, 5.6.HX, 5.7.HX, 5.8.HX, 5.9.HX and 5.10.HX were 
prepared as shown in Scheme 5.6 and were isolated as either their Cl or PF6 salts 



















Compound 5.4 was heated in MeCN or DMF with an excess of N‐substituted imidazole 
until all 5.4 had been consumed as determined by 1H‐NMR. Compounds 5.6.HPF6, 













Scheme 5.6: Synthesis of acetamide tethered 1,10-phenanthroline imidazolium salts 
5.5.HX, 5.6.HX, 5.7.HX, 5.8.HX, 5.9.HX and 5.10.HX from 5.4. Yields shown for most 




atmosphere. After this time the solvent was removed by rotary‐evaporation and the 
residue taken up in water, filtered and washed with DCM to remove unreacted 5.4 and 
by‐products, then washed with Et2O. Precipitating the product by addition of excess 
solid KPF6 and stirring for 30 minutes before filtering provided pure material as fine 
white powders in yields of 80% – 86%. The methyl compound 5.5.HPF6 was also 
prepared by this method using DMF at 100 oC for 2 hours. Although isolated in an 83% 
yield, it precipitated very slowly with the PF6 salt being isolated in several crops by 
condensing the aqueous solution. It was more easily isolated as 5.5.HCl (93% yield) by 
refluxing in MeCN for 24 hours and collecting the resultant precipitate by filtration and 
washing with DCM. Likewise, the diisopropyl‐phenyl derivative 5.9.HX  was better 
isolated as its chloride salt. Because 5.9.HCl is soluble in DCM, washing the aqueous 
solution of the reaction mixture with DCM resulted in the product being distributed 
between both phases. Instead it was found that filtering the aqueous solution through 
a plug of alumina and rinsing through with additional water provided a filtrate of pure 
5.9.HCl that could simply be rotary evaporated (86% yield) or precipitated as 5.9.HPF6. 
It is likely that this approach could also be applied to purification of the other 
imidazolium salts. Using MeCN as the reaction solvent was preferable to DMF because 
it could be easily removed making workup more straightforward. However, synthesis of 
5.9.HX required 96 hours in refluxing MeCN as opposed to 24 hours using DMF at 100 
oC. Synthesis of the pyridyl appended 5.10.HX was not attempted in MeCN but took 48 
hours to complete in DMF at 100 oC. It was isolated the same manner as compounds 
5.6.HPF6, 5.7.HPF6  and 5.8.HPF6, giving 5.10.HPF6 as a yellow powder in a 57% yield. 
 
These salts were spectroscopically characterised and crystal structures of 5.7.HPF6  and 
5.8.HPF6 were obtained. Aside from differences derived from their pendant group 
functionality, salts of 5.5.HX, 5.6.HX, 5.7.HX, 5.8.HX, 5.9.HX and 5.10.HX exhibit similar 
1H‐NMR, 13C‐NMR, IR and mass‐spectral features. NMR features of these ligands are 
discussed in relation to their Ru(II) complexes [Ru(phen)2(5.5.H – 5.10.H)][PF6]3 in the 
next section. 1H‐NMR spectra of 5.5HPF6 is shown in Figure 5.11a and some chemical 





Crystals of imidazolium salt 5.7.HPF6 were grown by slow vapour diffusion of Et2O into 
a MeCN solution of the compound. It crystallised in the monoclinic space group P21/n 
with four molecules of [5.7.H]+, four PF6 anions and four MeCN solvate molecules in the 
asymmetric unit (Figure 5.6). The four molecules of [5.7.H]+, are distinguished by the 
suffix A, B, C or D.  A Z‐configuration of the amide is observed and bond lengths related 
to the amide as follows (A / B / C / D); O1 – C16 = 1.227(5) Å / 1.231(5) Å / 1.220(5) Å / 
1.231(5) Å, N15 – C16 = 1.338(5) Å / 1.336(6) Å / 1.358(6) Å / 1.347(5) Å, N15 – C5 = 
1.409(6) Å / 1.420(6) Å / 1.421(5) Å / 1.415(6) Å. In addition to characterisation, this 
structure is interesting for its extended architecture which arises from mutual hydrogen‐





Several examples of crystal structures where acetamide compounds have 
uncoordinated amides such as this are explored in Chapters 1 and 2. In all of these cases 
the Z‐amide supports bridged hydrogen bonds between the amide‐NH and amide‐O of 
Figure 5.6: Contents of the asymmetric unit of 5.7.HPF6 with hydrogen bonding 
interactions highlighted. Hydrogen atoms not involved in intermolecular contacts have 
been omitted for clarity along with PF6 counter anions and MeCN solvate molecules. 




Figure 5.7 (a): NH ··· N bonding resulting in a helical motif and, (b) view along the 
crystallographic b axis revealing a rectangular channel. Molecules of MeCN occupying 
the channel are not shown. 
adjacent molecules resulting in unidimensional hydrogen bonded polymers (see 2.1, 
section 2.2.1 for a representative case). In this structure, however, the N1 nitrogen of 
two out of the four unique phenanthroline‐moieties accepts a hydrogen bond from an 
amide‐NH (N15A ··· N1B = 2.841(5) Å and N15B ··· N1A = 2.950(5) Å), terminating chain 
formation. Instead a helical arrangement of [5.7.H]+ molecules occurs, resulting in 
rectangular channels of 6.942(4) Å by 7.504(4) Å that propagate along the 
crystallographic b axis (Figure 5.7). These are occupied by acetonitrile. 
 
 














All four sides of these channels are insulated by another molecule of [5.7.H]+ that is 
emplaced by a hydrogen bond of the type NH ··· O between amide units (N15C ··· O1B = 
2.817(5) Å and N15D ··· O1A = 2.774(5) Å). Each pair of phenanthroline groups stack such 
that they are almost overlaid at a plane‐to‐plane distance of 3.480(3) Å (B‐to‐C) and 
3.427(3) Å (A‐to‐D) (Figure 5.7b). Interestingly, this pairing of phenanthroline units 
appears to be stabilised by a hydrogen bond donating clip formed between the 
imidazolyl NCHN donor and amide NH donor as seen in Figure 5.6. Relative to the solvent 
channel, this supporting CH ··· N interaction occurs between the NCHN of the “inner” 




Figure 5.8: Contents of the asymmetric unit of 5.8.HPF6 Hydrogen atoms not involved in 
intermolecular contacts have been omitted for clarity. Thermal ellipsoids have been 
drawn at 50% probability. 
related to this secondary association are C19A ··· N1C = 3.337(6) Å and C19B ··· N1D = 
3.135(6) Å. It is difficult to determine whether this clip‐like behaviour has a significant 
effect on templating the arrangement observed here as this structural motif is not 
present in the crystal structure of 5.8.HPF6.  
 
Single crystal X‐ray diffraction was performed on 5.8.HPF6 using crystals grown by slow 
vapour diffusion of Et2O into MeCN. Unlike 5.7.HPF6, this crystallises with unit cell 
contents of a single molecule of [5.8.H]+, one PF6 anion and one water molecule in the 
orthorhombic space group Pbca (Figure 5.8). As expected the amide crystallises in its Z-
configuration and is characterised by the bond lengths C16 – O1 = 1.225(5) Å, C16 – N15 
= 1.337(5) Å and C5 – N15 = 1.428 Å all of which are comparable with those recorded 
















The acetamide linkage is rotated such that it is perpendicular to the plane of the 
imidazolyl ring as represented by the torsion angle C19‐N18‐C17‐C16 of 95.9(4)o. 
Hydrogen bonding in the packed structure is exclusively mediated by the water molecule 
which is an OH donor in two interactions O2 ··· O1 = 2.819(5) Å and O2 ··· N10 = 2.831(5)Å 




Figure 5.9: Highlighting the role of the water molecule in hydrogen bonding within the 
packed structure. 
Stacking of the phenanthroline groups is much less notable, with only the benzenoid 
ring and N1‐pyridyl ring slightly overlapped at a centroid‐to‐centroid distance of 3.717 
Å and shift distance of 1.192 Å. Molecules of [5.8.H]+, hydrogen bonded via the N15H ··· 
O2H ··· O1 chain are arranged such that the phenyl pendant of one molecule, and 
imidazolyl ring of the other are co‐planar but largely offset. Their centroid‐to‐centroid 
distance is 4.266(3) Å with a shift of 2.590(7) Å however, the plane‐to‐centroid distance 
is 3.293(5) Å. Perhaps it is because the aromatic phenyl pendant of [5.8.H]+ can 
participate in additional interactions that a different packing arrangement is observed 



























5.2.2.2. Synthesis of acetamide linked metallo-NHC proligands 
 
Complexes of the type [Ru(phen)2(5‐PA)][PF6]3 were sought as prospective NHC 
metalloproligands from which Δ / Λ enantiomers could be resolved or synthesised from 
resolved precursors. Racemic forms of these were prepared in the first instance to 
provide material for analysis and to assess their applicability as proligands in palladium 
mediated catalysis. Synthesis and characterisation of the racemic complexes 
[Ru(phen)2(5.5.H)][PF6]3, [Ru(phen)2(5.6.H)][PF6]3, [Ru(phen)2(5.7.H)][PF6]3, 
[Ru(phen)2(5.8.H)][PF6]3, [Ru(phen)2(5.9.H)][PF6]3 and [Ru(phen)2(5.10.H)][PF6]3 will be 
discussed here. Enantiomeric resolution of [Ru(phen)2(5.9.H)][PF6]3 into Δ ‐ 
[Ru(phen)2(5.9.H)][PF6]3 and Λ ‐ [Ru(phen)2(5.9.H)][PF6]3 is explored in section 5.7.  
 
Preparation of complexes [Ru(phen)2(5.5.H – 5.10.H)][PF6]3 was achieved by refluxing 
one of the imidazolium salt ligands 5.5.HX – 5.10.HX with Ru(phen)2Cl2 in a 4 : 1 
EtOH/water mixture (Scheme 5.7). Before use, the EtOH/water mixture was degassed 
with bubbling argon and all reactions were performed under an argon atmosphere with 
reaction progress monitored by TLC (silica, 9:1.5:1 MeCN/water/saturated KNO3(aq)). 
Several of these reactions were allowed to reflux overnight for ~ 20 hours, however, it 
was typically found that 2 – 4 hours was sufficient for total conversion to product. All 
complexes were isolated by flash chromatography on silica, eluting with 9:1.5:1 
MeCN/water/saturated KNO3(aq) solution. Pure material was obtained by condensing the 
appropriate fractions which were then taken up in water and treated with aqueous KPF6 
solution. The resultant precipitate was collected by filtration providing the PF6 salt of 
the product as a bright orange powder. Yields were typically between 70% – 80% except 
for [Ru(phen)2(5.10.H)][PF6]3 which was 58%. Yields returned for the pyridyl‐pendant 
imidazolium salt compounds [Ru(phen)2(5.10.H)][PF6]3 and ligand 5.10.HPF6 were 
always lower than the other imidazolium salts. This continues a trend of lower yields for 
pyridyl‐substituted derivatives beginning with the synthesis of 2.5.HCl (55% yield) and 
2.5.HCl (67% yield). Such variations in yield may be caused by the electron deficient 
pyridine unit rendering 1‐(2‐pyridyl)‐imidazole less nucleophilic than its alkyl or phenyl 
appended counterparts. Furthermore, it is postulated that the inherently basic pyridine 




leading to decomposition via the NHC. The latter decomposition pathway may be 
exacerbated under the aqueous reaction conditions employed in the synthesis of 
[Ru(phen)2(5.10.H)][PF6]3. Coordination of the pyridyl‐pendant to the ruthenium 






















Besides differences derived from their pendant group functionality, the complexes 
[Ru(phen)2(5.5.H – 5.10.H)][PF6]3 exhibit similar 1H‐NMR, 13C‐NMR, IR and mass‐spectral 
features. Table 5.1 summarises the key proton and carbon resonances for the 
























5.5.H 5.6.H 5.7.H 5.8.H 5.9.H 5.10.H 5.5.HPF6 5.9.HCl
H15 11.00 11.00 11.00 11.06 11.15 11.06 10.74 —
H17 5.46 5.45 5.45 5.55 5.61 5.58 5.46 5.47
C16 166.13 166.13 166.08 165.75 165.96 165.33 165.34 165.88
C17 51.96 51.82 52.88 52.14 52.30 51.83 51.20 53.21
H19 9.13 9.20 9.27 9.86 9.54 10.14 ~ 9.17 9.65
H21 ~ 7.73 ~ 7.80 7.95 ~ 8.37 ~ 8.13 ~ 8.58 ~ 7.82 ~ 8.21
H22 ~ 7.77 ~ 7.84 ~ 7.80 ~ 8.05 ~ 8.09 ~ 8.05 7.74 8.11
C19 138.39 137.39 136.67 137.23 139.97 136.42 137.95 139.66
C21 123.68 124.39 124.56 121.37 125.03 118.85 123.13 124.68
C22 124.47 124.65 124.75 125.50 125.32 125.40 124.03 125,37
H2 8.10 8.12 8.13 8.13 ~ 8.12 ~ 8.12 ~ 9.17 9.07
H9 7.99 7.99 8.00 8.00 8.01 7.99 9.07 8.94
H4 8.91 8.91 8.92 8.92 8.94 8.92 8.75 8.87
H7 8.70 ~ 8.71 ~ 8.71 ~ 8.72 ~ 8.77 ~ 8.73 8.53 8.34
H6 8.56 8.57 8.59 8.59 8.57 ~ 8.58 8.21 ~ 8.21
C2 153.22 153.49 153.51 153.55 153.54 153.10 150.06 149.98
C9 153.19 153.19 152.55 152.60 152.59 152.17 149.22 148.80
C4 132.83 132.87 132.80 133.24 132.94 132.82 132.07 132.70
C7 136.87 136.77 136.81 136.83 136.88 136.89 136.82 135.74
C5 133.14 — 132.83 — 133.25 132.43 124.50 123.48





















































Table 5.1: Selected proton and carbon NMR resonances for complexes [Ru(phen)2(5.5.H 
- 5.10.H)][PF6]3 and two free ligands. Atomic labelling shown in Figure 5.10. 
 




Also contained in Table 5.1 are related environments for uncoordinated ligands 5.5.HPF6 
and 5.9.HCl which provide representative examples of PF6 and Cl ligand salts and a 
reference point for coordination induced shifts. Not shown in the table are resonances 
due to the 1,10‐phenanthroline ancillary ligands which have conserved signals at ~ 8.75 
ppm (H4’ / H7’), ~ 8.37 ppm (H5’ / H6’), ~ 8.05 ppm (H2’ / H9’) and ~ 7.76 ppm (H3’ / 
H8’). Their carbon environments are similarly conserved. Also absent are environments 
related to the pendant group and environments H3 and H8 which are consistently found 
in a multiplet between 7.83 – 7.70 ppm. 
 
Unsurprisingly, chemical shifts of proton and carbon environments of the imidazolyl 
moiety are most affected by changes to the pendant group. The proton resonant 
frequencies are lower for alkyl‐appended imidazolium groups than their aryl 
counterparts and the H19 and H21 environments differ most. Of the aryl appended 
species, the diisopropyl‐phenyl derivative [Ru(phen)2(5.9.H)][PF6]3 displays lower H19 
and H21 frequencies (9.54 ppm and ~ 8.13 ppm, respectively) than the phenyl‐appended 
and pyridyl‐appended derivatives ([Ru(phen)2(5.8.H)][PF6]3, 9.86 ppm and ~ 8.37 ppm; 
and [Ru(phen)2(5.10.H)][PF6]3, 10.14 ppm and ~ 8.37 ppm). This is presumably because 
the rotation around the N – Ar bond is restricted by the isopropyl groups in 
[Ru(phen)2(5.9.H)][PF6]3, forcing it the spend more time orthogonal to the imidazolium‐
ring. Therefore the H19 and H21 environments experience less anisotropic deshielding 
due to the aromatic pendant than in [Ru(phen)2(5.8.H)][PF6]3 and 
[Ru(phen)2(5.10.H)][PF6]3. Modulation of the pendant group affects the imidazolium 
carbon environments to a much lesser extent. All other environments are largely 
conserved. The phenanthroline carbon environment bonded to the amide (C5) was not 
always detectable but in some cases a small signal at ~ 132.8 ppm could be found with 
assistance from an HMBC correlation to H4.  
 
Coordination induced shifts are as predicted for a phenanthroline based ligand that is 
coordinated to a ruthenium‐polypyridine system. Such behaviour has been addressed 
for ligand 5.2.HPF6 and its complex [Ru(bipy)2(5.2.H)][PF6]3 in section 5.2.1.2 and will be 




The 1H‐NMR spectra of 5.5.HPF6 and [Ru(phen)2(5.5.H)][PF6]3 in DMSO‐d6 are shown in 

























As expected, anisotropic shielding of the proton environments H2 and H9 by the 
phenanthroline ancillary ligands causes them to shift upfield by ~ 1.1 ppm.  Signals due 
to H3 and H8 are also shifted upfield but only very slightly. Environments H4 and H7 are 
not influenced by through space magnetisation and instead shift downfield by ~ 0.2 ppm 
as a result of electron density withdrawal onto the Ru(II). The most important shift to 


















Figure 5.11 (a): 1H-NMR spectra of the uncoordinated ligand 5.5.HPF6 and, (b) its 




downfield upon coordination of ligand 5.5.HPF6 to Ru(II). The observed deshielding of 
this environment supports the assertion that coordination to Ru(II) withdraws electron 
density from the amide proton through the conjugated π‐system (see Figure 5.23). 
Stabilisation of the amidate conjugate base in this manner means that the amide proton 
will be more acidic in the coordinated ligand (see Scheme 5.16). The nearby H6 
environment also responds with a downfield shift of similar magnitude (Δδ = + 0.35 ppm) 
which verifies this cross‐ligand influence. The amide carbonyl carbon environment C16 
only changes marginally. Environments associated with the imidazolium‐moiety 
including its pendants remain unchanged as expected due to their remoteness to the 
site of coordination. 
 
Phenanthroline‐acetamide imidazolium salts were prepared with various pendant 
functionalities (5.5.HX – 5.10.HX) in order to illustrate the versatility of this approach. It 
was also necessary to have options with which to attempt the synthesis of NHC 
complexes because, as has been discussed, the nature of the pendant group can be 
highly influential. It was originally intended that the impact of different pendent groups 
on catalysis would be assessed as well, however, this could not be attempted in the time 
available. NHC complexes in the bornyl‐acetamide and cyclohexyl‐acetamide series 
were obtained with methyl, diisopropyl‐phenyl and pyridyl pendant ligands. For this 
reason, PA‐NHC complexes with ligands 5.5, 5.9 and 5.10 were targeted exclusively. 
 
5.3. Synthesis of [Ru(1,10-phenanthroline)2(5-PA)]3+ derived NHC 
complexes 
5.3.1. [Ru(1,10-phenanthroline)2(Pd{5.9 - H}{allyl})][PF6]2 
 
The Ru(ppy)3 – NHC – Pd(II) complex [Ru(phen)2(Pd{5.9}{allyl}Cl)][PF6]2 was targeted to 
finalise the series with Pd(2.4)(allyl)Cl and Pd(3.3)(allyl)Cl. This would provide NHC – 
acetamide complexes with an achiral‐organic, enantiopure‐organic and enantiopure‐
metal‐centred component.  Rewardingly, instead of isolating the pendant complex as is 




[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 was obtained (Scheme 5.8). Spontaneous amidate 
coordination under mild conditions without additional base has been noted for some 
NHC – Ru(II) acetamide complexes114, 158 but never with Pd(II). Such behaviour is 
recurrent for all Ru(ppy)3 – NHC – Pd type complexes in this study and the reasons for 
this are examined in section 5.6. It is significant because, to the authors knowledge, no 
examples of Pd(allyl) complexes with anionic chelating ligands exist. This is because 
conditions under which a proligand is deprotonated to give the anionic chelate are 
typically too harsh for the allyl auxiliary to withstand. Therefore, this ligand system 


















Because N-amidate/NHC chelation occurs readily for the metalloligand 
[Ru(phen)2(5.9)]2+, it presents an opportunity to understand how this influences 
catalysis when using NHC – acetamide ligands. A detailed structural analysis of the 
related bornane functionalised ligand 2.4 revealed chelation to be disfavoured on a 
steric basis, whereas its cyclohexyl functionalised cousin 3.3 would chelate under basic 
conditions. Now with [Ru(phen)2(5.9)]2+, which exhibits preferential chelation, it is 
[Ru(phen)2(Pd{5.9}{allyl}Cl)][PF6]2 
[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 
Scheme 5.8: Conversion of the expected complex [Ru(phen)2(Pd{5.9}{allyl}Cl)][PF6]2   to 




possible to study a complete range of amidate coordination ability and it effect on 
catalysis. 
 
5.3.1.1. Synthesis and characterisation of [Ru(1,10-
phenanthroline)2(Pd{5.9 - H}{allyl})][PF6]2 
 
 
Complex [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 was synthesised from the metalloproligand  
[Ru(phen)2(5.9.H)][PF6]3 by transmetalation from an intermediary NHC – Ag(I) complex 
(Scheme 5.9). This synthesis was performed similarly to that which produced 
Pd(2.4)(allyl)Cl and Pd(3.3)(allyl)Cl but with some minor modifications. Unlike the other 
[Ru(phen)2(5‐PA)][PF6]3 metalloproligands, [Ru(phen)2(5.9.H)][PF6]3 is adequately 
soluble in DCM because of its diisopropyl‐phenyl pendant and this is the favoured 
solvent for NHC – Ag(I) transmetalation. DCM accommodates clean, proligand 
conversion by Ag2O to provide NHC – Ag(I) for subsequent transmetalation and its 
volatility simplifies work up of potentially sensitive products. However, while the PF6 salt 
salts solubilises well, the chloride salt of [Ru(phen)2(5.9.H)]3+ is poorly organic soluble. 
This is important because it has been mentioned previously that having a coordinating 
anion such as chloride present can improve the synthesis of mono‐NHC products via the 
Ag(I) transmetalation approach. This is because chloride favours mono‐NHC 
intermediate of the type Ag(NHC)Cl as opposed to the bis‐NHC [Ag(NHC)2]+ type 
complexes favoured by non‐coordinating counteranions such as PF6. The impact of this 
is examined further in section 5.3.2.1 regarding the synthesis of [Ru(phen)2(Pd{5.10 - 
H}Cl)][PF6]2. Because it was not possible to use a chloride salt of the metallo‐NHC 
proligand, the synthesis of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 was modified from 
previous works to include addition of a molar equivalent of tetraethyl‐ammonium 
chloride as a source of coordinating anion. Although sparingly soluble in DCM, only a 
small quantity tetraethyl‐ammonium chloride was required relative to the volume of 
solvent. It was found to serve its function, however, the more suitably soluble 
tetrabutyl‐ammonium chloride would have been used if available and is recommended 



























The reaction was performed once by stirring [Ru(phen)2(5.9.H)][PF6]3 and an equivalent 
of tetraethyl‐ammonium chloride in anhydrous DCM under an inert atmosphere. Once 
the solution was homogeneous, half an equivalent of Ag2O was added under a blanket 
of nitrogen and the reaction stirred in darkness. After 15 hours the reaction mixture was 
seen to be a bright red solution with some suspended solid. An aliquot analysed by 1H‐
NMR showed it to be a mixture of starting material and NHC product in a 1 : 2 ratio. 
Because NHC – Ag(I) intermediates are not always stable it is difficult to say whether or 
not the observed starting material was regenerated from the product by, for example, 
removing a proton from water in the NMR solvent.  Stirring was continued for a further 
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[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2, 64% 
[Ru(phen)2(5.9.H)][PF6]3 
Scheme 5.9: Synthesis of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 from 




After stirring for a further 48 hours the mixture was filtered through celite to remove a 
light grey precipitate and the filtrate rotary‐evaporated to provide a flaky red solid.  
 
The 1H‐NMR spectrum of this material was messy with only baseline‐level signals 
attributable to allyl ligand environments and evidence of significant tetraethyl‐
ammonium salt contamination. It did, however, contain definite Ru(ppy)3 environments 
and no imidazolium NCHN or amide NH signals. It is now known that the product 
[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 has an intrinsically complex spectrum due to the 
dynamic allyl group and, in fact, the material recovered here is relatively pure with the 
exception of the tetraethyl‐ammonium salt. Likewise, the low resolution mass‐spectrum 
of this crude confirmed the presence of the desired complex with large signals at 357.41 
and at 535.61 corresponding to the cations [Ru(phen)2(Pd{5.9}{allyl})]3+ and  
[Ru(phen)2(Pd{5.9 - H}{allyl})]2+ (m/z calculated, [Ru(phen)2(Pd{5.9}{allyl})]3+ = 357.41 
and [Ru(phen)2(Pd{5.9 - H}{allyl})]3+ = 535.61). There was also an equally intense signal 
due to starting material at 308.76 (m/z calculated, [Ru(phen)2(5.9.H)]3+ = 308.76).  
 
Unfortunately, the tetraethyl‐ammonium salt had similar solubility to the desired 
product and could not be removed by solvent washes or precipitation. Instead the batch 
of material was halved for separate purification attempts. First, ion‐exchange 
chromatography was attempted using sephadex‐C25 and gradient elution with NaCl 
solution. In order to load the material it was converted into a water soluble chloride 
form by stirring in MeOH with AmberliteR IRA‐400 (chloride form) ion exchange resin 
for several hours then filtering and removing the solvent.  The leading band was 
collected by elution with 0.15 M NaCl solution and found to be a small quantity of 
imidazolium salt proligand. The material that followed this streaked extensively down 
the column and was collected in many dilute fractions over a range of high NaCl eluent 
concentrations (0.2 M – 1.0 M). After obtaining the material as its PF6 salt it was analysed 
by 1H‐NMR and found contain slightly more aromatic impurities than the crude material 
but with no tetraethyl‐ammonium contamination. Being in aqueous media for several 
days no‐doubt contributed to the emergence of additional impurities however, the 
product remained largely intact. In retrospect, the observed smearing of the product 




chloride anions) and product degradation. Despite this, similar chromatography has 
been applied successfully to the isolation of [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2. 
 
Instead traditional flash chromatography (alumina, 2% MeOH/chloroform) was 
performed on a separate portion of the original crude material with greater success. 
Again the product band smeared broadly but was able to be collected cleanly, providing 
pure [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2. Scaling the isolated product to the overall 
synthesis gave [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 in a yield of 64%.  
 
The identity of this species was confirmed by X‐ray crystallography and NMR analysis. 
Mass‐spectrometry was also performed on the same batch of crystals. It was important 
to do so given that the allyl environments were difficult to identify by NMR but were 
unambiguously verified crystallographically and with support from mass‐spec. Crystals 
of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 were grown by slow evaporation of an acetone 
solution of the compound spiked with a small amount of benzene. It was found that 
larger samples of the compound, such as the impure material obtained from the 
sephadex column, could be purified by crystallising similarly. After drying the 
crystallisation vessel under vacuum, pure crystalline product could be shaken out 
leaving behind non‐crystalline impurity residues fused to the interior.  
 
Samples for X‐ray analysis were best prepared by slow evaporation of an 
acetone/benzene mixture with some benzene anti‐solvent in the outer‐vial to ensure 
the crystals remained solvated. Crystals grown in this manner were clusters of thin 
diamond platelets too small for analysis by diffraction of home‐source X‐rays and were 
therefore analysed using synchrotron radiation of frequency 0.71073 nm (Mo/Kα).  
Complex [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 crystallises in the monoclinic space group 
P2/c with one molecule of [Ru(phen)2(Pd{5.9 - H}{allyl})]2+ and two PF6 anions in the 
asymmetric unit (Figure 5.12). One water molecule is hydrogen bonded to the amide 
and resides on single site however, voids in the lattice are occupied by a benzene 
molecule and at least four water molecules, all of which are highly disordered and 
difficult to model. Poor data collection contributed to challenges in modelling solvate 




Pd(II) centre remains coordinated to the allyl ligand and that the amide nitrogen is 





As seen for Pd(3.3)(allyl)Cl, the allyl group is disordered over two positions with site 
occupancies for the central carbon of 60 : 40, C30 : C32. A distorted square‐planar 
geometry of the Pd(II) centre is observed due to the constricted chelate angle of the allyl 
ligand, C29 – Pd1 – C31 of 69.8(5)o. For the NHC – amidate chelate, C17 – Pd1 – N15 is 
86.4(4)o and the Pd(II) – ligand bond lengths are as follows; Pd1 – C19 = 2.002(11) Å, Pd1 
– N15 = 2.101(8) Å, Pd1 – C29 = 2.075(14) Å and Pd1 – C29 = 2.153(10) Å. As is routinely 
observed the NHC – metal bond is shortest and the bond trans to it is longest. 
Interestingly, the Pd – amidate bond, Pd1 – N15 is long compared with those of related 
compounds in this study. For Pd(2.4 - H)(O,O’‐acac) and Pd(3.3 - H)(O,O’‐acac) this bond 
is 2.030(4) Å / 2.046(4) Å and 2.032(2) Å respectively and, for the related Ru(ppy)3 – NHC 
complexes [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]3 and [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]3 these 
are 2.026(10) Å / 2.007(11) Å and 2.035(6) Å. This is because the carbon donor allyl‐
ligand, like the NHC, is a strongly σ‐donating,192 hence the Pd – amidate bond also 
experiences a trans‐influence. This is similarly why the NHC – Pd bond is slightly longer 
for complexes with allyl‐auxiliaries such as Pd(3.3)(allyl)Cl and related literature 
Figure 5.12: Asymmetric unit of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2. Hydrogen atoms, 
PF6 anions and solvate molecules have been omitted for clarity. Thermal ellipsoids have 




compounds.184, 186, 193 The six membered NHC – amidate chelate ring is slightly puckered 
with the apical methylene C17 raised from the Pd(II) mean‐plane at an angle of 11.1(2)o. 
Puckering in this fashion minimises steric interactions between the diisopropyl‐phenyl 
pendant an the allyl ligand.  The octahedral coordination geometry of the Ru(II) is 
characterised by the bond angles N1 – Ru – N10, N1A' – Ru – N1A'' and N1B' – Ru – N1B'' 
are 80.2(2)o, 78.6(2)o and 78.7(2)o, respectively. Ru – N bond lengths fall within the range 
of 2.047(3) Å for Ru – N1B'' and 2.076(3) Å for Ru – N10. The Δ enantiomer of this 
stereochemical propeller arrangement is shown in Figure 5.12 though the structure is 
racemic overall. As will be elaborated further in section 5.3.2.1, the orthogonal 
orientation of the Pd(II) complex relative to the phenanthroline plane of ligand 5.9 - H 
results in a stereochemical axis along the N15 – C5 bond generating M or P enantiomers. 
As such, the plane defined by ligand donor sites around the Pd(II) centre is twisted at an 
angle of 69.3(3)o to the phenanthroline plane and has an M‐stereochemical axis along 
the N15 – C5 bond. Because the complex has two stereochemical components (Δ, Λ and 
M, P), it is capable of forming diastereomers. Diastereoisomerism of this type may 
contribute to the convolution of the compounds NMR spectra as will be discussed. One 
well‐defined water molecule participates in bridging hydrogen bond donation between 
the amide‐carbonyl groups of two [Ru(phen)2(Pd{5.9 - H}{allyl})]3+ molecules at an 
internuclear distance of O1 ··· O2 = 2.830(13) Å. Several CH ··· F type interactions are 
also noted, the shortest of which having C ··· F distances of 3.296(10) Å, 3.298(11) Å and 
3.311(12) Å. 
 
As with the crude material, mass spectrometry performed on the crystallised sample 
showed three strong signals at 357.4077, 535.6089 and 549.1136. The former two have 
been accounted for previously (m/z calculated, [Ru(phen)2(Pd{5.9}{allyl})]3+ = 357.4076 
and [Ru(phen)2(Pd{5.9 - H}{allyl})]3+ = 535.6072), however, the final signal, which was 
also noted in the crude, has not been discussed. Surprisingly, this mass corresponds to 
that of a cyanide ligated cation [Ru(phen)2(Pd{5.9}{allyl}CN)]2+ which has a calculated 
m/z of 549.1136 (Figure 5.13). The occurrence of similar cyanide complexes is also noted 



























MeCN is known to contain trace quantities of cyanide and these samples were all run 
as, or at least prepared from, a MeCN solution. Because cyanide forms strong complexes 
with Pd(II)253 it is clearly able to displace the amidate. Given the low concentrations of 
compound required for mass‐spectrometry it may be possible to detect the NHC – 
Pd(CN) complex at a meaningful intensity, especially if the complex is actively “picking 
up” cyanide. Furthermore, this system is attuned to the detection of such species 
because of the permanently cationic [Ru(ppy)]2+ component which behaves like a mass‐
spectral antenna, allowing the detection of adducts that would otherwise be neutral. It 
is this principle that allows the detection of the free‐NHC fragment in the mass‐spectrum 








Figure 5.13: Experimental and simulated mass-spectra identifying fragments 




The mass‐spectrum affirms that the bulk sample contains a Pd(allyl) moiety although, 
this cannot be verified by 1H‐NMR and 13C‐NMR analysis of the crystalline sample. Peak 
suppression in the NMR is a consequence of both syn-anti interchange of the allyl group 
and, conformational flipping of the 6‐membered N‐amidate/NHC chelate. Both of these 
concepts have been explored previously in Chapters 1 and 2. After standing the CD3CN 
NMR solution of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 for two weeks and analysing again, 
three large signals, possibly attributable to the allyl functionality emerge at 3.53 ppm, 
3.42 ppm and 3.28 ppm. The 1H‐NMR spectrum of both the fresh, and weeks old sample 
of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 is shown in Figure 5.14. Interestingly there is 
minimal difference in the aromatic region of the two spectra suggesting that the overall 
structure is conserved. In both cases the diagnostic acetamide methylene environment 
(H17) is completely supressed, registering as a nub at 4.85 ppm. This environment will 
also be heavily affected by chelate ring flipping. These observations imply that the 
compound has not lost the Pd(allyl) group but it is instead involved in an equilibrium 
that has slowly become established, allowing certain environments to be viewed. 
Coordinating solvents such as MeCN are known to influence syn-anti interchange and 
this may be true here also. However, it is important to note that the same analysis 
performed in the non‐coordinating solvents acetone‐d6 and CDCl3 did not improve the 
clarity of the spectra. It is probable that the allyl group of [Ru(phen)2(Pd{5.9 - 
H}{allyl})][PF6]2 is intrinsically mobile, irrespective of the solvent, unlike Pd(2.4)(allyl)Cl 
and Pd(3.3)(allyl)Cl which are static, or very slowly interchanging, in these solvents. 
Additional conformational changes can occur in the form of chelate ring flipping and 
rotation around the C5 – N15 bond to produce different atropisomeric diastereomers. 
Spectral convolution as a consequence of this dynamic behaviour made the spectrum 
difficult to assign. This also contributed to being unable to obtain a high quality 13C‐NMR 
spectrum. However, environments belonging to the 1,10‐phenanthroline ancillary 
ligands, and some of the phenanthroline component of ligand 5.9 could be identified. 
This was assisted by comparison with the fully assigned 1H‐NMR and 13C‐NMR spectra of 






























In the aromatic region of the original CD3CN 1H‐NMR spectra there are four well defined 
doublets, the largest at 8.58 ppm and 8.03 ppm attributable to the respective H4’ / H7’ 
and H2’ / H9’ proton of the 1,10‐phenanthroline ancillaries. Smaller doublets at 8.36 
ppm and 7.94 ppm belong to H4 or H7 and H2 or H9 of the 5.9 phenanthroline. Any 
environments in the vicinity of the Pd(II) ligands sphere, including H6 and H7 are seen 
as severely broadened peaks. Although the 13C‐NMR spectrum was difficult to assign, a 
signal at 170.13 ppm due the amide carbonyl environment (C16) was identified as well 
as one at 57.30 ppm due to the acetamide methylene (C17). The carbenic carbon 
environment (C19) can usually be identified by HMBC correlation to the methylene 
allyl region 
isopropyl 
MeCN H2O benzene 
H17 
Figure 5.14 (a): The 1H-NMR spectrum of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 in CD3CN 




proton resonance and those of the two imidazolyl proton H21 and H22. However, this 
was not possible here due to signal broadening.  
 
In previous analysis of NHC‐acetamide complexes, IR spectroscopy provided insight into 
the amide’s coordination state by evaluating any changes in the compound’s carbonyl 
C=O stretching frequency from that of the free ligand. Unfortunately, for all of the 
Ru(ppy)3 – NHC – M type complexes in this study, this was not possible. Both the free 
metalloproligands and Ru(ppy)3 – NHC – M complexes produced unhelpful IR spectra 
due to the fact that only weak, broad signals in the diagnostic region between 2000 – 
1000 cm‐1 were observed. Signals due to the PF6 anion were distinguishable in all 
spectra, particularly the strong PF6 asymmetric stretch at ~ 830 cm‐1, a weaker 
symmetric stretch between 624 – 680 cm‐1 and PF6 scissor bending below 600 cm‐1, all 
of which are in accordance with the literature.254, 255   
 
Despite inconclusive NMR support, the assigned structure of [Ru(phen)2(Pd{5.9 - 
H}{allyl})][PF6]2 was deemed correct on the basis of its crystal structure and mass‐
spectrum. Further evaluation of its structural and chemical attributes is undertaken in 
section 5.6. 
 
5.3.2. [Ru(1,10-phenanthroline)2(M{5.10 - H}Cl)][PF6]2 
 
A Ru(ppy)3 analogue of the pyridyl pendant bornyl‐acetamide complex Pd(2.5)Cl2 was 
sought in the hope that the ordering influence of NHC – Py chelation would support 
more structurally defined NHC – Pd(II) core, unlike the allyl‐ligated [Ru(phen)2(Pd{5.9 - 
H}{allyl})][PF6]2. As such, the complex [Ru(phen)2(Pd{5.10}Cl2)][PF6]2 was targeted with 
the expectation that the amidate‐chelated complex [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 
would be isolated. This would provide valuable insight into the structural attributes of 
these truly unique Ru(ppy) – NHC – Pd(II) systems. To some extent this ambition was 
achieved; Synthesis of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 proceeded with spontaneous 




however, the isolated species was found to be mixture of diastereoisomers in an 2:1 













5.3.2.1. Synthesis and characterisation of [Ru(1,10-
phenanthroline)2(Pd{5.10 - H}Cl)][PF6]2 
 
Synthesis of [Ru(phen)2(Pd{5.10 - H}Cl2)][PF6]2 was performed by transmetalation from 
an intermediate NHC‐Ag(I) complex to Pd(MeCN)2Cl2 or Pd(PhCN)2Cl2 as per the generic 
method shown in Scheme 5.10. The metallo‐NHC proligand for this synthesis, 
[Ru(phen)2(5.10.H)][PF6]3, is not DCM soluble as was the case with 
[Ru(phen)2(5.9.H)][PF6]3 hence the alternative solvents MeCN and DMSO were trialled. 
This being the case, there were no solubility advantages to using the PF6 salt over 
chloride as both are soluble in these solvents. Using the precursor chloride salt 
[Ru(phen)2(5.10.H)]Cl3 provides coordinating chloride anions without the addition of 
tetraalkyl‐ammonium salts as these introduce a persistent impurity as was found in the 
work‐up of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2. Because all of the metallo‐NHC 
proligand complexes were isolated as their PF6 salts, obtaining chloride salts does add 
another synthetic step.  
[Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 


















Synthesis of the desired Ru(ppy)3 – NHC – Pd(II) complex was successfully achieved using 
the chloride salt of the metallo‐NHC proligand [Ru(phen)2(5.10.H)]Cl3 in DMSO as will be 
discussed shortly. Following this, the synthesis was repeated using the PF6 salt of the 
proligand without chloride present to determine whether this conversion step was 
necessary. It was incorrectly predicted that steric and electronic repulsion between the 
large, cationic [Ru(phen)3]2+ pendant functionalities of the [Ru(phen)2(5.10.H)]2+ ligands 
would disfavour formation of bis‐NHC complexes (Figure 5.16). After addition of 
Pd(PhCN)2Cl2 to the NHC – Ag(I) intermediate solution and stirring for 20 hours, 1H‐NMR 
analysis of the reaction mixture revealed an extremely complicated aromatic region and 
a broad, highly irregular methylene environment. The reaction was allowed to continue 
[Ru(phen)2(Pd{5.10 - H}Cl)]2+ 
[Ru(phen)2(5.10.H)][X]3 
Scheme 5.10: General method for the synthesis of [Ru(phen)2(Pd{5.10 - H}Cl]2+ by the 




for a further 24 hours, however, the constitution of the 1H‐NMR spectrum remained 
unchanged. Crude material was isolated simply by pouring the reaction mixture into 












The mass‐spectrum of this material, as with those of the reaction mixtures, showed a 
dominant signal at 447.0651 corresponding to the bis‐NHC 4+ cation {Pd[Ru(phen)2(5.10 
- H)]2}4+ for which m/z is calculated to be 447.0622. At two‐thirds the intensity was a 
signal attributable to the desired product then a smaller signal at 644.4081 due to 
[Pd(Ru{phen}2{5.10 - H})2][PF6]3+ (m/z calculated, [Pd(Ru{phen}2{5.10 - H})2][PF6]3+ = 
644.4045). Evidently, one or more bis‐NHC species is prevalent in the product mixture 
which explains the ambiguity observed in the 1H‐NMR spectrum. A small portion of the 
desired complex was selectively crystallised by bulk slow vapour diffusion of diisopropyl‐
ether into a MeCN solution of the crude product and recovered in a 12% yield. No 





























                      transmetalation 
crowded Pd(II) centre 
repulsion by cationic complexes 
Figure 5.16: Highlighting why formation of bis-NHC complexes is unexpected on the 
basis of steric and electronic repulsion between ligands of [Ru(phen)2(5.10)]2+ during 




proved the importance of having chloride present in order to avoid the formation of bis‐
NHC complexes when using the silver‐transmetalation method.  
Conversion of [Ru(phen)2(5.10.H)][PF6]3 into its chloride salt was initially performed 
using Amberlite® IRA‐400 (chloride form) anion exchange resin, an approach commonly 
used throughout this work. It involves stirring a weighed quantity of the original complex 
in MeOH and adding a portion of amberlite resin, approximately 0.400 grams of 
amberlite to 0.100 moles of sample in 20 mL of MeOH. Removal of PF6 by the resin can 
be monitored using 19F‐NMR on an aliquot of sample.  Upwards of 24 hours was 
necessary for quantitative conversion of [Ru(phen)2(5.10.H)][PF6]3 to 
[Ru(phen)2(5.10.H)]Cl3. However, this is only necessary if one wishes to have a batch of 
pure [Ru(phen)2(5.10.H)]Cl3 from which to accurately calculate molar quantities. For the 
purposes here it was only required that sufficient chloride be present to improve 
formation of mono‐nuclear Ag(NHC)Cl intermediates and to produce a water soluble 
product, which proved important to the workup. Only 2 hours was necessary to achieve 
this level of exchange and, provided losses of material were minimised, the amount of 
[Ru(phen)2(5.10.H)]3+ could be estimated based on the mass of 
[Ru(phen)2(5.10.H)][PF6]3 used initially.  
Salt metathesis was eventually found to be a more expedient method of obtaining 
chloride salts of these compounds.256 This was achieved by dropwise addition of 
saturated tetraethyl‐ammonium chloride solution in acetone into an acetone solution 
of [Ru(phen)2(5.10.H)][PF6]3 (~ 0.100 mmol in 20 mL) and collecting the resultant 
precipitate. After rinsing with cold acetone the fine orange powder was dried in vacuo 
providing [Ru(phen)2(5.10.H)]Cl3 quantitatively, although, 19F‐NMR was not performed 
to confirm the absence of all PF6. 
The first attempt at the synthesis of [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 was performed in 
MeCN as per the approach shown in Scheme 5.10 but was unsuccessful because the 
NHC – Ag(I) intermediate precipitated as a brick‐red solid after stirring in darkness for 
20 hours. The supernatant remained red also so Pd(PhCN)Cl2 in MeCN was added in the 
hope that sufficient NHC – Ag(I) material was dissolved to perform the reaction. An 




starting material was present, however, there was clearly a complicated mixture of NHC 
– Pd(II) and NHC – Ag(I) products. After reacting for a further 20 hours the mixture was 
analysed again by NMR but the mixture remained complicated. It was decided to repeat 
the synthesis in DMSO to avoid complications arising due to the insolubility of the NHC 
– Ag(I) intermediate. Although this does provide an effective route to synthesising and 
isolating the intermediate species, presumed to be [Ru(phen)2(Ag{5.10}Cl2)]Cl2, if 
desired for future investigation.  
 
Using DMSO as the solvent proved effective; proligand [Ru(phen)2(5.10.H)]Cl3 and half 
an equivalent of Ag2O were combined under an inert atmosphere and DMSO added by 
syringe. The reaction was stirred in darkness for 20 hours before adding an equivalent 
of Pd(MeCN)2Cl2 as a solution in DMSO and stirring for a further 24 hours. No AgCl 
precipitated as is commonly observed, however, NMR indicated that the reaction was 
complete. Pouring the reaction mixture into water and stirring for several hours still did 
not prompt precipitation of AgCl as expected, potentially due to the formation of an Ag‐
DMSO adduct. It was found that the presence of Ag(I) hampered purification by the 
preferred method of crystallisation so it was necessary to remove it at an early stage. 
This was achieved by taking an aqueous solution of the reaction mixture and loading it 
onto a short plug of sephadex‐C25 ion‐exchange resin. After rinsing with water the 
desired product was eluted using a steep gradient going from 0.1 – 0.5 M NaCl solution 
and precipitated by addition of KPF6 solution. Filtering and drying provided moderately 
pure [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 as a brick‐red powder. Pure material was obtained 
by bulk slow vapour diffusion of diisopropyl‐ether into a MeCN solution. Collecting the 
crystalline material by filtration provided [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 in an overall 
yield of 51%. Note that to obtain crystals suitable for X‐ray analysis this crystallisation 
process had to be repeated. Employing a Sephadex‐C25 plug allowed the removal of 
both DMSO and AgCl with elution by NaCl solution ensuring the complex remained 
ligated by chloride.  
 
Complex [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 was obtained in a highly pure form and its 
identity confirmed by X‐ray crystallography, mass‐spectrometry and NMR analysis. As 




characterisation tool due to supressed transmittance of signals informative of the core 
structure. Remarkably, the mass‐spectrum contained a dominant peak belonging to the 
cyanide adduct [Ru(phen)2(Pd{5.10 - H}{CN})]2+ in which the chloride ligand has been 
substituted. This arises at 486.5405 (m/z calculated, [Ru(phen)2(Pd{5.10 - H}{CN})]2+ = 
486.5396). Often this signal is accompanied by relatively minor, M2+ peaks. One at 
474.0390 is likely related to a fragment without the chloride ligand, [Ru(phen)2(Pd{5.10 
- H})]3+, however, this yields a disparate mass to charge ratio. A hydride adduct of this, 
[Ru(phen)2(Pd{5.10 - H}{H})]2+ has the correct calculated m/z of 474.0420, although, this 
presents another unusual fragment. The other at 495.5338 is similar to that of the 
hydrated cyanide adduct [Ru(phen)2(Pd{5.10}{CN}{OH2})]2+ which has a calculated m/z 
of 495.5449. 
 
Rationalising the features of the NMR spectra was tremendously benefited by X‐ray 
crystallography. Therefore, the crystallographic attributes of [Ru(phen)2(Pd{5.10 - 
H}Cl)][PF6]2, particularly regarding its conformational arrangement, will be discussed 
foremost. 
 
As mentioned above, crystals suitable for X‐ray diffraction were grown by slow vapour 
diffusion of diisopropyl‐ether into a MeCN solution of [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2. 
This crystallised in the triclinic space group P   with two molecules of [Ru(phen)2(Pd{5.10 
- H}Cl)]2+ (designated by the suffixes A and B) and four PF6 anions in the asymmetric unit 
(Figure 5.17). The structure contains moderate solvent accessible void space occupied 
by numerous, highly disordered MeCN molecules causing a poor overall refinement (Rf 










The Ru(phen)3 complex component is observed as a distorted octahedron represented 
by the bond angles N1 – Ru – N10, N1’ – Ru – N10’ and N1” – Ru – N10” (A / B) of 79.4(3)o 
/ 80.2(3)o, 79.5(4)o / 80.5(4)o and 79.6(4)o / 79.9(4)o. Ru – N bond lengths falling within 
the range 2.060(9) Å (Ru1B – N1B) and 2.106(8) Å (Ru1B – N10B). The incorporation of 
a Pd(II) centre is unambiguously verified, adopting a characteristic square planar 
geometry. Distortion of this geometry occurs due to the NHC – Py chelate ring having a 
less than 90o bite angle of 78.8(5)o / 79.2(5)o along with the NHC – amidate chelate (C19 
– Pd1 – N15 = 87.2(5)o / 87.1(5)o). Interestingly, the NHC – amidate chelate ring exhibits 
a planar conformation, in stark contrast to the puckered ring‐structures of previously 
discussed NHC – amidate complexes including [Ru(phen)2(Pd{5.9 - H}{allyl})]2+, Pd(2.4 - 
H)(O,O’-acac) and Pd(3.3 - H)(O,O’-acac). This is quantified by θCH2 which describes the 
angle between the line intersecting Pd1 and the methylene carbon C17, and the plane 
Figure 5.17: Contents of the asymmetric unit of [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 with 
hydrogen atoms, PF6 anions and MeCN solvate molecules omitted for clarity. Thermal 




Figure 5.18 (a): An alternative view of the asymmetric unit clarifying the face-stacked 
arrangement of the Pd(II) complex units and, (b) the related spacefill model highlighting 
the steric constraints within the complex. 
defined by N15, C19 and Pd. Here, θCH2 is 1.5(2)o / 1.8(2)o but for [Ru(phen)2(Pd{5.9 - 
H}{allyl})]2+ it is 11.1(2)o and Pd(2.4 - H)(O,O’-acac) it is 28.4(2)o. For [Ru(phen)2(Pd{5.10 
- H}Cl)]2+, ligand 5.10 - H coordinates in a 5,6‐tridenate motif in which the planarity of 
the 5‐membered NHC – Py chelate is imposed on the more flexible 6‐membered chelate 
in order to retain the correct coordination geometry.  Bond distances to the Pd(II) centre 
are as follows; Pd1 – C19 = 1.901(12) Å / 1.909(12) Å, Pd1 – N15 = 2.026(10) Å / 2.007(11) 
Å, Pd1 – N28 = 2.089(11) Å / 2.057(10) Å and Pd1 – Cl1 = 2.385(3) Å / 2.393(3) Å. As is 
commonly observed, the Pd – NHC bond is shortest and causes a lengthening in the 
opposite bond due to its trans influence. The planar Pd(NHC)Cl fragment is oriented 
perpendicular to the phenanthroline ligand to which it is appended producing a twist 
angle between the phenanthroline ligand plane and that of the 6‐membered chelate 
ring of 90.9(3)o / 80.4(4)o. This directs the chloride ligand towards the front edge of one 
of the phenanthroline ancillaries resulting in a Cl1 ··· C2’ distance of 4.194(14) Å / 
4.153(13) Å. In this conformation, the two [Ru(phen)2(Pd{5.10 - H}Cl)]2+ molecules  
within the asymmetric unit can align such that the faces of the Pd(NHC)Cl moieties are 
coplanar whilst the N10 pyridyl rings of the phenanthroline are stacked at a centroid‐to‐
plane distance of 3.380(14) Å / 3.855(12) Å, shifted by 2.602(17) Å / 1.855 Å (Figure 
5.18).  
 
















The NHC‐pyridyl ring overlaps with the opposing NHC ring at an inter‐planar distance of 
3.428(15) Å / 3.518(15) Å with related plane‐to‐plane shifts of 2.16(2) Å / 2.01(3) Å. A 
distance of 4.0128 Å is noted between Pd(II) centres. The H21 hydrogen atoms of 
adjacently stacked NHC rings participate in separate CH ··· F interactions with two 
fluorine atoms of a single PF6 anion at a C ··· F of 3.026(15) Å and 3.089(16) Å. 
 
The relative conformation of the planar phenanthroline and Pd(NHC)Cl units is 
atropisomeric, possessing either an M or P stereochemical axis along the C5 – N15 bond. 
Coupling this with the Δ or Λ stereochemistry of the octahedral Ru(II) produces Δ,M and 
Λ,M enantiomers which are diastereomers of the Δ,P and Λ,P configurations and 
responsible for the two species observed by NMR, as will be discussed shortly. The Δ,M 
and Λ,M enantiomers have been crystallised here. A steric evaluation of the crystal 
structure strongly suggests that the stereochemical axis cannot freely interconvert when 
in solution. Viewing the complex as a spacefill model helps to illustrate this point (Figure 
5.18b). Converting between the M and P configurations of [Ru(phen)2(Pd{5.10 - H}Cl)]2+ 
relies on rotation around the C5 – N15 bond which appears to be prevented by the 
chloride ligand and to a lesser extent, on the opposite side by the amide oxygen. Having 
only crystallised one diastereomer it is difficult to determine which of the two might be 
favoured on a steric basis. 
 
NMR analysis reveals that the compound exists as a mixture of two diastereomers in a 
2 : 1 ratio. The same ratio of products is always observed, whether it is a crude reaction 
mixture or crystalline sample. Generally speaking, this diastereoisomerism is the 
product of two stereogenic components; the (Δ/Λ) – Ru(phen)3 group and an axial‐
enantiomer designated M or P arising from the fixed configuration of the Pd(NHC‐Py)Cl 
fragment relative to the phenanthroline. This stereochemical‐axis was referenced in the 
discussion of the compounds crystal structure as occurring along the C5 – N15 bond. 
Figure 5.19 illustrates both diastereomeric conformations in relation to the Λ 





























The following discussion will focus on the structural confirmation of [Ru(phen)2(Pd{5.10 
- H}Cl)][PF6]2 and justifying the aforementioned mode of stereoisomerism with 
supplementary analysis performed in section 5.6.1. Aromatic regions of the 1H‐NMR and 
13C‐NMR spectra of [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 are shown in Figure 5.20. Where 
relevant, the major and minor isomers are denoted by the suffix j or n, respectively. 
Interestingly the acetamide methylene proton (H17) resonances at 5.12 ppm are 
observed as a singlet with the two diastereomers being barely distinguishable. This is 
despite the two protons being confined to separate, diastereotopic chemical 
environments by N‐amidate/NHC chelation. It is presumed that these environments are 
chemically identical due to the planarity of the chelate and directed away from the bulk 
Λ                      M 
Λ                       P 
Figure 5.19: Depiction of Λ,M and Λ,P diastereoisomers of [Ru(phen)2(Pd{5.10 - H}Cl)]2+ 
that arise due to restricted rotation around the C – N bond as shown. Projections of these 
along the vertical axis highlight the relative orientations of the Pd(NHC)Cl moiety 

















of the complex. This also explains why little distinction between diastereomers is 
observed for this environment including for the corresponding carbon resonance at 
























































Figure 5.20: The 1H-NMR and 13C-NMR spectra of [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]3 with 




Unlike many of the proton environments, carbon nuclei were not greatly affected by the 
differences in diastereomer conformation. This allowed detection of connectively 
identical but chemically distinct proton environments by HSQC, HSQC‐TOCSY and HMBC 
correlation to the comparatively localised diastereomeric carbon resonances. HMBC 
correlation with the methylene H17 was used to identify the amide carbonyl carbon 
environment at the predictably downfield position of 167.92 ppm / 167.80 ppm (C16‐n 
/ C16‐j) and the carbenic carbon environment at 157.79 ppm / 157.44 ppm (C19‐n / C19‐
j). Correlation to C19 signals enable detection of the other imidazolyl‐proton 
environments at 7.93 ppm / 7.91 ppm (H21‐j /H21‐n) and ~ 7.40 ppm (H22). These 
imidazolyl‐environments appear as doublets (JH‐H = 2.0 Hz) which is rarely observed. The 
typically downfield H27 environment of the pyridyl pendant group displays a significant 
difference between the diastereomers producing doublets at 8.93 ppm (H27‐j) and ~ 
8.81 ppm (H27‐n) (Δδ ~ 0.12 ppm). COSY‐NMR enabled assignment of the other proton 
in this ring system at ~ 7.48 ppm / ~ 7.42 ppm (H26‐n / H26‐j, Δδ ~ 0.06 ppm), ~ 8.24 
ppm / ~ 8.20 ppm (H25‐j / H25‐n, Δδ ~ 0.04 ppm), and ~ 7.80 ppm / ~ 7.76 ppm (H24‐j 
/ H24‐n, Δδ ~ 0.04 ppm). A significant difference between the major and minor H27 
environments, followed by H26 is a result of their proximity to the stereochemical zone. 
Similarly, the H4 major and minor environments are distinct at ~ 8.83 and 8.76 ppm (Δδ 
~ 0.07 ppm). The H2’ environments of the phenanthroline ancillary ligand facing into the 
Pd(II) complex fragment are found at 8.45 ppm (H2’‐j) and 8.31 (H2’‐n), notably 
downfield of the other related phenanthroline environments H2, H4, H2’ and H2’’ which 
resonate between 8.06 – 7.82 ppm. This results from the interaction between this 
proton and the chloride ligand of the Pd(II) which, as mentioned regarding the crystal 
structure, are spatially adjacent. In the Λ,M and Δ,P enantiomers the H2’ proton is 
directed towards the chloride ligand which is expected to enable greater deshielding 
than in the Λ,P and Δ,M enantiomers where H2’ is pointed orthogonally. It is tentatively 
deduced from this that the major diasteriomers are Λ,M and Δ,P‐[Ru(phen)2(Pd{5.10 - 
H}Cl)][PF6]2.  
 
Carbon environments adjoining most of the hydrogen nuclei discussed above are 
labelled on the 13C‐NMR spectrum in Figure 5.20. Besides the carbenic carbon 




diastereomers. Resonances due to C5, C6 and H6 would have been informative to this 
discussion however, due to the complexity of the spectra, they could not be confidently 
assigned without a scrupulous and time‐consuming analysis. 
 
The occurance of diatereoisomers that are distinguishable by NMR demonstrates that 
the stereochemistry of the Ru(phen)3 unit does influence the stereochemical 
environment of the NHC – complex, at least when chelated via the amidate. Not only 
that, they show selectivity for one diastereomer over the other, boding well for their 
eventual application as stereodirecting metalloligands in asymmetric catalysis. This 
isomerism will be discussed further in section 5.6.1 through comparison with complexes 
[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]3 and [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]3. 
 
5.4. Synthesis of 2,2’-bipyridine derived metallo-NHC proligands  
 
It was identified in section 5.3.2.1 that the metallo‐NHC complex [Ru(1,10‐
phenanthroline)2(Pd[5.10 - H]Cl)][PF6]2 exists as a 2:1 mixture of atropisomeric 
diastereomers. These isomers arise due to restricted rotation around the 
phenanthroline – N(amide) bond and are differentiated by the extent of the steric 
interaction between the 1,10‐phenanthroline ancillary ligands and the chloride ligand of 
the NHC – Pd(II) fragment. It was envisaged that moving the NHC – Pd(II) fragment to 
the 4‐position of 1,10‐phenanthroline would maximise the interaction with the Ru(II)‐
polypyridine ligand sphere, increasing selectivity for one diastereomeric product (Figure 





























Because the required amine precursor, 4‐amino‐1,10‐phenanthroline, cannot be 
sourced easily, it was necessary to proceed via 4‐amino‐2,2’‐bipyridine which can be 
prepared from 2,2‐bipyridine. This necessitated the switch to a 2,2‐bipyridyl‐acetamide 
basis to target the complex [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 (Figure 5.22). Ligands 










5-acetamide derived diastereomers 
4-acetamide derived diastereomers 
increased steric  
interactions 
Figure 5.21: Projections of [Ru(phen)2(Pd{5.10 - H}Cl)]2+ type diastereomers highlighting 
a difference in the relative proximity of groups between the 5-functionalised and 4-
functionalised derivatives. 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 




Both 5‐acetamido‐phenanthroline and 4‐acetamido‐bipyridine systems can stabilise the 
amidate anion through conjugation onto the pyridine nitrogen, however, their electron 
distribution is markedly different. This is illustrated through a comparison of resonance 
structures of their respective core amines in which the amino lone‐pair is delocalised 
onto the pyridine‐nitrogen (Figure 5.23). As shown, 5‐amino‐1,10‐phenanthroline 
exhibits a large charge separation, sacrificing aromaticity in all three rings whereas 
charge separation is small for 4‐amino‐2,2’‐bipyridine derivatives and aromaticity is 
maintained in one ring. The amino hydrogen of 4‐amino‐pyridine derivatives are well 
known to be more acidic than 3‐amino‐pyridines and anilines.221, 244, 246 On the basis of 
mesomeric electron withdrawal, 4‐amino‐2,2’‐bipyrdine is also expected to have a more 
acidic, less nucleophilic amine than 5‐amino‐1,10‐phenanthroline. This concept 







5.4.1. Acetamide tethered 2,2’-bipyridine NHC precursors and their 
ruthenium-polypyridine complexes. 
 
Synthesis of 4‐amino‐2,2’bipyridine from 2,2’‐bipyridine was achieved in three steps 
(Scheme 5.11), the first of which being the formation of 2,2’‐bipyridine‐N‐oxide. A 
variety of literature preparations for this exist, the most efficient of which employ 
hydrogen peroxide in either acetic acid,257 or tri‐fluoroacetic  acid,258 which form a 
potentially explosive per‐acid intermediate. Milder approaches employ excess 
MCPBA,259 which is expensive on the large scale required here. Hence, a safe and 
5-amino-phenanthroline 4-amino-bipyridine 
Figure 5.23: Resonance form of 5-amino-1,10-phenanthroline and 4-amino-2,2’-




affordable synthesis was designed using potassium monopersulfate (oxone) as the 










After 48 hours a crude material containing 2,2’‐bipyridine and 2,2’‐bipyridine‐N‐oxide is 
recovered by extraction of the aqueous reaction mixture with chloroform after the 
removal of MeOH. This is then evaporated and the resulting light brown oil run through 
a short alumina plug with Et2O which recovers the 2,2’‐bipyridine then 2,2’‐bipyridine‐
N‐oxide is eluted with 10% MeOH / DCM. Pure N‐oxide is consistently isolated in 40‐50% 
yields and, although this is low compared with other techniques, the unreacted 2,2’‐
bipyridine can be recycled. Spectra of 2,2’‐bipyridine‐N‐oxide isolated by this method 
are consistent with those reported.258  
 
The nitration of 2,2’‐bipyridine‐N‐oxide to give 4‐nitro‐2,2’‐bipyridine‐N-oxide was 
initially performed following a  literature procedure259 using concentrated H2SO4 and 
KNO3, however, 4‐nitro‐2,2’‐bipyridine and 4‐nitro‐2,2’‐bipyridine‐N-oxide were 
isolated together in low, inconsistent yields. Yields upwards of 40% were obtained via 
an alternative preparation using concentrated H2SO4 and fuming HNO3.257 The 
subsequent reduction of 4‐nitro‐2,2’‐bipyridine‐N-oxide to give 4‐amino‐2,2’‐bipyridine 
was performed efficiently by a previously reported method.260  
 
Chloroacetylation of 4‐amino‐2,2’‐bipyridine to produce 2‐chloro‐N‐(4‐amino‐2,2’‐
bipyridine)‐acetamide (5.11) has not been reported. This was performed similarly to the 
 
Scheme 5.11: Synthesis of 4-amino-2,2’bipyridine from 2,2’-bipyridine in three steps. The 




synthesis of 5.4, however, anhydrous DCM was used in place of THF due to its availability 
at the time (Scheme 5.12). Surprisingly, 5.11 was only recovered in a 26% yield despite 
previous acetamide syntheses in this study proceeding smoothly. Upon addition of the 
chloroacetyl‐chloride to the cooled reaction mixture the solution immediately turned 











At the conclusion of the reaction the dark solid was removed by filtration and the DCM 
filtrate washed with water before drying over MgSO4 and removing the solvent by rotary 
evaporation. This material was also almost black but was identified as crude 5.11 by 1H‐
NMR. Pure 5.11 was obtained as a terracotta powder following flash chromatography 
(alumina, 1% MeOH/DCM). The dark brown/black precipitate was only sparingly soluble 
in DMSO and produced messy, uninformative NMR and mass‐spectra. Having obtained 
a sufficient quantity of material no effort was made to improve this preparation. 
 
The adverse reactivity of 4‐amino‐2,2’‐bipyridine to chloroacetylation is likely the result 
of the decreased nucleophilicity of the amine when compared with 5‐amino‐1,10‐
phenanthroline, as noted above. Likewise, the comparatively labile amide‐proton makes 
it susceptible to further substitution under the basic reaction conditions. The product 
5.11 may undergo additional acetylation of the amide‐nitrogen or even substitution of 
the chloride to form polymeric species. However, chloroacetylation of the related 4‐
amino‐pyridine has been reported under similar conditions (58% yield)261 but it has been 
shown that using bromoacetyl‐bromide instead proceeds more cleanly, producing 2‐
Bromo‐N‐pyridin‐4‐yl‐acetamide in a 76% yield.262   
5.11, 26% 





5.4.1.1. Synthesis of a 4-BipA imidazolium salt 
 
Only the pyridyl‐imidazolium salt 5.12.HCl of the 2,2‐bipyridine‐acetamide was 
prepared for the express purpose of comparison with the complex [Ru(1,10‐
phenanthroline)2(Pd{5.10 - H}Cl)][PF6]2. It was synthesised in the same manner as 
5.10.HPF6 by refluxing 5.11 with a two‐fold excess of 1‐(2‐pyridyl)‐imidazole in MeCN 
under an inert atmosphere. Consumption of the precursor acetamide 5.11 was 
monitored by TLC (alumina, 1% MeOH/DCM) and after 48 hours the reaction was cooled 
to room temperature. Work‐up was simplified by pouring the reaction mixture onto Et2O 
and stirring, then collecting the resultant white precipitate and washing with addition of 
Et2O. This provided pure 5.12.HCl in a 78% yield without the intervening conversion to 













Compound 5.12.HCl was identifiable as three signals in the mass‐spectrum with the 
most intense at 357.1458 corresponding to the [5.12.H]+ cation (m/z calculated, 
[5.12.H]+ = 357.1458). Lesser signals at 713.2863 and 749.2627 belong to dimeric 
clusters [5.12 + 5.12.H]+ and [5.12.H + 5.12.HCl]+ respectively (m/z calculated, [5.12 + 
5.12.H]+ = 713.2838 and [5.12.H + 5.12.HCl]+ = 749.2611). Isolating and analysing the 
chloride salt benefitted collection of a clear IR spectrum as it did not suffer from dilution 
of [5.12.H]+ signals due to a large PF6 anion. This revealed a prominent amide C = O 
stretching mode at 1709.63 cm‐1 which lies beyond the routinely reported range of 1680 
5.11 5.12.HCl, 78% 





– 1630 cm‐1.263 For the PA‐imidazolium salts the carbonyl stretching frequency was 
comparatively stunted and broad, even for the chloride salts and cover a range of 1688 
– 1711 cm‐1 which encompasses the above value. This may be due to the competition of 
the imino‐resonance form (Figure 5.23), meaning the carbonyl has greater π‐character 
than in an unconjugated amide. IR analysis of a related N‐pyridin‐4‐yl‐acetamido 
imidazolium salt system reported C = O stretching frequencies of 1794 cm‐1 (methyl 
pendant) and 1795cm‐1 (isopropyl pendant).158 This supports that the C = O stretching 
frequency probably increases as a result of imino‐conjugation, although, no discussion 
was provided in the text.158 Surprisingly the carbonyl‐stretch is less intense than five 
sharp stretches within 1594 – 1535cm‐1 corresponding the aromatic C – C and C – N 
stretching.263  
 
NMR spectra of 5.12.HCl were fully assigned with expected downfield signals in the 1H‐
NMR belonging to the amide NH and imidazolyl NCHN signals 11.98 ppm and 10.27 ppm 
respectively. The acetamide group is represented in the 1H‐NMR and 13C‐NMR spectra 
by the methylene environment at 5.56 ppm and 52.13 ppm respectively as well as the 
carbonyl‐carbon C14 signal at 164.90 ppm. Functionalisation of the 4‐position of 2,2‐
bipyridine is confirmed by assignment of the C4 resonance at 146.21 ppm by HMBC 
correlation with H6 and H13 (amide NH). A singlet resonance at 8.76 ppm exhibits a one‐
bond HSQC correlation to 109.99 ppm which is confirmed to belong to H3 by HMBC 
correlation to the H5 and H6 environments. All remaining pyridyl‐environments were 
assigned similarly by correlation NMR. 
 
5.4.1.2. Synthesis of [Ru(phen)2(5.11)][PF6]3 
 
The metallo‐NHC proligand [Ru(phen)2(5.12.H)][PF6]3 was synthesised from acetamide 
tethered 2,2’‐bipyridine imidazolium salt ligand 5.12.HCl by the same method used for 



























Complex [Ru(phen)2(5.12.H)][PF6]3 was characterised spectroscopically, producing NMR 
spectra with the expected attributes (1H‐NMR spectrum, Figure 5.24). Proton 
resonances due to the imidazolium ring are found at 10.07 ppm (H17), 8.58 ppm (H19) 
and ~ 7.96 ppm. Figure 5.24 compares the 1H‐NMR spectra of [Ru(phen)2(5.12.H)][PF6]3 
with its pyridyl‐pendant, 5‐acetamido phenanthroline analogue 
[Ru(phen)2(5.10.H)][PF6]3. For [Ru(phen)2(5.12.H)][PF6]3, the amide NH resonance is 
found at 11.54 ppm (H13), markedly downfield of the equivalent resonance in 
[Ru(phen)2(5.10.H)][PF6]3 which arises at 11.06 ppm (Δδ = 0.48 ppm). The 4‐substituted 
2,2’‐bipyridine core facilitates greater electron donation from the amide NH onto the 
Ru(II) centre as has been explained. Differences in the NH chemical shift of 
5.12.HCl 
[Ru(phen)2(5.12.H)][PF6]3, 61% 














Figure 5.24 (a): The 1H-NMR spectrum of [Ru(phen)2(5.12.H)][PF6]3 and, (b) of the 
related complex [Ru(phen)2(5.10.H)][PF6]3. Selected signals have been highlighted. 
[Ru(phen)2(5.12.H)][PF6]3 compared with [Ru(phen)2(5.10.H)][PF6]3 arise as a result of 
this. The difference observed between the carbonyl carbon environments of these two 


























As expected, proton environments adjacent to the pyridyl‐nitrogen H6 and H12 exhibit 
dramatic upfield coordination induced shifts of 1.00 ppm and 0.97 ppm. This is 
respective to the uncoordinated ligand 5.12.HCl for which these signals arise at 7.58 


























slightly upfield relative to the free ligand with H3 repositioned from 8.76 ppm to 8.90 
ppm (Δδ = 0.14 ppm) and H9 from 8.37 ppm to 8.52 ppm (Δδ = 0.15 ppm). This reflects 
the affixing of the 2,2‐bipyridine ligand such that these environments are now 
anisotropically deshielded by the neighbouring ring. Proton and carbon environments 
attributable to the 1,10‐phenanthroline ancillary ligands and the pyridyl‐pendant are 
accounted for. 
 
Confirmation was provided by mass spectrometry in which complex 
[Ru(phen)2(5.12.H)][PF6]3 is identifiable by two signals at 273.0608 and 409.0897. These 
are attributable to [Ru(phen)2(5.12.H)]3+ and the free carbene adduct 
[Ru(phen)2(5.12)]2+ which have calculated m/z values of 273.0626 and 409.0900 
respectively.  
 
5.5. Synthesis of [Ru(1,10-phenanthroline)2(4-BipA)]3+ derived NHC 
complexes 
5.5.1. [Ru(1,10-phenanthroline)2(Pd{5.12 - H}Cl)][PF6]2 
 
Synthesis of complex [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 was attempted using the metallo‐
NHC proligand [Ru(phen)2(5.12.H)]Cl3 by the procedure used for the preparation of 
[Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 (Scheme 5.15). In this case however, a mixture of the 
“chelate” complex [Ru(phen)2(Pd{5.12 - H}Cl)]2+ and “pendant” complex 
[Ru(phen)2(Pd{5.12}{L}Cl)]n+  was obtained. 
 
Isolation was performed by dissolving the DMSO reaction mixture in water and filtering 
the deep red, turbid solution through celite. This was then loaded onto a short plug of 
Sephadex C25 cation exchange resin and eluted with a gradient of 0 – 0.1 mol/L NaCl 
solution. Three fractions were collected; the first was a mixture of both chelate and 
pendant complexes, the second was pure pendant and the final fraction was again a 
mixture of the two complexes. Complexes were isolated as PF6 salts. Given the high 




L of [Ru(phen)2(Pd{5.12}{L}Cl)]n+, is chloride. The isolated form would therefore be 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 (as was true for Pd(2.5)Cl2), although, this was not 
confirmed by elemental analysis. Assuming this is the case, complex 









Characterisation of the pendant complex [Ru(phen)2(Pd{5.12}Cl2)][PF6]2 was performed 
by 1H‐NMR, 13C‐NMR, mass‐spectrometry and X‐ray crystallography along with IR and 
UV‐vis spectroscopy. Interestingly, while the NMR clearly indicated pendant type 
coordination, the crystal structure obtained was that of the chelated species 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2. The mass‐spectrum also indicated chelation with a 
dominant signal at 474.5393 corresponding to the cyanide ligated adduct of the N‐
[Ru(phen)2(Pd{5.12 - H}Cl)]2+ 
[Ru(phen)2(Pd{5.12}{L}Cl)]2+ 
Scheme 5.15: Synthesis of [Ru(phen)2(Pd{5.12 - H}Cl]2+ and [Ru(phen)2(Pd{5.12}{L}Cl]2+




amidate/NHC chelated form [M – HCl + CN]2+ (calculated m/z, 474.5399). This motif is 
reminiscent of that observed for the 5‐phenanthroline chelated complex 
[Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2. 
 
Crystallisation of [Ru(phen)2(Pd{5.12}Cl2)][PF6]2 was attempted by slow vapour 
diffusion, however, the crystal selected for analysis was found to be  [Ru(phen)2(Pd{5.12 
- H}Cl)][PF6]2. An 1H‐NMR analysis on the same crop of crystals showed it to be a mixture 
of both pendant and chelate forms of the complex. It appears likely that crystallisation 
of the chelated form is thermodynamically favoured with chelation reversible in 
solution. This is explored further in section 5.6.1.  
 
Crystals of complex [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]3 suitable for X‐ray diffraction 
analysis were grown by slow vapour diffusion of Et2O into a MeCN solution of 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2. It crystallised in the monoclinic space group I2/a with 
one molecule of [Ru(phen)2(Pd{5.12 – H}Cl)]2+ and two PF6 anions in the asymmetric unit 





Figure 5.25: Asymmetric unit of [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2. Hydrogen atoms, PF6




Three MeCN molecules were modelled adequately, however, a portion of the residual 
electron density was dealt with using OLEX2 solvent mask function. For the unit cell, a 
total of 1608.4 Å3 (13.5%) of solvent accessible volume containing 419 electrons was 
masked, equating to 2.2 MeCN molecules per asymmetric unit. It may also be assigned, 
in part, to water or an Et2O molecule. 
 
Complex [Ru(phen)2(Pd{5.12 - H}Cl)]2+ shares many structural attributes with the 5‐
acetamido phenanthroline based [Ru(phen)2(Pd{5.10 - H}Cl)]2+ complex. The Ru(ppy)3 
component is in the expected octahedral geometry with the Λ‐enantiomer shown in 
Figure 5.25. An intrachelate bond angle, N1 – Ru – N7 of 78.5(3)o is observed for the 2,2‐
bipyridine of 5.12 - H and N1’ – Ru – N10’, and N1” – Ru – N10” angles of 80.0(3)o and 
80.7(4)o for the two phenanthroline ligands. Ru – N bond lengths are as follows; Ru1 – 
N1 = 2.064(6) Å, Ru1 – N7 = 2.048(8) Å, Ru1 – N1’ = 2.061(7) Å, Ru1 – N10’ = 2.076(6) Å, 
Ru1 – N1” = 2.068(7) Å and Ru1 – N10” = 2.086(9) Å. Ligand 5.12 - H coordinates to the 
Pd(II) in a tridentate motif of the type N-amidate – NHC – Py enforcing a distorted square 
planar geometry with a chloride ligand occupying the fourth site. Distortion occurs due 
to the narrow NHC – Py bite angle C17 – Pd1 – N26, of 78.9(3)o whereas the 6‐ 
membered N‐amidate/NHC chelate is more conducive to 90o coordination with a C17 – 
Pd1 – N13 angle of 88.2(3)o. Bond angles relative to the chloride are C26 – Pd1 – Cl1 = 
93.8(2)o and N13 – Pd1 – Cl1 = 99.0(2)o. Metal to ligand distances for the Pd(II) centre 
are Pd1 – C17 = 1.897(7) Å, Pd1 – N13 = 2.035(6) Å, Pd1 – N26 = 2.059(6) Å and Pd1 – 
Cl1 = 2.375(2) Å. Relative bond lengths are as expected given coordinating ability of each 
ligand. Again it is noted that the NHC – amidate chelate ring is planar as a result of 5,6‐
tridentate chelation resulting in a θCH2 of 1.79(9)o. The NHC – amidate coordination 
plane is oriented at 97.6(2)o relative to the N1 pyridyl ring of the bipyridine. As with 
[Ru(phen)2(Pd{5.10 - H}Cl)]2+ this is an atropisomeric relationship defined by the 
stereochemical axis along the C4 – N13 bond and is designated, in this case, as the P 
enantiomer. Thus, the complex depicted is the Λ,P‐diastereomer.  
 
In the extended structure, the planar Pd(II) complex components of neighbouring 
[Ru(phen)2(Pd{5.12 - H}Cl)]2+ are overlaid in a similar packing motif to 




orientation appears to maximise stabilising intermolecular hydrogen bonding contacts 






Opposing Pd(NHC)Cl fragments, as defined by the Pd(II) coordination plane, have a 
plane‐to‐plane centroid distance of 3.508(9) Å at a relative twist angle of 20.0(6)o. The 
internuclear distance between Pd(II) centres, Pd1 – Pd1 is 3.966(2)  Å. A strong CH ··· O 
type interaction is noted between H9 of 2,2‐bipyridine and the amide‐carbonyl of 
neighbouring complexes such that C9 ··· O1 = 3.193(11) Å. There is also an apparent 
supporting interaction between the chloride ligand and methylene hydrogen, C14 ··· Cl1 
= 3.638(10) Å. Beyond this dimeric‐structure the most significant interaction is a face‐
to‐face π – π stack between the pendant pyridyl and N10’‐pyridyl ring of an adjacent 
Figure 5.26: Dimeric packing arrangement of [Ru(phen)2(Pd{5.12 - H}Cl)]2+ with 




phenanthroline at a plane‐to‐plane centroid distance of 3.443(8) Å / 3.339(8) Å with a 
shift of 1.50(2) Å / 1.723(2) Å. Interactions with the PF6 anion occur in the form of CH ··· 
F contacts, the shortest of which with an appropriate geometry being C8” ··· F = 
3.276(17) Å and C20 ··· F = 3.321(11) Å. 
 
Unlike ligand 5.10 - H, the functionalised pyridyl‐ring of 5.12 - H has no ortho‐
substituents relative to the acetamide group making free rotation around the C4 – N13 
bond more likely when in solution. However, the crystallised diastereomer of 
[Ru(phen)2(Pd{5.12 - H}Cl)]2+ has the chloride ligand of the Pd(NHC)Cl fragment situated 
much closer to the front edge of the phenanthroline auxiliary resulting in a Cl1 ··· C2’ 
distance of 3.581(9) Å. This is significantly shorter than the 4.194(14) Å / 4.153(13) Å 
seen for [Ru(phen)2(Pd{5.10 - H}Cl)]2+ confirming that moving the Pd(NHC)Cl moiety to 
the 4‐position has maximised its interaction with the stereochemical Ru(ppy)3 
component as desired. Figure 5.27 compares the spacefilled models of 











[Ru(phen)2(Pd{5.12 - H}Cl)]2+ [Ru(phen)2(Pd{5.10 - H}Cl)]2+ 
Figure 5.27: Perspective view highlighting the potential for increased steric interactions 
between the Pd(NHC)Cl and Ru(ppy)3 components of [Ru(phen)2(Pd{5.12 - H}Cl)]2+ when 





Pendant type coordination in the chromatographically isolated sample of 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 was confirmed by NMR analysis. Furthermore, it was 
found that simply adding solid K2CO3 to the NMR sample of 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 in CD3CN achieved conversion to the chelated form 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 after 24 hours. The 1H‐NMR spectra of the two 
compounds are shown in Figure 5.28, note that the spectrum of 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 contains a small amount of chelate impurity.  
 
Upon going from [Ru(phen)2(Pd{5.12}Cl2)][PF6]2 to [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 a 
disappearance of the diagnostic amide NH (H13) proton resonance at 9.82 ppm is 
observed as expected. Further evidence of N‐amidate/NHC chelation is seen in the 
upfield shift of the methylene H15 signal from 5.74 ppm to 4.99 ppm due to shielding 
by the adjacent anionic moiety. The H3 environment responds similarly, shifting upfield 
from 8.83 ppm to 8.20 ppm as does H5 which shifts from the region between 7.40 – 7.50 
ppm to 6.98 ppm. In the pendant form, both phenanthroline ancillary ligands are 
magnetically equivalent, however, they become non‐equivalent in the chelated form as 
a result of interaction with the Pd(NHC)Cl component. Hence we see H4’ shift from a 
doublet at 8.65 ppm in [Ru(phen)2(Pd{5.12}Cl2)][PF6]2 to two separate doublets in 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 at 8.68 pm and 8.65 ppm.  A similar effect is also seen 
for H2’ and H3’. Importantly, only one of the two possible diastereomers of 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 is observed implying that conversion of 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 to [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 is diastereoselective. 
Furthermore, it must be fixed as one diastereomer because the two phenanthroline 
ligands are distinguished by unique H2’, H3’ and H4’ environments. If rotation around 
the C4 – N14 bond was occurring rapidly on the NMR timescale such that the 

































It appears that the pendant and chelated forms can exist in an equilibrium which is 
dependent on the pH or thermodynamic transformations such as crystallisation. This, in 
part, would explain why chromatographic isolation provided a fraction of pure pendant 















“chelate” [Ru(phen)2(Pd{5.12 - H}Cl)]2+ 
Figure 5.28: Aromatic region of the 1H-NMR spectrum of [Ru(phen)2(Pd{5.12}Cl2)][PF6]2




5.6. Comparative analysis of Ru – NHC – Pd complexes 
 
Conjugate stabilisation of the amidate anion is crucial to the properties of the metallo‐
NHC complexes [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2, [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 
and [Ru(phen)2(Pd[5.12 - H]Cl)][PF6]2. It has been shown that the 5‐acetamido‐
phenanthroline derivatives [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 and [Ru(phen)2(Pd{5.10 
- H}Cl)][PF6]2 form an N‐amidate/NHC chelate through spontaneous deprotonation of 
the amide (section 5.3). However, this process is not as dominant for the 4‐acetamido‐
bipyridine analogue which was isolated in both chelate and pendant forms, 
[Ru(phen)2(Pd[5.12 - H]Cl)][PF6]2 and  [Ru(phen)2(Pd[5.12]Cl2)][PF6]2, respectively. It is 
reasonable to assume that the amide of the 4‐acetamido‐bipyrdine will be more acidic 
than the 5‐acetamido‐phenanthroline amide due better resonance stabilisation of the 
conjugate base amidate as noted previously. With regard to the metallo‐NHC proligands, 
stabilisation of the amidate‐anion is enhanced tremendously by delocalisation onto the 
pyridine‐nitrogen coordinated to ruthenium. Deprotonation also serves to decrease the 
overall charge of the system. Scheme 5.16 depicts this scenario in terms of the Ru(II) 
coordinated acetamide‐ligand to reiterate this point.  
 
For both 5‐acetamido‐phenanthroline and 4‐acetamido‐bipyrdine ligands, the anion 
participates in stabilising donation to the Ru(II) centre, however, the stability penalty in 
terms of loss of aromaticity is much greater for the 5‐amino‐1,10‐phenanthroline 
system. Scheme 5.17 illustrates two possible canonical forms, A and B, of the bimetallic 
4‐acetamido‐bipyrdine complex [Ru(phen)2(Pd[5.12 - H]Cl)][PF6]2. Delocalisation of the 
anion onto the oxygen is not shown. For the reasons stated above, resonance structure 
B contributes more and, as a result, the amidate is less basic and has a weaker 
coordination bond to palladium in the NHC complex. The observed interchangeability 
between the chelate and pendant forms in [Ru(phen)2(Pd[5.12 - H]Cl)][PF6]2 is attributed 
to weakening of the Pd – N bond and is important to the isolation of a single 


















Scheme 5.16: Showing deprotonation of a ruthenium bound 5-phenanthroline-
acetamide derivative and resonance stabilisation of the resultant amidate. 
A B 





5.6.1. Atropisomerism and system dynamics 
 
Two diastereomers of the complex [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 occur due to the 
presence of two enantiomeric components; the metal‐centred Δ/Λ‐Ru(phen)3 and a P/M 
chiral axis along the bond conjoining the planar Pd(NHC)Cl moiety to the phenanthroline 
ligand. On the other hand, the related bipyridine derivative [Ru(phen)2(Pd{5.12 - 
H}Cl)][PF6]2 is isolated as a single diastereomer in its chelated form. Similarly, the allyl 
complex [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 does not exhibit the same 
diastereoisomerism due to the chiral axis, although, it is difficult to say definitively based 
on its NMR spectra. 
 
The two diastereomers of [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2, referred to as (Δ/Λ),M and 
(Δ/Λ),P, form in a 2 : 1 ratio.  Evidently the major diastereomer is favoured on steric 
grounds, however, it is yet to be assigned to (Δ/Λ),M or (Δ/Λ),P forms. For 
Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 it is proposed that either; (a) N‐amidate chelation 
occurs irreversibly locking the compound in one of two diastereomeric configurations 
or, (b) the two configurations are in equilibrium. It seems unlikely, however, that there 
is a pathway for bond rotation, or on‐off N‐amidate chelation, which would enable an 
equilibrium to exist. 
 
In [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 and [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2, there may 
be a pathway leading to the prevalence of one diastereomer. It was noted for 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 that N‐amidate/NHC chelation appears to be reversible 
during synthesis and work‐up. Treating the pendant form, 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2, with base leads to a single diastereomer of 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2. Reversibility of chelation could lead to formation of a 
single diastereomer under thermodynamic control as per the mechanism in Scheme 
5.18.  This is possible due to the weaker N‐amidate coordination detailed in the above 
section. Alternatively, it may simply be that only one diastereomer is sterically 
favourable (or possible) given the shorter distance between the Pd(NHC)Cl group and 









The 5‐phananthroline based ligands in Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2  and allyl 
complex [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 are expected to have the same N‐
amidate/NHC chelation properties. However, in [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 
rotation about the chiral axis may be enabled as a result of allyl‐group syn-anti 
interchange. Effectively, movement of the allyl group could “unlock” the axial‐bond, 
allowing rotation to generate the favoured diastereomer (Scheme 5.19). Looking at the 
crystal structure of [Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 it appears as though the allyl‐
group has less interaction with the phenanthroline ancillary ligands compared with 












































Λ, P Λ, M 
pendant 
Scheme 5.18: Possible route to interconversion between P and M atropisomers of 










It is important to consider possible pathways for diastereomeric interconversion of 
these compounds for their application as asymmetric catalysts. Essentially, substrates 
bound to the palladium centre during the catalytic cycle need to be selectively arranged 
in one diastereomeric configuration for consistent asymmetric induction. In this sense, 
it is promising that the 2,2’‐bipyridine derivative [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 forms 
as a single diastereomer and there is no reason why this would not also be true in a 
catalytic scenario. For compounds with 5‐phenanthroline cores as in [Ru(phen)2(Pd{5.9 
- H}{allyl})][PF6]2 and Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2, diastereoselectivity could be 
improved by a larger ligand at palladium. This would increase steric interactions 
between the two complex‐fragments. In the case of Suzuki coupling, the aryl substrate 
would hopefully constitute a large enough ligand to invoke the desired level of 









































Λ, M Λ, P 
σ-bound allyl 
Scheme 5.19: Possible route to interconversion between M and P atropisomers of 




5.7. Enantiomeric Resolution 
 
Methods for the enantiomeric resolution of chiral, tris‐bidentate octahedral complexes 
are well established, particularly for ruthenium‐polypyridine complexes of the type 
[Ru(ppy)3]n+.15, 45, 264 These approaches are summarised in Scheme 5.20, as applied to 






resolution of racemic product 
‐ column chromatography 
‐ crystallization with chiral anion 
synthesis from resolved precursors 
Δ‐enantiomer Λ‐enantiomer 
Scheme 5.20: Routes employed for the resolution of acetamide-linked metallo-NHC 




In essence, these are all forms of the resolution techniques introduced in Chapter 1, 
section 1.1.2, this includes chiral chromatography, synthesis from resolved precursors 
and classical resolution. Enantiomeric precursors are usually obtained by classical 
resolution and can be enriched through synthesis using a chiral auxiliary ligand.265 The 
latter approach was not explored in this study. The following sections outline 
approaches to resolve the Δ and Λ enantiomers of diisopropyl‐phenyl appended 
complex [Ru(phen)2(5.9.H)]3+. 
 
5.7.1. Resolution of [Ru(phen)2(5.9.H)]3+ 
5.7.1.1. Chromatographic resolution 
 
Chromatographic resolution is advantageous because it can provide both enantiomers 
in a single step. Methods for the resolution of ruthenium‐polypyridine type complexes 
by low pressure ion‐exchange chromatography have been comprehensively established 
by Keene and co‐workers.264, 266‐268 This is performed using a column of Sephadex‐C25 
cation‐exchange resin and eluting with an aqueous solution of a chiral anion such as 
sodium (—)‐O,O’‐di‐benzoyl‐L‐tartrate, sodium (+)‐O,O’‐di‐benzoyl‐D‐tartrate, sodium 
(—)‐O,O’‐di‐p-toluoyl‐L‐tartrate or sodium (+)‐O,O’‐ di‐p-toluoyl‐D‐tartrate. As well as 
the eluent, the dextran‐derived sephadex‐C25 support is also chiral. Separation 
therefore occurs on the basis of a three‐way interaction between complex, chiral eluent 
and the Sephadex support. Efficiency of resolution by this method is difficult to predict 
and large variations are often observed between different eluents (and eluent 
concentrations) for the same complex and between different complexes for the same 
eluent. However, some general trends have been noted, for example, a larger degree of 
aromaticity typically improves resolution ([Ru(phen)3]2+ > [Ru(bipy)3]2+) and the 
presence of hydrophobic groups increases the length of column required for resolution 
by causing a stronger association of the complex with the stationary phase.  
 
In this investigation, low pressure chromatographic resolution was attempted following 
procedures outlined in the above references. SP Sephadex C‐25 cation exchange resin 




ends of the column were sealed with a capillary tube port. Eluent flow was regulated 
with a peristaltic pump and during separations a flow rate of 1.5 mL/min was used, 
although, this could be adjusted as desired. Conjoining the two ends of capillary tubing 
via the peristaltic pump allows eluent to be recycled through the column. If a “longer 
column” is needed, the product can be reticulated through more than one column 
length. Achieving this requires there to be no solvent head‐space between the capillary 
intake and the stationary phase to prevent band mixing. The “effective column length” 
(ECL) is the overall length of column through which the compound passes before 
effective separation is achieved and provides a measure of separation efficiency.  
 
Eluent solutions of sodium O,O’‐di‐benzoyl‐tartrate or sodium O,O’‐di‐p-toluoyl‐tartrate 
where prepared by neutralisation of their respective acids with NaOH. Stock solutions 
of these were prepared and diluted to the desired concentration prior to use.  
 
The instrumental set‐up was trialled for the resolution of Δ/Λ‐[Ru(phen)3]2+ using a 0.075 
mol/L solution of sodium (—)‐O,O’‐di‐benzoyl‐L‐tartrate as specified in the literature.268 
Separation is reportedly observed at an ECL of 60 cm. A Sephadex column was packed 
using distilled water and after settling to a constant height, was rinsed with flowing 
distilled water to ensure even packing. A sample of racemic [Ru(phen)3][PF6]2 was 
converted to the water soluble chloride salt using Amberlite® IRA‐400 (chloride form) 
anion exchange resin. It was then loaded onto a short Sephadex plug and rinsed with 
distilled water before eluting with dilute NaCl solution. This removes impurities before 
attempting chromatographic resolution, helping to minimise the accumulation of 
contaminants through re‐use of the column. The solution of [Ru(phen)3]Cl2 was loaded 
and rinsing with distilled water continued for a further two hours before beginning 
elution with 0.075 mol/L sodium (—)‐O,O’‐di‐benzoyl‐L‐tartrate solution at 1.5 mL/min. 
The increased ionic strength of the anion solution causes compaction of the sephadex 
medium resulting in shortening of the column. It can be necessary to add additional 
sephadex to reduce solvent head‐space for product reticulation. The red product band 
travelled cleanly and separation began to be observed after 50 cm as it approached the 
end of the column. Total separation of Δ‐[Ru(phen)3]2+ and Λ‐[Ru(phen)3]2+ would have 




the material was rinsed off and the column prepped for re‐use by rinsing with saline 
solution followed by distilled water. 
 
Resolution of racemic [Ru(phen)2(5.9.H)]3+ was attempted similarly as above, although, 
this was met with some complications. A sample of [Ru(phen)2(5.9.H)]Cl3 (0.040 g) was 
run through the preliminary sephadex plug, however, this required a higher NaCl 
concentration of 0.3 mol/L for elution. It was necessary to dilute this to 0.001 mol/L NaCl 
(800 mL) to ensure the product did not run on the column during loading. Loading such 
a large volume was slow and minor compacting of the column was noted due to the 
ionic strength of the loading solution. To accelerate the process, the flow rate was 
increased to 2 mL/min, however, this caused drying and cracking of the column near the 
base. Once loaded the column was rinsed with distilled water causing the column to re‐
expand and the product band to broaden as a result. Regardless, elution with 0.075 
mol/L sodium (—)‐O,O’‐di‐benzoyl‐L‐tartrate solution was conducted and the band 
travelled well. Unfortunately, due to the initial broadening of the compound band 
following loading, and cracks in the column media, it seemed unlikely clean separation 
could be achieved. Instead the product was collected for re‐use and the separation 
repeated. 
 
It was decided to skip the initial Sephadex plug and load a distilled water solution of 
[Ru(phen)2(5.9.H)]Cl3 directly, leaving some brown residue at the top of the column. The 
compound was loaded and rinsed expediently, providing a neat band which travelled 
cleanly when eluted with 0.075 mol/L sodium (—)‐O,O’‐di‐benzoyl‐L‐tartrate solution at 
1.5 mL/min. Over time, the bright orange band began to broaden, however, there was 
no indication of band separation. It was necessary to cycle the compound through 
another column length, although, whilst the band grew larger, no separation occurred. 
This process required two working days and, for over‐night periods, the flow rate was 
slowed to 0.5 mL/min. It is likely that a more concentrated sodium (—)‐O,O’‐di‐benzoyl‐
L‐tartrate eluent solution could provide separation over a shorter ECL, reducing the time 
for diffusion and mixing of product bands. This would increase interactions of the 




state than [Ru(phen)3]2+. Changing the chiral anion in addition to manipulating the 
eluent concentration is also possible.  
 
Despite these insights, it had been found concurrently that enantiomers of 
[Ru(phen)2(5.9.H)]3+ could be isolated by synthesis from a resolved precursor and 
fractional crystallisation with a chiral anion. For this reason, chromatographic resolution 
was not pursued further. It was, however, successfully demonstrated that the set‐up 
and methodology used here are operable and warrants further attention.  
 
5.7.1.2. Synthesis from a resolved precursor 
 
It is possible to obtain enantiomers of a ruthenium‐polypyridine complex by synthesis 
using a previously resolved precursor. For [Ru(phen)2(L)]n+ type complexes this can be 
achieved using resolved Δ or Λ [Ru(phen)2(py)2]2+. This approach was executed 
successfully for the synthesis of Δ‐(—)‐[Ru(phen)2(5.9.H)][PF6]3 using Δ‐
[Ru(phen)2(py)2][As‐(—)‐Otart]2 which was obtained via a literature procedure. 269 270 
 
The racemic precursor complex [Ru(phen)2(py)2]Cl2 was prepared by refluxing 
Ru(phen)2Cl2 in aqueous pyridine (pyridine/water, 1:2) for three hours.269  The reaction 
mixture is cooled, filtered, washed with water and dried in vacuo. Crystallisation of the 
crude solid from an MeOH solution by addition of Et2O provides pure [Ru(phen)2(py)2]Cl2 
as a burnt‐orange microcrystalline powder in 97% yield. Complex [Ru(phen)2(py)2]Cl2 is 
resolved into its Δ and Λ optical isomers by precipitation with sodium arsenyl‐L‐(—)‐
tartrate (As‐(—)‐Otart) and sodium arsenyl‐D‐(+)‐tartrate respectively (As‐(+)‐Otart) 
















An aqueous solution of sodium arsenyl‐tartrate (0.80 M, 2.5 equivalents) is warmed to 
60 oC and added to an aqueous solution of racemic [Ru(phen)2(py)2]Cl2, also at 60 oC. 
Crystals of the diastereoisomer form upon cooling slowly to room temperature. The 
mixture is refrigerated at 4 oC for 24 hours before filtering and washing with water and 
acetone. This was only performed for Δ‐[Ru(phen)2(py)2][As‐(—)‐Otart]2 which was 
obtained in a 48.5% yield. Its optical rotation was recorded in a 0.0003 g/mL solution in 
MeCN at 20 oC giving a [α]D of – 174o which agrees with the reported value.271 The 
opposite, Λ‐[Ru(phen)2(py)2]2+ enantiomer can be isolated from the filtrate by further 
manipulations,269 although, this was not performed. Light was excluded from all 
preparations and analysis with Δ‐[Ru(phen)2(py)2][As‐(—)‐Otart]2 to minimise the risk of 
photo‐racemisation. 
 
Synthesis of Δ‐(—)‐[Ru(phen)2(5.9.H)][PF6]3 from Δ‐[Ru(phen)2(py)2][As‐(—)‐Otart]2 was 
undertaken by adapting a literature procedure.256 Ligand 5.9.HCl and Δ‐
[Ru(phen)2(py)2][As‐(—)‐Otart]2 were combined under an inert atmosphere and 
dissolved in an ethylene‐glycol/water (9:1) mixture. This was heated at 110 oC and, after 
6 hours the reaction was stopped and the reaction mixture run through a column of 
Sephadex C‐25 cation‐exchange resin eluting with a 0 – 0.4 mol/L NaCl solution gradient. 
The desired product was collected and isolated as the PF6 salt in a 20% yield. A 
moderated proportion of the 5‐amino‐1,10‐phenanthroline complex [Ru(phen)2(5‐
amino‐phen)][PF6]2 was also isolated (19% yield) indicating that the amide bond is 
 
classical resolution 





cleaved under these conditions. A similar outcome was noted previously for the 
attempted synthesis of [Ru(phen)2(5.5.H)][PF6]3  in ethylene‐glycol with microwave 
irradiation. Employing the less energetic conditions of refluxing EtOH/water (4:1) failed 
to provide any product. Evidently, substitution of the pyridine ligands of 
[Ru(phen)2(py)2]2+ requires more heat input than with neutral Ru(phen)2Cl2. 
Unfortunately, such conditions contribute to decomposition of the acetamide linking 
unit of the NHC proligand. 
 
Isolation of enantiomeric Δ‐(—)‐[Ru(phen)2(5.9.H)][PF6]3 was confirmed by polarimetry, 
having a [α]D value of – 678o for a 0.004 g/mL solution in MeCN at 20 oC. With an 
analytical sample of Δ‐(—)‐[Ru(phen)2(5.9.H)][PF6]3 in hand, resolution of Δ/Λ‐
[Ru(phen)2(5.9.H)]3+ by direct crystallisation with sodium arsenyl‐L‐(—)‐tartrate was 
sought as a more efficient, high yielding method. 
 
5.7.1.3. Crystallisation with a chiral anion; classical resolution 
 
Enantiomeric resolution of Δ‐[Ru(phen)2(5.9.H)]3+ and Λ‐[Ru(phen)2(5.9.H)]3+ was 
performed analogously to the above isolation of Δ‐[Ru(phen)2(py)2][As‐(—)‐Otart]2. 
Racemic Δ/Λ‐[Ru(phen)2(5.9.H)]Cl3 was dissolved in a minimum of warm water and a 
solution of sodium arsenyl‐L‐(—)‐tartrate in warm water (3.6 equivalents, 0.13 mol/L) 
was added resulting in immediate precipitate formation. The solution was heated at 80 
oC and water added dropwise until all material had dissolved, it was then allowed to 
crystallise slowly before refrigerating for 24 hours. The resultant bright orange 
microcrystalline powder was collected by filtration and washed with cold water then 
acetone before drying in vacuo to give Δ‐[Ru(phen)2(5.9.H)][As‐(—)‐Otart]3 in a 43% 
yield. Material in the aqueous filtrate was recovered by precipitation of the PF6 salt and 
extraction into DCM. This is enriched with Λ‐[Ru(phen)2(5.9.H)]3+ and following 
conversion back into the chloride salt, could be subjected to the above procedure with 
sodium arsenyl‐D‐(+)‐tartrate to recover the opposite enantiomer, Λ‐
[Ru(phen)2(5.9.H)][As‐(+)‐Otart]3. This was not performed due to time limitations. 
A portion of Δ‐[Ru(phen)2(5.9.H)][As‐(—)‐Otart]3 was dissolved in hot water and 




extracts dried over MgSO4 before removal of the solvent. This provided Δ‐
[Ru(phen)2(5.9.H)][PF6]3 for analysis by polarimetry. In this case it is necessary to remove 
the chiral anion to ensure that any observed optical rotation is attributable to 
enantiomeric enrichment of the chiral complex itself without interference from the 
anion. The product was found to have an [α]D value of – 526o for a 0.005 g/mL solution 
in MeCN at 20 oC which is lower than the – 678o recorded for Δ‐[Ru(phen)2(5.9.H)][PF6]3 
obtained in the previous section. This suggests that obtaining Δ‐[Ru(phen)2(5.9.H)][PF6]3 
from a well resolved precursor yields a superior enantiomeric excess than direct 
crystallisation with sodium arsenyl‐L‐(—)‐tartrate as performed here. The latter 
approach demonstrates that an enriched sample of the metallo‐NHC proligand can be 
obtained expediently and in high yield. Better enrichment might be achieved following 
further method development.  
 
5.8. Summarising remarks 
 
The synthesis and isolation of a novel, appended metallo‐NHC proligand 
[Ru(bipy)2(5.2.H)][PF6]3 has been outlined, however, this approach was encumbered by 
challenges in obtaining the necessary 1,0‐phenanthroline halides and subsequent 
reactions of the 3‐imidazole‐1,10‐phenanthroline derivatives. Comparatively, 
acetamide linked species [Ru(phen)2(5.5.H – 5.10.H)][PF6]3 and 
[Ru(phen)2(5.12.H)][PF6]3 were prepared expediently from the readily accessible amine 
precursor 5‐amino‐1,10‐phenanthroline and 4‐amino‐2,2’‐bipyridine, respectively. 
Ultimately, only the acetamide‐linked class of metallo‐NHC proligands were carried 
forward into catalysis trials. Irrespective of this, the 3‐imidazolyl‐1,10‐phenanthroline 
system retains interest due to the close proximity of the NHC to the enantiomeric 
ruthenium‐polypyridine complex. Being monodentate NHC ligands may also be 
advantageous to catalysis. This is in light of the poor performance of acetamide linked 
[Ru(phen)2(5‐PA)]2+ type NHC ligands in palladium mediated Suzuki coupling which is 





Several remarkable hetero‐dinuclear NHC complexes were prepared from these 
metallo‐NHC proligands and subject to a detailed structural evaluation. Complex 
[Ru(phen)2(Pd{5.9}{allyl}Cl)][PF6]2 represents a unique example of a Pd(allyl) system 
with an anionic‐chelating ligand and provides an excellent demonstration of how 
spontaneous N‐amidate/NHC chelation occurs for these acetamide linked metallo‐NHC 
ligands under mild conditions. Similarly, complex [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 also 
exhibits a previously un‐reported coordination motif, having a Pd(II) centre bound within 
a tridentate N‐amidate – NHC – Py chelate. Unusual conformational diastereomers of 
[Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 arise through steric interplay of the enantiomeric 
Ru(phen)3  component with the atropisomeric Pd(5.10 - H)Cl fragment. These are 
identified as existing in a 2:1 ratio in solution and are not thought to be interchangeable. 
Synthesis of a 4‐acetamido‐2,2’‐bipyridine based system was undertaken to prove that 
this isomeric relationship could be manipulated by increasing the steric interaction 
between the complex groups. In practice, both the chelated and pendant forms, 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 and [Ru(phen)2(Pd{5.12}Cl2)][PF6]2, were obtained. 
Chelation could be promoted by treating the pendant form with base and gives 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 as a single diastereomer. The reversibility of N‐amidate 
binding in the 4‐BipA systems is thought to allow isolation of the thermodynamically 
favoured diastereomeric conformation which is desirable for application in asymmetric 
catalysis. That one diastereomer is favoured in both [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 
and [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 represents the accomplishment of this chapter’s 
underpinning objective; to prepare a metallo‐NHC ligand in which an enantiomeric 
ruthenium‐polypyridine moiety has stereochemical influence over a catalytic centre. 
 
Effective protocols for the enantiomeric resolution of the metallo‐NHC proligand 
[Ru(phen)2(5.9.H)][PF6]3 were established leading to isolation of Δ‐(—)‐
[Ru(phen)2(5.9.H)][PF6]3. This was achieved either by synthesis from the resolved 
precursor Δ‐[Ru(phen)2(py)2][As‐(—)‐Otart]2 or by selective crystallisation of racemic 
[Ru(phen)2(5.9.H)][PF6]3 with a chiral anion, arsenyl‐(—)‐tartrate. Methods were also 
emplaced for resolution by chiral chromatography, although, this could not be achieved 
in the required timeframe. Chromatographic resolution seems accomplishable through 





Overall, this chapter outlines the synthesis of metallo‐NHC ligands bearing an 
enantiomerically resolved ruthenium‐polypyridine unit. That these are capable of 
coordinating to a catalytically active centre is supported by the synthesis of several 
plausible Pd(II) precatalysts. 
 
5.9. Scope and future work 
 
In light of the diastereoselective synthesis of [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2, the 4‐
BipA derived NHC ligands show tremendous promise going forward in the context of 
asymmetric catalysis. It would be extremely interesting to prepare other BipyA 
derivatives such as an analogue of the Pd(allyl) complex 
[Ru(phen)2(Pd{5.9}{allyl}Cl)][PF6]2.  
 
With regard to the isolation of enantiomerically resolved metallo‐NHC proligands, it was 
demonstrated that synthesis of Δ‐[Ru(phen)2(5.9.H)][PF6]3 from the resolved precursor 
Δ‐[Ru(phen)2(py)2][As‐(—)‐Otart]2 was achievable yet low yielding due to the instability 
of the acetamide‐linked ligand [5.9.H]+ under the required conditions. A more effective 
approach would be to use this synthesis to prepare resolved enantiomers of a 5‐amino‐
1,10‐phenanthroline precursor complex, Δ‐[Ru(phen)2(5‐amino‐phen)]2+ or Λ‐
[Ru(phen)2(5‐amino‐phen)]2+ (Scheme 5.22). These could then be used to synthesise 
resolved metallo‐NHC proligands including Δ‐[Ru(phen)2(5.9.H)][PF6]3 and Λ‐
[Ru(phen)2(5.9.H)][PF6]3, similarly to the preparation of the free ligand 5.9.HCl.  
Chloroacetylation of [Ru(phen)2(5‐amino‐phen)][PF6]2 to give [Ru(phen)2(5.4)][PF6]2 has 














Being heteroleptic bridging ligands, these species are potential supramolecular synthons 
and ripe for diversification of the metal centre at either the polypyridine terminus, NHC 
terminus or both. Focussing on the metallo‐NHC ligands [Ru(phen)2(5.5 – 5.10)][PF6]3 
already developed, these could be applied to use in different catalytic systems with 
metals such as with Ni(II), Pt(II) or Ru(II). Additionally, NHCs have been employed to affix 
functional groups to metallic surfaces including gold nano‐particles.273 These ligands 
could therefore provide a means of tethering a photoactive ruthenium‐polypyridine 






























Λ‐NHC proligand Λ‐[Ru(phen)2(5‐amino‐phen)]2+ 
Scheme 5.22: Route to enantiomerically resolved metallo-NHC proligands prepared from 






























Several of the NHC proligands and complexes prepared in the preceding chapters were 
trialled in the asymmetric synthesis of axially chiral biaryl compounds by Suzuki cross‐
coupling. Rotationally hindered biaryls such as BINOL and BINAP possess a chiral axis 
along the biaryl‐bond, enantiomers resulting from this are known as atropisomers (see 
section 1.1). Enantiomeric biaryl motifs are important structural components in 
numerous natural products, several of which have demonstrable therapeutic properties 
including those shown in Figure 6.1.274 As such, the targeted synthesis of atropisomeric 







Atroposelective Suzuki couplings were first reported in 2000, nearly simultaneously, by 
Buchwald et al.275 and Cammidge et al.276 Both demonstrated the synthesis of 
enantiomeric bis‐2,2’‐naphthalene derivatives using existing chiral ligands. Since then, 
the application of asymmetric Suzuki couplings have graduated to more complex 
systems, although, enantioselective couplings with chiral ligands remain fairly 
uncommon.92 A successful example, shown in Scheme 6.1, demonstrates the 
enantioselective synthesis of a cumyl‐amide substituted biaryl compound.277 Removal 
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Physical separation of atropisomers is accomplishable if racemisation is slow at a given 
temperature, that is, the free energy barrier to rotation is sufficiently high. The 
configurational stability of an axially chiral biaryl compound is determined by the steric 
demand of substituents in proximity to the axis. Rotation may also be prevented by 
bridging units. Interconversion of atropisomeric enantiomers is often thermally driven, 
however, may be chemically or photochemically induced depending on the compound. 
 
Thermal stability in non‐bridged biaryls is governed by the number and size of ortho‐
substituents. Typically, the rotational energy barrier in di‐ortho‐substituted biaryls with 
methyl‐groups and larger are stable to resolution.274 Moderately hindered tetra‐ortho-
substituted biaryl compounds are practically inert to thermally induced rotation, 
however, di‐ortho-substituted aryl substrates are much more challenging coupling 
partners. The simple di‐ortho‐substituted biaryl 1‐o‐tolyl‐naphthalene and 1,1’‐
binaphtalene was targeted in this study as they are rotationally stable enough to allow 
measurement of enantiomeric enrichment by chiral HPLC while being synthetically 
achievable. Once catalysis had been demonstrated using these substrates, graduation 
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to more hindered systems was intended to ensure reliable measurement of 
enantiomeric excess.  
 
Performing these catalysis trials proved to be extremely time consuming in addition to 
the time spent establishing a working methodology. Time limitations restricted the 
breadth of NHC ligands trialled and prevented the screening of more substrates and 
reaction conditions. Likewise, evaluating catalysis of 1,1’‐binaphtalene formation was 
abandoned for this reason. Most unfortunate of all, progress was halted before 
enantiomeric resolution of product mixtures could be performed by chiral HPLC and 
therefore, enantiomeric excesses are not calculated. However, several new chiral NHC 
ligands were proven to be operable in catalysis of Suzuki couplings. Preliminary insight 
into the effect of N‐amido substituents on catalysis was also obtained. Most importantly 
however, the emplacement of methodologies and instrumentation with which to 
experimentally evaluate asymmetric catalysis will allow future investigators to continue 
this work.   
 
6.2. Control system 
 
Wholescale screening of homogenous catalysts is not regularly attempted in the 
University of Canterbury chemistry department and hence there is no existing precedent 
for this. As such, methodologies were developed to replicate literature analyses as best 
possible. To ensure the efficacy of this, a published NHC catalyst based on the PEPPSI 
system (see section 1.3.3) was used as a control. The PEPPSI precatalyst 6.1 was 
prepared following a literature procedure in which the imidazolium salt is heated with 

















Pyridine was used instead of 3‐chloropyridine, as reported, due to availability. 
Employing a pyridine ligated precatalyst was not expected to greatly impact the overall 
yield of the Suzuki coupling because the slightly more electron deficient 3‐
chloropyridine ligand is typically used to improve precatalyst initiation rates.278 The NHC 
proligand used for this was 1,3‐bis(2,6‐diisopropylphenyl)imidazolium chloride (IPr.HCl), 
which was prepared by an established method.279 
Precatalyst 6.1 was applied to the synthesis of 1‐o‐tolyl‐naphthalene and 1,1’‐
binaphtalene to provide sample for the standardisation and calibration of the GC‐FID 
used in the analysis of reaction mixtures (see section 6.3.2). This was performed as 
reported for PEPPSI type catalysts.87 A sample of 1‐o‐tolyl‐naphthalene was obtained by 
stirring 6.1 and t‐BuOK in isopropanol for 20 minutes before adding naphthalene‐1‐
boronic acid and o‐bromo‐toluene. These initial syntheses were monitored by TLC. After 
1.5 hours it appeared that all o‐bromo‐toluene had been consumed, however, it was 
later found that it was not well visualised on the TLC plate. Pure 1‐o‐tolyl‐naphthalene 
was obtained by flash chromatography (silica, pentane) in a modest yield of 50% due to 
the incomplete reaction. 
The synthesis of 1,1’‐binaphthalene was also attempted under the above conditions 
using naphthalene‐1‐boronic acid and 1‐bromo‐naphthalene, however, this was found 
to proceed slowly. Instead K2CO3 was used as the base and the reaction heated at 60 oC. 
After 4 hours the reaction was complete, however, it was left to continue for 24 hours. 
IPr.HCl 6.1, 88 % 




Flash chromatography (silica, pet ether) provided 1,1’‐binaphtalene in an isolated yield 
of 83%. In addition to providing analyte samples of 1‐o‐tolyl‐naphthalene and 1,1’‐
binaphtalene, these reactions served as preliminary trials of reaction conditions and 
proved 6.1 to be a relevant model catalyst. 
 
6.3. Methodology and experimental set-up 
6.3.1. Conditions and instrumentation 
 
Each catalysis trial reaction was performed in a microscale conical reaction vial sealed 
with screw cap and septum. Custom made aluminium blocks were used to house up to 
eight reaction vials at a time. Placing the block on a heater/stirrer allowed stirring of the 
reaction mixtures and heating when necessary. Blocks were pre‐heated to the desired 
temperature before studying reactions at elevated temperature. Reactions were 
performed under an argon atmosphere administered through a Schlenk line. Gas hosing 
was split into multiple lines ending with syringe needles to provide gas‐flow through the 
septum of each vial. Undecane was used as an internal standard for the GC‐FID analysis. 
Stock solutions of precatalysts were prepared prior to the reaction and were used within 
2 days of preparation. Pre‐formed precatalyst solutions were prepared in the reaction 
solvent such that 1.0 mL delivered the desired mol%. When using unformed 
precatalysts, the NHC proligand and palladium source were introduced as a combined 
solution in MeCN and 0.30 mL of solution provided the desired mol%. Using MeCN was 
necessary to ensure solubilisation of all components, particularly when using the 
metallo‐NHC proligands. A smaller volume was used to minimise the influence of the 
MeCN solvent. 
 
All trials were duplicated and typically performed as follows; the boronic acid (1.2 equiv.) 
and base (equivalents depend on base and catalyst) were weighed into a microscale 
conical reaction vial equipped with a spin vane.  Solvent was added (2.0 mL for 
preformed precatalysts or 2.7 mL for unformed precatalysts) followed by undecane 




Argon was bubbled through the sample for 15 minutes before the aryl‐halide was added 
(1 equiv.) followed by the precatalyst solution (1.0 mL or 0.30 mL). The vial cap was 
tightened and the argon needle raised from solution but left in the septum. Gas flow 
was switched to a static pressure to maintain an inert atmosphere. If heating was 
required, the vial was transferred to a heated block. The total solvent and internal 
standard volume was 3.1 mL. These conditions were adapted from published 
procedures.37, 87, 122 
 
Most aspects of sample analysis are not well described in the literature and had to be 
developed from scratch. Sampling for analysis was performed by removing 0.1 mL 
aliquots of reaction mixture by syringe and injecting onto a short silica plug. This was 
rinsed through into an autosampler vial with 1 mL of HPLC grade Et2O and sealed for 
later analysis. Silica plugs for this purpose were prepared by plugging a Pasteur pipette 
with a small amount of glass wool and adding silica to a height of ~ 1.5 cm. This step is 
important for removal of insoluble material and boronic acid prior to GC‐FID analysis as 
these can damage the auto‐injector needle and/or contaminate the column. 
 
Sampling was initially performed hourly to provide an accurate reaction profile for 
calculation of TON and TOF, however, this proved to be incredibly laborious. Focus 
eventually shifted to simply assessing the product yield as a measure of system 
performance as these were, after all, preliminary and explorative trials. For this purpose, 
it was sufficient to sample at zero minutes (immediately after catalyst added), 3 hours, 
24 hours, 48 hours and so forth if necessary. This also allowed greater trial throughput. 
The zero‐minute sample was useful for error checking, ensuring the GC‐FID trace was as 
expected with an internal standard present etcetera.  
 
6.3.2. Analysis by GC-FID 
 
Aliquots were subjected to GC‐FID analysis to determine the amount of aryl‐halide 
converted and the product yield. GC‐FID (Gas Chromatography with a Flame Fonisation 




compounds are eluted. Gradually raising the column temperature drives the analyte into 
the helium carrier gas (mobile phase) causing them to elute. The time at which they are 
detected is the compounds retention time and this is used to differentiate the species 
in the mixture. It is important that analyte signals are well resolved, that is, their 
retention times are very different. Retention times are best tuned by adjusting the rate 
at which the column temperature increases and can include pauses where the 
temperature is fixed for an interval. At the end of each GC‐FID run the column 
temperature was held at 300 oC for 5 minutes to ensure all sample was eluted before 
the next run. The column standby temperature was set at 150 oC to avoid adsorption of 
water.  
 
Individual stock solutions of the key analytes o‐bromo‐toluene, 1‐bromo‐naphthalene 
and 1‐o‐tolyl‐naphthalene and the internal standard undecane were used to identify the 
retention times of these compounds. A solution containing all four components was 
then used to obtain a heating profile which provided good compound resolution. This 
method was used for all analyses and provided average retention times, in minutes, of 
8.11, 9.36, 13.86 and 16.17 for undecane, o‐bromo‐toluene, 1‐bromo‐naphthalene and 
1‐o‐tolyl‐naphthalene, respectively. Analyses that did not adequately conform to these 
retention times were repeated to minimise signal drift as this can indicate a source of 
instrumental error. 
 
The molar quantity of eluted compound is proportional to the area of the signal peak 
and is measured by integration. As signal areas differ between compounds at a given 
concentration, a calibration curve must be obtained for each analyte. This was 
performed by measuring the signal area of the compound at various concentrations over 
a range that encompasses the experimental concentration of the analyte in a sample. 
For experimental samples, the compound concentration is calculated by relating the 
peak integral to the calibration curve equation. In addition to the initial calibration, GC‐
FID traces of a stock mixture containing a known concentration of undecane, o‐bromo‐
toluene, 1‐bromo‐naphthalene and 1‐o‐tolyl‐naphthalene was regularly collected as an 
external standard. This was at the beginning and end of each batch of samples and at 




against this external standard. At the conclusion of a batch of samples, an aliquot of 
MeOH was run to purge the column before standby. 
 
Yields and conversion were calculated as follows; integrals of relevant signals in the GC‐
FID trace were measured and tabulated. These were normalised against the undecane 
internal standard signal. The calibration equation obtained as above was used to 
calculate the number of moles of analyte compound present in the aliquot solution. 
Based on the volume of the original aliquot removed (0.10 mL), its concentration in the 
reaction mixture was determined and from that, yield and conversion. Although solution 
volumes were kept as regular as possible, the undecane internal standard ensured that 
fluctuations were corrected for. It was only critical to strictly maintain the original 
reaction mixture volume. 
 
6.4. Results of catalysis trials 
 
For the following discussion the catalyst systems trialled are subdivided into separate 
categories. One being “preformed NHC‐Pd precatalyst systems” which are NHC‐Pd 
complexes that have been synthesised an characterised previously. The other is “NHC 
proligand systems” which is where the imidazolium salt NHC proligand and Pd(II) source 
are introduced to form an active NHC‐Pd complex in situ. Compounds analysed in this 
section have been renamed as shown in Figure 6.2 and Figure 6.3. This is for the benefit 
of clarity in this discussion, and to simplify the results tables. 
 
6.4.1. Preformed NHC-Pd precatalyst systems 
 
Preformed precatalyst systems were trialled first as these possess NHC‐Pd moieties 
known for their activity in Suzuki couplings including Pd(NHC)(O,O’‐acac) and 
Pd(NHC)(allyl)Cl. The systems studied here are shown in Figure 6.2 and include the 
control precatalyst 6A. Having been fully characterised, their structural features are 











A preliminary set of reactions were performed using the literature standard 6A and the 
organic, achiral N-amidate/NHC complex 6B as per the methodology given in section 
6.3.1.  Table 6.1 provides the conversion and yield percentages for this series of 
reactions. Again in the interest of time, only a limited survey of solvents and bases could 
be performed based closely on what is known to work for related systems. It was found 
that the conditions reported for the use of the literature precatalyst 6A (entry 5, Table 
6.1) also suited 6B (entry 6, Table 6.1). It was heartening to find that the control 
compound 6A performed as well as reported with regard to yield (83%),87 albeit over a 
longer time period. This is unsurprising given that pyridine ligated PEPPSI catalysts are 
known to initiate more slowly than their 3‐chloro‐pyridine counterparts. The results for 
6A confirm that the procedures and analysis used provide an accurate measure of yield. 
Pd(2.4)(allyl)Cl = 6D  
6.1 = 6A Pd(3.3 - H)(O,O’‐acac) = 6B Pd(3.3)(allyl)Cl = 6C  
[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 = 6E 
preformed NHC-Pd precatalyst systems  

















Precatalyst 6B performed comparably to 6A producing a yield of 79%, although, this 
required 24 hours and it was necessary to heat reactions with 6B at 60 oC. Presumably 
heating is required for 6B because its initiation is slowed by the more stable acac “throw‐
away” ligand. This has been noted in other Pd(NHC)(acac) precatalyst systems and is a 
common trade‐off for greater precatalyst stability.38, 162  Better yields for both 6A and 
6B were obtained in isopropanol, when using 1‐bromo‐naphthalene as the aryl‐halide 
with o‐tolyl‐boronic acid as opposed to the other way around. Using 1,4‐dioxane and t‐
BuOK with 6B resulted in a dark‐grey/brown slurry forming after 2 hours and analysis 
revealed that the reaction stopped with incomplete conversion due to apparent 
deactivation of the catalyst. Using K2CO3 as base with 1,4‐dioxane resulted in immediate 
deposition of dark‐grey material and no reaction progress was observed (not shown).  
 
Table 6.1: Condition sets trialled with precatalyst systems 6A and 6B for the synthesis of 
1-o-tolyl-naphthalene. 
Loading base solvent T time Conv yield
[mol%] (equiv) [
o
C] [hr] [%] [%]
5 6A 1 t ‐BuOK (1.3) iPrOH 20 2 100 83
6 6B 2 t ‐BuOK (1.3) iPrOH 60 4 100 79
7 6B 2 K2CO3 (3) iPrOH 60 24 78 42
8 6B 2 t ‐BuOK (1.3) 1,4‐diox 60 24 28 0
entry cat
Loading base solvent T time Conv yield
[mol%] (equiv) [
o
C] [hr] [%] [%]
1 6A 1 t ‐BuOK (1.3) iPrOH 20 24 90 65
2 6B 2 t ‐BuOK (1.3) iPrOH 60 5 69 55
3 6B 2 K2CO3 (3) iPrOH 60 24 49 18





Satisfied that the experimental set‐up, analysis and condition sets were performing as 
desired, the trial was expanded to include the Pd(NHC)(allyl) systems 6C, 6D and the 




The organic NHC derivatives 6C and 6D performed moderately well producing yields of 
~ 60 % after 24 hours at room temperature. This was accelerated for 6D to give the same 
result after 3 hours by heating at 60 oC. After 24 hours, the product yield was unchanged 
suggesting that catalysis had terminated, the 99% conversion suggest that the 1‐bromo‐
naphthalene was consumed in other side reactions. Additional signals in the GC‐FID 
trace does support this although no characterisation of these was performed. Addition 
of precatalysts 6C and 6D to the colourless reaction mixture solutions resulted in a rapid 
change to pink before fading back to colourless. A white suspension formed shortly 
thereafter. A similar white suspension was observed for reactions with 6A and 6B under 
analogous conditions and proved to be a useful visual indicator of a healthy reaction. 
The metallo‐NHC precatalyst 6E produced no product at room temperature or with 
heating at 60 oC.  After 24 hours at room temperature, the reaction mixture remained a 
bright orange, homogenous solution. Performing the reaction at 60 oC resulted in 
immediate darkening of the solution upon heating and deposition of a dark brown solid 
after 24 hours. Heating is probably necessary for initiation of 6E, as was the case also 
 
Table 6.2: Condition sets trialled with precatalyst systems 6C, 6D and 6E for the synthesis 
of 1-o-tolyl-naphthalene. 
Loading base solvent T time Conv yield
[mol%] (equiv) [
o
C] [hr] [%] [%]
1 6C 2 t ‐BuOK (1.3) iPrOH 20 24 78 61
2 6D 2 t ‐BuOK (1.3) iPrOH 20 24 80 60
3 6D 2 t ‐BuOK (1.3) iPrOH 60 3 99 67
4 6E 2 t ‐BuOK (1.3) iPrOH 20 24 15 0





with 6B, because of the stabilising N‐amidate/NHC chelate which is not initially present 
in 6C and 6D. However, it appears under these conditions heating facilitated 
decomposition of the catalyst species. Unfortunately, there was not enough 6E available 
for further trials. It is possible a mild base such as K2CO3 would be more successful as t‐
BuOK is highly reactive and may contribute to catalyst breakdown. Also, 6E was on the 
cusp of solubility in isopropanol, solvents such as MeCN and DMF might be better suited 
for use with 6E as was the case with 6H in the next section. Reasons for the inactivity of 
6E are discussed further in section 6.4.3. 
 
Further tuning of conditions to improve the yield of 6C and 6D was not performed as 
the current conditions produced an analysable amount of product. Product mixtures 
from reactions with the chiral precatalyst 6D were rotary evaporated to give a crude 
solid material. These were set aside for chiral HPLC analysis to determine their 
enantiomeric excess which, in the end, could not be performed. 
 
6.4.2. NHC proligand systems 
 
Attention turned to establishing an operational system using NHC proligands with a 
Pd(II) source. Those trialled are shown in Figure 6.3, all of which are diisopropyl‐phenyl 
appended species. These were chosen to examine first as NHCs with a diisopropyl‐
phenyl pendant group are generally reliable for catalytic applications.280 Employing NHC 
proligands was aimed, in particular, at finding a condition set in which the metallo‐NHC 
complexes might function as it is easier to use the proligand than to synthesise the 
metallo‐NHC‐Pd precatalysts. It was hoped at least some product could be obtained 
using a metallo‐NHC system in order to measure their enantiomeric excess and gauge 


























Reactions were performed following the methodology given in section 6.3.1, however, 
t‐BuOK was avoided as the base. Instead milder bases such as K2CO3 and NaOH were 
favoured as was the case in the published example of Suzuki couplings performed with 
addition of an N‐amide/NHC proligand (see section 1.4.1).122 These bases are also better 
suited to in situ precatalyst formation without degradation of the NHC ligand. Trials 
were performed using NHC proligands 6F, 6G and 6H with PdCl2 under various 
conditions. Some successful condition sets are summarised in Table 6.3. Solvents 
including toluene and MeCN were also surveyed without success as was the use of NaOH 
as a base. These less informative trials will not be discussed further in the interest of 






3.3.HCl = 6F 2.4.HCl = 6G 
NHC proligand systems  
 
Figure 6.3: NHC proligands used with PdCl2 in catalysis trials. Relabelling also shown. 
















It was found that addition of water was crucial for a successful reaction. Without water, 
reactions in isopropanol and DMF produced negligible product with 6F and 6G. Addition 
of water is common for Suzuki couplings and aids solubilisation of inorganic bases and 
formation of the reactive boronate coupling partner. As with the preformed precatalyst 
systems, there was an obvious preference for using 1‐bromo‐naphthalene and o‐tolyl‐
boronic acid instead of o‐bromo‐toluene and naphthyl‐1‐boronic acid. When the latter 
was used, the solution immediately darkened to grey upon addition of the 
proligand/PdCl2 mixture and the reaction did not proceed. The 6G/PdCl2 combination 
operated acceptably, producing a 67% yield in isopropanol/water and 95% yield in 
 
proligand Loading base T time Conv yield
PdCl2 [mol%] (equiv) [
o
C] [hr] [%] [%]
1 6F 2 K2CO3 (3) iPrOH/H2O (5/1) 60 24 40 5
2 6G 2 K2CO3 (3) iPrOH/H2O (5/1) 60 24 38 22
3 6H 2 K2CO3 (3) iPrOH/H2O (5/1) 60 24 28 2
entry solvent
Table 6.3: Condition sets trialled with NHC proligand systems 6F, 6G and 6H with PdCl2 
for the synthesis of 1-o-tolyl-naphthalene. Entry 4 is a run with PdCl2 and no proligand. 
proligand Loading base T time Conv yield
(+ PdCl2) [mol%] (equiv) [
o
C] [hr] [%] [%]
4 x 2 K2CO3 iPrOH/H2O (5/1) 60 3 10 2
5 6F 2 K2CO3 iPrOH/H2O (5/1) 60 3 85 42
6 6G 2 K2CO3 iPrOH/H2O (5/1) 60 3 72 67
7 6G 2 K2CO3 DMF/H2O (5/1) 60 3 100 95
8 6H 2 K2CO3 iPrOH/H2O (5/1) 60 24 14 2
9 6H 2 K2CO3 DMF/H2O (5/1) 60 24 48 5
10 6H 2 K2CO3 DMF/H2O (5/1) 120 24 24 0





DMF/water after 24 hours. As before, these reaction mixtures were rotary‐evaporated 
and set aside for chiral HPLC analysis. The achiral system 6F/PdCl2 was slightly less 
efficient, providing a 42% yield in isopropanol/water. Reactions with organic proligands 
6F and 6G begun as colourless solutions, sometimes with a separated aqueous phase, 
and became grey slurries over the 3‐hour period. Measuring conversion/yields again 
after 24 hours showed them to be unchanged, suggesting the reactions had ceased. 
Catalyst deactivation likely occurs by precipitation of metallic Pd(0) and its adducts, 
explaining the greying of the mixture. A dummy run using only PdCl2 and no proligand 
(entry 4, Table 6.3) produced a trace amount of product confirming that an NHC ligand 
is required. 
 
Metallo‐NHC proligand 6H could, at best, produce a trace amount of product 
comparable to when only PdCl2 was used. Some of the trialled condition sets are shown 
in entry 8 – 11, Table 6.3. MeCN and MeCN/water as solvent was trialled with K2CO3 and 
NaOH as base but these were equally unsuccessful. Interestingly, when performing 
reactions with 6H/PdCl2 at 60 oC, the bright orange solution remained homogenous; no 
grey/black material deposited as happens when 6F and 6G are used. Performing the 
reaction at 120 oC instead of 60 oC also failed to promote the reaction, however, after 
48 hours the solution had darkened slightly. This suggests that the in situ NHC‐Pd species 
formed with 6H is more stable than 6F and 6G. It is likely that this heightened NHC‐Pd 
complex stability contributes to the inactivity of metallo‐ligand NHC systems as 
demonstrated with 6E and 6H.  
 
A qualitative investigation of the synthesis of biphenyl using bromo‐benzene or iodo‐
benzene with phenyl‐boronic acid was perfomed using 6H to determine whether the 
steric bulk of the substrates, or the reactivity of the aryl‐halide could be influential. This 
was initially performed using 6G/PdCl2 in isopropanol/water with K2CO3 and bromo‐
benzene as the aryl halide at 60 oC. GC‐FID analysis showed all bromo‐benzene had been 
consumed and a lone spike due to biphenyl was present after 3 hours. Repeating this 
reaction with 6H produced a small spike due to biphenyl and after 48 hours, minimal 
consumption of bromo‐benzene was observed. Repeating with iodo‐benzene proved to 




the GC‐FID trace compared with a large signal due to biphenyl. Evidently, turnover with 
6H occurs slowly but can be achieved with the more reactive aryl‐iodide and the catalyst 
does not appear to degrade over this long reaction time. It may also be possible to 
perform the synthesis of more hindered biaryls using 6H and aryl‐iodides to assess 
asymmetric induction.  
 
6.4.3. Preliminary insights 
 
The key insight provided by these catalysis trials is that the metallo‐NHC systems do not 
function under the same conditions as their organic‐NHC counterparts. This supports 
the assertion that the nature of the N‐amido group is extremely influential. This has 
been noted by Lee et al. (see scheme 1.17, section 1.4.1), albeit to a lesser extent.122 
This is particularly evident for the Pd(allyl) precatalyst systems 6C, 6D and 6E which have 
been well characterised. It was found that while the cyclohexyl‐acetamide and bornyl‐
acetamide derivatives 6C and 6D turned over yields of ~ 60%, no product was observed 
using 6E under the same conditions (at room temperature), or with heating. Of these, 
6E is the only one with the Pd(II) centre bound within an N‐amidate/NHC chelate. 
However, successful trials using the Pd(acac) derivative 6B proved that having a 
preformed N‐amidate/NHC chelate does not negate catalysis. As explained in the 
previous chapter, synthesis of the metallo‐NHC complexes [Ru(phen)2(Pd{5.9 - 
H}{allyl})][PF6]2 (6E) and [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 proceeded with spontaneous 
deprotonation of the amide. Clearly this process is highly favourable and, during 
catalysis, it could compete heavily with substrate binding. This also explains why the 
metallo‐NHC proligand system 6H was able to function, albeit slowly, with the more 
reactive phenyl‐iodide. For this reason, a BipA system related to [Ru(phen)2(Pd{5.12 - 
H}Cl)][PF6]2 might be better suited as it is suspected these engender weaker N‐amidate 
coordination to Pd(II). 
 
The results of trials using an N‐amido/imidazolium salt NHC proligand with PdCl2 
tentatively imply that the favourability of N‐amidate/NHC chelation correlates to the 




derivative 6G which gave a yield of 67% after 3 hours, compared with 42% for the 
cyclohexyl analogue 6F. As discussed in Chapters 1 and 2, N‐amidate coordination is 
sterically disfavoured by the bulky bornane of 6G (NHC ligand 2.4) more so than the 
cyclohexyl group of 6F (NHC ligand 3.3). In the extreme case of the readily chelating 
metallo‐NHC proligand 6H (NHC ligand [Ru(phen)(5.9)]2+), negligible biaryl product was 






















When using 6F and 6G a grey aggregate due to Pd(0) material deposited, however, this 
is not observed with 6H suggesting that the in situ generated precatalyst species is 
resistant to degradation. The prolonged, 48‐hour trial synthesis of biphenyl using 
6H/PdCl2 showed that the metallo‐NHC ligand supports a long lived active species but 
this stability consequently inhibits efficient turnover.  
Scheme 6.3: Comparison of yields for proligand systems 6F, 6G and 6H in relation to the 
favourability of N-amidate/NHC chelation 
6H, 2% 6F, 42% 6G, 67% Yield =  




6.5. Summarising remarks 
 
The performance of several novel NHC precatalyst and proligand systems in palladium 
mediated Suzuki cross‐coupling was investigated successfully. Procedures and analysis 
techniques were established on the basis of reported methods and referenced against 
a known PEPPSI precatalyst, 6A. Trials were performed for the synthesis of moderately 
hindered atropisomeric biaryl compounds, however, enantiomeric excesses were 
unable to be calculated within the available timeframe. 
 
Organic NHC precatalysts 6B (Pd(3.3 - H)(O,O’‐acac)), 6C (Pd(3.3)(allyl)) and 6D 
(Pd(2.4)(allyl)) provided satisfactory yields of the product 1‐o‐tolyl‐naphthalene 
comparable to related literature systems.37  Organic proligands 6F and 6G were also able 
to generate product but all trials performed using metallo‐NHC derivatives (6E and 6H) 
failed to produce any 1‐o‐tolyl‐naphthalene. This has been attributed to N‐amidate 
coordination outcompeting substrate binding when using the metallo‐NHC ligands. This 
is supported by experimental observations discussed in previous chapters. 
 
6.6. Scope and future work 
 
Determination of enantiomeric excesses for reactions involving enantiomeric NHC 
ligands is the critical next step for the evaluation asymmetric induction and can be 
performed by chiral HPLC. Bornyl‐acetamide systems trialled above have provided 
sample that could be analysed for this purpose. 
 
Several NHC ligands possessing an enantiomeric ruthenium‐polypyridine group as the 
stereodirecting component were prepared however, only catalysis using 
[Ru(phen)2(5.9)]2+, could be studied in the time available. This was unsuccessful for 
asymmetric Suzuki couplings however, further screening of conditions sets, metallo‐
NHC ligands and the use of different substrates is required before ruling out the activity 




The 4‐acetamido‐2,2‐bipyridine (BipA) derived metallo‐NHC system is a promising 
candidate due its weaker N‐amidate coordination. This may allow substrate conversion 
to occur unlike in the 5‐acetamido‐1,10‐phenanthroline based derivatives. It would also 
be beneficial to trial some of the novel monodentate metallo‐NHC systems including the 
fused IP NHC proligand [Ru(bipy)2(4.9.H)][PF6]3 or the appended 3‐imidazol‐
phenanthroline species [Ru(bipy)2(5.2.H)][PF6]. This would inform on whether chelation 
is involved in quenching catalysis or if some other process involving the ruthenium 
centre is responsible. 
 
Finally, all metallo‐NHC proligands and precatalysts developed in this work could be 
applied to one of numerous other palladium (or other metal) mediated syntheses such 
as Buchwald‐Hartwig couplings, Heck couplings or α‐Ketone arylation, not necessarily 
looking at asymmetric induction. The scope for further catalytic studies with the ligand 

















































Presented in this thesis is the synthesis and characterisation of thirty‐three previously 
un‐reported imidazolium salts (and precursors) including; six new bornane‐derivatives, 
two new cyclohexyl‐derivatives and twelve new organic 1,10‐phenanthroline‐
derivatives. Incorporation of the 1,10‐phenanthroline‐derived species into ruthenium‐
polypyridine complexes generated thirteen novel metallo‐NHC proligands and 
precursors. Imidazolium salts were employed in the synthesis of NHC‐complexes, 
fourteen of which were isolated, characterised and subject to a comprehensive 
structural evaluation. 
 
A majority of the compounds introduced in this work are of the acetamide‐tethered 
family and are capable of coordinating to a metal in an N‐amidate/NHC motif. Chapter 
1 introduces the new bornyl‐acetamide NHC ligands 2.2 – 2.5 and explores the structure 
and properties of their complexes prepared with catalytically relevant metal centres 
Pd(II), Pt(II) and Ru(II) as well as several Ag(I) precursor complexes. One important 
insight presented is that the steric bulk of the bornane N‐amido substituent disfavours 
N‐amidate/NHC chelation. The synthesis of less hindered cyclohexyl‐acetamide 
analogues in Chapter 2 helped to support this assertion, in particular through 
comparison of the synthetic yields, NMR spectra and X‐ray crystal structures of the 
chelated complexes Pd(2.4 - H)(O,O’‐acac) and Pd(3.3 - H)(O,O’‐acac). Consequently, it 
was synthetically challenging to generate N‐amidate/NHC chelated complexes in the 
bornyl‐acetamide series. A succinct demonstration of this was provided by the 
unsuccessful conversion of an O-amidate/NHC chelated bornyl‐species, [Ru(2.2)(p‐
cymene)Cl][PF6], to the N‐amidate/NHC chelated [Ru(2.2 - H)(p‐cymene)Cl][PF6] 
complex using a methodology reported for a related compound. 
 
Developing NHC‐ligands incorporating an enantiomeric ruthenium‐polypyridine moiety 
was one of the central objectives of this work. Synthesis of phenanthroline‐annelated 
NHC derivatives in Chapter 3 identified several of the regiosynthetic obstacles to 




the isolation and characterisation of compounds 4.11.I, 4.12.I and 4.13.I which formed 
by the undesired N‐alkylation of the phenanthroline nitrogen. A post‐complexation 
methodology in which the imidazolium salt is prepared following coordination of the 
phenanthroline‐terminus to ruthenium was demonstrated as a plausible mitigating 
approach. UV/visible and fluorometric analysis of the previously unexplored 
phenanthrolinum salts implicates intramolecular charge transfer as the cause of their 
unusually intense yellow colouration.  
 
Avoidance of the synthetic issues identified in Chapter 3 was achieved by adopting an 
acetamide linking unit. This provided a diverse selection of metallo‐NHC proligands 
[Ru(phen)2(5.5.H – 5.10.H)][PF6]3 and [Ru(phen)2(5.12.H)][PF6]3 and the NHC complexes 
[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2, [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2, 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 and [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2. The latter were 
prepared by the silver‐transmetalation method and proceeded with deprotonation of 
the amide to give N-amidate/NHC chelated complexes without the use of additional 
base. Here, N‐amidate formation is promoted by conjugate stabilisation of the anion 
and the reduction in molecular charge that deprotonation affords, neither of which is 
possible with bornane or cyclohexyl‐amido substituents. This led to previously unseen 
coordination motifs including tridentate coordination of an N‐amidate‐NHC‐pyridine 
chelate. In addition to the chiral ruthenium‐polypyridine moiety, these complexes 
possess an internal chiral axis leading to diastereomers. In the 2,2’‐bipyridine derivative 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2, the probable reversibility of N‐amidate chelation 
enables a single diastereomer to be obtained as the thermodynamic product.  
 
Chapter 6 outlines the screening of precatalyst and proligand systems in an asymmetric 
Suzuki‐coupling producing atropisomeric biaryl compounds. Organic NHC precatalysts 
Pd(3.3 - H)(O,O’‐acac), Pd(3.3)(allyl) and Pd(2.4)(allyl) provided satisfactory yields of the 
product 1‐o‐tolyl‐naphthalene comparable to yields reported for related systems.  
Organic proligands 2.4.HCl and 3.3.HCl were also able to generate product but all trials 
performed using metallo‐NHC derivatives ([Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 and 
[Ru(bipy)2(5.9.H)][PF6]3) were unsuccessful. Inhibition of catalysis has been attributed to 




Evidently, the coordination ability of the N‐amidate has implications for product 
turnover during catalysis. 
 
7.2. Future perspectives 
 
Avenues for further investigation are outlined at the conclusion of each chapter with a 
focus on transition metal catalysis. However, the novel NHC proligands developed in this 
work have by no means been studied to their full potential and are not limited to use in 
metal‐mediated processes.  
 
For example, no acetamide coupled NHCs have been reported in an organocatalytic role 
and hence the novel NHC proligands developed here provide an excellent start‐point. Of 
particular interest is the potential for hydrogen‐bonding by the amide unit to participate 
in transformations. It is plausible that acetamide‐triazole derivatives could be prepared 
by the methods established in this work to provide interesting chiral‐precatalysts for 
asymmetric benzoin condensation.  
 
The synthesis of f‐block NHC complexes stabilised by N‐amidate/NHC chelation is 
another novel pursuit.  Numerous f‐block metal complexes with NHCs have been 
reported in which the NHC ligand bears an anionic chelating arm.281 Stabilisation by 
anionic groups is often essential for maintaining NHC coordination to highly 
electropositive lanthanide and actinide centres.111 Surprisingly, amidate‐based 
chelation has not been explored in this context. Acetamide linked metallo‐NHC ligands 
of the type introduced in Chapter 5 could be particularly effective in this role as they are 
proven to be proficient N‐amidate chelators. These would be highly unusual and 





































8.1. General information 
 
Unless otherwise specified, all reagents and starting materials were reagent grade, 
purchased from standard suppliers and used as received. Water was purified by reverse 
osmosis in-house. Anhydrous solvents were either obtained from a commercial source 
or, HPLC‐grade solvent was dried via the in-house solvent system by passing over a 
sealed column of activated alumina. All air and water sensitive manipulations were 
carried out under either an argon or nitrogen atmosphere using standard Schlenk 
techniques. Melting points were recorded on an electrothermal melting point apparatus 
and are uncorrected. The following compounds were prepared following literature 
procedures: exo‐(‐)‐isobornylamine,135 exo‐3‐aminoborneol,149 1‐isopropyl‐
imidazole,282 1‐(2,6‐diisopropyl)phenyl‐imidazole,283 1‐(2‐pyridyl)‐imidazole,284 1‐
phenyl‐imidazole,285 1‐(2‐bromoethyl)‐3‐methylimidazolium bromide (2.9.HBr),154 1,10‐
phenanthro‐5,6‐dione,217 imidazo[4,5‐f][1,10]phenanthroline (4.1),218 3‐bromo‐1,10‐
phenanthroline,243 5‐amino‐1,10‐phenanthroline,251, 4‐amino‐2,2’‐bipyridine,260 cis-
Ru(bipy)2Cl2 and cis-Ru(phen)2Cl2,286 cis‐[Ru(phen)2(py)2]Cl2 and Δ‐[Ru(phen)2(py)2][As‐
(—)‐Otart]2,269 [Pd(allyl)Cl],37 [Ru(p‐cymene)Cl2]2,206 1,3‐bis(2,6‐diisopropyl‐
phenyl)imidazolium chloride,279 napthalene‐1‐boronic acid and tolyl‐o‐boronic acid.275 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
 
Spectra were recorded on a Varian VNMRS 600, Varian INOVA 500 or an Agilent 400‐MR 
instrument operating at 600, 500 and 400 MHz, respectively, for 1H, and at 150, 125, 
and 100 MHz, respectively, for 13C. Experiments using the 600 MHz instrument were 
performed externally by Ian Vorster at Victoria University, Wellington. All samples were 
dissolved in commercially available deuterated solvents and spectra were referenced to 
the residual solvent peak. When required, COSY, HSQC, HMBC, and TOCSY experiments 







Mass spectrometry (ESI-MS) 
  
Mass spectra were recorded by Dr. Marie Squire, Dr. Alexander Goroncy and Dr. Amelia 
Albrett on either a DIONEX Ultimate 3000 or Bruker MaXis 4G spectrometer, operated 
in high resolution positive ion electrospray mode. Samples were prepared in HPLC grade 
MeCN, MeOH or water.  
 
Infra-red spectroscopy (FT-IR) 
 
FT‐IR spectra were recorded using on a Bruker ALPHA Platinum ATR FT‐IR spectrometer 
in the range of 4000 – 550 cm‐1 using a solid sample of the analyte. Abbreviations used 
to describe signal intensity are as follows; strong (s), medium (m), weak (w) and broad 
(br). 
 
UV/visible spectroscopy (UV-vis)  
 
UV/Visible spectra were recorded on an Agilent Cary 300 spectrophotometer over a 200 
‐ 800 nm range using spectroscopy grade MeCN or DCM solutions. Samples were 




Emission spectra were recorded on a Horiba Fluorolog‐3 spectrometer over 300 ‐ 800 
nm range using spectroscopy grade MeCN or DCM solutions. Samples were measured 




Optical rotation values were recorded on a Perkin Elmer polarimeter (Model 341) using 
a sodium lamp producing D‐line radiation of 589.3 nm. Samples were prepared in 
spectroscopy grade MeCN or MeOH and measured at room temperature in a cell of path 






Elemental analysis was carried out by Campbell Microanalytical Laboratory, University 
of Otago. 
 
X-Ray Crystallography  
 
X‐ray crystallographic data collection and refinement was carried out on an Oxford‐
Agilent SuperNova instrument with focussed microsource Cu Kα (λ = 1.5418 Å) radiation 
or Mo Kα (λ = 0.71073 Å) and ATLAS CCD area detector. All structures were solved using 
direct methods with SHELXS or SHELXT and refined on F2 using all data by full matrix 
least‐squares procedures with SHELXL within OLEX‐2.3. Non‐hydrogen atoms were 
refined with anisotropic displacement parameters. Hydrogen atoms were included in 
calculated positions, or were manually assigned from residual electron density where 
appropriate, with isotropic displacement parameters 1.2 times the isotropic equivalent 
of their carrier atoms. The functions minimized were Σw(F2o - F2c), with w = [σ2(F2o) + aP2 
+ bP] ‐ 1, where P = [max(Fo)2 + 2F2c]/3. Graphical representations of crystallographic 
data were prepared using Mercury. Crystallographic data for all compounds is available 
in .cif format if required.  
 
Gas Chromatography (GC-FID) 
 
GC‐FID traces were recorded using a Shimadzu GC‐2010 gas chromatograph with FID 
detector and a Shimadzu AOC‐20i auto injector set at a 1 μL injection volume. Samples 
were prepared in HPLC grade Et2O. A helium carrier gas was used at flow rate of 5 
mL/min. The FID detector required hydrogen and air at a flow rate of 20 mL/min and 









8.2. Chapter 2 




In a 100 mL round‐bottom flask and under an argon atmosphere, 
exo‐bornylamine (2.27 g, 14.8 mmol) was dissolved in DCM (50 
mL) and cooled to 0 oC. Freshly distilled triethylamine (3.1 mL, 22.2 
mmol) was added followed by the dropwise addition of 
chloroacetyl‐chloride (1.3 mL, 16.3 mmol) in DCM (25 mL). The reaction mixture was 
stirred for 1 hour at 0 oC then for a further 14 hours at room temperature. To the brown 
mixture was added Et2O (100 mL) and the precipitated triethylamine.HCl salt filtered off 
and rinsed with Et2O (50 mL). Rotary‐evaporation of the filtrate gave an oily brown, 
semi‐crystalline residue which was purified by flash chromatography (silica, 3:2 
Et2O/pet‐ether). The desired product 2.1 was obtained as a white, crystalline solid. Yield 
2.751 g (81%). MP: 88 – 89 oC. 1H NMR (400 MHz, DMSO‐d6): δ 7.50 (1H, d, J = 6.7 Hz, 
H11), 4.07 (1H, d, J = 12.5 Hz, H13a), 4.01 (1H, d, J = 12.5 Hz, H13b), 3.68 (1H, dd, J = 8.2 
Hz, 5.9 Hz, H2), 1.69 – 1.56 (4H, m, H3α, H3β, H4, H5α), 1.51 – 1.43 (1H, m, H6α), 1.16 – 
1.03 (2H, m, H5β, H6β), 0.87 (3H, s, H8), 0.76 (3H, s, H9), 0.73 (3H, s, H10). 13C NMR (100 
MHz, DMSO‐d6): δ 166.15 (C12), 56.93 (C2), 49.31 (C1), 46.91 (C7), 44.70 (C4), 43.18 
(C13), 37.48 (C3), 36.14 (C6), 27.11 (C5), 20.72 (C8), 20.37 (C9), 11.84 (C10). FT-IR ν/cm‐
1 (intensity): 3366 (w), 3323 (m), 2955 (m), 2938 (m), 2878 (w), 1673 (m), 1652 (s), 1550 
(m), 1527 (s), 1458 (m), 1432 (m), 1393 (m), 1156 (w), 1081 (w), 790 (w), 678 (m), 571 
(m). ESI-MS: Found [MH]+ 230.1263, [2M + H]+ 459.2466. [C12H21NOCl]+ requires 










1-methyl-3-[N-exo-(2-bornyl)acetamido]-1H-imidazolium chloride (2.2.HCl) 
 
In a 50 mL round‐bottom flask and under a nitrogen 
atmosphere, 2.1 (0.526 g, 2.29 mmol) and 1‐methyl‐
imidazole (0.56 mL, 7.00 mmol) were dissolved in MeCN 
(25 mL). The colourless solution was refluxed for 24 hours 
then cooled to room temperature and concentrated by rotary‐evaporation. The product 
was precipitated from the concentrate by addition of Et2O (80 mL) with stirring then 
collected by filtration and washed further with Et2O. The slightly tacky solid was re‐
crystallised from hot DCM to give 2.2.HCl as colourless rectangular plates. Yield 0.629 g 
(88%). MP: 190 – 192 oC. 1H NMR (400 MHz, DMSO‐d6): δ 9.23 (1H, s, H15), 8.32 (1H, d, 
J = 7.4 Hz, H11), 7.71 (2H, br.s, H17, H18), 5.10 (2H, s, H13), 3.88 (3H, s, H19), 3.67 (1H, 
m, H2β), 1.84 – 1.67 (1H, m, H3α), 1.67 – 1.57 (3H, m, H3β, H4, H5α), 1.47 (1H, m, H6α), 
1.21 – 0.99 (2H, m, H5β, H6β), 0.93 (3H, s, H8), 0.75 (6H, s, H9, H10). 13C NMR (100 MHz, 
DMSO‐d6): δ 165.20 (C12), 138.07 (C15), 124.00 (C18), 123.43 (C17), 57.32 (C2), 51.09 
(C13), 49.31 (C1), 46.91 (C7), 44.72 (C4), 37.29 (C3), 36.20 (C19), 36.19 (C6), 27.15 (C5), 
20.80 (C9), 20.65 (C8), 12.05 (C10). FT-IR ν/cm‐1 (intensity): 3372 (w), 2948 (m), 2878 
(m), 1689 (m), 1659 (s), 1535 (m), 1458 (w), 1389 (w), 1372 (w), 1188 (w), 1170 (m), 739 
(w), 701 (w), 619 (m), 450 (m).  ESI-MS: Found [M]+ 276.1785, [2M + Cl]+ 587.3234, 
[3M+2Cl]+ 898.5616. [C16H26N3O]+ requires 276.2070, [C32H52N6O2Cl]+ requires 
587.3829, [C48H78N9O3Cl2]+  898.5588. [α]D (MeOH, 20 oC): ‐ 13.44o. 
 
1-isopropyl-3-[N-exo-(2-bornyl)acetamido]-1H-imidazolium chloride (2.3.HCl) 
 
In a 50 mL round‐bottom flask and under a nitrogen 
atmosphere, 2.1 (0.264 g, 1.15 mmol) and 1‐isopropyl‐
imidazole (0.40 mL, 3.50 mmol) were dissolved in MeCN 
(15 mL). The faint yellow solution was refluxed for 24 
hours then cooled to room temperature and concentrated by rotary‐evaporation. The 
product was precipitated from the amber coloured concentrate by addition of Et2O (80 
mL), with stirring, then collected by filtration and washed further with Et2O. Air drying 




MHz, DMSO‐d6): δ 9.34 (1H, s, H15), 8.19 (1H, d, J = 7.4 Hz, H11), 7.91 (1H, s, H17), 7.71 
(1H, s, H18), 5.04 (2H, s, H13), 4.67 (1H, spt, J = 6.5 Hz, H19), 3.72 – 3.63 (1H, m, H2β), 
1.79 – 1.54 (4H, m, H3α, H3β, H4, H5α), 1.52 – 1.41 (7H, m, H6α, H20), 1.13 – 0.99 (2H, 
m, H5β, H6β), 0.92 (3H, s, H8), 0.75 (3H, s, H9), 0.74 (3H, s, H10). 13C NMR (100 MHz, 
DMSO‐d6): δ 165.16 (C12), 136.44 (C15), 124.35 (C18), 120.35 (C17), 57.29 (C2), 52.64 
(C19), 51.08 (C13), 49.28 (C1), 46.91 (C7), 44.68 (C4), 37.38 (C3), 36.17 (C6), 27.13 (C5), 
22.79 (C20a), 22.77 (C20b), 20.79 (C9), 20.58 (C8), 12.04 (C10). FT-IR ν/cm‐1 (intensity): 
3208 (w), 3065 (w), 2952 (m), 2925 (w), 2874 (w), 1683 (m), 1673 (s), 1556 (m), 1539 
(m), 1458 (w), 1264 (m), 1212 (m), 1180 (m), 897 (w), 778 (m), 624 (m), 605 (m). ESI-MS: 
Found [M]+ 304.2072, [2M + Cl]+ 643.3803. [C18H30N3O]+ requires 304.2383, 





Synthesis performed as reported for 2.3.HCl using 
2.1 (0.530 g, 2.31 mmol) and 1‐(2,6‐
diisopropyl)phenyl‐imidazole (1.00 g, 4.36 mmol) in 
MeCN (50 mL). Compound 2.4.HCl was obtained as 
a fine white powder. Yield 0.945 g (89%). MP: 159 
oC with decomposition. 1H NMR (400 MHz, DMSO‐d6): δ 9.60 (1H, s, H15), 8.30 (1H, d, J 
= 7.4 Hz, H11), 8.06 (1H, s, H17), 8.04 (1H, s, H18), 7.61 (1H, t, J = 7.8 Hz, H22), 7.43 (2H, 
d, J = 7.8 Hz, H21), 5.20 (2H, s, H13), 3.76 – 3.69 (1H, m, H2β), 2.29 (2H, dq, J = 13.1 Hz, 
6.6 Hz, H23), 1.75 – 1.61 (4H, m, H3α, H3β, H4, H5α), 1.54‐1.43 (1H, m, H6α), 1.13 (14H, 
m, H5β, H6β, H24), 0.96 (3H, s, H8), 0.77 (6H, s, H9, H10). 13C NMR (100 MHz, DMSO‐
d6): δ 165.03 (C12), 145.59 (C20), 139.57 (C15), 131.87 (C22), 131.02 (C19), 125.02 
(C18), 124.82 (C21), 124.73 (C17), 57.36 (C2), 51.74 (C13), 49.37 (C1), 46.95 (C7), 44.74 
(C4), 37.38 (C3), 36.17 (C6), 28.44 (C23), 27.16 (C5), 24.28 (C24a), 24.20 (C24b), 20.81 
(C9), 20.68 (C8), 11.98 (C10). FT-IR ν/cm‐1 (intensity): 3208 (w), 3018 (w), 2960 (m), 2928 
(m), 2872 (w), 1687 (s), 1548 (s), 1459 (m), 1367 (m), 1256 (w), 1168 (m), 1066 (w), 816 
(m), 766 (w), 672 (w). ESI-MS: Found [M]+ 422.2739, [2M + Cl]+ 879.5132. [C27H40N3O]+ 





1-(2-pyridyl)-3-[N-exo-(2-bornyl)acetamido]-1H-imidazolium chloride (2.5.HCl) 
 
Synthesis performed as reported for 2.3.HCl using 
2.1 (0.265 g, 1.15 mmol) and 1‐(2‐pyridyl)‐imidazole 
(0.250 g, 1.73 mmol) in MeCN (15 mL).. Compound 
2.5.HCl was obtained as a fine white powder. Yield 
0.236 g (55%). MP: 256 – 258 oC. 1H NMR (400 MHz, DMSO‐d6): δ 10.15 (1H, s, H15), 
8.65 (1H, m, H23), 8.55 (1H, s, H17), 8.24 – 8.13 (2H, m, H11, H21), 8.08 (1H, d, J = 8.2 
Hz, H20), 7.98 (1H, s, H18), 7.65 (1H, t, J = 5.3 Hz, H22), 5.19 (2H, s, H13), 3.72 (1H, m, 
H2β), 1.69 (4H, m, H3α, H3β, H4, H5α), 1.51 (1H, m, H6α), 1.06 (2H, m, H5β, H6β), 0.96 
(3H, s, H8), 0.80 (6H, s, H9, H10). 13C NMR (100 MHz, DMSO‐d6): δ 164.59 (C12), 149.52 
(C23), 146.50 (C19), 140.91 (C21), 136.33 (C15), 125.55 (C22), 125.34 (C18), 118.86 
(C17), 114.51 (C20), 57.22 (C2), 51.45 (C13), 49.11 (C1), 46.73 (C7), 44.51 (C4), 37.29 
(C3), 35.99 (C6), 26.92 (C5), 20.58 (C9), 20.37 (C8), 11.87 (C10). FT-IR ν/cm‐1 (intensity): 
3238 (w), 3067 (w), 2985 (m), 2880 (m), 1673 (s), 1599 (m), 1544 (s), 1477 (m), 1447 (s), 
1233 (s), 1158 (m), 968 (w), 794 (m), 784 (m), 701 (w), 619 (m). ESI-MS: Found [M]+ 
339.2187. [C20H27N4O]+ requires 339.2179. [α]D (MeOH, 20 oC): ‐ 2.78o. 
 
2.10.2HBr and 2.13.2HBr 
 
In an oven dried Schlenk tube, exo-3‐aminoborneol (0.100 g, 3.90 mmol) was dissolved 
in anhydrous DMSO (1 mL) and freshly distilled trimethylamine added (0.62 mL, 4.43 
mmol). A solution of 1‐(2‐bromoethyl)‐3‐methylimidazolium bromide (2.9.HBr) (0.800 
g, 2.96 mmol) in DMSO (2 mL) was added dropwise. The colourless solution was stirred 
for 48 hours at room temperature, becoming a cloudy, faint yellow suspension.  After 
this time the reaction mixture was pipetted into vigorously stirring EtOAc (150 mL) 
resulting in deposition of a sticky white solid. The supernatant was decanted off, acetone 
added (100 mL) and stirring continued until the residue became a powdered solid which 
was collected by filtration. This material (0.270 g) was shown by 1H‐NMR to contain both 
the bis‐imidazolium bromide salt 2.12.2HBr and the desired product 2.10.2HBr in a 1.5 




(0.101 g). The initial EtOAc supernatant was condensed by rotary evaporation and THF 
(100 mL) added producing a faint yellow solution. Treatment with an HBr solution in THF 
(~ 0.5 M, 3 mL) resulted in immediate precipitation of a white solid that was collected 
by filtration and rinsed with THF. The material (0.153 g) was found by 1H‐NMR to be a 
mixture of 2.10.2HBr and the camphidine derivative 2.13.2HBr. Washing the material 
with DCM left behind pure 2.10.2HBr (0.105 g), taking 2.13.2HBr into the filtrate which, 
after removal of the solvent, was obtained as a fine white, hygroscopic powder (0.0063 
g). 
 
2.10.2HBr   
 
Overall yield 0.207 g (15.9%). 1H NMR (400 MHz, CD3OD): δ 
9.17 (1H, s, H15), 7.81 (1H, s, H18), 7.73 (1H, s, H17), 4.72 (2H, 
m, H13), 3.98 (3H, s, H19), 3.93 (1H, d, J = 7.4 Hz, H2β), 3.69 
(2H, t, J = 7.0 Hz, H12), 3.49 (1H, d, J = 7.4 Hz, H3β), 2.19 (1H, 
d, J = 4.3 Hz, H4), 1.89 – 1.69 (1H, m, H5α), 1.55 (1H, td, J = 12.4 Hz, 3.7 Hz, H6α), 1.24 
(1H, m, H5β), 1.13 (4H, m, H6β, H8), 0.97 (3H, m, H9), 0.89 (3H, m, H10). 13C NMR (100 
MHz, CD3OD): δ 138.86 (C15), 125.30 (C17), 123.89 (C18), 77.96 (C2), 67.07 (C3), 50.58 
(C1), 49.87 (C4), 49.39 (C12), 47.91 (C7), 46.03 (C13), 36.80 (C19), 32.90 (C6), 27.31 (C5), 
21.77 (C9), 21.15 (C8), 11.35 (C10). ESI-MS: Found M+ 278.2229. [C16H28N3O]+ requires 
278.2221.  
 
2.13.2HBr   
 
Yield 0.0063 g (0.5%). 1H NMR (400 MHz, CD3OD): δ 9.14 
(1H, s, H15), 7.80 (1H, s, H18), 7.64 (1H, s, H17), 4.82 (2H, 
m, H13), 3.97 (3H, s, H19), 3.73 (2H, m, H12), 3.43 (2H, m, 
H3), 3.26 (1H, d, J = 12.5 Hz, H2a), 3.16 (1H, d, J = 12.5 Hz, 
H2b), 2.17 – 1.95 (3H, m, H4, H5α, H6α), 1.94 – 1.80 (2H, m, H5β, H6β), 1.15 (3H, s, H8), 
1.00 (3H, m, H9), 0.96 (3H, m, H10). 13C NMR (100 MHz, CD3OD): δ 138.99 (C15), 125.55 




(C1), 42.69 (C7), 36.93 (C19), 34.14 (C6), 25.32 (C5), 23.62 (C9), 18.78 (C8), 17.37 (C10). 
ESI-MS: Found M+ 262.2281. [C16H28N3]+ requires 262.2278.  
 
8.2.2. NHC complexes of bornyl-acetamide derivatives 
 
Pd(2.4 - H)(O,O’-acac) 
 
In an oven dried Schlenk tube, 2.4.HCl (0.0916 g, 0.200 mmol) and 
PdCl2 (0.337 g, 0.190 mmol) were combined and the vessel 
sparged with nitrogen. Dry MeCN (3 mL) was added by syringe 
and the solution heated at 80 oC until the PdCl2 had dissolved. 
Finely powdered, oven dried K2CO3 (0.197 g, 1.43 mmol) was 
added under flowing nitrogen and allowed to react for 1 hour 
before adding acetylacetone (20.5 μL, 0.200 mmol). Heating was 
continued for 4 hours before cooling to room temperature and stirring overnight. The 
off‐white mixture was filtered through celite and the filtrate condensed by rotary 
evaporation. The residue was then taken up in Et2O and again filtered and the solvent 
removed before triturating the material in pentane for 2 hours to give Pd(2.4 - H)(O,O’‐
acac) as a fine light‐brown solid. Crystals suitable for X‐ray diffraction were grown by 
slow evaporation of an Et2O solution. Yield 0.0266 g (14%). MP: 192 oC with 
decomposition. 1H NMR (400 MHz, CDCl3): 7.37 (1H, m, H22), 7.22 (1H, d, J = 7.4 Hz, 
H21a), 7.16 (1H, d, J = 7.4 Hz, H21b), 7.09 (1H, s, H18), 6.78 (1H, s, H17), 5.05 (2H, m, 
H13a, H27), 4.63 (1H, br.s, H13b), 4.09 (1H, br.s, H2), 2.32 (1H, br.s, H3α), 1.89 (3H, s, 
H25), 1.76‐1.32 (9H, m, H3β, H4, H5α, H6α, H23), 1.17 – 0.98 (17H, m, H5β, H6β, H24, 
H29), 0.89 (6H, s, H8, H9/H10), 0.71 (3H, s, H9/H10). 13C NMR (100 MHz, CDCl3): δ 185.98 
(C26/28), 184.44 (C26/C28), 170.29 (C12), 153.55 (C15), 146.28 (C20a), 145.10 (C20b), 
134.42 (C19), 129.31 (C22), 124.73 (C17), 123.65 (C21a), 123.54 (C21b), 120.13 (C18), 
99.50 (C27), 63.00 (C2), 55.66 (C13), 52.66 (C1/C7), 46.85 (C1/C7), 45.28 (C4), 41.32 (C3), 
36.25 (C6), 28.32 (C23a), 28.28 (C23b), 27.62 (C5), 26.47 (C25/C29), 25.21 (C25/C29), 
25.00 (C24a), 24.88 (C24b), 23.63 (C24c), 20.77 (C8/C9/C10), 20.56 (C8/C9/C10). FT-IR 




1382 (m), 1289 (w), 1269 (w), 1058 (w), 907 (w), 802 (w), 727 (s), 690 (w). ESI-MS: Found 




In an oven dried Schlenk tube, 2.4.HCl (0.0911 g, 
0.199 mmol) and PdCl2 (0.347 g, 0.196 mmol) were 
combined and the vessel sparged with nitrogen. Dry 
MeCN (4 mL) was added by syringe and the solution 
heated at 80 oC until the PdCl2 had dissolved. Finely 
powdered, oven dried sodium‐acetylacetonate 
(0.124 g, 1.02 mmol) was added under flowing nitrogen and allowed to react for 1.5 
hours before cooling to room temperature. The faint yellow suspension was stirred at 
room temperature for a further 16 hours. The reaction mixture was taken up in Et2O (20 
mL) and filtered, washing through with additional Et2O. The filtrate was condensed, 
dissolved in a minimum of Et2O then pentane (30 mL) added resulting in a turbid solution 
which was filtered through celite. The filtrate solvent was removed giving the 
Pd(2.4)(O,O’‐acac)(γC‐acac) as a fluffy, banana yellow solid. Yield 0.0957 g (59%). MP: 
130 – 135 oC. 1H NMR (600 MHz, CD3CN) δ 7.53 (1H, m, H22‐j,n), 748 – 7.36 (3H, m, H21‐
j,n, H18‐j,n), 7.28 (0.7, s, H17‐j), 7.25 (0.3H, s, H17‐n), 6.79 (0.7H, d, J = 7.6 Hz, H11‐j), 
6.67 (0.3H, d, J = 7.6 Hz, H11‐n), 5.34 (0.7H, d, J = 15.8 Hz, H13a‐j), 5.32 (0.7H, s, H27‐j), 
5.32 (0.3H, s, H27‐n), 5.19 (0.3H, d, J = 15.8 Hz, H13a‐n), 4.98 (0.3H, d, J = 15.8 Hz, H13b‐
n), 4.75 (0.7H, d, J = 15.8 Hz, H13b‐j), 3.95 (0.7H, m, H2‐j), 3.84 (0.3H, m, H2‐n), 3.40 
(0.7H, s, H32‐j), 3.32 (0.3H, s, H32‐n), 2.86 (1H, m, H23a), 2.70 – 2.54 (1H, m, H23b), 2.24 
(2.1H, s, H30/H34‐j), 2.23 (0.9H, s, H30/H34‐n), 2.00 – 2.06 (0.7H, m, H3α‐j), 1.83 (3.4H, 
m, H3α‐n, H25/H29), 1.79 (3H, s, H25/H29), 1.77 – 1.55 (4H, m, H3β, H4, H5α, H6α), 1.32 
– 1.12 (12.8H, m, H5β, H6β, H24a, H24b, H24c), 1.08 (3H, m, H30/H34), 0.99 (3H, m, 
H24d), 0.91 (4H, s, H8, H10‐n), 0.88 (2.5H, s, H10‐j), 0.83 (1.5H, s, H9‐n), 0.82 (2.2H, s, 
H9‐j). 13C NMR (150 MHz, CD3CN): 207.80 (C31/C33‐j), 207.44 (C31/C33‐n), 207.11 
(C31/C33‐j), 206.94 (C31/C33‐n), 187.63 (C26/C28), 187.40 (C26/C28), 167.41 (C12‐j), 
167.05 (C12‐n), 166.26 (C15‐j), 166.18 (C15n), 148.36 (C20a), 147.24 (C20b‐j), 147.11 




126.39 (C17‐n), 125.95 (C21a‐j), 125.94 (C21a‐n), 125.92 (C21b‐j), 125.89 (C21b‐n), 
123.49 (C18), 100.38 (C27), 58.81 (C2‐n), 58.41 (C2‐j), 55.32 (C13‐j), 54.57 (C13‐n), 50.66 
(C1/C7‐j), 49.87 (C1/C7‐n), 48.68 (C32‐j), 48.31 (C32‐n), 48.14 (C1/C7‐n), 47.95 (C1/C7‐
j), 46.20 (C4), 39.84 (C3‐n), 37.86 (C3‐j), 37.48 (C6‐n), 37.17 (C6‐n), 31.19 (C30/C34‐j), 
31.12 (C30/C34‐n), 30.42 (C30/C34), 29.94 (C23a‐j), 29.90 (C23a‐n), 29.87 (C23b‐n), 
29.49 (C23b‐j), 28.67 (C30/C34), 28.20 (C5‐j), 28.08 (C5‐n), 27.95 (C30/C34‐n), 27.74 
(C30/C34‐j), 27.16 (C24a‐n), 27.08 (C24a‐j), 26.28 (C24b‐n), 26.20 (C24b‐j), 23.74 (C24c‐
j), 23.65 (C24c‐n), 23.51 (C24d‐j), 23.47 (24d‐n), 21.23 (C9‐j), 21.09 (C8‐n), 21.02 (C9‐n), 
20.42 (C8‐j), 12.83 (C10‐j), 12.77 (C10‐n). FT-IR ν/cm‐1 (intensity): 2956 (w), 2928 (w), 
2870 (w), 1672 (s), 1626 (w), 1578 (s), 1541 (w), 1515 (s), 1458 (w), 1386 (s), 1354 (w), 
1265 (w), 1157 (w), 1019 (w), 933 (w), 804 (w), 739 (w). ESI-MS: Found [M ‐ acac]+ 
626.2570. [C32H46N3O3Pd]+ requires 626.2574. Micro-analysis (%): Found C, 60.74; H, 
7.58; N, 5.79. Calc. for C37H53N3O5Pd C, 61.19; H, 7.36; N, 5.79. 
 
Pt(2.4 - H)(O,O’-acac) and Pt(2.4)(O,O’-acac)(γC-acac) 
 
 In an oven dried Schlenk tube 2.4.HCl (0.0910 g, 0.199 mmol) and Pd(DMSO)2Cl2 (0.0853 
g, 0.202 mmol) were combined and the vessel sparged with nitrogen. Dry DMSO (3mL) 
was added by syringe and the solution heated at 80 oC. Finely powdered, oven dried 
K2CO3 (0.138 g, 1.00 mmol) was added under flowing nitrogen and allowed to react for 
1 hour before adding sodium‐acetylacetonate (0.0366 g, 0.300 mmol). The temperature 
was elevated to 110 oC and reacted for 4 hours before cooling to room temperature and 
stirring overnight. The brown suspension was taken up in DCM (20 mL), filtered through 
celite then washed with water (3 x 10 mL) and brine (2 x 10 mL) before drying over 
MgSO4 and removing the solvent by rotary evaporation. The light brown residue was 
dissolved in a minimum of Et2O and Pt(2.4 - H)(O,O’‐acac) precipitated by the addition 
of pet‐ether (30 mL). This was collected by filtration, air dried and obtained as a fine off‐
white powder of satisfactory purity. Crystals of Pt(2.4 - H)(O,O’‐acac) suitable for X‐ray 
diffraction were grown by slow vapour diffusion of pentane into a toluene solution of 
the compound. Rotary evaporation of the pet‐ether filtrate provided adequately pure 
compound Pt(2.4)(O,O’‐acac)(γC‐acac) as a faint yellow powder. An extremely pure 




and extracting into pentane. Evaporation of the pentane extract gave Pt(2.4)(O,O’‐
acac)(γC‐acac) as a white, microcrystalline solid. 
 
Pt(2.4 - H)(O,O’-acac)  
 
Yield, 0.0310 g (22%). MP: Decomposition onset at 208 oC. 1H 
NMR (400 MHz, CDCl3): δ 7.36 (1H, m, H22), 7.22 (1H, m, H21a), 
7.15 (1H, d, J = 7.0 Hz, H21b), 7.08 (1H, s, H16), 6.72 (1H, s, H15), 
5.13 (1H, s, H27), 4.89 (1H, d, J = 15.3 Hz, 13a), 4.52 (1H, d, J = 
15.3 Hz, 13b), 4.25 (1H, br.s, H2), 2.81 (1H, br.s, H3α), 1.77 (3H, s, 
H25/29), 1.71 – 1.55 (2H, m, H3β, H5α), 1.52 (1H, br.s, H4), 1.48 
– 1.23 (6H, m, H6α, H23, H24a), 1.17 – 0.97 H5β, H6β, H24b, 
H25/H29), 0.84 (3H, s, H8), 0.78 (3H, br.s, H10), 0.71 (3H, s, H9). 13C NMR (100 MHz, 
CDCl3): δ 183.56 (C26/C28), 182.64 (C26/C28), 171.56 (C12), 146.59 (C20a), 145.02 
(C20b), 139.25 (C15), 134.52 (C19), 129.17 (C22), 123.95 (C17), 123.64 (C21a), 123.53 
(C21b), 119.78 (C18), 101.18 (C27), 63.87 (C2), 55.50 (C13), 52.46 (C1/C7), 46.69 (C1/C7), 
45.21 (C4), 40.14 (C3), 36.35 (C6), 28.25 (C24a), 28.13 (C24b), 27.51 (C5), 26.57 
(C25/C29), 25.19 (C25/C29), 25.01 (C24c), 24.81 (C24d), 23.54 (C23a), 23.44 (c23b), 
20.76 (C8/C9/C10), 20.69 (C8/C9/C10). FT-IR ν/cm‐1 (intensity): 2956 (w), 2927 (w), 2870 
(m), 1574 (s), 1521 (s), 1458 (m), 1421 (m), 1383 (m), 1311 (w), 1289 (w), 1190 (w), 1057 





Yield 0.0957 g (59%). MP: 133 – 135 oC. 1H NMR (600 
MHz, CD3CN) δ 7.54 – 7.47 (1H, m H22), 7.42 – 7.29 
(3H, H18, H21), 7.22 (0.7H, s, H17‐j), 7.21 (0.3H, s, 
H17‐n), 6.58 (0.7H, d, J = 7.6 Hz, H11‐j), 6.43 (0.3H, d, 
J = 7.3 Hz, H11‐n), 5.50 (0.7H, d, J = 15.8 Hz, H13a‐j), 
5.41 (1H, m, H27) 5.14 (0.3H, d, J = 16.1 Hz, H13a‐n), 




m, H32‐j, H2‐j), 3.89 (0.3H, s, H32‐n), 3.84 (0.3H, m, H2‐n), 2.82 (1H, m, H23a), 2.77 – 
2.64 (1H, m, H23b), 2.17 (3H, m, H30/H34), 2.04 (0.7H, m, H3α‐j), 1.82 (0.3H, m, H3α‐n), 
1.79 ‐ 1.50 (4H, m, H3β, H4, H5α, H6α), 1.32 ‐ 1.13 (11H, m, H5β, H6β, H24a, H24b, 
H24c), 1.10 (3H, m, H30/H34), 0.98 (3H, m, H24d), 0.97 (2.1H, s, H8‐j), 0.89 (1.8H, s, H8‐
n, H10‐n), 0.88 (2.1H, s, H10‐j), 0.83 (2.1H, s, H9‐j), 0.82 (0.9H, s, H9‐n). 13C NMR (150 
MHz, CD3CN): δ 210.38 (C31/C33‐n), 209.89 (C31/C33‐j), 209.72 (C31/C33‐j), 209.07 
(C31/C33‐n), 185.6 (C26/C28‐j), 185.55 (C26/C28‐n) 185.25 (C26/C28‐j), 185.19 
(C26/C28‐n), 167.49 (C12‐j), 167.18 (C12‐n), 148.46 (C20a‐j), 148.44 (C20a‐n), 148.19 
(C15), 147.11 (C20b‐j), 146.96 (C20b‐n), 136.10 (C19‐n), 136.02 (C19‐j), 131.55 (C22‐j), 
131.50 (C22‐n), 126.05 (C17‐j), 125.75 (C17‐n), 125.72 (C21a), 125.71 (C21b‐j), 125.65 
(C21b‐n), 122.67 (C18‐n), 122.56 (C18‐j), 102.09 (C27‐n), 102.06 (C27‐j), 58.66 (C2‐n), 
58.37 (C2‐j), 54.39 (C13‐j), 53.75 (C13‐n), 50.6 (C1/C7‐j), 49.87 (C1/C7‐n), 48.09 (C1/C7‐
j), 47.93 (C1/C7‐n), 46.18 (C4), 40.07 (C32‐j), 39.79 (C3‐n), 39.52 (C32‐n), 37.83 (C3‐j), 
37.36 (C6‐n), 37.12 (C6‐j), 30.25 (C30/C34), 30.17 (C30/C34), 29.83 (C23a‐j), 29.8 (C23a‐
n), 29.53 (C23b‐n), 29.48 (C23b‐j), 29.42 (C30/C34‐n), 28.38 (C20/C34‐j), 28.16 (C5‐j), 
28.02 (C5‐n), 27.97 (C24a‐n), 27.75 (C24a‐j), 27.27 (C24b‐n), 27.16 (C24b‐j), 23.44 (C24c‐
j), 23.39 (C24c ‐n), 23.22 (C24d‐j), 23.14 (C24d‐n), 21.17 (C9‐j), 21.05 (C8‐n), 20.96 (C9‐
n), 20.39 (C8‐j), 12.78 (C10‐j), 12.69 (C10‐n). FT-IR ν/cm‐1 (intensity): 2957 (w), 2937 (w), 
2872 (m), 1674 (s), 1641 (m), 1575 (m), 1520 (s), 1389 (m), 1353 (m), 1273 (w), 1242 
(m), 1021 (w), 934 (m), 801 (m), 741 (w), 616 (w). ESI-MS: Found [MH]+ 815.3714. 
[C37H53N3O5Pt]+ requires 815.3711. Micro-analysis (%): Found C, 54.33; H, 6.87; N, 4.80. 




In a Schlenk tube, 2.4.HCl (0.0916 g, 0.200 mmol) 
and Ag2O (0.0255 g, 0.110 mmol) were combined 
under nitrogen. DCM (5 mL) was added and the 
suspension stirred in the absence of light for 48 
hours. A solution of [Pd(allyl)Cl]2 (0.0366 g, 0.100 
mmol) in DCM (2 mL) was added to the cloudy white solution and stirring continued for 




solvent removed by rotary evaporation providing Pd(2.4)(allyl)Cl in a pure form as a 
fluffy, faint yellow solid. Yield 0.102 g (82%). MP: 89 – 96 oC. 1H NMR (400 MHz, DMSO‐
d6): δ 7.60 – 7.38 (4H, m, H11, H17, H18, H22), 7.26 (1H, d, J = 7.8 Hz, H21), 5.16 (1H, d, 
J = 15.7 Hz, H13a), 4.97 (2H, m, H13b, H26), 3.81 (1H, d, J = 7.4 Hz, H27syn), 3.72 (1H, m 
H2), 2.76 (1H, d, J = 13.3 Hz, 27anti), 2.60 (2H, br.s, H23), 1.65 (4H, br.s, H3α, H3β, H4, 
H5α), 1.47 (1H, m, H6α), 1.18 (6H, d, J = 6.3 Hz, H24a), 1.09 (2H, m, H5β, H6β), 0.99 (6H, 
d = 6.3 Hz, 24b), 0.85 (3H, s, H8), 0.74 (3H, s, H10), 0.71 (3H, s, H9). 13C NMR (100 MHz, 
DMSO‐d6): δ 182.22 (C15), 167.09 (C12), 146.29 (C20), 136.18 (C19), 130.09 (C22), 
125.23 (C17), 123.94 (C21a), 123.86 (C21b), 123.17 (C18), 114.79 (C26), 71.22 (C27), 
56.77 (C2), 53.58 (C13), 49.22 (C25, C7), 46.85 (C1), 44.69 (C4), 37.37 (C3), 36.09 (C6), 
28.02 (C23), 27.14 (C5), 26.31 (C18a), 23.11 (C18b), 23.03 (C18c), 20.76 (C9), 20.34 (C8), 
11.9 (C10). FT-IR ν/cm‐1 (intensity): 3264 (w), 2956 (m), 2872 (w), 1672 (s), 1536 (m), 
1458 (m), 1411 (w), 1384 (w), 1363 (w), 1220 (w), 1179 (w), 935 (w), 804 (m), 762 (m), 




In a Schlenk tube, 2.5.HCl (0.0760 g, 0.200 mmol) 
and Ag2O (0.0255 g, 0.110 mmol) were combined 
under nitrogen. DCM (5 mL) was added and the 
suspension stirred in the absence of light for 20 
hours. A solution of Pd(PhCN)2Cl2 (0.0767 g, 0.200 mmol) in DCM (2 mL) was added to 
the cloudy white solution and stirring continued for a further 12 hours. The light yellow 
suspension was filtered through a celite pad and the solvent removed by rotary 
evaporation. The light brown residue was rinsed with Et2O (20 mL) then water (30 mL) 
and dried in a desiccator under vacuum. It was purified further by bulk slow vapour 
diffusion of toluene into a MeCN solution of the compound. The resultant white 
microcrystalline deposit was collected by filtration and washed with acetone giving 
Pd(2.5)Cl2 as an off‐white powder. Yield 0.077 g (75%). MP: Decomposition onset at 250 
oC. 1H NMR (400 MHz, DMSO‐d6): δ 9.21 (1H, br.s, H23), 8.37 (2H, m, H17, H21), 8.15 
(1H, d, J = 8.2 Hz, H20), 7.63 (1H, t, J = 6.7 Hz, H22), 7.53 (2H, m, H18, H11), 5.68 (1H, d, 




H3β, H4, H5α), 1.49 (1H, m, H6α), 1.11 (2H, m, H5β, H6β), 0.95 (3H, s, H8), 0.81 (3H, s, 
H10), 0.79 (3H, s, H9). 13C NMR (100 MHz, DMSO‐d6): δ 165.66 (C12), 153.78 (C15), 
151.38 (C19), 149.18 (C23), 142.99 (C21), 126.35 (C18), 123.08 (C22), 116.11 (C17), 
112.32 (C20), 56.71 (C2), 51.77 (C13), 48.89 (C7), 46.46 (C1), 44.29 (C4), 37.26 (C3), 35.77 
(C6), 26.75 (C5), 20.38 (C9), 20.12 (C8), 11.77 (C10). FT-IR ν/cm‐1 (intensity): 3326 (w), 
3101 (w), 2948 (w), 2876 (w), 1665 (s), 1615 (w), 1530 (m), 1492 (s), 1459 (m), 1383 (m), 
1333 (m), 1245 (w), 1141 (w), 1101 (w), 780 (s), 717 (s), 687 (w). ESI-MS: Found [MH]+ 





In a Schlenk tube and in the absence of light, 
Ag(2.2)Cl (0.0912 g, 0.218 mmol) was dissolved in 
DCM (5mL) under an argon atmosphere. A 
solution of [Ru(p‐cymene)Cl2]2 (0.0726 g, 0.119 
mmol) in DCM (3 mL) was added and the resulting 
turbid mixture stirred in darkness for 24 hours. The orange suspension was filtered 
through a celite pad and the solvent removed by rotary evaporation. Adequately pure 
[Ru(2.2)(p‐cymene)Cl]Cl was recovered by this method (Yield 0.164 g, 89%). The brown 
solid was purified further by dissolving in water (5 mL) and precipitating it as a PF6 salt 
by addition of saturated KPF6 solution. The solid was collected by filtration, washed with 
water then Et2O and dried in a vacuum desiccator to give pure [Ru(2.2)(p‐
cymene)Cl][PF6] as a fine orange/yellow powder. Yield 0.113 g (75%). MP: 256 – 258 oC. 
1H NMR (400 MHz, CDCl3): δ 7.25 (4H, m, H11, H18), 7.07 (2H, s, H17), 5.63 (3H, m, H22), 
5.58 (1H, d, J = 5.6 Hz, H22), 5.40 (1H, d, J = 5.4 Hz, H21), 5.36 (1H, d, J = 5.4 Hz, H21), 
5.25 (2H, d, J = 5.9 Hz, H21),  5.12 (2H, d, J = 16.0 Hz, H13a), 4.60 (2H, d, J = 16.0 Hz, 
H13b), 3.89 (2H, s, H19), 3.88 (3H, s, H19), 3.81 (3H, s, H2), 2.92 (2H, sept, J = 7.0, H24), 
2.15 (6H, s, H26), 1.96 – 1.46 (10H, m, H3α, H3β, H4, H5α, H6α), 1.33 (12H, m, H25), 1.25 
– 1.04 (4H, m, H5β, H6β), 0.98 (3H, s, H10a), 0.93 (3H, s, H8b) 0.91 (3H, s, H8a), 0.83 (3H, 
s, H9a), 0.79 (3H, s, H9b), 0.74 (3H, s, H10b). 13C NMR (100 MHz, CDCl3): δ 175.24 (C15), 




111.11 (C23), 110.80 (C23), 100.03 (C20), 99.61 (C20), 86.26 (C22), 85.92 (C22), 84.99 
(C22), 80.48 (C21), 80.37 (C21), 80.00 (C21), 79.94 (C21), 59.54 (C2), 59.27 (C2), 51.73 
(C13), 51.64 (C13), 49.33 (C7a), 48.68 (C7b), 47.15 (C1), 47.12 (C1), 44.84 (C4), 44.76 
(C4), 38.37 (C3), 37.95 (C19), 37.92 (C19), 37.65 (C3), 36.18 (C6), 36.06 (C6), 31.48 (C24), 
26.97 (C5), 26.84 (C5), 23.53 (C24), 23.23 (C24), 21.84 (C24), 21.48 (C24), 20.18 (C9), 
20.09 (C9), 19.66 (C8), 19.62 (C8). 19.08 (C26), 19.06 (C26), 11.46 (C10), 11.40 (C10). FT-
IR ν/cm‐1 (intensity): 2956 (w), 2875 (w), 1614 (s), 1557 (m), 1459 (m), 1390 (w), 1345 
(w), 1243 (w), 1192 (w), 1115 (w), 832 (s), 737 (m), 681 (m). ESI-MS: Found [M]+ 
546.1817. [C26H39N4OClRu]+ requires 546.1820. 
 
8.3. Chapter 3 
8.3.1. Cyclohexyl-acetamide (CyA) derivatives 
 
1-methyl-3-[N-(cyclohexyl)acetamido]-imidazolium hexafluorophosphate (3.2.HPF6) 
 
In an oven dried Schlenk flask, 1‐methyl‐imidazole (1.60 
mL, 20.0 mmol) was added to a stirred solution of 2‐chloro‐
N‐cyclohexylacetamide (3.1) (1.755 g, 9.99 mmol) in MeCN 
(50 mL). The system was flushed with nitrogen and heated 
at reflux for 48 hours. The reaction mixture was allowed to cool and the solvent removed 
by rotary‐evaporation. The resultant residue was dissolved in water (50 mL) and a tacky 
white solid was deposited following addition of excess KPF6 solution. After decanting off 
the supernatant and washing with additional portions of water the residue was 
dissolved in a minimum of MeCN and transferred to a 250 mL round‐bottom flask before 
removing the solvent and drying under high‐vacuum. The colourless oily residue was 
triturated in 150 mL chloroform with vigorous stirring. After 2 hours 3.2.HPF6 had 
become a white crystalline solid which was collected by filtration and rinsed with 
chloroform then Et2O. Yield 1.750 g (48%). MP: 64 oC. 1H NMR (400 MHz, DMSO‐d6): δ 
9.04 (1H, s, H9), 8.29 (1H, d, J = 7.0 Hz, H5), 7.66 (2H, s, H11, H12), 4.92 (2H, s, H7), 3.88 




1.35 – 1.08 (17H, m, H2a, H3a, H4a). 13C NMR (100 MHz, DMSO‐d6): δ 163.65 (C6), 
137.67 (C9), 123.76 (C12), 124.42 (C15), 122.91 (C11), 50.47 (C7), 48.06 (C1), 35.77 (13), 
32.23 (C2), 25.07 (C4), 24.32 (C3). FT-IR ν/cm‐1 (intensity): 3287 (w), 2942 (w), 2856 (w), 
1657 (m), 1567 (m), 1450 (w), 1375 (w), 1276 (w), 1176 (m), 954 (w), 826 (s), 719 (m), 





In an oven dried Schlenk flask 1‐(2,6‐diisopropyl)‐
imidazole (1.259 g, 5.51 mmol) was added to a stirred 
solution of 2‐chloro‐N‐cyclohexylacetamide (3.1) 
(0.880 g, 5.03 mmol) in DMF (20 mL). The system was 
flushed with nitrogen and heated at 100 oC for 48 
hours. The reaction mixture was allowed to cool and the solvent removed by rotary‐
evaporation. The resultant residue was dissolved in a minimum amount of DCM and 
added dropwise to stirring Et2O (150 mL). The resulting green/grey gelatinous solid was 
collected by filtration and allowed to air dry. The crude material was purified by 
recrystallisation from acetone giving 3.3.HCl as a white microcrystalline solid. Yield 
1.410 g (69%). MP: 259 oC. 1H NMR (400 MHz, DMSO‐d6): δ 99.65 (1H, s, H9), 8.88 (1H, 
d, J = 6.7 Hz, H5), 8.10 (1H, s, H12), 8.06 (1H, s, H11), 7.62 (1H, t, J = 7.8 Hz, H16), 7.45 
(2H, d, J = 7.8 Hz, H15), 5.17 (2H, s, H7), 3.59 (1H, br.s, H1), 2.31 (2H, sept, J = 6.7 Hz, 
H17), 1.86 – 1.62 (4H, m, H2e, H3e), 1.55 (1H, d, J = 11.0 Hz, H4e), 1.41 – 1.01 (17H, m, 
H2a, H3a, H4a, H18). 13C NMR (100 MHz, DMSO‐d6): δ 163.56 (C6), 145.19 (C14), 139.25 
(C9), 131.51 (C16), 130.59 (C13), 124.60 (C12), 124.42 (C15), 124.30 (C11), 51.13 (C7), 
48.21 (C1), 32.29 (C2), 28.04 (C17), 25.15 (C4), 24.40 (C3), 23.86 (C18a), 23.80 (C18b). 
FT-IR ν/cm‐1 (intensity): 3186 (w), 3035 (w), 2961 (m), 2922 (m), 1672 (s), 1560 (s), 1544 
(m), 1459 (w), 1365 (w), 1315 (w), 1254 (m), 1188 (w), 1066 (m), 944 (w), 807 (s), 761 
(m). ESI-MS: Found [M]+ 368.2693, [2M+Cl]+ 771.5085. [C23H34N3O]+ requires 368.2702, 






1-(2-pyridyl)-3-[N-exo-(cyclohexyl)acetamido]-1H-imidazolium chloride (3.4.HCl) 
 
 In an oven dried Schlenk tube 1‐(2‐pyridyl)‐
imidazole (0.800 g, 5.51 mol) was added to a stirred 
solution of 2‐chloro‐N‐cyclohexylacetamide (3.1) 
(0.888 g, 5.06 mmol) in DMF (10 mL). The system was 
flushed with nitrogen and heated at 100 oC for 24 hours. The reaction mixture was 
allowed to cool and the solvent removed by rotary‐evaporation. The resultant residue 
was stirred vigorously with Et2O (50 mL) for 1 hour then the off white solid collected by 
filtration. Washing with acetone give the pure 3.4.HCl as a white powder. Yield 1.079 g 
(67%). MP: 212 oC. 1H NMR (400 MHz, DMSO‐d6): 10.15 (1H, s, H9), 8.67 (1H, d, J = 7.0 
Hz, H17), 8.63 (1H, d, J = 4.3 Hz, H5), 8.54 (1H, s, H11), 8.19 (1H, m, H15), 8.07 (1H, d, J 
= 8.2Hz, H14), 7.92 (1H, s, H12), 7.62 (1H, dd, J = 7.0 Hz, 5.1Hz, H16), 5.11 (2H, s, H7), 
3.55 (1H, br.s, H1), 1.83 – 1.60 (4H, m, H2e, H3e), 1.52 (1H, d, J = 11.3 Hz, H4e), 1.33 – 
1.07 (5H, m, H2a, H3a, H4a). 13C NMR (100 MHz, DMSO‐d6): δ 163.36 (C6), 149.27 (C17), 
146.68 (C13), 140.66 (C15), 136.14 (C9), 125.29 (C12), 125.12 (C16), 118.60 (C11), 
114.28 (C14), 51.15 (C7), 48.16 (C1), 32.21 (C2), 25.11 (C4), 24.33 (C3). FT-IR ν/cm‐1 
(intensity): 3213 (w), 3048 (m), 2929 (w), 2850 (w), 1690 (s), 1603 (m), 1538 (s), 1478 
(m), 1446 (m), 1345 (w), 1282 (m), 1232 (m), 1056 (s), 788 (m), 715 (m). ESI-MS: Found 














8.3.2. NHC complexes of cyclohexyl-acetamide derivatives 
 
Pd(3.3 - H)(O,O’-acac) 
 
In an oven dried Schlenk tube 3.3.HCl (0.204 g, 0.505 mmol) and 
PdCl2 (0.887 g, 0.499 mmol) were combined and the vessel 
sparged with nitrogen. Dry MeCN (8 mL) was added by syringe 
and the solution heated at reflux until the PdCl2 had dissolved. 
Finely powdered, oven dried K2CO3 (0.346 g, 2.50 mmol) was 
added under flowing nitrogen and allowed to react for 1 hour 
before adding acetylacetone (51.3 μL, 0.500 mmol). Heating was 
continued for 4 hours before cooling to room temperature and stirring overnight. The 
off‐white mixture was filtered and the solvent removed under vacuum. The resultant 
residue was stirred in pentane then filtered and the collected solid rinsed with water 
then quickly with MeCN to give Pd(3.3 - H)(O,O’‐acac) as a fine white powder. Crystals 
suitable for X‐ray diffraction were grown by slow evaporation of an Et2O solution. Yield 
0.145 g (46%). MP: Decomposition onset at 198 oC. 1H NMR (400 MHz, CDCl3): δ 7.35 
(1H, t, J = 7.4 Hz, H16), 7.20 (2H, d, J = 7.4 Hz, H15), 7.10 (1H, s, H12), 6.75 (1H, s, H11), 
5.07 (1H, s, H21), 4.75 (2H, s, H7), 3.39 (1H, m, H1), 2.89 (2H, m, H17), 2.12 – 1.96 (2H, 
m, H2e), 1.88 (3H, s, H19), 1.82 – 1.61 (4H, m, H2a, H3e), 1.54 (1H, d, J = 12.1 Hz, H4e), 
1.44 – 1.18 (8H, m, H3a, H18a), 1.14 (3H, s, H23), 1.07 (7H, m, H4a, H18b). 13C NMR (100 
MHz, CDCl3): δ 183.87 (C22), 185.40 (C20), 168.01 (C6), 145.31 (C9), 134.58 (C14), 134.58 
(C13), 129.28 (C16), 123.81 (C15), 123.68 (C11), 120.88 (C12), 99.82 (C21), 58.76 (C1), 
57.81 (C7), 32.52 (C2), 28.41 (C17), 26.53 (C19), 26.50 (C3), 26.20 (C4), 25.35 (C23), 24.99 
(C18b), 23.50 (C18a). FT-IR ν/cm‐1 (intensity): 3121 (w), 3093 (w), 2963 (w), 2927 (w), 
2849 (m), 1575 (s), 1543 (s), 1519 (s), 1428 (s), 1317 (w), 1297 (w), 1271 (w), 1024 (w), 
937 (m), 815 (w), 776 (w), 767 (w), 743 (m), 689 (w). ESI-MS: Found [MH]+ 572.2117. 







Pt(3.3 - H)(O,O’-acac) 
 
In an oven dried Schlenk tube 3.3.HCl (0.202 g, 0.500 mmol) and 
Pt(DMSO)2Cl2 (0.211 g, 0.500 mmol) were combined and the 
vessel sparged with nitrogen. Dry DMSO (5 mL) was added by 
syringe and the solution heated to 100 oC. Finely powdered, oven 
dried K2CO3 (0.420 g, 3.00 mmol) was added under flowing 
nitrogen and allowed to react for 1 hour before adding 
acetylacetone (51.3 μL, 0.500 mmol). Heating was continued for 
4 hours before cooling to room temperature and stirring overnight. The off‐white 
suspension was then poured onto 40 mL of DCM and filtered through a celite pad. The 
filtrate was washed with water (2 x 20 mL) then brine (2 x 20 mL), dried over MgSO4 and 
the solvent removed by rotary‐evaporation. The off‐white residue was washed quickly 
with cold MeCN and filtered giving Pt(3.3 - H)(O,O’‐acac) as a fine white powder. Crystals 
suitable for X‐ray diffraction were grown by slow evaporation of an Et2O solution. Yield 
0.156 g (47%). MP: Decomposition onset at 215 oC. 1H NMR (400 MHz, CDCl3): δ 7.35 
(1H, t, J = 7.8 Hz, H16), 7.19 (2H, d, J = 7.8 Hz, H15), 7.09 (1H, s, H12), 6.73 (1H, s, H11), 
5.16 (1H, s, H21), 4.70 (2H, s, H7), 3.52 (1H, m, H1), 2.92 (2H, m, H17), 2.06 (2H, m, H2e), 
1.83 (3H, s, H19), 1.70 (4H, m, H2a, H3e), 1.56 (1H, d, J = 12.1 Hz, H4e), 1.25 (8H, m, H3a, 
H18a), 1.08 (10H, m, H4a, H18b, H23). 13C NMR (100 MHz, CDCl3): δ 183.59 (C22), 183.55 
(C20), 167.73 (C6), 145.61 (C14), 138.8 (C9), 134.54 (C13), 129.20 (C16), 123.64 (C15), 
123.07 (C11), 120.40 (C12), 101.52 (C21), 59.57 (C1), 56.85 (C7), 32.44 (C2), 28.35 (C17), 
26.61 (C19), 26.54 (C3), 26.24 (C4), 25.38 (C23), 25.01 (C18b), 23.38 (C18a). FT-IR ν/cm‐
1 (intensity): 3123 (w), 3093 (w), 2962 (w), 2928 (w), 2871 (m), 1598 (m), 1574 (s), 1551 
(m), 1524 (s), 1390 (s), 1298 (w), 1255 (w), 1153 (w), 1028 (w), 939 (m), 807 (w), 780 












In an oven dried Schlenk tube 3.3.HCl (0.108 g, 0.268 
mmol) and Ag2O (0.0311 g, 0.134 mmol) were 
combined under nitrogen. DCM (5 mL) was added and 
the suspension stirred in the absence of light for 48 
hours. A solution of [Pd(allyl)Cl]2 (0.0490 g, 0.134 
mmol) in DCM (2 mL) was added to the cloudy white solution and stirring continued for 
a further 20 hours. The white suspension was filtered through a celite pad and the 
solvent removed by rotary evaporation. This gave the desired complex Pd(3.3)(allyl)Cl in 
a pure form as a fluffy, faint yellow solid. Yield 0.115 g (78%). MP: Decomposition onset 
at 165 oC. 1H NMR (400 MHz, DMSO‐d6): δ 8.03 (1H, d, J = 7.4 Hz, H5), 7.49 (1H, s, H12), 
7.45 (1H, s, H11), 7.42 (1H, t, J = 7.8 Hz, H16), 7.26 (2H, d, J = 7.8 Hz, H15), 4.97 (3H, m, 
H7, H20), 3.79 (1H, d, J = 7.4 Hz, H21syn), 3.52 (1H, m, H1), 2.76 (1H, d, J = 13.7 Hz, 
H21anti), 2.61 (2H, br.s, H17), 1.67 (4H, m, H2e/H3e), 1.51 (1H, d, J = 11.7 Hz, H4e), 1.39 
– 1.07 (14H, m, H2a, H3a, H4a, H18a), 1.00 (6H, d, J = 6.7 Hz, H8b). 13C NMR (100 MHz, 
DMSO‐d6): δ 182.15 (C9), 166.20 (C6), 146.23 (C14), 136.22 (C13), 130.04 (C16), 124.96 
(C11), 123.87 (C15), 123.55 (C12), 114.75 (C20), 71.01 (C21), 53.24 (C7), 49.30 (C19), 
48.11 (C1), 32.71 (C2), 27.99 (C17), 26.28 (C18b), 25.60 (C4), 24.82 (C3), 23.06 (18a). FT-
IR ν/cm‐1 (intensity): 3292 (w), 2963 (w), 2933 (m), 2856 (w), 1651 (s), 1544 (m), 1469 
(m), 1446 (m), 1413 (m), 1363 (w), 1255 (m), 1224 (w), 1153 (w), 959 (w), 892 (w), 804 
(w), 763 (w), 735 (w), 704 (w), 690 (w). ESI-MS: Found [M – Cl]+ 514.2055. 









8.4. Chapter 4 




In an oven dried Schlenk tube imidazo[4,5‐
f][1,10]phenanthroline (4.1) (0.440 g, 2.00 mmol) and oven 
dried K2CO3 (0.830 g 6.00 mmol) were combined and 
anhydrous DMF (8 mL), and benzylbromide (0.35 mL, 2.94 
mmol) added by syringe. A condenser was fitted and the 
system sparged with argon. The reaction was heated at 100 oC for 48 hours then allowed 
to cool to room‐temperature. DCM (20 mL) was added to the dark brown mixture which 
was then filtered, washed with additional DCM (20 mL) and the combined organic 
filtrates washed with water (3 x 20 mL). The organic phase was then extracted with HCl 
solution (0.5 M, 3 x 20 mL). The combined light yellow acid extracts were neutralised 
with solid K2CO3 and extracted back into DCM (3 x 25 mL). The combined organic extracts 
were dried over MgSO4, the solvent removed and the oily residue washed with Et2O and 
filtered giving 4.2 as a fine, light peach powder. Yield 0.288 g (47%). MP: 195 – 197 oC 
1H NMR (400 MHz, DMSO‐d6): δ 9.03 (1H, d, J = 3.3 Hz, H10), 8.93 (2H, m, H8, H2), 8.57 
(1H, s, H6), 8.51 (1H, d, J = 8.6 Hz, H4), 7.82 (1H, dd, J = 7.8 Hz, 4.3 Hz, H9), 7.62 (1H, dd, 
J = 8.6 Hz, 4.3 Hz, H3), 7.31 (2H, t, J = 7.4 Hz, H21), 7.24 (1H, t, J = 7.1 Hz, H22), 7.12 (2H, 
d, J = 7.4 Hz, H20), 6.05 (2H, s, H18). 13C NMR (100 MHz, DMSO‐d6): δ 148.76 (C10), 
147.89 (C2), 145.60 (C6), 144.16 (C12), 144.00 (C17), 137.22 (C15), 137.09 (C19), 130.03 
(C8), 129.71 (C4), 129.43 (C21), 128.14 (C22), 126.44 (C20), 124.26 (C16), 124.21 (C14), 
124.15 (C9), 123.1 (C3), 119.77 (C13), 50.3 (C18). ESI-MS: Found [MH]+ 311.1294, 
[C20H15N4]+ requires 311.1297. UV-vis (DCM) λmax/nm (ε, 103 M‐1cm‐1): 252 (25.8), 283 



































In an oven dried Schlenk tube imidazo[4,5‐f][1,10]phenanthroline 
(4.1) (0.440 g, 2.0 mmol) and oven dried K2CO3 (0.607 g, 4.00 mmol) 
were combined and anhydrous DMF (5 mL), and iodobenzene (1.12 
mL, 10.0 mmol) added by syringe. A condenser was fitted and the 
system sparged with argon. The reaction was heated to reflux for 
one hour then Cu(OAc)2.H2O (0.040 g 0.20 mmol) was added under 
an argon blanket causing the yellow suspension to bubble vigorously and turn dark 
brown. Refluxing was continued for 48 hours then upon cooling to room temperature 
solid EDTA.2Na (0.101 g, 0.300 mmol) was added and the mixture stirred briefly before 
pouring onto DCM (40 mL). The mixture was filtering through a celite pad and rinsed 
through with additional DCM (10 mL). The organic filtrate was washed with water (30 
mL) and brine (30 mL), then condensed by rotary evaporation. The oily dark brown 
residue was purified by column chromatography (alumina, 2% MeOH/DCM) to give 4.3 
as a fine off white powder. Yield 0.352 g (60%). MP: 225 – 227 oC. 1H NMR (500 MHz, 
CD3OD): δ 9.04 (1H, dd, J = 4.4 Hz, 1.7 Hz, H10), 8.97 (1H, dd, J = 8.2 Hz, 1.6 Hz, H8), 8.93 
(1H, dd, J = 4.4 Hz, 1.5 Hz, H2), 8.38 (1H, s, H6), 7.83 (1H, dd, J = 8.0 Hz, 4.4 Hz, H9), 7.75 
– 7.74 (3H, m, H20, H21), 7.72 – 7.70 (3H, m, H4, H19), 7.44 (1H, dd, J = 8.5 Hz, 4.2 Hz, 
H3). 13C NMR (125 MHz, CD3OD): δ 148.23 (C10), 147.69 (C2), 143.83 (C17), 143.70 (C6), 
143.45 (C12), 136.68 (C18), 135.50 (C15), 130.17 (C8, C21), 130.14 (19), 128.54 (C4), 
127.04 (C20), 124.89 (C14), 123.74 (C9), 123.61 (C16), 122.43 (C3), 119.39 (C13). ESI-
MS: Found [MH]+ 297.1135, [C19H13N4]+ requires 297.1140. UV-vis (DCM) λmax/nm (ε, 





































Synthesis performed as reported for 4.3 using imidazo[4,5‐
f][1,10]phenanthroline (4.1) (0.220 g, 0.999 mmol) and 2‐bromo‐
pyridine (0.48 mL, 5.00 mmol). Column chromatography (alumina, 
2% MeOH/DCM) provided 4.4 as a fine off white powder. Yield 
0.134 g (45%). MP: 224 oC. 1H NMR (400 MHz, CDCl3): δ 9.18 (1H, 
d, J = 4.3 Hz, H10), 9.10 (1H, d, J = 4.3 Hz, H2), 9.02 (1H, d, J = 7.9 
Hz, H8), 8.77 (1H, d, J = 4.3 Hz, H22), 8.23 (1H, s, H6), 8.05 (1H, t, J = 7.4 Hz, H20), 7.93 
(1H, d, J = 8.2 Hz, H4), 7.74 (1H, dd, J = 4.3 Hz, 8.3 Hz, H9), 7.60 (2H, m, H19, H21), 7.41 
(1H, dd, J = 4.3 Hz, 8.3 Hz, H3). 13C NMR (100 MHz, CDCl3): δ 150.17 (C22), 150.04 (C18), 
149.20 (C10), 148.45 (C2), 144.95 (C12), 144.50 (C17), 144.62 (C6), 139.57 (C20), 137.54 
(C15), 130.57 (C8), 129.49 (C4), 124.69 (C21), 124,39 (C14), 124.03 (C16), 123.60 (C9), 
122.03 (C3), 120.21 (C19), 119.49 (C13). ESI-MS: Found [MH]+ 298.1061, [C18H12N5]+ 
requires 298.1093. UV-vis (DCM) λmax/nm (ε, 103 M‐1cm‐1): 282 (15.8), 337 (0.7), 368 





In an oven dried pressure tube 4.3 (0.0988 g, 0.333 mmol) was dissolved in MeNO2 (0.5 
mL) and 1‐iodiobutane (1.0 mL, 8.7 mmol) was added. The tube was sealed and heated 
at 150 oC for 3 hours. Upon returning to room temperature the dark orange solution was 
poured onto pet ether (30 mL) and the resultant bright yellow precipitate was collected 
by filtration and the products isolated by gradient flash chromatography (alumina, 2% ‐ 
5% MeOH/DCM). Evaporation of the appropriate fractions gave 4.11.I and 4.12.I as 
bright yellow powders. Several fractions bore a mixture of isomers which had a 
combined mass of 0.0513 g and an overall isomeric ratio of 1 :  2.2, 4.11.I : 4.12.I. Overall 






1-phenyl-1H-imidazol[4,5f][1,10]phenanthrolin-(N′-butyl)-ium Iodide (4.11.I)   
 
Isolated yield 0.0255 g (16%). MP: 188 oC. 1H NMR (400 
MHz, CDCl3): δ 10.33 (1H, d, J = 5.5 Hz, H10), 9.80 (1H, d, J 
= 8.3 Hz, H8), 9.11 (1H, d, J = 3.5 Hz, H2), 8.52 (1H, m, H9), 
8.23 (1H, s, H6), 7.96 (1H, d, J = 8.2 Hz, H4), 7.75 (3H, m, 
H20, H21), 7.67 (1H, dd, J = 4.3H z, 8.7 Hz, H3), 7.59 (2H, m, 
H19), 6.16 (2H, m, H22), 2.15 (2H, m, H23), 1.65 (2H, m, 
H24), 1.02 (3H, m, H25). 13C NMR (100 MHz, CDCl3): δ 150.85 (C10), 147.48 (C2), 145.06 
(C6), 139.80 (C8), 138.67 (C12), 135.73 (C15), 134.63 (C17), 131.19 (C21), 130.99 (C20), 
129.57 (C4), 128.49 (C16), 126.91 (C18, C19), 126.84 (C14), 125.73 (C9), 124.74 (C3), 
122.56 (C13), 64.93 (C22), 33.96 (C23), 19.75 (C24), 13.84 (C25). ESI-MS: Found M+ 
353.1754, [C23H21N4]+ requires 353.1766. UV-vis (DCM) λmax/nm (ε, 103 M‐1cm‐1): 257 
(31.4), 301 (30.5), 389 (3.0). Fluorometry (DCM) λmax: 482 nm. 
 
1-phenyl-1H-imidazol[4,5f][1,10]phenanthrolin-(N′′-butyl)-ium Iodide  (4.12.I) 
 
Isolated yield 0.0081 g (5%). MP: insufficient sample. 1H 
NMR (400 MHz, CDCl3): δ 10.16 (1H, d, J = 5.9 Hz, H2), 9.27 
(1H, dd, J = 8.3 Hz, 1.5 Hz, H8), 9.20 (1H, dd, J = 4.2 Hz, 1.7 
Hz, H10), 8.45 (1H, d, J = 7.8 Hz, H4), 8.31 (1H, dd, J = 8.6 
Hz, 5.9 Hz, H3), 8.25 (1H, s, H6), 7.97 (1H, dd, J = 8.2 Hz, 4.3 
Hz, H9), 7.77 (3H, m, H20, H21), 7.58 (2H, m, H19), 6.16 
(2H, t, J = 7.8 Hz, H22), 2.19 (2H, p, J = 7.8 Hz, H23), 1.65 (2H, m, H24), 1.05, (3H, t, J = 
7.5 Hz, H25). 13C NMR (100 MHz, CDCl3): δ 150.20 (C2), 148.05 (C10), 145.81 (C6), 136.59 
(C4), 131.79 (C8), 131.42 (C21), 131.30 (C20), 126.86 (C19), 125.59 (C9), 125.30 (C3), 
65.72 (C22), 33.91 (C23), 19.73 (C24), 13.75 (C25). ESI-MS: Found M+ 353.1756, 
[C23H21N4]+ requires 353.1766. UV-vis (DCM) λmax/nm (ε, 103 M‐1cm‐1): 227 (23.2), 252 

































































1-Phenyl-3′-methyl-1H-imidazolium[4,5f][1,10]phenanthroline Iodide (4.9.HI) 
 
In an oven dried Schlenk tube 4.3 (0.149 g, 0.503 mmol) was 
dissolved in MeNO2 (0.75 mL) under an argon atmosphere. 
Iodomethane (1.00 mL, 16.1 mmol) was added and the solution 
heated to reflux. After 20 hours a yellow suspension had formed 
which was cooled to room temperature and Et2O (20 mL) added 
resulting in a yellow precipitate. This was collected by filtration 
and washed with warm DCM (2 x 5 mL) to give 4.9.HI as a fine, pale brown powder. Yield 
0.0707 g (32%). MP: 270 – 272 oC. 1H NMR (400 MHz, DMSO‐d6): δ 10.15 (1H, s, H6), 
9.29 (1H, d, J = 3.9Hz, H10), 9.21 (1H, d, J = 8.2 Hz, H8), 9.16 (1H, d, J = 3.5 Hz, H2), 8.06 
(1H, 1, dd, J = 8.2 Hz, 4.3 Hz, H9), 7.96 – 7.87 (5H, m, H19, H20, H21), 7.68 (1H, dd, J = 
8.1 Hz, 4.1 Hz, H3), 7.53 (1h, d, J = 8.2 Hz, H4), 4.64 (3H, s, H22). 13C NMR (100 MHz, 
DMSO‐d6): δ 151.07 (C2), 151.05 (C10), 145.08 (C17), 144.97 (C12), 143.86 (C6), 134.80 
(C18), 132.55 (C21), 131.32 (C20), 131.23 (C8), 128.93 (C4), 127.73 (C19), 125.59 (C14), 
125.29 (C15), 124.71 (C9), 124.22 (C3), 118.57 (C16), 117.97 (C13), 38.41 (C22). ESI-MS: 
Found M+ 311.1290, [C20H15N4]+ requires 311.1297. UV-vis (MeCN) λmax/nm (ε, 103 M‐
1cm‐1): 244 (69.1), 270(sh) (20.6), 319 (0.9), 336 (0.5). Fluorometry (MeCN) λmax: 462 
nm. 
 
1-phenyl-1H-imidazol[4,5f][1,10]phenanthrolin-(N′-methyl)-ium Iodide (4.13.I) 
 
In an oven dried Schlenk tube 4.3 (0.0996 g, 0.336 mmol) was 
dissolved in DCM (10 mL) under an argon atmosphere. 
Iodomethane (25 uL, 0.40 mmol) was added and the solution 
heated to reflux. After 24 hours an additional equivalent of 
iodomethane (25 uL, 0.40 mmol) was added and refluxing 
continued for 20 hours. The yellow solution was then cooled to 
room temperature the solvent removed by rotary evaporation. Isolation of the product 
from the resultant yellow residue was achieved by flash chromatography (alumina, 2.5% 
MeOH/DCM) and evaporation of the appropriate fractions gave 4.13.I as a flaky dark 
























































(1H, d, J = 5.8 Hz, H10), 9.82 (1H, d, J = 7.8 Hz, H8), 9.12 (1H, dd, J = 4.1 Hz, 1.8 Hz, H2), 
8.47 (1H, dd, J = 8.2 Hz, 5.9 Hz, H9), 8.23 (1H, s, H6), 7.94 (1H, dd, J = 8.6 Hz, 1.6 Hz, H4), 
7.75 (3H, m, H20, H21), 7.60 (3H, m, H3, H19), 5.56 (3H, s, H22). 13C NMR (100 MHz, 
CDCl3): δ 151.36 (C10), 147.15 (C2), 144.92 (C6), 139.82 (C8), 131.01 (C21), 130.82 (C20), 
129.16 (C4), 126.87 (C19), 125.37 (C9), 124.27 (C3), 55.75 (C22). ESI-MS: Found M+ 
311.1299, [C20H15N4]+ requires 311.1297. UV-vis (DCM) λmax/nm (ε, 103 M‐1cm‐1): 235 
(22.7), 255 (20.8), 302 (15.7), 389 (1.9). Fluorometry (DCM) λmax: 482 nm. 
 




In a round‐bottom flask, 4.2 (0.103 
g, 0.322 mmol), Ru(bipy)2Cl2 (0.156 
g, 0.322 mmol) and ethylene‐glycol 
(15 mL) were combined and placed 
in a microwave reactor (350 W), 
with condenser fitted. The reaction 
was heated in 2 minute bursts with 
complex formation and ligand consumption monitored by TLC (silica, 4:1:1 
DMF/water/1 M NH4Cl). After two, 2 minute bursts the ligand had been consumed. 
Water (50 mL) was added to the solution, filtered through celite and washed through 
with additional water (20 mL). The product was isolated by ion‐exchange 
chromatography (sephadex – C25, 0 to 0.20 M NaCl). Solid KPF6 was added to the 
appropriate, dark orange fraction and stirred for 30 minutes. The resultant precipitate 
was collected by filtration and washed with KPF6 solution then water and dried with Et2O 
to give [Ru(bipy)2(4.2)][PF6]2 as a fine, bright orange powder. Yield 0.219 g (67%). MP: 
240 oC. 1H NMR (400 MHz, Acetone‐d6): δ 9.16 (1H, d, J = 8.3 Hz, H8), 8.89 – 8.76 (5H, 
m, H4, H3′, H3′′), 8.72 (1H, s, H6), 8.36 (1H, d, J = 5.5 Hz, H10), 8.30 (1H, d, J = 5.1 Hz, 
H2), 8.23 (2H, dd, J = 7.9 Hz, 7.8 Hz, H4′′), 8.14 – 8.09 (4H, m, H4′, H6′′), 7.96 (1H, dd, J = 




= 8.6 Hz, 5.4 Hz, H3), 7.61 (2H, dd, J = 6.6 Hz, 6.3 Hz, H5′′), 7.39 – 7.31 (7H, m, H20, H21, 
H22, H5′), 6.21 (2H, s, H18). 13C NMR (100 MHz, Acetone‐d6): δ 157.42 (C2′′), 157.37 
(C2′′), 157.23 (C2′), 157.22 (C2′), 151.95 (C6′′), 151.90 (C6′), 150.72 (C10), 150.14 (C2), 
146.64 (C6), 146.05 (C12), 145.92 (C17), 138.51 (C15), 138.09 (C4′′), 137.94 (C4′), 135.70 
(C19), 130.75 (C8), 130.25 (C4), 129.21 (C21), 128.24 (C22), 127.86 (C5′′), 127.84 (C5′′), 
127.70 (C5′), 127.66 (C5′), 126.71 (C16), 126.58 (C9), 126.54 (C20), 125.75 (C3), 125.47 
(C14), 124.42 (C3′/C3′′), 124.34 (C3′/C3′′), 121.94 (C13), 50.62 (C18). ESI-MS: Found M2+ 
362.0824, [M + PF6]+ 869.1283, [C40H30N8Ru]2+ requires 362.0819, [C40H30F6N8PRu]+ 
requires 869.1284. UV-vis (MeCN) λmax/nm (ε, 103 M‐1cm‐1): 254 (50.3), 284(79.3), 




Performed as reported for 
[Ru(bipy)2(4.2)][PF6]2 using 4.3 (0.0499 g, 
0.168 mmol), Ru(bipy)2Cl2 (0.0811 g, 
0.167 mmol) and ethylene‐glycol (7 mL). 
After two, 2 minute bursts the ligand and 
Ru(bipy)2Cl2 had been consumed. The 
solution was poured onto water (25 mL), 
filtered through celite and washed through with additional water (20 mL). With stirring, 
saturated KPF6 solution was added in excess resulting in immediate precipitate 
formation. This was stirred for 30 minutes then cooled in a refrigerator overnight. The 
resultant precipitate was collected by filtration, washed with water and Et2O then dried 
in a vacuum desiccator to give [Ru(bipy)2(4.3)][PF6]2 as a fine orange powder. Yield 
0.1551 g (93%). MP: + 300 oC. 1H NMR (400 MHz, Acetone‐d6): δ 9.20 (1H, d, J = 8.6 Hz, 
H8), 8.86 – 8.79 (4H, m, H3′, H3′′), 8.62 (1H, s, H6), 4.43 (1H, d, J = 5.1 Hz, H10), 8.32 (1H, 
d, J = 5.5 Hz, H2), 8.24 (2H, m, H4′′), 8.14 (4H, m, H4′, H6′′), 7.99 (2H, m, H4, H9), 7.93 
(1H, d, J = 5.9 Hz, H6′), 7.88 (1H, d, J= 5.9 Hz, H6′), 7.80 (5H, m, H19, H20, H21), 7.70 – 
7.59 (3H, m, H3, H5′′), 7.40 (2H, m, H5′). 13C NMR (100 MHz, Acetone‐d6): δ 157.44 (C2′′), 




(C12), 146.06 (C17), 145.71 (C6), 138.11 (C4′′), 137.98 (C4′), 137.68 (C15), 136.27 (C18), 
130.86 (C8), 130.67 (C21), 130.57 (C19), 128.08 (C4), 127.89 (C5′′), 127.87 (C5′′), 127.75 
(C5′), 127.71 (C5′), 127.20 (C20), 126.70 (C9), 126.60 (C16), 126.22 (C14), 125.66 (C3), 
124.44 (C3′′), 124.37 (C3′), 121.99 (C13). ESI-MS: Found M2+ 355.0743, [M + PF6]+ 
855.1131, [C39H28N8Ru]2+ requires 355.0740, [C39H28F6N8PRu]+ requires 855.1122. UV-vis 
(MeCN) λmax/nm (ε, 103 M‐1cm‐1): 254 (50.2), 284 (80.3), 425(sh) (13.5), 454 (17.0).   




In a round‐bottom flask Ru(bipy)2Cl2 
(0.0791 g, 0.163 mmol) and ethylene‐
glycol (6 mL) were combined and placed 
in a microwave reactor (350 W), with 
condenser fitted. The mixture was 
heated for 2 minutes to give a 
homogeneous solution then 4.4 (0.0497 
g, 0.167 mmol) was added. The solution was heated in 2 minute bursts with complex 
formation and starting material consumption monitored by TLC (silica, 4:1:1 
DMF/water/1 M NH4Cl). After two, 2 minute bursts the starting material had been 
consumed. Water (20 mL) was added to the solution, filtered through celite and washed 
through with additional water (20 mL). With stirring, saturated KPF6 solution was added 
in excess resulting in immediate precipitate formation. This was stirred for 30 minutes 
then cooled in a refrigerator overnight. The resultant precipitate was collected by 
filtration, washed with water and Et2O, and dried in a vacuum desiccator to give 
[Ru(bipy)2(4.4)][PF6]2 as a fine orange powder. Yield 0.1118 g (67%). MP: 239 – 244 oC. 
1H NMR (400 MHz, CD3CN): δ 9.16 (1H, d, J = 7.8 Hz, H8), 8.77 (1H, d, J = 2.9 Hz, H22), 
8.63 – 8.45 (5H, m, H6, H3′, H3′′), 8.30 – 8.19 (2H, m, H4, H20), 8.18 – 8.07 (3H, m, H10, 
H4′′), 8.07 – 7.97 (3H, m, 2H, H4′), 7.93 – 7.79 (4H, m, H9, H19, H6′′), 7.74 (1H, dd, J = 7.4 
Hz, 5.1 Hz, H21), 7.63 (1H, d, J = 5.5 Hz, H6′), 7.59 (1H, d, J = 5.5 Hz, H6′), 7.54 (1H, dd, J 
= 8.6 Hz, 5.1 Hz, H3), 7.46 (2H, m, H5′′, H5′′). 13C NMR (100 MHz, CD3CN): δ 158.29 (C2′′), 




(C6′/C6′′), 152.00 (C10), 151.59 (C2), 151.99 (C22), 150.27 (C18), 147.38 (C12), 147.29 
(C17), 146.45 (C6), 141.54 (C20), 139.32 (C15), 138.93 (C4′′), 138.79 (C4′), 132.00 (C4, 
C8), 128.64 (C5′′), 128.50 (C5′), 127.55 (C16), 127.45 (C9), 126.59 (C14, C21), 126.25 (C3), 
125.33 (C3′′), 125.25 (C3′), 123.20 (C13), 121.71 (C19). ESI-MS: Found M2+ 355.5706, 
[C38H27N9Ru]2+ requires 355.5716. UV-Vis (MeCN) λmax/nm (ε, 103 M‐1cm‐1): 253 (49.8), 




Argon was bubbled through a stock 
solution of 4:1 EtOH/water for 30 
minutes to degas. Ligand 4.9.HI (0.0219 
g, 0.0507 mmol) and Ru(bipy)2Cl2 
(0.0242 g, 0.0502 mmol) were combined 
in a 25 mL round‐bottom flask, a 
condenser fitted and an argon blanket 
applied. Degassed EtOH/water (5 mL) was added by syringe and the reaction mixture 
refluxed for 22 hours in the absence of light. The dark red solution was cooled to room 
temperature and condensed by rotary‐evaporation. The residue was purified by flash 
chromatography (silica, 9:1.5:1 MeCN/water/saturated KNO3(aq)) with the desired 
product eluting as a bright orange band.  The appropriate fractions were combined and 
condensed by rotary‐evaporation then dissolved in a minimum of distilled water and 
precipitated by addition of a saturated KPF6 solution. The resultant precipitate was 
collected by filtration and washed with saturated KPF6 solution, water and Et2O to give 
pure [Ru(bipy)2(4.7.H)][PF6]3 as a fine orange powder. Yield 0.0412 g (71%). MP: + 300 
oC.  1H NMR (400 MHz, CD3CN): δ 9.49 (1H, s, H6), 9.24 (1H, d, J = 8.6 Hz, H8), 8.62 – 8.50 
(4H, m, H3′, H3′′), 8.33 (1H, d, J = 5.1 Hz, H10), 8.24 – 8.00 (5H, m, H2, H4′, H4′′), 7.99 – 
7.79 (7H, m, H9, H19, H20, H6′′), 7.74 (2H, m, H4, H21), 7.61 – 7.53 (3H, m, H3, H6′), 7.48 
(2H, m, H5′′), 7.28 (2H, m, H5′), 4.66 (3H, s, H22). 13C NMR (100 MHz, CD3CN): δ 158.11 
(C2′/C2′′), 158.08 (C2′/C2′′), 158.03 (C2′/C2′′), 157.98 (C2′/C2′′), 154.42 (C10), 154.4 (C2), 




(C4′/C4′′), 139.25 (C4′/C4′′), 139.19 (C4′/C4′′), 139.17 (C4′/C4′′), 134.61 (C18), 132.33 
(C19), 132.16 (C8), 130.68 (C4), 128.82 (C5′/C5′′), 128.78 (C5′/C5′′), 128.61 (C5′/C5′′), 
128.60 (C5′/C5′′), 128.06 (C9, C20, C21), 127.96 (C14), 127.80 (C3), 127.54 (C15), 125.53 
(C3′/C3′′), 125.50 (C3′/C3′′), 125.49 (C3′/C3′′), 125.46 (C3′/C3′′), 122.23 (C16), 121.96 
(C13), 39.23 (C22). ESI-MS: Found M3+ 241.7178, [M + PF6]2+ 435.0582, [M + 2PF6]+ 
1015.0820. [C40H31N8Ru]3+ requires 241.7238, [C40H31N8F6PRu]2+ requires 435.0679, 
[C40H31N8OF12P2Ru]+ requires 1015.0999. UV-Vis (MeCN) λmax/nm (ε, 103 M‐1cm‐1): 245 





Complex [Ru(bipy)2(4.4)][PF6]2 (0.0469 
g, 0.0468 mmol) was weighed into a 
pressure tube and dissolved in dry DMF 
(2 mL) that had been degassed by 
bubbling argon prior use. Iodomethane 
(31.2 μL, 0.500 mmol) was added and 
the tube sealed with a Teflon screw‐top. 
The reaction was heated to 100  oC for 48 hours after which time the reaction was cooled 
to room temperature. TLC (silica, 9:1.5:1 MeCN/water/saturated KNO3(aq)) revealed 
minimal product formation, however, the reaction was not continued. The mixture was 
taken up in 20 mL of water, saturated KPF6 solution added and the resulting precipitate 
collected by filtration. Flash chromatography (silica, 9:1.5:1 MeCN/water/saturated 
KNO3(aq)) was used to isolate the desired product as well as recover the remaining 
starting material. The appropriate fractions were combined and condensed by rotary‐
evaporation then dissolved in a minimum of distilled water and precipitated by the 
addition of a saturated KPF6 solution. The resultant precipitate was collected by filtration 
and washed with saturated KPF6 solution, water and Et2O to give pure 
[Ru(bipy)2(4.9.H)][PF6]3 as a fine orange powder. Yield = 0.0116 g (21%). MP: + 300 oC. 
1H NMR (400 MHz, CD3CN): δ 9.51 (1H, s, H6), 9.22 (1H, d, J = 8.6 Hz, H8), 8.84 (1H, d, J 




J = 5.1 Hz, H2), 8.13 (2H, m, H4′′), 8.02 (2H, m, H4′), 7.98 – 7.86 (4H, m, H4, H9, H19, 
H21), 7.80 (1H, d, J = 5.5 Hz, H6′′), 7.80 (1H, d, J = 5.5 Hz, H6′′), 7.63 – 7.55 (2H, m, H3, 
H6′), 7.53 (1H, d, J = 5.5 Hz, H6′), 7.50 – 7.41 (2H, m, H5′′), 7.25 (2H, t, J = 6.5 Hz, H5′), 
4.65 (3H, s, H22). 13C NMR (100 MHz, CD3CN): δ 158.40 (C2′/C2′′, C2′/C2′′), 158.33 
(C2′/C2′′), 158.28 (C2′/C2′′), 154.95 (C2), 154.91 (C10), 153.44 (C6′/6′′), 153.35 (C6′/C6′′), 
153.31 (C6′/C6′′), 153.24 (C6′/C6′′), 152.37 (C22), 149.00 (C12/C17), 148.97 (C12/C17), 
147.83 (C18), 145.19 (C6), 142.90 (C20), 139.59 (C4′′), 139.57 (C4′′), 139.49 (C4′, C4′), 
132.51 (C8), 132.17 (C4), 129.38 (C21), 129.12 (C5′′), 129.09 (C5′′), 128.89 (C5′), 128.87 
(C5′), 128.35 (C9) 128.25 (C15), 128.09 (C3), 127.49 (C14), 125.83 (C3′/C3′′), 125.79 
(C3′/C3′′), 125.78 (C3′/C3′′), 125.75 (C3′/C3′′), 123.30 (C19), 122.55 (C16), 121.03 (C13), 
39.88 (C22). ESI-MS: Found M3+ 242.0527. [C39H30N9Ru]3+ requires 242.0556. UV-Vis 
(MeCN) λmax/nm (ε, 103 M‐1cm‐1): 245 (89.3), 276 (92.6), 285 (97.9), 437 (20.5), 469(sh) 
(16.9). Fluorometry (MeCN) λmax: 633 nm. 
 
8.5. Chapter 5 




An oven dried Schlenk tube was charged with 3‐bromo‐1,10‐
phenanthroline (0.350 g, 1.35 mmol), imidazole (0.153 g, 2.25 mmol) and 
anhydrous CuSO4 (0.008 g, 0.05 mmol). The vessel sparged with nitrogen 
heated at 180 oC forming a dark brown melt. After 4 hours the mixture 
was cooled and the resultant pellet crushed and stirred in water (15 mL) 
until all large chunks had dissolved, then extracted into chloroform. This 
was made difficult by formation of an emulsion and washes had to be 
filtered to remove green solid. Eventually organic extracts were obtained and dried over 
MgSO4 before removal of the solvent. The off white residue was triturated in acetone 
(10 mL) for 30 minutes before filtering and air drying to provide 5.1 as a white powder. 


























(1H, d, J = 2.3 Hz, H2), 9.22 (1H, d, J = 3.9 Hz, H9), 8.29 (1H, d, J = 8.2 Hz, H7), 8.23 (1H, 
d, J = 2.3 Hz, H4), 8.06 (1H, s, H16), 7.91 (1H, d, J = 9.0 Hz, H6), 7.85 (1H, d, J = 9.0 Hz, 
H5), 7.68 (1H, dd, J = 8.2 Hz, 4.3 Hz, H8), 7.49 (1H, s, H18), 7.34 (1H, s, H19). 13C NMR 
(100 MHz, CDCl3): δ 150.92 (C9), 145.83 (C14), 145.08 (C11), 143.53 (C2), 136.17 (C7), 
135.75 (C16), 132.62 (C3), 131.44 (C19), 128.71 (C12), 128.61 (C13), 128.49 (C6), 126.81 
(C4), 125.84 (C5), 124.15 (C8), 118.24 (C18). ESI-MS: Found [MH]+ 247.0986, [C15H11N4]+ 
requires 247.0984. 
 
3-(1-methylimidazolium)-1,10-phenanthroline hexafluorophosphate (5.2.HPF6) 
 
An oven dried Schlenk tube was charged with 5.1 (0.101 g, 0.411 
mmol) and sparged with nitrogen. Anhydrous DCM (10 mL) was 
added by syringe followed by iodomethane (0.13 mL, 2.09 mmol). The 
stirred solution was heated to reflux and, after 14 hours, additional 
iodomethane was added (0.13 mL, 2.09 mmol). After refluxing for a 
further 6 hours the yellow mixture was cooled to room temperature 
and the solid collected by filtration and washed with DCM (30 mL) 
and Et2O (30 mL) before drying under vacuum. The fine, light brown powder was 
dissolved in water (20 mL) and the turbid mixture filtered through celite. The desired 
product was precipitated from the colourless filtrate as a PF6 salt by addition of excess 
solid KPF6 and collected by filtration. The solid was washed with cold water followed by 
Et2O and dried under vacuum providing pure 5.2.HPF6 as a fine white powder. 
Recrystallisation from hot methanol provided extremely pure material for analysis. Yield 
0.0591 (35%). MP: decomposition onset at 150 oC. 1H NMR (400 MHz, CD3CN): δ 9.32 
(1H, d, J = 2.3 Hz, H2), 9.21 (1H, d, J = 4.3 Hz, H9), 9.07 (1H, s, H16), 8.65 (1H, d, J = 1.9 
Hz, H4), 8.50 (1H, d, J = 8.6 Hz, H7), 8.22 (1H, d, J = 9.0 Hz, H6), 8.04 (1H, d, J = 9.0 Hz, 
H5), 7.96 (1H, s, H19), 7.82 (1H, dd, J = 8.3 Hz, 4.4 Hz, H8), 7.67 (1H, s, H18), 4.04 (3H, s, 
H20).  13C NMR (100 MHz, CD3CN): δ 150.85 (C9), 146.47 (C11), 146.09 (C14), 143.51 
(C2), 136.48 (C7), 135.88 (C16), 130.35 (C3), 129.87 (C4), 129.62 (C12), 129.25 (C6), 





























Found [MH]2+ 131.0604, M+ 261.1136. [C16H14N4]2+ requires 131.0609, [C16H13N4]+ 
requires 261.1140. 
 




In a round‐bottom flask Ru(bipy)2Cl2 (0.113 g, 
0.232 mmol) and ethylene‐glycol (5 mL) were 
combined and placed in a microwave reactor 
(350 W) with condenser fitted. This was 
irradiated until all Ru(bipy)2Cl2 had dissolved. 
Ligand 5.2.HPF6 (0.0922 g, 0.238 mmol) was 
added and the solution was irradiated for a 
further 2 minutes. The cooled solution was 
poured onto water (10 mL) filtered through celite and washed through with additional 
water (15 mL). Saturated KPF6 solution was added in excess to the aqueous solution and 
stirred for 30 minutes. The resulting precipitate was then filtered and washed with 
saturated KPF6 solution followed by distilled water (15 mL), methanol (15 mL) and Et2O 
to give [Ru(bipy)2(5.2.H)][PF6]3 as a fine, orange powder. Yield 0.0229 g (89%). MP: + 300 
oC. 1H NMR (400 MHz, CD3CN): δ 8.82 (1H, d, J = 1.6 Hz, H4), 8.77 (1H, s, H16), 8.71 (1H, 
d, J = 8.2 Hz, H7), 8.57 – 8.50 (4H, m, H3’, H3”), 8.42 (1H, d, J = 9.0 Hz, H6), 8.35 (1H, d, J 
= 9.0 Hz, H5), 8.22 (1H, d, J = 1.9 Hz, H2), 8.16 – 8.02 (5H, m, H9, H4’, H4’’), 7.87 – 7.82 
(2H, m, H8, H6’’), 7.77 (1H, d, J = 5.5 Hz, H6’’), 7.71 (2H, m, H18/H19, H6’), 7.58 (1H, s, 
H18/H19), 7.50 – 7.43 (3H, m, H6’, H5’’), 7.27 (2H, dd, J = 15.2 Hz, 7.3 Hz, H5’), 3.95 (3H, 
s, H20). 13C NMR (100 MHz, CD3CN): δ 157.20 (C2’/C2’’), 157.15 (C2’/C2’’), 156.87 
(C2’/C2’’), 153.39 (C9), 152.33 (C6’/C6’’), 152.16 (C6’/C6’’), 151.99 (C6’/C6’’), 151.84 
(C6’/C6’’), 148.09 (C11), 147.50 (C2), 146.99 (C14), 138.18 (C4’/C4’’), 138.05 (C4’/C4’’), 
138.04 (C4’/C4’’), 138.02 (C4’/C4’’), 137.19 (C7), 136.27 (C16), 132.07 (C13), 131.60 (C4), 
130.28 (C12), 130.09 (C6), 127.82 (C5), 127.71 (C5’’), 127.67 (C5’’), 127.45 (C5’), 127.37 




(C3’/C3’’), 122.79 (C18/C19), 36.54 (C20). ESI-MS: Found M3+ 225.0476, [M – H]2+ 
337.0682, [M + PF6]2+ 410.0532, [M + 2PF6]+ 965.0666. [C36H29N8Ru]3+ requires 225.0517, 
[C36H28N8Ru]2+ requires 337.0739, [C36H29F6N8PRu]2+ requires 410.0599, 
[C36H29F12N8P2Ru]+ requires 965.0846. UV-vis (MeCN) λmax/nm (ε, 103 M‐1cm‐1): 235 
(43.6), 273 (72.2), 284 (68.8), 438 (15.5).  
 
[Ru(bipy)2(5.2.H)][PF6]3 and [Ru(bipy)2(5.3)][PF6]2 
 
In a round‐bottom flask 5.2.HPF6 (0.0313 g, 0.0770 mmol), Ru(bipy)2Cl2 (0.0353 g, 0.0729 
mol) and ethylene‐glycol (9 mL) were combined and placed in a microwave reactor (350 
W), with condenser fitted. The reaction was heated in 2 minute bursts and complex 
formation and ligand consumption monitored by TLC (silica, 4:1:1 DMF/water/1 M 
NH4Cl). After three, 2 minute bursts the Ru(bipy)2Cl2 had been consumed. The solution 
was poured onto water (10 mL) filtered through celite and washed through with 
additional water (20 mL). The product was isolated by ion‐exchange chromatography 
with gradient elution (sephadex – C25, 0 to 0.20 M NaCl). Complex [Ru(bipy)2(5.3)]2+ was 
collected in the leading band and [Ru(bipy)2(5.2.H)]3+ was collected in the final band with 
0.4 M NaCl washes. Both were isolated as their PF6 salts by addition of saturated KPF6 
solution to the appropriate fractions with stirring. The resulting bright orange, turbid 
suspensions were each extracted with DCM (3 x 20 mL), dried over MgSO4 and the 
solvent removed under vacuum to give [Ru(bipy)2(5.2.H)][PF6]3 and 
















Isolated yield 0.0322 g (40%). MP: + 300 oC. 1H 
NMR (400 MHz, CD3CN): δ 8.57 – 8.47 (5H, m, H7, 
H3’, H3’’), 8.18 (1H, d, J = 9 Hz, H6), 8.14 – 8.06 
(4H, m, H5, H4, H4”), 8.02 – 7.97 (3H, m, H9, H4’), 
7.85 (1H, d, J = 5.5 Hz, H6’’), 7.82 (1H, d, J = 5.5 
Hz, H6’’), 7.71 (1H, d, J = 2.7 Hz, H2), 7.66 – 7.61 
(2H, m, H8, H6’), 7.53 (1H, d, J = 5.1 Hz H6’), 7.44 
(2H, m, H5’’), 7.23 (2H, m, H5’), 4.22 (2H, m, H17), 
3.84 (2H, m, H16), 3.00 (1H, m, H18). 13C NMR (100 MHz, CD3CN): δ 158.33 (C2’/C2’’), 
158.27 (C2’/C2’’), 157.99 (C2’/C2’’), 157.92 (C2’/C2’’), 157.59 (C3), 153.17 (C9), 153.11 
(C6’’), 152.95 (C6’’), 152.92 (C6’), 152.79 (C6’), 148.62 (C14), 145.70 (C2), 142.46 (C11), 
138.85 (C4’/C4’’), 138.78 (C4’/C4’’), 138.69 (C4’/C4’’), 138.66 (C4’/C4’’), 137.78 (C7), 
133.20 (C12), 130.27 (C13), 129.48 (C6), 128.60 (C5), 128.47 (C5’/C5’’), 128.39 (C5’/C5’’), 
128.32 (C5’/C5’’), 125.85 (C8), 125.23 (C3’/C3’’), 125.20 (C3’/C3’’), 125.17 (C3’/C3’’), 
125.08 (C3’/C3’’), 117.65 (C4), 72.09 (C17), 60.83 (C16). ESI-MS: Found M2+ 327.0653, 
[M + PF6]+ 799.0946. [C34H28N6O2Ru]2+ requires 327.0659, [C34H28F6N6O2PRu]2+ requires 
799.0959. UV-vis (MeCN) λmax/nm (ε, 103 M‐1cm‐1): 232 (39.8), 243(sh) (38.4), 285 
(60.3), 428(sh) (13.1), 442 (15.0). 
 





In an oven dried Schlenk tube 1‐methyl‐imidazole (0.23 
mL, 2.9 mmol) was added to a stirred solution of 2‐chloro‐
N‐[1,10]‐phenanthrolin‐5‐yl‐acetamide (5.4) (0.0803 g, 
0.296 mmol) in DMF (1 mL). The system was flushed with 

































mixture was dissolved in water (10 mL) and washed with EtOAc (3 x 10 mL). Excess solid 
KPF6 was added to the aqueous phase which was stirred for 30 minutes then placed in 
the refrigerator overnight. The fine white precipitate that was deposited was collected 
by filtration and washed with saturated KPF6 solution, water and Et2O to give 0.0772 g 
of pure 5.5.HPF6 as a fine white powder. A second crop of 0.0361 g was obtained by 
taking the original aqueous filtrate and condensing by rotary‐evaporation then 
refrigerating overnight and collecting the precipitate as reported above. Overall yield 
0.113 g (83%). MP: 264 oC.  1H NMR (400 MHz, CD3CN): δ 9.68 (1H, s, H15), 8.95 (2H, m, 
H2, H9), 8.76 (1H, s, H19), 8.54 (1H, d, J = 8.2 Hz, H4), 8.29 (1H, d, J = 7.5 Hz, H7), 8.10 
(1H, s, H6), 8.42 (3H, m, H3, H8, H21), 7.44 (1H, s, H22), 5.37 (2H, s, H17), 3.93 (3H, s, 
H18). 13C NMR (100 MHz, CD3CN): δ 165.85 (1C), 150.83 (C2), 150.56 (C9), 146.75 (C11), 
145.02 (C14), 138.50 (C19), 137.16 (C7), 132.30 (C4), 131.56 (C5), 129.01 (C13), 125.53 
(C12), 124.91 (C21), 124.53 (C8), 124.16 (C22), 123.78 (C3), 121.76 (C6), 52.41 (C17), 
37.02 (C23). FT-IR ν/cm‐1 (intensity): 3217 (w), 3100 (w), 2974 (w), 1705 (m), 1681 (w), 
1555 (s), 1480 (w), 1456 (w), 1390 (m), 1225 (m), 1179 (m), 874 (m), 788 (m), 735 (s), 
630 (m). ESI-MS: Found [MH]2+ 159.5715, M+ 318.1353. [C18H17N5O]2+ requires 
159.5711, [C18H16N5O]+ requires 318.1349.  
 
 
1-methyl-3-[2-(1,10 phenanthrolin-5-ylamino)-2-oxoethyl]-1H-imidazolium chloride 
(5.5.HCl) 
 
In an oven dried Schlenk tube 1‐methyl‐imidazole (0.15 mL, 1.9 mmol) was added to a 
stirred suspension of 2‐chloro‐N‐[1,10]‐phenanthrolin‐5‐yl‐acetamide (5.4) (0.102 g, 
0.374 mmol) in MeCN (3 mL). The system was flushed with nitrogen and heated to reflux 
for 12 hours. The reaction mixture was allowed to cool to room temperature and the 
resulting precipitate collected by filtration. This was washed with DCM and Et2O and left 










In an oven dried Schlenk tube 1‐butyl‐imidazole (0.25 mL, 
1.9 mmol) was added to a stirred solution of 2‐chloro‐N‐
[1,10]‐phenanthrolin‐5‐yl‐acetamide (5.4) (0.105 g, 0.387 
mmol) in MeCN (3 mL). The system was flushed with 
nitrogen and heated at reflux for 20 hours. The reaction 
mixture was allowed to cool and the solvent removed by rotary‐evaporation. The 
resultant residue dissolved in water (20 mL) and washed with DCM (3 x 10 mL) then with 
Et2O (10 mL). Excess solid KPF6 was added to the aqueous phase resulting in immediate 
precipitation. This was stirred for 30 minutes and the solid material was collected by 
filtration and washed with saturated KPF6 solution, water and after drying, was washed 
with DCM and Et2O to give 5.6.HPF6 as a fine white powder. Yield 0.157 g (81%). MP: 
198 – 204 oC. 1H NMR (400 MHz, CD3CN): δ 9.79 (1H, s, H15), 8.95 (2H, m, H2, H9), 8.89 
(1H, s, H19), 8.54 (1H, d, J = 8.2 Hz, H4), 8.29 (1H, d, J = 7.5 Hz, H7), 8.12 (1H, s, H6), 7.63 
– 7.60 (2H, m, H8, H22), 7.54 (1H, dd, J = 8.2 Hz, 4.3 Hz, H3), 7.49 (1H, s, H21), 5.42 (2H, 
s, H17), 4.23 (2H, t, J = 7.3 Hz, H23), 1.85 (2H, m, H24), 1.34 (2H, m, H25), 0.93 (3, t, J = 
7.5 Hz, H26). 13C NMR (100 MHz, CD3CN): δ 164.97 (C16), 149.91 (C2), 149.65 (C9), 
145.99 (C11), 142.25 (C14), 137.12 (C19), 136.16 (C7), 131.31 (C4), 130.75 (C5), 128.14 
(C13), 124.64 (C12), 124.20 (1C, C22), 123.61 (C8), 122.84 (C3), 121.93 (C21), 120.76 
(C6), 51.62 (C17), 49.56 (C23), 31.51 (C24), 18.93 (C25), 12.61 (C26). FT-IR ν/cm‐1 
(intensity): 3167 (w), 2962 (w), 1710 (w), 1678 (m), 1558 (m), 1459 (w), 1314 (w), 1271 
(w), 1231 (w), 1170 (w), 829 (s), 738 (m), 628 (m). ESI-MS: Found [MH]2+ 180.5948, M+ 












































Synthesis performed as reported for 5.6.HPF6 using 2‐
chloro‐N‐[1,10]‐phenanthrolin‐5‐yl‐acetamide (5.4) 
(0.103 g, 0.378 mmol) and 1‐isopropyl‐imidazole (0.21 
mL, 1.8 mmol). The product 5.7.HPF6 was obtained as 
a fine white powder. Yield 0.151 g (81 %). MP: 153 oC. 
1H NMR (400 MHz, CD3CN): δ 9.31 (1H, s, H15), 9.09 (2H, m, H2, H9), 8.80 (1H, s, H19), 
8.57 (1H, d, J = 8.2 Hz, H4), 8.35 (1H, d, J = 7.8 Hz, H7), 8.16 (1H, s, H6), 7.70 (2H, m, H3, 
H8), 7.57 (2H, m, H21, H22), 5.32 (2H, s, H17), 4.70 (1H, m, H23), 1.57 (6H, m, H24). 13C 
NMR (100 MHz, CD3CN): δ 164.67 (C16), 150.13 (C2), 149.88 (C9), 146.33 (C11), 144.59 
(C14), 136.06 (C7), 135.75 (C19), 131.04 (C4), 130.59 (C5), 128.17 (C13), 124.57 (C12), 
124.24 (C22), 123.64 (C8), 122.90 (C3), 121.75 (C6), 120.10 (C21), 53.43 (C17), 51.58 
(C23), 21.58 (C24). FT-IR ν/cm‐1 (intensity): 3154 (w), 3025 (w), 1711 (m), 1561 (m), 1456 
(w), 1314 (w), 1244 (w), 1156 (w), 1132 (w), 835 (s), 738 (m), 649 (w), 629 (w). ESI-MS: 






Synthesis performed as reported for 5.6.HPF6 using 2‐
chloro‐N‐[1,10]‐phenanthrolin‐5‐yl‐acetamide (5.4) 
(0.109 g, 0.401 mmol) and 1‐phenyl‐imidazole (0.23 
mL, 1.8 mmol). The product 5.8.HPF6 was obtained as 
a fine white powder. Yield 0.232 g (86%). MP: 164 oC. 
1H NMR (400 MHz, CD3CN): δ 9.95 (1H, s, H15), 9.59 (1H, s, H19), 8.86 (2H, m, H2, H9), 
8.48 (1H, d, J = 8.2 Hz, H4), 8.24 (1H, d, J = 8.2 Hz, H7), 8.08 (1H, s, H6), 7.88 (1H, s, H21), 
7.84 (1H, s, H22), 7.65 – 7.56 (6H, m, H8, H24, H25, H26), 7.49 (1H, dd, J = 8.5 Hz, 4.0 Hz, 
H3), 5.54 (2H, s, H17). 13C NMR (100 MHz, CD3CN): δ 165.90 (C16), 150.99 (C2), 150.71 

































































131.89 (C5), 131.60 (C26), 131.56 (C24), 129.32 (C13), 126.17 (C22), 125.75 (C12), 
124.82 (C8), 124.02 (C3), 123.67 (C25), 122.51 (C21), 121.88 (C6) 53.13 (C17). FT-IR ν/cm‐
1 (intensity): 3162 (w), 1688 (m), 1589 (m), 1422 (w), 1312 (w), 1260 (w), 1220 (w), 1085 
(w), 826 (s), 773 (m), 695 (m). ESI-MS: Found [MH]2+ 190.5794, M+ 380.1509, [MH][PF6]+ 
526.1230. [C23H19N5O]2+ requires 190.5792, [C23H18N5O]+ requires 380.1506, 
[C23H19F6N5OP]+ requires 526.1226. 
 
1-(2,6-diisopropyl)phenyl-3-[2-(1,10 phenanthrolin-5-ylamino)-2-oxoethyl]-1H-
imidazolium chloride (5.9.HCl) 
 
In an oven dried Schlenk tube 1‐(2,6‐
diisopropyl)phenyl‐imidazole (0.882 g, 3.86 
mmol) was added to a stirred solution of 2‐chloro‐
N‐[1,10]‐phenanthrolin‐5‐yl‐acetamide (5.4) 
(0.875 g, 3.22 mmol) in MeCN (50 mL). The system 
was flushed with nitrogen and heated at reflux for 96 hours. The resultant peach 
coloured slurry was allowed to cool and the solvent removed by rotary‐evaporation. The 
residue was washed with Et2O, dissolved in water (40 mL), filtered through a short 
alumina plug and washed through with additional water. The aqueous filtrate was 
rotary‐evaporated to dryness, dissolved in a minimum of acetone and precipitated by 
addition of Et2O. This was collected by filtration giving pure 5.9.HCl as a very fine 
mustard yellow powder. Yield 1.317 g (83%). MP: 190 ‐ 208 oC with decomposition. 1H 
NMR (400 MHz, DMSO‐d6): δ 9.65 (1H, s, H19), 9.07 (1H, d, J = 4.3Hz, H2), 8.94 (1H, d, J 
= 4.3 Hz, H9) 8.87 (1H, d, J = 8.2 Hz, H4), 8.34 (1H, d, J = 7.8 Hz, H7), 8.21 (2H, m, H6, 
H21), 8.11 (1H, s, H22), 7.74 (1H, dd, J = 8.2 Hz, 4.3Hz, H3), 7.67 (1H, dd, J = 8.2 Hz, 4.3 
Hz, H8), 7.61 (1H, t, J = 7.8 Hz, H26), 7.44 (2H, d, J = 7.8 Hz, H25), 5.47 (2H, s, H17), 2.37 
(2H, m, H27), 1.12 (12H, m, H28). 13C NMR (100 MHz, DMSO‐d6): δ 165.88 (C16), 149.98 
(C2), 148.80 (C9), 146.44 (C11), 145.66 (C24), 143.11 (C14), 139.66 (C19), 135.74 (C7), 
132.70 (C4), 131.88 (C26), 131.10 (C23), 129.12 (C13), 126.36 (C12), 125.37 (C22), 
124.84 (C25), 124.68 (C21), 123.83 (C8), 123.48 (C5), 122.91 (C3), 118.75 (C6),  53.21 
(C17), 28.44 (C27), 24.25 (C28). FT-IR ν/cm‐1 (intensity): 3363 (w), 2965 (w), 1696 (w), 






































806 (m), 740 (s), 626 (m). ESI-MS: Found [MH]2+ 232.6270, M+ 464.2454. [C29H31N5O]2+ 





In an oven dried Schlenk tube 1‐(2‐pyridyl)‐imidazole 
(0.270 g, 1.86 mmol) was added to a stirred solution of 
2‐chloro‐N‐[1,10]‐phenanthrolin‐5‐yl‐acetamide (5.4) 
(0.142 g, 0.523 mmol) in DMF (2 mL). The system was 
flushed with nitrogen and heated at reflux for 48 hours. 
The reaction mixture was allowed to cool and the 
solvent removed by rotary‐evaporation. The resultant residue was dissolved in water 
(20 mL) and filtered through celite, washing through with additional water (20 mL). The 
dark yellow filtrate was washed with DCM (3 x 20 mL) then with Et2O (20 mL). Excess 
solid KPF6 was added to the aqueous phase resulting in immediate precipitation. This 
was stirred for 30 minutes then solid material collected by filtration and washed with 
saturated KPF6 solution, water and after drying, with Et2O to give 5.10.HPF6 as a fine 
mustard yellow powder. Yield 0.156 g (57%). MP: 175 oC with decomposition. 1H NMR 
(400 MHz, CD3CN): δ 9.78 (1H, s, H15), 9.69 (1H, s, H19), 8.94 (1H, m, H2, H9), 8.65 (1H, 
d, J = 8.6 Hz, H4), 8.56 (1H, d, J = 4.7 Hz, H27), 8.47 (1H, d, J = 8.2 Hz, H7), 8.23 (1H, s, 
H6), 8.16 (1H, s, H21), 8.08 (1H, t, J = 7.8 Hz, H25), 7.85 – 7.71 (3H, m, H8, H22, H24), 
7.69 (1H, dd, J = 8.2 Hz, 4.3 Hz, H3), 7.56 (1H, m, H26), 5.52 (1H, s, H17). 13C NMR (100 
MHz, CD3CN): δ 165.76 (C16), 150.78 (C2), 150.56 (C27), 149.21 (C9), 147.44 (C23), 
144.65 (C11), 142.52 (C14), 141.57 (C25), 139.65 (C7), 136.81 (C19), 133.58 (C4), 132.41 
(C5), 129.68 (C13), 126.62 (C26), 126.31 (C22), 126.95 (C12), 125.31 (C8), 124.85 (C3), 
121.28 (C6), 120.06 (C21), 115.30 (C24), 53.21 (C17). FT-IR ν/cm‐1 (intensity): 3158 (w), 
1697 (w), 1602 (m, 1477 (w), 1330 (s), 1230 (m), 1079 (w), 968 (w), 841 (s), 780 (m), 737 








Argon was bubbled through a 
stock solution of 4:1 EtOH/H2O 
for 30 minutes to degas. Ligand 
5.5.HCl (0.0498 g, 0.141 mmol) 
and an equivalent of Ru(phen)2Cl2 
(0.0752 g, 0.141 mmol) were 
combined in a 25 mL round‐
bottom flask, a condenser fitted and an argon blanket applied. Degassed EtOH/H2O (7 
mL) was added by syringe and the reaction mixture heated to reflux in the absence of 
light and monitored by TLC (silica, 9:1.5:1 MeCN/water/saturated KNO3(aq)). After 4 
hours no starting material was detected. The dark red solution was cooled to room 
temperature and condensed by rotary‐evaporation. The residue was purified by flash 
chromatography (silica, 9:1.5:1 MeCN/water/saturated KNO3(aq)) with the desired 
product eluting as a bright orange band.  The appropriate fractions were combined and 
condensed by rotary‐evaporation then dissolved in a minimum of distilled water and 
precipitated by addition of a saturated KPF6 solution. The resultant precipitate was 
collected by filtration and washed with saturated KPF6 solution, water and Et2O to give 
pure [Ru(phen)2(5.5.H)][PF6]3 as a fine orange powder. Yield 0.116 g (68%). MP: 
decomposition onset at 230 oC, melted at 241 oC. 1H NMR (400 MHz, DMSO‐d6): δ 11.00 
(1H, s, H15), 9.13 (1H, s, H19), 8.91 (1H, d, J = 8.2 Hz, H4), 8.78 – 8.75 (4H, m, H4’, H7’), 
8.70 (1H, d, J = 7.9 Hz, H7), 8.56 (1H, s, H6), 8.37 (4H, s, H5’, H6’), 8.10 (1H, d, J = 5.5 Hz, 
H2), 8.07 (3H, m, H2’/H9’), 8.04 (1H, d, J = 5.1 Hz, H2’/H9’), 7.99 (1H, d, J = 5.1 Hz, H9), 
7.83 – 7.69 (8H, m, H3, H8, H22, H21, H3’, H8’), 5.46 (2H, s, H17), 3.93 (3H, s, H23). 13C 
NMR (100 MHz, DMSO‐d6): δ 166.13 (C16). 153.22 (C2), 153.19 (C9, C2’, C9’), 148.19 
(C11’, C14’), 147.66 (C11’, C14’), 138.39 (C19), 137.33 (C4’, C7’), 136.82 (C7), 133.14 (C5), 
132.83 (C4), 130.92 (C12’, C13’), 128.51 (C5’, C6’), 126.77 (C3’, C8’), 126.22 (C14), 124.47 




(w), 1561 (w), 1426 (w), 1316 (w), 1243 (w), 1180 (w), 823 (s), 722 (m), 625 (w). ESI-MS: 
Found M3+ 260.0590, [M – H]2+ 389.5850. [C42H32N9ORu]3+ requires 260.0589, 
[C42H31N9ORu]2+ requires 389.5848. UV-vis (MeCN) λmax/nm (ε, 103 M‐1cm‐1): 223 




Performed as described for 
[Ru(phen)2(5.5.H)][PF6]3 using 
ligand 5.6.HPF6 (0.0243 g, 0.0500 
mmol) and reacting for 22 hours. 
The product was obtained as a 
fine orange powder. Yield 0.0442 
g (70%). MP: 202 – 220 oC. 1H 
NMR (400 MHz, DMSO‐d6): δ 11.00 (1H, s, H15), 9.20 (1H, s, H19), 8.91 (1H, d, J = 8.6 
Hz, H4), 8.76 – 8.70 (5H, m, H7, H4’, H7’), 8.57 (1H, s, H6), 8.37 (4H, s, H5’, H6’), 8.12 (1H, 
d, J = 5.1 Hz, H2), 8.19 (4H, m, H2’, H9’), 7.99 (1H, d, J = 4.3 Hz, H9), 7.83 – 7.68 (8H, m, 
H3, H8, H21, H22, H3’, H8’), 5.45 (2H, s, H17), 4.25 (2H, t, J = 7.1 Hz, H23), 1.79 (2H, m, 
H24), 1.27 (2H, m, H25), 0.90 (3H, t, J = 7.5 Hz, H26). 13C NMR (100 MHz, DMSO‐d6): δ 
166.13 (C16), 153.49 (C2), 153.19 (C9, C2’, C9’), 147.69 (C11’/C14’), 147.64 (C11’/C14’), 
137.89 (C19), 137.33 (C4’, C7’), 136.77 (C7), 132.82 (C4), 130.91 (C12’, C13’), 128.49 (C5’, 
C6’), 126.76 (C3’, C8’), 126.69 (C8), 126.15 (C3), 124.65 (C22), 124.39 (C21), 121.89 (C6), 
51.82 (C17), 49.16 (C23), 31.86 (C24), 19.18 (C25), 13.71 (C26). FT-IR ν/cm‐1 (intensity): 
1711 (w), 1632 (w), 1557 (w), 1428 (w), 1172 (w), 828 (s), 722 (m), 630 (w). ESI-MS: 
Found M3+ 274.0745, [M – H]2+ 410.6092, [M + PF6]2+ 483.5957, [M + 2PF6]+ 1112.1624. 
[C45H38N9ORu]3+ requires 274.0747, [C45H37N9ORu]2+ requires 410.6083, 
[C45H38F6N9OPRu]2+ requires 483.5943, [C45H38F12N9OP2Ru]+ requires 1112.1526. UV-vis 




























































Performed as described for 
[Ru(phen)2(5.5.H)][PF6]3 using 
ligand 5.7.HPF6 (0.0244 g, 0.0497 
mmol) and reacting for 22 hours. 
The product was obtained as a 
fine orange powder. Yield 0.0474 
g (77%). MP: 220 – 230 oC. 1H 
NMR (400 MHz, DMSO‐d6): δ 11.00 (1H, s, H15), 9.27 (1H, s, H19), 8.92 (1H, d, J = 8.2 
Hz, H4), 8.77 – 8.71 (5H, m, H7, H4’, H7’), 8.59 (1H, s, H6), 8.38 (4H, s, H5’, H6’), 8.13 (1H, 
d, J = 5.0 Hz, H2), 8.06 (4H, m, H2’, H9’), 8.00 (1H, d, J = 4.7 Hz, H9), 7.95 (1H, s, H21), 
7.81‐7.69 (7H, m, H3, H8, H22, H3’, H8’), 5.45 (2H, s, H17), 4.74 (1H, spt, J = 6.3 Hz, H23), 
1.51 (6H, d, J = 6.3 Hz, H24). 13C NMR (100 MHz, DMSO‐d6): δ 166.08 (C16), 153.51 (C2), 
153.19 (C2’, C9’), 152.55 (C9), 148.10 (C11), 147.65 (C11’, C14’), 145.70 (C14), 137.33 
(C4’, C7’), 136.81 (C7), 136.67 (C19), 132.83 (C5), 132.80 (C4), 130.92 (C12’, C13’), 128.50 
(C5’, C6’), 126.98 (C8), 126.77 (C3’, C8’), 126.18 (C3), 124.75 (C22), 124.56 (C21), 120.47 
(C6), 52.88 (C17), 51.81 (C23), 22.79 (C24). FT-IR ν/cm‐1 (intensity): 1711 (w), 1631 (w), 
1556 (w), 1428 (w), 1316 (w), 1243 (w), 1183 (w), 828 (s), 722 (m), 654 (w). ESI-MS: 
Found M3+ 269.4013, [M – H]2+ 403.5990, [M + PF6]2+ 476.5850, [M + 2PF6]+ 1098.1389. 
[C44H36N9ORu]3+ requires 269.4029, [C44H35N9ORu]2+ requires 403.6004, 
[C44H36N9OF6PRu]2+ requires 476.5864, [C44H36N9OF12P2Ru]+ requires 1098.1370. UV-vis 































































Performed as described for 
[Ru(phen)2(5.5.H)][PF6]3 using 
ligand 5.8.HPF6 (0.0298 g, 
0.0567 mmol) and reacting for 
20 hours. The product was 
obtained as a fine orange 
powder. Yield 0.0513 g (71%). 
MP: 222 oC. 1H NMR (400 MHz, DMSO‐d6): δ 11.06 (1H, s, H15), 9.86 (1H, s, H19), 8.92 
(1H, d, J = 8.2 Hz, H4), 8.76 – 8.70 (5H, m, H7, H4’, H7’), 8.59 (1H, s, H6), 8.37 (5H, s, H21, 
H5’, H6’), 8.13 (1H, d, J = 5.0 Hz, H2), 8.05 (5H, m, H22, H2’, H9’), 8.00 (1H, d, J = 4.7 Hz, 
H9), 7.99 – 7.62 (11H, m, H3, H8, H24, H25, H26, H3’, H8’), 5.55 (2H, s, H17). 13C NMR 
(100 MHz, DMSO‐d6): δ 165.75 (C16), 153.55 (C2), 153.19 (C2’, C9’), 152.60 (C9), 147.67 
(C11’/C14’), 147.64 (C11’/C14’), 137.34 (C4’, C7’), 137.23 (C19), 136.83 (C7), 133.24 (C4), 
130.92 (C12’, C13’), 130.85 (C24), 130.56 (C26), 128.49 (C5’, C6’), 127.00 (C8), 126.76 
(C3’, C8’), 126.22 (C3), 125.50 (C22), 122.41 (C25), 121.37 (C21), 120.66 (C6), 52.14 
(C17). FT-IR ν/cm‐1 (intensity): 1709 (w), 1632 (w), 1600 (w), 1554 (w0, 1496 (w), 1428 
(w), 1316 (w), 1210 (w), 1075 (w), 830 (s), 722 (m), 651 (w). ESI-MS: Found M3+ 280.7305, 
[M – H]2+ 420.5924, [M + PF6]+ 493.5781. [C47H34N9ORu]3+ requires 280.7309, 
[C47H33N9ORu]2+ requires 420.5926, [C47H33F6N9OPRu]2+ requires 493.5785. UV-vis 




Performed as described for 
[Ru(phen)2(5.5.H)][PF6]3 
using ligand 5.9.HPF6 (0.602 
g, 0.988 mmol) and reacting 
for 3 hours. The product 
was obtained as a fine 





















































(74%). MP: 224 – 232 oC. 1H NMR (400 MHz, DMSO‐d6): δ 11.15 (1H, s, H15), 9.54 (1H, 
s, H19), 8.94 (1H, d, J = 8.6 Hz, H4), 8.77 (5H, m, H7, H4’, H7’), 8.57 (1H, s, H6), 8.38 (4H, 
s, H5’, H6’), 8.15 – 8.08 (6H, m, H2, H22, H21, H2’, H9’), 8.05 (1H, d, J = 4.7 Hz, H2’/H9’), 
8.01 (1H, d, J = 5.1 Hz, H9), 7.82 (1H, dd, J = 8.6 Hz, 5.1 Hz, H3), 7.79 – 7.70 (5H, m, H8, 
H3’, H8’), 7.63 (1H, t, J = 7.8 Hz, H26), 7.47 (2H, d, J = 7.8 Hz, H25), 5.61 (2H, s, H17), 2.35 
(2H, spt, J = 6.3 Hz, H27), 1.15 (12H, d, J = 6.3 Hz, H28). 13C NMR (100 MHz, DMSO‐d6): 
δ 165.96 (C16), 153.54 (C2), 153.22 (C2’, C9’), 152.59 (C9), 148.15 (C11), 147.67 
(C11’/C14’), 147.65 (C11’/C14’), 145.82 (C14), 145.59 (C24), 139.79 (C19), 137.33 (C4’, 
C7’), 136.88 (C7), 133.25 (C5), 132.94 (C4), 132.01 (C26), 131.01 (C23), 130.92 (C12’, 
C13’), 130.44 (C13), 128.50 (C5’, C6’), 126.95 (C8), 126.90 (C12), 126.77 (C3’, C8’), 126.18 
(C3), 125.32 (C21), 125.03 (C22), 124.93 (C25), 120.97 (C6), 52.30 (C17), 28.48 (C27), 
24.28 (C28). FT-IR ν/cm‐1 (intensity): 1709 (w), 1549 (w), 1427 (w0, 1196 (w), 828 (s), 
721 (w), 629 (w). ESI-MS: Found M3+ 308.7626, [M – H]2+ 462.6397, [M + PF6]2+ 535.6258. 
[C53H46N9ORu]3+ requires 308.7623, [C53H45N9ORu]2+ requires 462.6396, 
[C53H45F6N9OPRu]2+ requires 535.6256. UV-vis (MeCN) λmax/nm (ε, 103 M‐1cm‐1): 221 




Performed as described for 
[Ru(phen)2(5.5.H)][PF6]3 using 
ligand 5.10.HPF6 (0.105 g, 
0.200 mmol) and reacting for 
4 hours. The product was 
obtained as a fine orange 
powder. Yield 0.150 g (58%). 
MP: decomposition onset at 219 oC. 1H NMR (400 MHz, DMSO‐d6): δ 11.06 (1H, s, H15), 
10.14 (1H, s, H19), 8.92 (1H, d, J = 8.2 Hz, H4), 8.79 – 8.69 (5H, m, H7, H4’, H7’), 8.66 (1H, 
d, J = 4.3 Hz, H27), 8.58 (2H, s, H6, H21), 8.36 (4H, s, H5’, H6’), 8.23 (1H, t, J = 7.8 Hz, 
H25), 8.12 (1H, d, J = 5.1 Hz, H2), 8.09 – 8.01 (6H, m, H22, H24, H2’, H9’), 7.99 (1H, d, J = 
5.1 Hz, H9), 7.82 (1H, m, H3), 7.80 – 7.58 (6H, m, H8, H26, H3’, H8’), 5.58 (2H, s, H17). 




(C9), 149.41 (C27), 147.67 (C11), 147.24 (C11’/C14’), 147.20 (C11’/C14’), 146.26 (C23), 
145.33 (C14), 140.81 (C25), 136.89 (C7, C4’, C7’), 136.42 (C19), 132.82 (C4), 132.43 (C5), 
130.47 (C12’, C13’), 129.96 (C13), 128.08 (C5’, C6’), 126.25 (C12), 125.78 (C3), 125.52 
(C26), 125.40 (C22), 120.28 (C6), 118.85 (C21), 114.28 (C24), 51.83 (C17). FT-IR ν/cm‐1 
(intensity): 1708 (w), 1631 (w), 1543 (w), 1477 (w), 1428 (w), 1317 (w), 1214 (w), 830 
(s), 722 (m), 624 (w). ESI-MS: Found M3+ 281.0625, [M – H]2+ 421.0901, [M + PF6]2+ 
494.0762. [C46H33N10ORu]3+ requires 281.0626, [C46H32N10ORu]2+ requires 421.0900, 
[C46H33F6N10OPRu]2+ requires 494.0760. UV-vis (MeCN) λmax/nm (ε, 103 M‐1cm‐1): 222 
(96.3), 263 (114.9), 428 (18.3), 446 (20.1). 
 




An oven dried Schlenk flask was charged with 4‐amino‐2,2’‐
bipyridine (0.286 g, 1.70 mmol) and sparged with nitrogen. 
Anhydrous DCM (20 mL) was added by cannula followed by freshly 
distilled trimethylamine (0.24 mL, 1.70 mmol) and the solution 
cooled to 0 oC. A solution of chloroacetyl‐chloride (0.14 mL, 1.70 
mmol) in anhydrous DCM (5 mL) was added dropwise resulting in a dark brown/black 
mixture. Stirring at 0 oC was continued for 1 hour before warming to room temperature. 
The black/brown suspension was filtered and the solid rinsed with DCM (25 mL). The 
combined organic phase was washed with water (3 x 30 mL) and dried over MgSO4 
before removal of the solvent. Purification of the black residue was achieved by flash 
column chromatography (alumina, 1% MeOH/DCM) providing 5.11 as a fine, off white 
powder. Yield, 0.109 g (26%). MP: 142 oC. 1H NMR (400 MHz, CDCl3): δ 8.74 (1H, br.s, 
H13), 8.67 (1H, d, J = 4.3 Hz, H12), 8.63 (1H, d, J = 5.5 Hz, H6), 8.41 (1H, d, J = 8.2 Hz, H9), 
8.28 (1H, m, H3), 7.99 (1H, m, H5), 7.84 (1H, t, J = 7.2 Hz, H10), 7.35 (1H, m, H11), 4.25 
(2H, s, H15). 13C NMR (100 MHz, CDCl3): δ 164.63 (C14), 156.98 (C2), 155.03 (C8), 150.37 
(C6), 149.110 (C12), 145.06 (C4), 137.13 (C10), 124.20 (C11), 121.19 (C9), 113.72 (C5), 




1681 (m), 1597 (m), 1581 (m), 1561 (m), 1530 (m), 1462 (s), 1397 (m), 1331 (w), 1247 
(m), 1216 (m), 1179 (w), 991 (m), 928 (w), 882 (w), 836 (m), 791 (s), 743 (m), 731 (m), 






An oven dried Schlenk flask was charged with 5.11 
(0.100 g, 0.404 mmol) and 1‐(2‐pyridyl)‐imidazole 
(0.119 g, 0.820 mmol), and sparged with nitrogen. 
MeCN (10 mL) was added by syringe and the 
solution heated to reflux with consumption of 5.11 
monitored by TLC (alumina, 1% MeOH/DCM). After 
48 hours the reaction was cooled to room temperature and added to Et2O (50 mL) with 
stirring. The resulting white precipitate was collected by filtration, washed with Et2O and 
dried under vacuum providing 5.12.HCl as a fine white powder.  Yield 0.124 g (78%). MP: 
154 oC. 1H NMR (400 MHz, DMSO‐d6): δ 11.98 (1H, s, H13), 10.27 (1H, s, H17), 8.76 (1H, 
s, H3), 8.66 (3H, m, H12, H19, H25), 8.58 (1H, d, J = 5.1 Hz, H6), 8.37 (1H, d, J = 7.8 Hz, 
H9), 8.23 (1H, m, H23), 8.12 (2H, m, H20, H22), 7.93 (1H, t, J = 3.9 Hz, H10), 7.73 (1H, d, 
J = 3.9 Hz, H5), 7.66 (1H, dd, J = 4.9 Hz, 7.2 Hz, H24), 7.45 (1H, m, H11), 5.56 (2H, s H15). 
13C NMR (100 MHz, DMSO‐d6): δ 164.90 (C14), 156.36 (C2), 154.97 (C8), 150.22 (C6), 
149.29 (C12), 149.19 (C25), 146.25 (C21), 146.21 (C4), 140.67 (C23), 137.23 (C10), 
136.43 (C17), 125.33 (C24), 125.30 (C20), 124.30 (C11), 120.47 (C9), 118.67 (C19), 
114.28 (C22), 113.46 (C5), 109.99 (C3), 52.13 (C15). FT-IR ν/cm‐1 (intensity): 3058 (w), 
2940 (w), 2894 (w), 2824 (w), 1710 (s), 1594 (s), 1579 (s), 1565 (s), 1552 (s), 1525 (s), 
1478 (m), 1459 (m), 1442 (m), 1401 (m), 1319 (m), 1239 (s), 1176 (m), 1083 (m), 991 (w), 
796 (m), 775 (s), 734 (m), 617 (m). ESI-MS: Found M+ 357.1458, [2M – H]+ 713.2863, [2M 
+ Cl]+ 749.2627. [C20H17N6O]+ requires 357.1458, [C40H33N12O2]+ requires 713.2838, 










Synthesis performed as 
described for [Ru(phen)2 
(5.5.H)][PF6]3 using ligand 
5.12.HCl (0.0999 g, 0.0254 
mmol) and Ru(phen)2Cl2 
(0.107 g, 0.0254 mmol) and 
reacting for 2 hours. The 
product was obtained as a fine orange powder. Yield 0.0442 g (70%). Yield 0.195 g (61%). 
MP: 204 oC with decomposition. 1H NMR (400 MHz, DMSO‐d6): δ 11.54 (1H, br.s, H13), 
10.07 (1H, s, H17), 8.90 (1H, s, H3), 8.83 (2H, dd, J = 8.2 Hz, 3.5 Hz, H4’/H7’), 8.78 – 8.64 
(3H, m, H25, H4’/H7’), 8.58 (1H, s, H19), 8.52 (1H, d, J = 8.2 Hz, H9), 8.47 – 8.33 (4H, m, 
H5’, H6’), 8.30 (1H, d, J = 5.1 Hz, H2’/H9’), 8.24 (2H, m, H23, H2’/H9’), 8.11 (1H, t, J = 7.8 
Hz, H10), 8.05 (1H, d, J = 8.2 Hz, H22), 8.02 – 7.86 (5H, m, H20, H2’/H9’, H3’/H8’), 7.78 – 
7.62 (4H, m, H12, H24, H3’/H8’), 7.58 (1H, d, J = 6.3 Hz, H6), 7.51 – 7.22 (2H, m, H5, H11), 
5.43 (2H, s, H15). 13C NMR (100 MHz, DMSO‐d6): δ 165.58 (C14), 157.39 (C2), 156.59 
(C8), 152.55 (C2'/C9'), 152.45 (C6), 151.98 (C12), 149.46 (C25), 147.30 (C11'/C14'), 
147.26 (C11'/C14'), 147.08 (C11'/C14'), 146.98 (C20), 146.25 (C4), 140.87 (C23), 138.12 
(C10), 136.94 (C4'/C7'), 136.79 (C4'/C7'), 136.41 (C17), 130.56 (C12'/C13'), 130.52 
(C12'/C13'), 128.10 (C5'/C6'), 127.98 (C11), 126.37 (C3'/C8'), 125.62 (C24), 125.37 (C20), 
124.08 (C9), 118.97 (C19), 116.96 (C5), 114.36 (C22), 113.06 (C3), 52.08 (C15). FT-IR 
ν/cm‐1 (intensity): 1721 (w), 1602 (w), 1527 (w), 1476 (w), 1428 (w), 1333 (w), 1272 (w), 
1234 (w), 827 (s), 783 (m), 721 (m), 625 (w). ESI-MS: Found M3+ 273.0608, [M‐H]2+ 

























































8.5.7. NHC complexes of ruthenium-polypyridine derivatives 
 
[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 
 
A 50 mL Schlenk flask was 
charged with [Ru(phen)2 
(5.9.H)][PF6]3 (0.136 g, 0.100 
mmol) and tetraethyl‐
ammonium chloride hydrate 
(0.0184 g, 0.100 mmol), and 
the flask sparged with 
nitrogen. Dry DCM (20 mL) was added and the mixture stirred until it became 
homogeneous. Ag2O (0.0116 g, 0.050 mmol) was then added and stirring continued at 
room temperature in the absence of light for 20 hours. A solution of [Pd(allyl)Cl]2 (0.0183 
g, 0.050 mmol) in dry DCM (2 mL) was added dropwise and stirring continued as above 
for a further 48 hours. After this time the red suspension was filtered through celite and 
solvent removed under vacuum providing material shown by 1H‐NMR to be a mixture of 
NHC products and tetraethyl‐ammonium salt (0.164 g). A portion of this (0.0813 g) was 
purified by flash chromatography (alumina, 2% MeOH/chloroform). The desired product 
eluted as a broad band that was collected in several fractions providing pure 
[Ru(phen)2(Pd{5.9 - H}{allyl})][PF6]2 as a bright red powder. Yield 0.0432 g (64%). 
Extremely pure material for analysis was obtained by bulk slow evaporation of an 
acetone/benzene solution of the compound and collecting the resulting crystals. MP: 
decomposition onset at 289 oC. 1H NMR (400 MHz, CD3CN): δ 8.56 (6H, m), 8.36 (1H, d, 
J = 8.2 Hz), 8.24 (5H, m), 8.03 (2H, d, J = 5.1 Hz), 7.94 (1H, d, J = 5.1 Hz), 7.81 (1H, br.s), 
7.76 – 7.42 (12H, m), 7.41 – 7.21 (6H, m), 4.85 (0.1H, m), 4.47 (0.2H, s), 4.24 (0.4H, t, J = 
6.7 Hz), 4.18 (0.6H, dd, J = 2.5 Hz, 5.7 Hz), 3.36 (0.3H, m), 2.73 (0.5H, m), 2.66 – 2.47 
(1.5H, m), 1.77 (0.25H, m), 1.68 (0.5H, m), 1.55 – 0.78 (25.6H, m). 13C NMR (100 MHz, 
CD3CN): δ 170.13, 153.94, 151.80, 149.02, 137.72, 136.60, 132.35, 132.04, 131.24, 
129.80, 129.08, 126.90, 126.44, 126.03, 124.89, 124.18, 123.73, 108.35, 57.32, 29.35, 




(m), 1384 (w), 1290 (w), 827 (s), 721 (m), 680 (m). ESI-MS: Found [MH – Cl]3+ 357.4115, 
[M – Cl]2+ 535.6089, [MH – Cl + CN]2+ 549.1136. [C56H50N9ORuPd]3+ requires 357.4072, 
[C56H49N9ORuPd]2+ requires 535.6072, [C57H50N10ORuPd]2+ requires 549.1127. UV-vis 
(MeCN) λmax/nm (ε, 103 M‐1cm‐1): 222 (102.6), 263 (107.8), 428 (18.7), 448 (20.7). 
 
[Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 
 
A Schlenk tube was charged with 
[Ru(phen)2(5.10.H)]Cl3 (0.0483 g, 
0.0509 mmol) and an equivalent 
of Ag2O (0.0117 g, 0.0505 mmol) 
and the flask sparged with 
nitrogen. Dry DMSO (3 mL) was 
added and the mixture stirred at 
room temperature in the absence of light for 20 hours. A solution containing an 
equivalent of Pd(MeCN)2Cl2 (0.0133 g, 0.0513 mmol) in DMSO (1.5 mL) was added to the 
deep red solution by syringe and rinsed through with additional DMSO (0.5 mL). Stirring 
was continued for 24 hours before pouring onto water (25 mL) and filtering through 
celite, rinsing the plug with additional water. The aqueous filtrate was loaded onto a 
short plug of sephadex‐C25 ion exchange resin and rinsed thoroughly with water before 
elution of the red band with 0.5 M NaCl solution. Adequately pure product was obtained 
from the eluent by precipitating as a PF6 salt and collecting the solid by filtration. After 
drying in a vacuum desiccator the material was purified by bulk slow vapour diffusion of 
diisopropyl‐ether into a MeCN solution and collection of the crystalline material. Yield 
0.0336 g (51%). Complex [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 is a mixture of atropisomeric 
diastereomers in a 2:1 ratio and for this reason the NMR spectra were too difficult to 
assign. MP: decomposition onset at 289 oC. 1H NMR (600 MHz, CD3CN): δ 8.93 (1H, d, J 
= 5.3 Hz), 8.86 – 8.79 (1.5H, m), 8.76 (0.5H, d J = 8.3 Hz), 8.67 – 8.61 (1.5H, m), 8.61 – 
8.53 (4.5H, m), 8.46 (1.5H, m), 8.42 (1H, d, J = 8.1 Hz), 8.31 (0.5H, d, J = 4.9 Hz), 8.30 – 
8.16 (7.5H, m), 8.06 (1H, d, 4.9 Hz), 8.04 – 7.97 (3.5H, m), 7.93 (1H, d, J = 2.0 Hz), 7.91 
(0.5H, d, J = 2.0 Hz), 7.87 (1H, d, J = 4.7 Hz), 7.83 (1H, t, J = 5.3 Hz), 7.82 – 7.67 (5.5H, m), 




(150 MHz, CD3CN): δ 167.92, 167.80, 157.79, 157.44, 154.43, 154.27, 154.21, 154.09, 
153.83, 153.37, 153.01, 152.83, 152.77, 152.32,  152.29, 151.77, 151.72, 150.67, 149.39, 
149.20, 149.15, 149.05, 149.03, 148.99, 148.97, 148.94, 147.10, 146.99, 143.89, 143.80, 
137.70, 137.69, 137.64, 136.77, 134.99, 134.92, 132.25, 132.15, 132.08, 132.06, 132.01, 
131.97, 131.95, 131.93, 131.91, 131.81, 131.78, 129.09, 129.07, 129.05, 129.04, 129.01, 
126.98, 126.91, 126.90, 126.85, 126.83, 126.77, 126.66, 126.51, 126.44, 125.98, 125.93, 
124.82, 124.48, 124.39, 123.01, 122.95, 117.99, 117.95, 113.09, 113.01, 54.18, 54.14. 
FT-IR ν/cm‐1 (intensity): 1623 (w), 1584 (w), 1563 (w), 1511 (w), 1481 (w), 1458 (w), 1423 
(w), 1361 (w), 1306 (w), 1143 (w), 1121 (w), 1094 (w), 824 (s), 719 (s), 657 (m). ESI-MS: 
Found [M – Cl + CN]2+ 486.5405. [C47H31N11OPdRu]2+ requires 486.5396. UV-vis (MeCN) 
λmax/nm (ε, 103 M‐1cm‐1): 221 (81.0), 263 (94.4), 428 (15.5), 447 (17.1). 
 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 and [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2 
 
Prepared by the same method as [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 using 
[Ru(phen)2(5.12.H)]Cl3 (0.0463 g, 0.050 mmol) and a slightly different work‐up. After 
pouring the reaction mixture onto water and filtering through celite, the aqueous filtrate 
was loaded onto a short plug of sephadex‐C25 ion exchange resin and rinsed thoroughly 
with water before gradient elution with NaCl solution (0 – 0.1 M NaCl). The desired 
product was obtained from the appropriate fractions by addition of excess KPF6 solution 
and extraction of the turbid suspension into DCM (3 x 20 mL). Drying of the organic 
extract over MgSO4 followed by removal of the solvent provided pure 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 as a fine red powder. Yield 0.0233 g (36%). Workup of 
other fractions provided additional material (0.0368 g) comprised of 
[Ru(phen)2(Pd{5.12}Cl2)][PF6]2 and [Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2. Further purification 












MP: decomposition onset at 
284 oC. 1H NMR (400 MHz, 
CD3CN): δ 9.82 (1H, br.s, 
H13), 9.24 (1H, d, J = 5.5 Hz, 
H25), 8.83 (1H, s, H3), 8.65 
(2H, d, J = 8.2 Hz, H4’), 8.53 
(2H, d, J = 8.2 Hz, H7’), 8.42 
(1H, d, J = 8.2 Hz, H9), 8.33 (1H, d, J = 5.1 Hz, H2’), 8.29 – 8.16 (6H, m, H23, H2’, H5’, H6’), 
7.99 (1H, t, J = 7.8 Hz, H10), 7.92 – 7.72 (6H, m, H19, H22, H3’, H9’), 7.66 (1H, d, J = 5.5 
Hz, H12), 7.54 (2H, dd, J = 3 Hz, 5.1 Hz, H8’), 7.50 – 7.40 (3H, m, H5, H6, H24), 7.25 (2H, 
m, H11, H20), 5.74 (2H, s, H15). 13C NMR (100 MHz, CD3CN): δ 168.34 (C14), 159.22 (C8), 
158.51 (C2), 158.62 (C4), 157.75 (C17), 154.44 (C2’), 154.17 (C2’), 154.08 (C9’), 153.99 
(C9’), 153.83 (C6), 153.61 (C12), 153.26 (C21), 151.23 (C25), 149.28 (C11’/C14’), 148.12 
(C11’/C14’), 144.04 (C23), 139.09 (C10), 138.08 (C4’/C7’), 137.94 (C4’/C7’), 132.39 
(C12’/C13’), 132.33 (C12’/C13’), 132.32 (C12’/C13’), 129.43 (C5’/C6’), 129.37 (C5’/C6’), 
128.77 (C11), 127.38 (C3’), 127.21 (C8’), 127.19 (C8’), 127.12 (C20), 125.54 (C9), 124.59 
(C24), 117.73 (C19), 117.49 (C5), 114.53 (C3), 113.60 (C22), 54.76 (C15).  FT-IR ν/cm‐1 
(intensity): 1687 (w), 1598 (w), 1526 (w), 1490 (w), 1427 (w), 1412 (w), 1331 (w), 1271 
(w), 1235 (w), 1205 (w), 1145 (w), 831 (s), 776 (m), 740 (w), 720 (m). ESI-MS: Found [M 
– Cl + CN]2+ 474.5393. [C45H31N11ORuPd]2+ requires 474.5399. UV-vis (MeCN) λmax/nm 












































Table A0.1: Crystallographic data for compounds 2.1, 2.9.2HBr, 2.12.2HBr and Pd(2.4 - H)(O,O’-acac). 
Thesis code 2.1 2.9.2HBr 2.12.2HBr Pd(2.4 - H)(O,O’‐acac) 
Collection identification code 5wrk38 5wrk13a 5wrk37 5wrk16_twin1_hklf4 
Empirical formula C12H20ClNO C32H58Br4N6O2 C32H58Br4N6O0.5 C32H45N3O3Pd 
Formula weight 229.74 878.48 854.47 626.11 
Temperature (K) 120.0(1) 120.0(1) 120.0(1) 120.0(1) 
Crystal system orthorhombic monoclinic orthorhombic monoclinic 
Space group P212121 P21 P21212 P21 
a  (Å) 9.7003(2) 11.5248(2) 22.9490(3) 15.0671(2) 
b  (Å) 10.6340(2) 10.8474(2) 15.1385(2) 12.5634(2) 
c  (Å) 24.0173(6) 15.4425(4) 10.7544(2) 16.2805(2) 
  (°) 90 90 90 90 
  (°) 90 94.361(2) 90 102.972(2) 
   (°) 90 90 90 90 
Volume (Å3) 2477.47(9) 1924.94(7) 3736.22(11) 3003.13(7) 
Z 8 2 4 4 
Density (calculated) (Mg/m3) 1.232 1.516 1.519 1.385 
Absorption coefficient (mm‐1) 0.284 4.217 5.492 5.266 
F(000) 992 896 1736.4 1312 
Crystal size (mm) 0.707 × 0.603 × 0.484 0.127 × 0.079 × 0.021 0.216 × 0.049 × 0.028 0.15 × 0.136 × 0.136 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) Cu Kα (λ = 1.54184) CuKα (λ = 1.54184) 
2ϴ range for data collection (°) 6.79 to 75.78 4.59 to 60.00 7 to 134.98 5.57 to 153.6 
Reflections collected 35603 29741 26081 21927 
Independent reflections [R(int)] 12738 [Rint = 0.0290] 10736 [Rint = 0.0370] 6739 [Rint = 0.0433] 21927 [Rint = ?] 
Data / restraints / parameters 12738/0/277 10736/19/511 6739/0/391 21927/1/723 
Goodness‐of‐fit on F2 1.035 1.022 1.026 1.067 
Final R indexes R1 [I>2σ (I)] R1 = 0.0453, wR2 = 0.1074 R1 = 0.0356, wR2 = 0.0745 R1 = 0.0468, wR2 = 0.1241 R1 = 0.0340, wR2 = 0.0954 
Final R indexes (all data) wR2 R1 = 0.0594, wR2 = 0.1188 R1 = 0.0482, wR2 = 0.0795 R1 = 0.0502, wR2 = 0.1273 R1 = 0.0343, wR2 = 0.0956 




































Thesis code Pt(2.4 - H)(O,O’‐acac) Pd(2.5)Cl2 [Ru(2.2)(p‐cymene)Cl][PF6] 
Collection identification code 5wrk20a wk4‐137‐1 5wrk29cu 
Empirical formula C32H45N3O3Pt C27H34Cl2N4OPd C111H164Cl28F24N13O4P4Ru4 
Formula weight  714.80 607.88 3721.18 
Temperature (K) 120.0(0) 293(2) 120.0(1) 
Crystal system  monoclinic orthorhombic triclinic 
Space group P21 P212121 P1 
a  (Å) 14.9618(2) 9.070(2) 12.3867(2) 
b  (Å) 12.5534(2) 17.570(4) 12.4102(2) 
c  (Å) 16.3368(2) 34.810(7) 27.9156(4) 
  (°) 90 90 90.025(2) 
  (°) 102.932(1) 90 90.025(2) 
   (°) 90 90 118.026(2) 
Volume (Å3) 2990.58(7) 5547.3(2) 3788.0(2) 
Z  4 8 1 
Density (calculated) (Mg/m3) 1.588 1.456 1.631 
Absorption coefficient (mm‐1) 4.729 0.888 8.81 
F(000) 1440 2496 1881 
Crystal size (mm) 0.158 × 0.128 × 0.047 0.465 × 0.055 × 0.039 0.37 × 0.14 × 0.02 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
2ϴ range for data collection (°) 5.25 to 75.68 2.60 to 55.77 8.07 to 154.01 
Reflections collected  85024 137857 83724 
Independent reflections [R(int)] 30492 [Rint = 0.0371] 13104 [Rint = 0.0606] 28795 [Rint = 0.0515] 
Data / restraints / parameters  30492/1/721 13104/46/590 28795/15/1765 
Goodness‐of‐fit on F2 1.068 1.067 1.03 
Final R indexes R1 [I>2σ (I)] R1 = 0.0368, wR2 = 0.0852 R1 = 0.0452, wR2 = 0.1097 R1 = 0.0498, wR2 = 0.1347 
Final R indexes (all data) wR2 R1 = 0.0460, wR2 = 0.0911 R1 = 0.0482, wR2 = 0.1115 R1 = 0.0520, wR2 = 0.1374 




Table A0.3: Crystallographic data for compounds Pd(3.3 - H)(O,O’-acac), Pt(3.3 - H)(O,O’-acac) and Pd(3.3)Cl2. 
Thesis code Pd(3.3 - H)(O,O’‐acac) Pt(3.3 - H)(O,O’‐acac) Pd(3.3)(allyl)Cl 
Collection identification code 5wrk22.a 5wrk23.a 5wrk28a 
Empirical formula C28H39N3O3Pd C28H39N3O3Pt C26H37ClN3OPd 
Formula weight  572.02 660.71 549.43 
Temperature (K) 120.0(1) 120.0(1) 285.2(1) 
Crystal system  monoclinic monoclinic monoclinic 
Space group P21/c P21/c P21/c 
a  (Å) 10.5941(3) 10.5909(3) 10.2536(4) 
b  (Å) 15.3153(4) 15.3547(5) 26.4965(10) 
c  (Å) 16.9971(6) 16.9427(5) 9.8590(3) 
  (°) 90 90 90 
  (°) 98.116(3) 98.372(3) 91.690(3) 
   (°) 90 90 90 
Volume (Å3) 2730.2(2) 2725.9(2) 2677.4(2) 
Z  4 4 4 
Density (calculated) (Mg/m3) 1.392 1.61 1.363 
Absorption coefficient (mm‐1) 0.712 5.18 6.667 
F(000) 1192 1320 1140 
Crystal size (mm) 0.18 × 0.116 × 0.051 0.222 × 0.158 × 0.064 0.21 × 0.098 × 0.035 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
2ϴ range for data collection (°) 3.60 to 62.80 4.706 to 66.182 6.67 to 154.90 
Reflections collected  23960 18726 24066 
Independent reflections [R(int)] 7869 [Rint = 0.0557] 9125 [Rint = 0.0389] 5611 [Rint = 0.0508] 
Data / restraints / parameters  7869/0/322 9125/0/322 5611/6/302 
Goodness‐of‐fit on F2 1.016 1.032 1.05 
Final R indexes R1 [I>2σ (I)] R1 = 0.0428, wR2 = 0.0868 R1 = 0.0358, wR2 = 0.0619 R1 = 0.0469, wR2 = 0.1250 
Final R indexes (all data) wR2 R1 = 0.0702, wR2 = 0.0989 R1 = 0.0545, wR2 = 0.0693 R1 = 0.0559, wR2 = 0.1343 






Table A0.4: Crystallographic data for compounds 4.6.HPF6, 4.11.HI, [Ru(bipy)2(4.2)][PF6]2. 
Thesis code 4.6.HPF6 4.11.HI [Ru(bipy)2(4.2)][PF6]2 
Collection identification code 5wrk1a 5wrk30b 5wrk2a 
Empirical formula C27H21F6N4P C23H21N4I C40H30F12N8P2Ru 
Formula weight  546.45 480.34 1013.73 
Temperature (K) 120.0(1) 120.0(1) 120.0(1) 
Crystal system  monoclinic Triclinic monoclinic 
Space group P21/c P‐1 P21/c 
a  (Å) 11.9184(5) 11.3337(4) 11.7918(2) 
b  (Å) 13.5720(4) 13.6113(6) 13.7398(2) 
c  (Å) 15.0568(6) 15.6739(6) 33.1338(5) 
  (°) 90 100.595(4) 90 
  (°) 108.105(4) 105.368(3) 94.064(2) 
   (°) 90 112.324(4) 90 
Volume (Å3) 2314.9(2) 2044.1(2) 5354.7(2) 
Z  4 4 4 
Density (calculated) (Mg/m3) 1.568 1.561 1.257 
Absorption coefficient (mm‐1) 1.728 1.582 3.603 
F(000) 1120 960 2032 
Crystal size (mm) 0.3248 × 0.175 × 0.1114 0.409 × 0.185 × 0.059 0.213 × 0.124 × 0.08 
Radiation CuKα (λ = 1.54184) MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
2ϴ range for data collection (°) 7.804 to 147.85 4.026 to 55.00 6.97 to 134.99 
Reflections collected  8577 20955 26849 
Independent reflections [R(int)] 4524 [Rint = 0.0315] 9394 [Rint = 0.0350] 9650 [Rint = 0.0305] 
Data / restraints / parameters  4524/0/343 9394/0/507 9650/0/568 
Goodness‐of‐fit on F2 1.044 1.037 1.065 
Final R indexes R1 [I>2σ (I)] R1 = 0.0883, wR2 = 0.2362 R1 = 0.0339, wR2 = 0.0733 R1 = 0.0354, wR2 = 0.0933 
Final R indexes (all data) wR2 R1 = 0.1122, wR2 = 0.2634 R1 = 0.0462, wR2 = 0.0804 R1 = 0.0405, wR2 = 0.0959 




Table A0.5: Crystallographic data for compounds [Ru(bipy)2(4.3)][PF6]2 and [Ru(bipy)2(4.9.H)][PF6]3. 
Thesis code [Ru(bipy)2(4.3)][PF6]2 [Ru(bipy)2(4.9.H)][PF6]3 
Collection identification code 5wrk3a 5wrk33b 
Empirical formula C49H47F12N11OP2Ru C42H34F18N9P3Ru 
Formula weight  1196.98 1200.76 
Temperature (K) 120.0(1) 120.0(1) 
Crystal system  Triclinic monoclinic 
Space group P‐1 P21/c 
a  (Å) 13.5205(3) 18.0604(2) 
b  (Å) 13.8672(3) 11.9307(2) 
c  (Å) 15.8109(3) 21.5060(2) 
  (°) 108.098(2) 90 
  (°) 95.841(2) 91.702(1) 
   (°) 111.463(2) 90 
Volume (Å3) 2543.4(1) 4631.93(9) 
Z  2 4 
Density (calculated) (Mg/m3) 1.563 1.722 
Absorption coefficient (mm‐1) 0.465 4.789 
F(000) 1216 2400 
Crystal size (mm) 0.326 × 0.263 × 0.165 0.218 × 0.187 × 0.041 
Radiation MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
2ϴ range for data collection (°) 4.85 to 64.49 4.90 to 135.0 
Reflections collected  31744 69032 
Independent reflections [R(int)] 15775 [Rint = 0.0259] 8338 [Rint = 0.0344] 
Data / restraints / parameters  15775/0/690 8338/0/663 
Goodness‐of‐fit on F2 1.03 1.04 
Final R indexes R1 [I>2σ (I)] R1 = 0.0438, wR2 = 0.1105 R1 = 0.0302, wR2 = 0.0811 
Final R indexes (all data) wR2 R1 = 0.0523, wR2 = 0.1168 R1 = 0.0327, wR2 = 0.0832 






Table A0.6: Crystallographic data for compounds 5.2.HPF6, [Ru(bipy)2(5.2.H)][PF6]3, [Ru(bipy)2(5.3)][PF6]2 and 5.7.HPF6. 
Thesis code 5.2.HPF6 [Ru(bipy)2(5.2.H)][PF6]3 [Ru(bipy)2(5.3)][PF6]2 5.7.HPF6 
Collection identification code 5wrk6a 5wrk5a_twin1_hklf4 5wrk27a 5wrk8a 
Empirical formula C16H13F6N4P C36H29F18N8P3Ru C40H34F12N6O2P2Ru C90H95F24N25O4P4 
Formula weight  406.27 1109.65 1021.74 2170.78 
Temperature (K) 120.0(1) 120.0(1) 285.2(1) 120.0(1) 
Crystal system  monoclinic monoclinic triclinic monoclinic 
Space group P21/c P21/c P‐1 P21/n 
a  (Å) 12.8656(2) 14.7162(3) 11.8816(3) 28.011(2) 
b  (Å) 16.7917(3) 18.7579(2) 13.1625(5) 11.2189(3) 
c  (Å) 7.7312(1) 15.0007(3) 13.5986(4) 31.849(2) 
  (°) 90 90 95.004(3) 90 
  (°) 98.943(2) 107.590(2) 96.348(2) 91.559(4) 
   (°) 90 90 107.386(3) 90 
Volume (Å3) 1649.91(5) 3947.3(2) 2000.8(2) 10005.1(7) 
Z  4 4 2 4 
Density (calculated) (Mg/m3) 1.636 1.867 1.696 1.441 
Absorption coefficient (mm‐1) 2.184 5.547 4.848 1.646 
F(000) 824 2208 1028 4472 
Crystal size (mm) 0.313 × 0.079 × 0.045 0.207 × 0.096 × 0.067 0.316 × 0.224 × 0.127 0.787 × 0.044 × 0.03 
Radiation CuKα (λ = 1.54184) CuKα (λ = 1.54184) CuKα (λ = 1.54184) CuKα (λ = 1.54184) 
2ϴ range for data collection (°) 6.96 to 148.65 6.30 to 148.76 6.59 to 154.26 5.55 to 153.55 
Reflections collected  16332 36450 16979 52714 
Independent reflections [R(int)] 3329 [Rint = 0.0267] 7906 [Rint = 0.0552] 8150 [Rint = 0.0523] 20621 [Rint = 0.1147] 
Data / restraints / parameters  3329/30/311 7906/0/596 8150/0/570 20621/13/1356 
Goodness‐of‐fit on F2 1.041 0.983 1.096 0.996 
Final R indexes R1 [I>2σ (I)] R1 = 0.0425, wR2 = 0.1050 R1 = 0.0387, wR2 = 0.0961 R1 = 0.0507, wR2 = 0.1382 R1 = 0.0715, wR2 = 0.1632 
Final R indexes (all data) wR2 R1 = 0.0464, wR2 = 0.1081 R1 = 0.0472, wR2 = 0.0995 R1 = 0.0555, wR2 = 0.1456 R1 = 0.1440, wR2 = 0.2136 




Table A0.7: Crystallographic data for compounds 5.8.HPF6, [Ru(phen)2(Pd{5.9 - H}{allyl}Cl)][PF6]2, [Ru(phen)2(Pd{5.10 - H}Cl)][PF6]2 and 
[Ru(phen)2(Pd{5.12 - H}Cl)][PF6]2. 
Thesis code 5.8.HPF6 [Ru(phen)2(Pd{5.9 - H} 
{allyl})][PF6]2 
[Ru(phen)2(Pd{5.10 - H}Cl)] 
[PF6]2 
[Ru(phen)2(Pd{5.12 - H}Cl)] 
[PF6]2 
Collection identification code 5wrk9a WK5‐41‐3 5wrk25 5wrk34a 
Empirical formula C23H20F6N5O2P C59.5H50.5F12N9O4P2PdRu C52H32.5ClF12N13OP2PdRu C50H35.5ClF12N13OP2PdRu 
Formula weight  543.41 1452.32 1388.27 1383.22 
Temperature (K) 120.0(1) 293(2) 284.9(1) 120.0(1) 
Crystal system  orthorhombic monoclinic triclinic monoclinic 
Space group Pbca P2/c P‐1 I2/a 
a  (Å) 9.9233(7) 17.438(4) 15.7816(5) 27.235(1) 
b  (Å) 12.9691(8) 16.695(3) 18.0559(3) 18.5139(5) 
c  (Å) 35.856(3) 21.723(4) 21.6397(4) 23.746(1) 
  (°) 90 90 90.724(2) 90 
  (°) 90 91.90(3) 107.681(2) 97.203(4) 
   (°) 90 90 94.721(2) 90 
Volume (Å3) 4614.5(6) 6321(2) 5850.5(2) 11879.2(7) 
Z  8 4 4 8 
Density (calculated) (Mg/m3) 1.564 1.526 1.576 1.547 
Absorption coefficient (mm‐1) 1.807 0.662 6.285 6.811 
F(000) 2224 2921 2754 5480 
Crystal size (mm) 0.211 × 0.091 × 0.066 0.15 × 0.1 × 0.01 0.439 × 0.346 × 0.054 0.213 × 0.075 × 0.043 
Radiation CuKα (λ = 1.54184) MoKα (λ = 0.71073) CuKα (λ = 1.54184) CuKα (λ = 1.54184) 
2ϴ range for data collection (°) 10.19 to 153.18 2.34 to 51.49 6.65 to 150.00 5.786 to 134.998 
Reflections collected  12310 82287 106656 32959 
Independent reflections [R(int)] 4577 [Rint = 0.0837] 11772 [Rint = 0.1401] 24063 [Rint = 0.1835] 10690 [Rint = 0.0663] 
Data / restraints / parameters  4577/0/337 11772/72/826 24063/10/1531 10690/0/752 
Goodness‐of‐fit on F2 1.003 1.038 1.039 0.979 
Final R indexes R1 [I>2σ (I)] R1 = 0.0632, wR2 = 0.1417 R1 = 0.0791, wR2 = 0.1908 R1 = 0.1260, wR2 = 0.3084 R1 = 0.0743, wR2 = 0.1980 
Final R indexes (all data) wR2 R1 = 0.1237, wR2 = 0.1821 R1 = 0.1203, wR2 = 0.2185 R1 = 0.1523, wR2 = 0.3309 R1 = 0.1085, wR2 = 0.2325 
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